primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
130111945,13011194,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Albumin urine present,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
130111945,13011194,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Hypertension,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
130111945,13011194,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Left ventricular hypertrophy,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
130111945,13011194,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Red blood cell count increased,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
130111945,13011194,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Urine ketone body present,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
130111945,13011194,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Albumin urine present,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
130111945,13011194,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Hypertension,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
130111945,13011194,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Left ventricular hypertrophy,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
130111945,13011194,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Red blood cell count increased,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
130111945,13011194,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Urine ketone body present,,2020,Q1,5,F,20160810.0,20200312.0,20161208,20200316,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-NB-001158",BOEHRINGER INGELHEIM,,38.0,YR,,F,Y,85.1,KG,20200316.0,,MD,JP,JP,2020,Q1,Adult
145448823,14544882,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2020,Q1,Dizziness,,2020,Q1,3,F,20170605.0,20200313.0,20180217,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-000688",BOEHRINGER INGELHEIM,,34.0,YR,,F,Y,137.2,KG,20200320.0,,MD,JP,JP,2020,Q1,Young Adult
145448823,14544882,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2020,Q1,Dyslipidaemia,,2020,Q1,3,F,20170605.0,20200313.0,20180217,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-000688",BOEHRINGER INGELHEIM,,34.0,YR,,F,Y,137.2,KG,20200320.0,,MD,JP,JP,2020,Q1,Young Adult
145448823,14544882,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2020,Q1,Musculoskeletal stiffness,,2020,Q1,3,F,20170605.0,20200313.0,20180217,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-000688",BOEHRINGER INGELHEIM,,34.0,YR,,F,Y,137.2,KG,20200320.0,,MD,JP,JP,2020,Q1,Young Adult
145448823,14544882,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2020,Q1,Urine ketone body present,,2020,Q1,3,F,20170605.0,20200313.0,20180217,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-000688",BOEHRINGER INGELHEIM,,34.0,YR,,F,Y,137.2,KG,20200320.0,,MD,JP,JP,2020,Q1,Young Adult
145448823,14544882,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,TABLET,,2020,Q1,Dizziness,,2020,Q1,3,F,20170605.0,20200313.0,20180217,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-000688",BOEHRINGER INGELHEIM,,34.0,YR,,F,Y,137.2,KG,20200320.0,,MD,JP,JP,2020,Q1,Young Adult
145448823,14544882,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,TABLET,,2020,Q1,Dyslipidaemia,,2020,Q1,3,F,20170605.0,20200313.0,20180217,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-000688",BOEHRINGER INGELHEIM,,34.0,YR,,F,Y,137.2,KG,20200320.0,,MD,JP,JP,2020,Q1,Young Adult
145448823,14544882,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,TABLET,,2020,Q1,Musculoskeletal stiffness,,2020,Q1,3,F,20170605.0,20200313.0,20180217,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-000688",BOEHRINGER INGELHEIM,,34.0,YR,,F,Y,137.2,KG,20200320.0,,MD,JP,JP,2020,Q1,Young Adult
145448823,14544882,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,TABLET,,2020,Q1,Urine ketone body present,,2020,Q1,3,F,20170605.0,20200313.0,20180217,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-000688",BOEHRINGER INGELHEIM,,34.0,YR,,F,Y,137.2,KG,20200320.0,,MD,JP,JP,2020,Q1,Young Adult
1459376326,14593763,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,,,TABLET,QD,2020,Q1,Acute kidney injury,,2020,Q1,26,F,20170822.0,20200109.0,20180302,20200113,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-001564",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,102.0,KG,20200113.0,,MD,US,US,2020,Q1,Elderly
1459376326,14593763,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,,,TABLET,QD,2020,Q1,Ascites,,2020,Q1,26,F,20170822.0,20200109.0,20180302,20200113,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-001564",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,102.0,KG,20200113.0,,MD,US,US,2020,Q1,Elderly
1459376326,14593763,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,,,TABLET,QD,2020,Q1,Cardiac failure,,2020,Q1,26,F,20170822.0,20200109.0,20180302,20200113,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-001564",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,102.0,KG,20200113.0,,MD,US,US,2020,Q1,Elderly
1459376326,14593763,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,,,TABLET,QD,2020,Q1,Fall,,2020,Q1,26,F,20170822.0,20200109.0,20180302,20200113,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-001564",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,102.0,KG,20200113.0,,MD,US,US,2020,Q1,Elderly
1459376326,14593763,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,,,TABLET,QD,2020,Q1,Metabolic acidosis,,2020,Q1,26,F,20170822.0,20200109.0,20180302,20200113,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-001564",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,102.0,KG,20200113.0,,MD,US,US,2020,Q1,Elderly
1459376326,14593763,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,,,TABLET,QD,2020,Q1,Seizure,,2020,Q1,26,F,20170822.0,20200109.0,20180302,20200113,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-001564",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,102.0,KG,20200113.0,,MD,US,US,2020,Q1,Elderly
1459376326,14593763,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,,,TABLET,QD,2020,Q1,Subdural haematoma,,2020,Q1,26,F,20170822.0,20200109.0,20180302,20200113,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-001564",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,102.0,KG,20200113.0,,MD,US,US,2020,Q1,Elderly
146428473,14642847,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Iron deficiency anaemia,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
146428473,14642847,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Lipids abnormal,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
146428473,14642847,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Nasopharyngitis,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
146428473,14642847,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Urine ketone body present,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
146428473,14642847,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Uterine leiomyoma,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
146428473,14642847,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Iron deficiency anaemia,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
146428473,14642847,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Lipids abnormal,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
146428473,14642847,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Nasopharyngitis,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
146428473,14642847,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Urine ketone body present,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
146428473,14642847,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Uterine leiomyoma,,2020,Q1,3,F,20170316.0,20200313.0,20180315,20200319,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001244",BOEHRINGER INGELHEIM,,43.0,YR,,F,Y,74.9,KG,20200319.0,,MD,JP,JP,2020,Q1,Adult
156762352,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,2,F,20180430.0,20200106.0,20181130,20200117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.3,KG,20200117.0,,HP,US,US,2020,Q1,Elderly
156762352,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,20180430.0,20200106.0,20181130,20200117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.3,KG,20200117.0,,HP,US,US,2020,Q1,Elderly
156762352,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q1,Hypovolaemia,,2020,Q1,2,F,20180430.0,20200106.0,20181130,20200117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.3,KG,20200117.0,,HP,US,US,2020,Q1,Elderly
156762352,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q1,Peripheral ischaemia,,2020,Q1,2,F,20180430.0,20200106.0,20181130,20200117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.3,KG,20200117.0,,HP,US,US,2020,Q1,Elderly
156762352,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q1,Polyuria,,2020,Q1,2,F,20180430.0,20200106.0,20181130,20200117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.3,KG,20200117.0,,HP,US,US,2020,Q1,Elderly
156762352,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q1,Splenic infarction,,2020,Q1,2,F,20180430.0,20200106.0,20181130,20200117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.3,KG,20200117.0,,HP,US,US,2020,Q1,Elderly
156762352,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q1,Temporal arteritis,,2020,Q1,2,F,20180430.0,20200106.0,20181130,20200117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.3,KG,20200117.0,,HP,US,US,2020,Q1,Elderly
156855748,15685574,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,8,F,20181018.0,20200110.0,20181204,20200114,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-051737",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,126.0,KG,20200114.0,,MD,AU,AU,2020,Q1,Elderly
156855748,15685574,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Hyperkalaemia,,2020,Q1,8,F,20181018.0,20200110.0,20181204,20200114,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-051737",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,126.0,KG,20200114.0,,MD,AU,AU,2020,Q1,Elderly
156855748,15685574,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Hypotension,,2020,Q1,8,F,20181018.0,20200110.0,20181204,20200114,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-051737",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,126.0,KG,20200114.0,,MD,AU,AU,2020,Q1,Elderly
156855748,15685574,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Renal impairment,,2020,Q1,8,F,20181018.0,20200110.0,20181204,20200114,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-051737",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,126.0,KG,20200114.0,,MD,AU,AU,2020,Q1,Elderly
157557355,15755735,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Blood urine present,,2020,Q1,5,F,20161001.0,20200225.0,20181224,20200228,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-004809",BOEHRINGER INGELHEIM,,44.0,YR,,F,Y,67.5,KG,20200228.0,,MD,JP,JP,2020,Q1,Adult
157557355,15755735,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Multiple sclerosis,,2020,Q1,5,F,20161001.0,20200225.0,20181224,20200228,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-004809",BOEHRINGER INGELHEIM,,44.0,YR,,F,Y,67.5,KG,20200228.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Alanine aminotransferase increased,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Aspartate aminotransferase increased,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Seasonal allergy,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Urine ketone body present,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Alanine aminotransferase increased,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Aspartate aminotransferase increased,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Seasonal allergy,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
157608382,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Urine ketone body present,,2020,Q1,2,F,20160531.0,20200312.0,20181226,20200318,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
159851664,15985166,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Malignant melanoma,,2020,Q1,4,F,20120322.0,20200102.0,20190220,20200103,EXP,,US-PFIZER INC-2019077961,PFIZER,,62.0,YR,,,Y,,,20200103.0,,LW,US,US,2020,Q1,Adult
159900232,15990023,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,200.417,MG,U,,,,,10.0,MG,TABLET,,2020,Q1,Cardiac failure,,2020,Q1,2,F,20181019.0,20200117.0,20190221,20200123,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-TORRENT-00020359,TORRENT,,68.0,YR,E,F,Y,82.0,KG,20200123.0,,MD,GB,GB,2020,Q1,Elderly
159900232,15990023,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,200.417,MG,U,,,,,10.0,MG,TABLET,,2020,Q1,Dyspnoea,,2020,Q1,2,F,20181019.0,20200117.0,20190221,20200123,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-TORRENT-00020359,TORRENT,,68.0,YR,E,F,Y,82.0,KG,20200123.0,,MD,GB,GB,2020,Q1,Elderly
159900232,15990023,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,200.417,MG,U,,,,,10.0,MG,TABLET,,2020,Q1,Fluid retention,,2020,Q1,2,F,20181019.0,20200117.0,20190221,20200123,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-TORRENT-00020359,TORRENT,,68.0,YR,E,F,Y,82.0,KG,20200123.0,,MD,GB,GB,2020,Q1,Elderly
159900232,15990023,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,200.417,MG,U,,,,,10.0,MG,TABLET,,2020,Q1,Pericardial effusion,,2020,Q1,2,F,20181019.0,20200117.0,20190221,20200123,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-TORRENT-00020359,TORRENT,,68.0,YR,E,F,Y,82.0,KG,20200123.0,,MD,GB,GB,2020,Q1,Elderly
160194022,16019402,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;,200.41667,MG,,, UNKNOWN,,,10.0,MG,TABLET,,2020,Q1,Cardiac failure,,2020,Q1,2,F,20181019.0,20200122.0,20190228,20200129,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-TEVA-2019-GB-1017485,TEVA,,68.0,YR,,F,Y,82.0,KG,20200129.0,,MD,GB,GB,2020,Q1,Elderly
160194022,16019402,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;,200.41667,MG,,, UNKNOWN,,,10.0,MG,TABLET,,2020,Q1,Dyspnoea,,2020,Q1,2,F,20181019.0,20200122.0,20190228,20200129,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-TEVA-2019-GB-1017485,TEVA,,68.0,YR,,F,Y,82.0,KG,20200129.0,,MD,GB,GB,2020,Q1,Elderly
160194022,16019402,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;,200.41667,MG,,, UNKNOWN,,,10.0,MG,TABLET,,2020,Q1,Fluid retention,,2020,Q1,2,F,20181019.0,20200122.0,20190228,20200129,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-TEVA-2019-GB-1017485,TEVA,,68.0,YR,,F,Y,82.0,KG,20200129.0,,MD,GB,GB,2020,Q1,Elderly
160194022,16019402,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;,200.41667,MG,,, UNKNOWN,,,10.0,MG,TABLET,,2020,Q1,Pericardial effusion,,2020,Q1,2,F,20181019.0,20200122.0,20190228,20200129,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-TEVA-2019-GB-1017485,TEVA,,68.0,YR,,F,Y,82.0,KG,20200129.0,,MD,GB,GB,2020,Q1,Elderly
160438122,16043812,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Cardiac arrest,,2020,Q1,2,F,20190204.0,20200301.0,20190306,20200306,EXP,GB-MHRA-EYC 00194595,GB-TEVA-2019-GB-1018337,TEVA,,83.0,YR,,F,Y,,,20200306.0,,PH,GB,GB,2020,Q1,Elderly
160438122,16043812,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Malaise,,2020,Q1,2,F,20190204.0,20200301.0,20190306,20200306,EXP,GB-MHRA-EYC 00194595,GB-TEVA-2019-GB-1018337,TEVA,,83.0,YR,,F,Y,,,20200306.0,,PH,GB,GB,2020,Q1,Elderly
160438122,16043812,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Sinus node dysfunction,,2020,Q1,2,F,20190204.0,20200301.0,20190306,20200306,EXP,GB-MHRA-EYC 00194595,GB-TEVA-2019-GB-1018337,TEVA,,83.0,YR,,F,Y,,,20200306.0,,PH,GB,GB,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Heart rate irregular,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Syncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Arrhythmia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Atrial fibrillation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Bradycardia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Dehydration,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Dizziness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Drug interaction,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Haematocrit increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Haemoglobin increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Heart rate irregular,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Hypotension,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Hypovolaemia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Left atrial dilatation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Mucosal dryness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Presyncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Skin disorder,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Syncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
1615119811,16151198,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q1,Urosepsis,,2020,Q1,11,F,20190317.0,20200326.0,20190403,20200330,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-013915",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,91.0,KG,20200330.0,,MD,DE,DE,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Arrhythmia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Atrial fibrillation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Bradycardia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Dehydration,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Dizziness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Drug interaction,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Haematocrit increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Haemoglobin increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Hypotension,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Hypovolaemia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Left atrial dilatation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Mucosal dryness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Oedema peripheral,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Presyncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Pulmonary congestion,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Renal disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Skin disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,8,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2020,Q1,Syncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
161659752,16165975,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,200.41667,MG,,,,,,10.0,MG,TABLET,,2020,Q1,Cardiac failure,,2020,Q1,2,F,20181019.0,20200116.0,20190406,20200123,EXP,GB-MHRA-ADR 24378545,GB-ACCORD-118471,ACCORD,,68.0,YR,,F,Y,82.0,KG,20200123.0,,MD,GB,GB,2020,Q1,Elderly
161659752,16165975,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,200.41667,MG,,,,,,10.0,MG,TABLET,,2020,Q1,Dyspnoea,,2020,Q1,2,F,20181019.0,20200116.0,20190406,20200123,EXP,GB-MHRA-ADR 24378545,GB-ACCORD-118471,ACCORD,,68.0,YR,,F,Y,82.0,KG,20200123.0,,MD,GB,GB,2020,Q1,Elderly
161659752,16165975,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,200.41667,MG,,,,,,10.0,MG,TABLET,,2020,Q1,Fluid retention,,2020,Q1,2,F,20181019.0,20200116.0,20190406,20200123,EXP,GB-MHRA-ADR 24378545,GB-ACCORD-118471,ACCORD,,68.0,YR,,F,Y,82.0,KG,20200123.0,,MD,GB,GB,2020,Q1,Elderly
161659752,16165975,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,200.41667,MG,,,,,,10.0,MG,TABLET,,2020,Q1,Pericardial effusion,,2020,Q1,2,F,20181019.0,20200116.0,20190406,20200123,EXP,GB-MHRA-ADR 24378545,GB-ACCORD-118471,ACCORD,,68.0,YR,,F,Y,82.0,KG,20200123.0,,MD,GB,GB,2020,Q1,Elderly
162050946,16205094,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,6,F,20180717.0,20200122.0,20190416,20200127,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-038274",BOEHRINGER INGELHEIM,,83.0,YR,,F,Y,,,20200127.0,,MD,AU,AU,2020,Q1,Elderly
162050946,16205094,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Fall,,2020,Q1,6,F,20180717.0,20200122.0,20190416,20200127,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-038274",BOEHRINGER INGELHEIM,,83.0,YR,,F,Y,,,20200127.0,,MD,AU,AU,2020,Q1,Elderly
162050946,16205094,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Urinary tract infection,,2020,Q1,6,F,20180717.0,20200122.0,20190416,20200127,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-038274",BOEHRINGER INGELHEIM,,83.0,YR,,F,Y,,,20200127.0,,MD,AU,AU,2020,Q1,Elderly
166257812,16625781,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",200.417,MG,,,,,,10.0,MG,TABLET,QD,2020,Q1,Cardiac failure,,2020,Q1,2,F,20181019.0,20200225.0,20190724,20200302,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-MYLANLABS-2019M1068190,MYLAN,,68.0,YR,,F,Y,82.0,KG,20200302.0,,MD,GB,GB,2020,Q1,Elderly
166257812,16625781,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",200.417,MG,,,,,,10.0,MG,TABLET,QD,2020,Q1,Dyspnoea,,2020,Q1,2,F,20181019.0,20200225.0,20190724,20200302,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-MYLANLABS-2019M1068190,MYLAN,,68.0,YR,,F,Y,82.0,KG,20200302.0,,MD,GB,GB,2020,Q1,Elderly
166257812,16625781,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",200.417,MG,,,,,,10.0,MG,TABLET,QD,2020,Q1,Fluid retention,,2020,Q1,2,F,20181019.0,20200225.0,20190724,20200302,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-MYLANLABS-2019M1068190,MYLAN,,68.0,YR,,F,Y,82.0,KG,20200302.0,,MD,GB,GB,2020,Q1,Elderly
166257812,16625781,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",200.417,MG,,,,,,10.0,MG,TABLET,QD,2020,Q1,Pericardial effusion,,2020,Q1,2,F,20181019.0,20200225.0,20190724,20200302,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,GB-MYLANLABS-2019M1068190,MYLAN,,68.0,YR,,F,Y,82.0,KG,20200302.0,,MD,GB,GB,2020,Q1,Elderly
166310782,16631078,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Cardiac arrest,,2020,Q1,2,F,20190204.0,20200316.0,20190725,20200323,EXP,GB-MHRA-EYC 00194595,GB-MYLANLABS-2019M1068870,MYLAN,,83.0,YR,,F,Y,,,20200323.0,,PH,GB,GB,2020,Q1,Elderly
166310782,16631078,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Malaise,,2020,Q1,2,F,20190204.0,20200316.0,20190725,20200323,EXP,GB-MHRA-EYC 00194595,GB-MYLANLABS-2019M1068870,MYLAN,,83.0,YR,,F,Y,,,20200323.0,,PH,GB,GB,2020,Q1,Elderly
166310782,16631078,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Sinus node dysfunction,,2020,Q1,2,F,20190204.0,20200316.0,20190725,20200323,EXP,GB-MHRA-EYC 00194595,GB-MYLANLABS-2019M1068870,MYLAN,,83.0,YR,,F,Y,,,20200323.0,,PH,GB,GB,2020,Q1,Elderly
167020817,16702081,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Haemorrhage,,2020,Q1,7,F,,20200123.0,20190814,20200131,EXP,,JP-PFIZER INC-2019348002,PFIZER,"YAMAMOTO, S.. SEVERE BLEEDING DUE TO CYTOMEGALOVIRUS ESOPHAGITIS IN A PATIENT WITH DIABETES AFTER INTERBODY FUSION SURGERY. INTERNAL MEDICINE. 2019;58 (20):2949-2955",49.0,YR,,M,Y,,,20200131.0,,MD,JP,JP,2020,Q1,Adult
167020817,16702081,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Mucosal disorder,,2020,Q1,7,F,,20200123.0,20190814,20200131,EXP,,JP-PFIZER INC-2019348002,PFIZER,"YAMAMOTO, S.. SEVERE BLEEDING DUE TO CYTOMEGALOVIRUS ESOPHAGITIS IN A PATIENT WITH DIABETES AFTER INTERBODY FUSION SURGERY. INTERNAL MEDICINE. 2019;58 (20):2949-2955",49.0,YR,,M,Y,,,20200131.0,,MD,JP,JP,2020,Q1,Adult
167020817,16702081,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Oesophageal haemorrhage,,2020,Q1,7,F,,20200123.0,20190814,20200131,EXP,,JP-PFIZER INC-2019348002,PFIZER,"YAMAMOTO, S.. SEVERE BLEEDING DUE TO CYTOMEGALOVIRUS ESOPHAGITIS IN A PATIENT WITH DIABETES AFTER INTERBODY FUSION SURGERY. INTERNAL MEDICINE. 2019;58 (20):2949-2955",49.0,YR,,M,Y,,,20200131.0,,MD,JP,JP,2020,Q1,Adult
167020817,16702081,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Oesophageal ulcer,,2020,Q1,7,F,,20200123.0,20190814,20200131,EXP,,JP-PFIZER INC-2019348002,PFIZER,"YAMAMOTO, S.. SEVERE BLEEDING DUE TO CYTOMEGALOVIRUS ESOPHAGITIS IN A PATIENT WITH DIABETES AFTER INTERBODY FUSION SURGERY. INTERNAL MEDICINE. 2019;58 (20):2949-2955",49.0,YR,,M,Y,,,20200131.0,,MD,JP,JP,2020,Q1,Adult
167020817,16702081,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Oesophagitis,,2020,Q1,7,F,,20200123.0,20190814,20200131,EXP,,JP-PFIZER INC-2019348002,PFIZER,"YAMAMOTO, S.. SEVERE BLEEDING DUE TO CYTOMEGALOVIRUS ESOPHAGITIS IN A PATIENT WITH DIABETES AFTER INTERBODY FUSION SURGERY. INTERNAL MEDICINE. 2019;58 (20):2949-2955",49.0,YR,,M,Y,,,20200131.0,,MD,JP,JP,2020,Q1,Adult
167100288,16710028,8,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,TABLETS,,2020,Q1,Intestinal haemorrhage,,2020,Q1,8,F,20190805.0,20200303.0,20190816,20200305,EXP,,JP-CELGENEUS-JPN-20190804062,CELGENE,,76.0,YR,,M,Y,64.4,KG,20200305.0,,MD,JP,JP,2020,Q1,Elderly
167384523,16738452,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Blood glucose increased,,2020,Q1,3,F,20160507.0,20200116.0,20190826,20200123,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004279",BOEHRINGER INGELHEIM,,67.0,YR,,F,Y,79.3,KG,20200123.0,,MD,JP,JP,2020,Q1,Elderly
167384523,16738452,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Blood pressure increased,,2020,Q1,3,F,20160507.0,20200116.0,20190826,20200123,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004279",BOEHRINGER INGELHEIM,,67.0,YR,,F,Y,79.3,KG,20200123.0,,MD,JP,JP,2020,Q1,Elderly
167384523,16738452,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Diabetic ketosis,,2020,Q1,3,F,20160507.0,20200116.0,20190826,20200123,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004279",BOEHRINGER INGELHEIM,,67.0,YR,,F,Y,79.3,KG,20200123.0,,MD,JP,JP,2020,Q1,Elderly
167384523,16738452,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Pruritus,,2020,Q1,3,F,20160507.0,20200116.0,20190826,20200123,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004279",BOEHRINGER INGELHEIM,,67.0,YR,,F,Y,79.3,KG,20200123.0,,MD,JP,JP,2020,Q1,Elderly
167384523,16738452,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Blood glucose increased,,2020,Q1,3,F,20160507.0,20200116.0,20190826,20200123,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004279",BOEHRINGER INGELHEIM,,67.0,YR,,F,Y,79.3,KG,20200123.0,,MD,JP,JP,2020,Q1,Elderly
167384523,16738452,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Blood pressure increased,,2020,Q1,3,F,20160507.0,20200116.0,20190826,20200123,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004279",BOEHRINGER INGELHEIM,,67.0,YR,,F,Y,79.3,KG,20200123.0,,MD,JP,JP,2020,Q1,Elderly
167384523,16738452,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Diabetic ketosis,,2020,Q1,3,F,20160507.0,20200116.0,20190826,20200123,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004279",BOEHRINGER INGELHEIM,,67.0,YR,,F,Y,79.3,KG,20200123.0,,MD,JP,JP,2020,Q1,Elderly
167384523,16738452,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Pruritus,,2020,Q1,3,F,20160507.0,20200116.0,20190826,20200123,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004279",BOEHRINGER INGELHEIM,,67.0,YR,,F,Y,79.3,KG,20200123.0,,MD,JP,JP,2020,Q1,Elderly
167777813,16777781,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Atrioventricular block complete,,2020,Q1,3,F,20190812.0,20200227.0,20190905,20200311,EXP,GB-MHRA-EYC 00206271,GB-ELI_LILLY_AND_COMPANY-GB201908013655,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20200311.0,,PH,GB,GB,2020,Q1,Elderly
167777813,16777781,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Cardiac arrest,,2020,Q1,3,F,20190812.0,20200227.0,20190905,20200311,EXP,GB-MHRA-EYC 00206271,GB-ELI_LILLY_AND_COMPANY-GB201908013655,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20200311.0,,PH,GB,GB,2020,Q1,Elderly
167791142,16779114,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2020,Q1,Acute myocardial infarction,,2020,Q1,2,F,,20200110.0,20190906,20200117,EXP,,JP-009507513-1909JPN000117J,MERCK,,50.0,YR,,M,Y,,,20200117.0,,MD,JP,JP,2020,Q1,Adult
167878593,16787859,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Breast cancer female,,2020,Q1,3,F,201612.0,20200206.0,20190909,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002303",BOEHRINGER INGELHEIM,,49.0,YR,,F,Y,73.2,KG,20200213.0,,MD,JP,JP,2020,Q1,Adult
167878593,16787859,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Hypertension,,2020,Q1,3,F,201612.0,20200206.0,20190909,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002303",BOEHRINGER INGELHEIM,,49.0,YR,,F,Y,73.2,KG,20200213.0,,MD,JP,JP,2020,Q1,Adult
167925977,16792597,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Nocardiosis,,2020,Q1,7,F,20190902.0,20200310.0,20190910,20200312,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-101221",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,96.0,KG,20200312.0,,MD,DE,DE,2020,Q1,Elderly
168194975,16819497,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Acute kidney injury,Acute kidney injury,2020,Q1,5,F,20181024.0,20200219.0,20190917,20200224,EXP,,"SG-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-052665",BOEHRINGER INGELHEIM,,58.0,YR,,F,Y,70.0,KG,20200224.0,,MD,SG,SG,2020,Q1,Adult
1684464112,16844641,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,TABLETS,,2020,Q1,Diarrhoea,,2020,Q1,12,F,20190912.0,20200122.0,20190924,20200127,PER,,DE-EISAI MEDICAL RESEARCH-EC-2019-062532,EISAI,,63.0,YR,,F,Y,84.5,KG,20200127.0,,MD,DE,DE,2020,Q1,Adult
1684464112,16844641,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,TABLETS,,2020,Q1,Hypertension,,2020,Q1,12,F,20190912.0,20200122.0,20190924,20200127,PER,,DE-EISAI MEDICAL RESEARCH-EC-2019-062532,EISAI,,63.0,YR,,F,Y,84.5,KG,20200127.0,,MD,DE,DE,2020,Q1,Adult
168671262,16867126,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Papillary thyroid cancer,,2020,Q1,2,F,,20190917.0,20190930,20200220,EXP,,AR-NOVOPROD-686074,NOVO NORDISK,,60.0,YR,,M,Y,,,20200220.0,,MD,AR,AR,2020,Q1,Adult
168773938,16877393,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Ascites,,2020,Q1,8,F,20190301.0,20200115.0,20191002,20200117,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-104458",BOEHRINGER INGELHEIM,,77.0,YR,,M,Y,62.4,KG,20200117.0,,MD,AR,AR,2020,Q1,Elderly
168773938,16877393,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Liver disorder,,2020,Q1,8,F,20190301.0,20200115.0,20191002,20200117,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-104458",BOEHRINGER INGELHEIM,,77.0,YR,,M,Y,62.4,KG,20200117.0,,MD,AR,AR,2020,Q1,Elderly
168825512,16882551,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Angina pectoris,,2020,Q1,2,F,20181104.0,20200129.0,20191003,20200204,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-104902",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,106.7,KG,20200204.0,,MD,JP,JP,2020,Q1,Adult
168970153,16897015,33,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q1,Thyroid cancer,,2020,Q1,3,F,20190924.0,20200228.0,20191009,20200304,EXP,,IT-ROCHE-2429873,ROCHE,,66.0,YR,,M,Y,,,20200305.0,,MD,IT,IT,2020,Q1,Elderly
169146962,16914696,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,2050.0,MG,Y,,,,,25.0,MG,,QD,2020,Q1,Dehydration,,2020,Q1,2,F,20190831.0,20200109.0,20191014,20200113,EXP,GB-MHRA-EYC 00207470,GB-EMD SERONO-E2B_90071423,EMD SERONO INC,,64.0,YR,,M,Y,,,20200113.0,,HP,GB,GB,2020,Q1,Adult
169146962,16914696,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,2050.0,MG,Y,,,,,25.0,MG,,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,2,F,20190831.0,20200109.0,20191014,20200113,EXP,GB-MHRA-EYC 00207470,GB-EMD SERONO-E2B_90071423,EMD SERONO INC,,64.0,YR,,M,Y,,,20200113.0,,HP,GB,GB,2020,Q1,Adult
169146962,16914696,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,2050.0,MG,Y,,,,,25.0,MG,,QD,2020,Q1,Lactic acidosis,,2020,Q1,2,F,20190831.0,20200109.0,20191014,20200113,EXP,GB-MHRA-EYC 00207470,GB-EMD SERONO-E2B_90071423,EMD SERONO INC,,64.0,YR,,M,Y,,,20200113.0,,HP,GB,GB,2020,Q1,Adult
169238542,16923854,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",2050.0,MG,Y,, UNKNOWN,,,25.0,MG,,,2020,Q1,Dehydration,,2020,Q1,2,F,20190831.0,20200106.0,20191016,20200120,EXP,GB-MHRA-ADR 24433630,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-0929,EMCURE,,64.0,YR,,M,Y,,,20200120.0,,HP,GB,GB,2020,Q1,Adult
169238542,16923854,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",2050.0,MG,Y,, UNKNOWN,,,25.0,MG,,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,2,F,20190831.0,20200106.0,20191016,20200120,EXP,GB-MHRA-ADR 24433630,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-0929,EMCURE,,64.0,YR,,M,Y,,,20200120.0,,HP,GB,GB,2020,Q1,Adult
169238542,16923854,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",2050.0,MG,Y,, UNKNOWN,,,25.0,MG,,,2020,Q1,Lactic acidosis,,2020,Q1,2,F,20190831.0,20200106.0,20191016,20200120,EXP,GB-MHRA-ADR 24433630,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-0929,EMCURE,,64.0,YR,,M,Y,,,20200120.0,,HP,GB,GB,2020,Q1,Adult
169428292,16942829,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Lung neoplasm,,2020,Q1,2,F,201902.0,20200327.0,20191021,20200330,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-012145",BOEHRINGER INGELHEIM,,86.0,YR,,M,Y,80.0,KG,20200330.0,,MD,IT,IT,2020,Q1,Elderly
169576843,16957684,4,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,"12.5-1000,MG,DAILY",,,,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,3,F,20191016.0,20200109.0,20191024,20200113,EXP,,US-GILEAD-2019-0433605,GILEAD,,66.0,YR,E,M,Y,84.8,KG,20200113.0,,MD,US,US,2020,Q1,Elderly
169647922,16964792,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,15.0,DF,,, UNKNOWN,,,1.0,DF,,,2020,Q1,Swelling face,,2020,Q1,2,F,20191001.0,20200211.0,20191028,20200214,EXP,GB-MHRA-TPP51533152C6120645YC1569943139320,GB-TEVA-2019-GB-1127711,TEVA,,67.0,YR,,F,Y,89.0,KG,20200214.0,,MD,GB,GB,2020,Q1,Elderly
169990182,16999018,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2020,Q1,Abdominal pain,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
169990182,16999018,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2020,Q1,Appendicitis,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
169990182,16999018,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
169990182,16999018,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2020,Q1,Peritoneal abscess,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
169990182,16999018,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2020,Q1,Pyrexia,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
170016552,17001655,16,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Waldenstrom's macroglobulinaemia,,2020,Q1,2,F,20180605.0,20200106.0,20191106,20200114,EXP,,GB-NOVOPROD-693831,NOVO NORDISK,,68.0,YR,,M,Y,116.3,KG,20200114.0,,MD,GB,GB,2020,Q1,Elderly
170184242,17018424,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, UNK",,,,,,,,10.0,MG,,,2020,Q1,Pancreatitis acute,,2020,Q1,2,F,20180529.0,20200214.0,20191111,20200221,EXP,,PHHO2018PT007933,NOVARTIS,,46.0,YR,,F,Y,,,20200221.0,,MD,PT,PT,2020,Q1,Adult
170185015,17018501,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Osteonecrosis of jaw,,2020,Q1,5,F,20190914.0,20200305.0,20191111,20200310,EXP,,PHHO2019ES009322,NOVARTIS,,66.0,YR,,F,Y,78.0,KG,20200310.0,,MD,ES,ES,2020,Q1,Elderly
170475986,17047598,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Cardiac failure,,2020,Q1,6,F,20191112.0,20200122.0,20191119,20200124,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-114461",BOEHRINGER INGELHEIM,,82.0,YR,,F,Y,52.2,KG,20200124.0,,MD,BR,BR,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Brain contusion,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Bronchitis,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Cardiac failure congestive,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Cerebral haemorrhage,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Dyspnoea exertional,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Ejection fraction decreased,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Generalised tonic-clonic seizure,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Influenza like illness,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Liver function test increased,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Malaise,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Myocardial infarction,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Productive cough,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170822364,17082236,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 UNK, UNK",,,,,,,,,,,,2020,Q1,Ventricular tachycardia,,2020,Q1,4,F,20191124.0,20200123.0,20191127,20200127,EXP,,CA-PFIZER INC-2019416587,PFIZER,,68.0,YR,,M,Y,100.4,KG,20200127.0,,HP,CA,CA,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Diabetes mellitus,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Drug hypersensitivity,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dyspepsia,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Muscle spasms,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Neutrophilia,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
171016822,17101682,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Renal failure,,2020,Q1,2,F,20191119.0,20200323.0,20191202,20200327,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-116380",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,101.0,KG,20200327.0,,MD,PL,PL,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Adverse drug reaction,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Benign abdominal neoplasm,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Decreased appetite,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Heart rate irregular,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Hypomagnesaemia,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Nausea,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Palpitations,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Supraventricular tachycardia,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171071973,17107197,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2020,Q1,Tremor,,2020,Q1,3,F,20191113.0,20200129.0,20191203,20200305,EXP,,US-GLAXOSMITHKLINE-US2019TSO206096,GLAXOSMITHKLINE,,76.0,YR,,F,Y,100.0,KG,20200305.0,,CN,US,US,2020,Q1,Elderly
171288186,17128818,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Duodenal neoplasm,,2020,Q1,6,F,20191129.0,20200222.0,20191209,20200227,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-117744",BOEHRINGER INGELHEIM,,80.0,YR,,M,Y,64.0,KG,20200227.0,,MD,BR,BR,2020,Q1,Elderly
171430322,17143032,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q1,Ventricular tachycardia,,2020,Q1,2,F,20190403.0,20200221.0,20191211,20200227,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-114923",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,64.0,KG,20200227.0,,MD,GB,GB,2020,Q1,Elderly
171627932,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Anhedonia,,2020,Q1,2,F,20161018.0,20200314.0,20191217,20200320,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200320.0,,LW,US,US,2020,Q1,Adult
171627932,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Anxiety,,2020,Q1,2,F,20161018.0,20200314.0,20191217,20200320,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200320.0,,LW,US,US,2020,Q1,Adult
171627932,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,2,F,20161018.0,20200314.0,20191217,20200320,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200320.0,,LW,US,US,2020,Q1,Adult
171627932,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Economic problem,,2020,Q1,2,F,20161018.0,20200314.0,20191217,20200320,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200320.0,,LW,US,US,2020,Q1,Adult
171627932,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Emotional distress,,2020,Q1,2,F,20161018.0,20200314.0,20191217,20200320,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200320.0,,LW,US,US,2020,Q1,Adult
171627932,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Glomerulonephritis membranous,,2020,Q1,2,F,20161018.0,20200314.0,20191217,20200320,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200320.0,,LW,US,US,2020,Q1,Adult
171627932,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Pain,,2020,Q1,2,F,20161018.0,20200314.0,20191217,20200320,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200320.0,,LW,US,US,2020,Q1,Adult
171627932,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Tooth loss,,2020,Q1,2,F,20161018.0,20200314.0,20191217,20200320,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200320.0,,LW,US,US,2020,Q1,Adult
171695562,17169556,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Diabetic ketosis,,2020,Q1,2,F,20180529.0,20200117.0,20191218,20200121,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-120395",BOEHRINGER INGELHEIM,,62.0,YR,,F,Y,82.7,KG,20200121.0,,MD,JP,JP,2020,Q1,Adult
171814633,17181463,8,C,Empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Encephalopathy,,2020,Q1,3,F,20191205.0,20200217.0,20191219,20200225,EXP,,CH-EXELIXIS-XL18419026014,EXELIXIS,,61.0,YR,,M,Y,92.5,KG,20200225.0,,MD,CH,CH,2020,Q1,Adult
171814633,17181463,8,C,Empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Visceral venous thrombosis,,2020,Q1,3,F,20191205.0,20200217.0,20191219,20200225,EXP,,CH-EXELIXIS-XL18419026014,EXELIXIS,,61.0,YR,,M,Y,92.5,KG,20200225.0,,MD,CH,CH,2020,Q1,Adult
171839014,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,4,F,20190313.0,20200205.0,20191220,20200324,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200324.0,,MD,IT,IT,2020,Q1,Elderly
171839014,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Anaemia,,2020,Q1,4,F,20190313.0,20200205.0,20191220,20200324,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200324.0,,MD,IT,IT,2020,Q1,Elderly
171839014,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Anuria,,2020,Q1,4,F,20190313.0,20200205.0,20191220,20200324,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200324.0,,MD,IT,IT,2020,Q1,Elderly
171839014,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Intentional self-injury,,2020,Q1,4,F,20190313.0,20200205.0,20191220,20200324,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200324.0,,MD,IT,IT,2020,Q1,Elderly
171839014,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Pulmonary sepsis,,2020,Q1,4,F,20190313.0,20200205.0,20191220,20200324,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200324.0,,MD,IT,IT,2020,Q1,Elderly
171839014,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Respiratory acidosis,,2020,Q1,4,F,20190313.0,20200205.0,20191220,20200324,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200324.0,,MD,IT,IT,2020,Q1,Elderly
171839014,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Respiratory failure,,2020,Q1,4,F,20190313.0,20200205.0,20191220,20200324,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200324.0,,MD,IT,IT,2020,Q1,Elderly
171840732,17184073,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,2,F,20191203.0,20200106.0,20191220,20200107,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-121021",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,107.9,KG,20200107.0,,MD,US,US,2020,Q1,Elderly
172008592,17200859,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 ?G, QD",,,,,,,,25.0,UG,,QD,2020,Q1,Burning sensation,,2020,Q1,2,F,20190430.0,20200109.0,20191226,20200119,EXP,,GB-NOVOPROD-700068,NOVO NORDISK,,54.0,YR,,F,Y,73.0,KG,20200119.0,,HP,GB,GB,2020,Q1,Adult
172008592,17200859,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 ?G, QD",,,,,,,,25.0,UG,,QD,2020,Q1,Diarrhoea,,2020,Q1,2,F,20190430.0,20200109.0,20191226,20200119,EXP,,GB-NOVOPROD-700068,NOVO NORDISK,,54.0,YR,,F,Y,73.0,KG,20200119.0,,HP,GB,GB,2020,Q1,Adult
172008592,17200859,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 ?G, QD",,,,,,,,25.0,UG,,QD,2020,Q1,Nausea,,2020,Q1,2,F,20190430.0,20200109.0,20191226,20200119,EXP,,GB-NOVOPROD-700068,NOVO NORDISK,,54.0,YR,,F,Y,73.0,KG,20200119.0,,HP,GB,GB,2020,Q1,Adult
172008592,17200859,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 ?G, QD",,,,,,,,25.0,UG,,QD,2020,Q1,Urticaria,,2020,Q1,2,F,20190430.0,20200109.0,20191226,20200119,EXP,,GB-NOVOPROD-700068,NOVO NORDISK,,54.0,YR,,F,Y,73.0,KG,20200119.0,,HP,GB,GB,2020,Q1,Adult
172008592,17200859,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 ?G, QD",,,,,,,,25.0,UG,,QD,2020,Q1,Weight decreased,,2020,Q1,2,F,20190430.0,20200109.0,20191226,20200119,EXP,,GB-NOVOPROD-700068,NOVO NORDISK,,54.0,YR,,F,Y,73.0,KG,20200119.0,,HP,GB,GB,2020,Q1,Adult
172030274,17203027,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q1,Acute respiratory failure,,2020,Q1,4,F,20191104.0,20200102.0,20191226,20200109,PER,,NVSC2019US079162,NOVARTIS,,57.0,YR,,F,Y,99.34,KG,20200109.0,,HP,US,US,2020,Q1,Adult
172030274,17203027,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q1,Hypoxia,,2020,Q1,4,F,20191104.0,20200102.0,20191226,20200109,PER,,NVSC2019US079162,NOVARTIS,,57.0,YR,,F,Y,99.34,KG,20200109.0,,HP,US,US,2020,Q1,Adult
172030274,17203027,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q1,Streptococcus test positive,,2020,Q1,4,F,20191104.0,20200102.0,20191226,20200109,PER,,NVSC2019US079162,NOVARTIS,,57.0,YR,,F,Y,99.34,KG,20200109.0,,HP,US,US,2020,Q1,Adult
172030342,17203034,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,5.0,MG,TABLET,,2020,Q1,Knee operation,,2020,Q1,2,F,20170501.0,20200206.0,20191226,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002014",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,68.0,KG,20200213.0,,MD,JP,JP,2020,Q1,Elderly
172030342,17203034,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,5.0,MG,TABLET,,2020,Q1,Osteoporosis,,2020,Q1,2,F,20170501.0,20200206.0,20191226,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002014",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,68.0,KG,20200213.0,,MD,JP,JP,2020,Q1,Elderly
172188792,17218879,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Hyperkalaemia,,2020,Q1,2,F,20190527.0,20200108.0,20191231,20200116,EXP,,AU-JNJFOC-20191237766,JOHNSON AND JOHNSON,,60.0,YR,,M,Y,,,20200116.0,,HP,AU,AU,2020,Q1,Adult
172188792,17218879,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Metabolic acidosis,,2020,Q1,2,F,20190527.0,20200108.0,20191231,20200116,EXP,,AU-JNJFOC-20191237766,JOHNSON AND JOHNSON,,60.0,YR,,M,Y,,,20200116.0,,HP,AU,AU,2020,Q1,Adult
172226921,17222692,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Death,,2020,Q1,1,I,20191104.0,20191230.0,20200102,20200102,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-125306,BRISTOL MYERS SQUIBB,,78.0,YR,,F,Y,,,20200102.0,,HP,US,US,2020,Q1,Elderly
172230501,17223050,3,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,QD,2020,Q1,Pemphigoid,,2020,Q1,1,I,20191218.0,20191225.0,20200102,20200102,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-124163,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20200102.0,,PH,ES,ES,2020,Q1,Adult
172420231,17242023,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,20200104.0,,20200106,20200106,DIR,,,FDA-CTU,,49.0,YR,,M,N,86.8,KG,20200106.0,N,PH,US,US,2020,Q1,Adult
172420231,17242023,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20200104.0,,20200106,20200106,DIR,,,FDA-CTU,,49.0,YR,,M,N,86.8,KG,20200106.0,N,PH,US,US,2020,Q1,Adult
172420501,17242050,10,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MILLIGRAM DAILY; 10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Fall,,2020,Q1,1,I,,20191229.0,20200107,20200107,EXP,,DE-TEVA-2019-DE-1162089,TEVA,,80.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
172420501,17242050,10,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MILLIGRAM DAILY; 10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Haematoma,,2020,Q1,1,I,,20191229.0,20200107,20200107,EXP,,DE-TEVA-2019-DE-1162089,TEVA,,80.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
172420501,17242050,10,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MILLIGRAM DAILY; 10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Musculoskeletal pain,,2020,Q1,1,I,,20191229.0,20200107,20200107,EXP,,DE-TEVA-2019-DE-1162089,TEVA,,80.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
172452923,17245292,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Cellulitis,,2020,Q1,3,F,201912.0,20200309.0,20200108,20200313,EXP,,GB-BAUSCH-BL-2020-000273,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200313.0,,CN,GB,GB,2020,Q1,Elderly
172452923,17245292,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,3,F,201912.0,20200309.0,20200108,20200313,EXP,,GB-BAUSCH-BL-2020-000273,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200313.0,,CN,GB,GB,2020,Q1,Elderly
172452923,17245292,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Feeling abnormal,,2020,Q1,3,F,201912.0,20200309.0,20200108,20200313,EXP,,GB-BAUSCH-BL-2020-000273,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200313.0,,CN,GB,GB,2020,Q1,Elderly
172452923,17245292,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Flatulence,,2020,Q1,3,F,201912.0,20200309.0,20200108,20200313,EXP,,GB-BAUSCH-BL-2020-000273,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200313.0,,CN,GB,GB,2020,Q1,Elderly
172452923,17245292,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Lower respiratory tract infection,,2020,Q1,3,F,201912.0,20200309.0,20200108,20200313,EXP,,GB-BAUSCH-BL-2020-000273,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200313.0,,CN,GB,GB,2020,Q1,Elderly
172452923,17245292,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Malaise,,2020,Q1,3,F,201912.0,20200309.0,20200108,20200313,EXP,,GB-BAUSCH-BL-2020-000273,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200313.0,,CN,GB,GB,2020,Q1,Elderly
172452923,17245292,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Mucous stools,,2020,Q1,3,F,201912.0,20200309.0,20200108,20200313,EXP,,GB-BAUSCH-BL-2020-000273,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200313.0,,CN,GB,GB,2020,Q1,Elderly
172452923,17245292,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Product administration interrupted,,2020,Q1,3,F,201912.0,20200309.0,20200108,20200313,EXP,,GB-BAUSCH-BL-2020-000273,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200313.0,,CN,GB,GB,2020,Q1,Elderly
172452923,17245292,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Psoriasis,,2020,Q1,3,F,201912.0,20200309.0,20200108,20200313,EXP,,GB-BAUSCH-BL-2020-000273,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200313.0,,CN,GB,GB,2020,Q1,Elderly
172481601,17248160,10,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q1,Fall,,2020,Q1,1,I,,20191230.0,20200108,20200108,EXP,,DE-DRREDDYS-GER/GER/19/0117956,DR REDDYS,,80.0,YR,,M,Y,,,20200108.0,,MD,DE,DE,2020,Q1,Elderly
172481601,17248160,10,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q1,Haematoma,,2020,Q1,1,I,,20191230.0,20200108,20200108,EXP,,DE-DRREDDYS-GER/GER/19/0117956,DR REDDYS,,80.0,YR,,M,Y,,,20200108.0,,MD,DE,DE,2020,Q1,Elderly
172481601,17248160,10,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q1,Musculoskeletal pain,,2020,Q1,1,I,,20191230.0,20200108,20200108,EXP,,DE-DRREDDYS-GER/GER/19/0117956,DR REDDYS,,80.0,YR,,M,Y,,,20200108.0,,MD,DE,DE,2020,Q1,Elderly
172509701,17250970,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,GB-MHRA-ADR 24462428,GB-ACCORD-169085,ACCORD,,75.0,YR,,M,Y,95.0,KG,20200109.0,,PH,GB,GB,2020,Q1,Elderly
172509701,17250970,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,,2020,Q1,Blood glucose abnormal,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,GB-MHRA-ADR 24462428,GB-ACCORD-169085,ACCORD,,75.0,YR,,M,Y,95.0,KG,20200109.0,,PH,GB,GB,2020,Q1,Elderly
172509701,17250970,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,GB-MHRA-ADR 24462428,GB-ACCORD-169085,ACCORD,,75.0,YR,,M,Y,95.0,KG,20200109.0,,PH,GB,GB,2020,Q1,Elderly
172509701,17250970,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,GB-MHRA-ADR 24462428,GB-ACCORD-169085,ACCORD,,75.0,YR,,M,Y,95.0,KG,20200109.0,,PH,GB,GB,2020,Q1,Elderly
172509701,17250970,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,,2020,Q1,Pneumonia,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,GB-MHRA-ADR 24462428,GB-ACCORD-169085,ACCORD,,75.0,YR,,M,Y,95.0,KG,20200109.0,,PH,GB,GB,2020,Q1,Elderly
172518072,17251807,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,25.0,MG,,QD,2020,Q1,Device malfunction,,2020,Q1,2,F,2018.0,20200110.0,20200109,20200206,PER,,US-ASTRAZENECA-2019SF81816,ASTRAZENECA,,62.0,YR,,M,Y,115.2,KG,20200206.0,,CN,US,US,2020,Q1,Adult
172518072,17251807,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,25.0,MG,,QD,2020,Q1,Haemorrhage,,2020,Q1,2,F,2018.0,20200110.0,20200109,20200206,PER,,US-ASTRAZENECA-2019SF81816,ASTRAZENECA,,62.0,YR,,M,Y,115.2,KG,20200206.0,,CN,US,US,2020,Q1,Adult
172518072,17251807,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,25.0,MG,,QD,2020,Q1,Incorrect dose administered,,2020,Q1,2,F,2018.0,20200110.0,20200109,20200206,PER,,US-ASTRAZENECA-2019SF81816,ASTRAZENECA,,62.0,YR,,M,Y,115.2,KG,20200206.0,,CN,US,US,2020,Q1,Adult
172518072,17251807,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,25.0,MG,,QD,2020,Q1,Injection site nodule,,2020,Q1,2,F,2018.0,20200110.0,20200109,20200206,PER,,US-ASTRAZENECA-2019SF81816,ASTRAZENECA,,62.0,YR,,M,Y,115.2,KG,20200206.0,,CN,US,US,2020,Q1,Adult
172525521,17252552,3,C,EMPAGLIFLOZIN/METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Daydreaming,,2020,Q1,1,I,,20200108.0,20200109,20200109,EXP,,ES-PFIZER INC-2020008460,PFIZER,,60.0,YR,,F,Y,,,20200109.0,,CN,ES,ES,2020,Q1,Adult
172525521,17252552,3,C,EMPAGLIFLOZIN/METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Disorientation,,2020,Q1,1,I,,20200108.0,20200109,20200109,EXP,,ES-PFIZER INC-2020008460,PFIZER,,60.0,YR,,F,Y,,,20200109.0,,CN,ES,ES,2020,Q1,Adult
172525521,17252552,3,C,EMPAGLIFLOZIN/METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Vitamin B12 deficiency,,2020,Q1,1,I,,20200108.0,20200109,20200109,EXP,,ES-PFIZER INC-2020008460,PFIZER,,60.0,YR,,F,Y,,,20200109.0,,CN,ES,ES,2020,Q1,Adult
172532913,17253291,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Small cell lung cancer,,2020,Q1,3,F,20200103.0,20200121.0,20200109,20200123,EXP,,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-000658",BOEHRINGER INGELHEIM,,82.0,YR,,F,Y,74.0,KG,20200124.0,,MD,NL,NL,2020,Q1,Elderly
172532913,17253291,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q1,Small cell lung cancer,,2020,Q1,3,F,20200103.0,20200121.0,20200109,20200123,EXP,,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-000658",BOEHRINGER INGELHEIM,,82.0,YR,,F,Y,74.0,KG,20200124.0,,MD,NL,NL,2020,Q1,Elderly
172551131,17255113,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,,GB-AUROBINDO-AUR-APL-2020-001434,AUROBINDO,,75.0,YR,,M,Y,95.0,KG,20200110.0,,PH,GB,GB,2020,Q1,Elderly
172551131,17255113,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Blood glucose abnormal,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,,GB-AUROBINDO-AUR-APL-2020-001434,AUROBINDO,,75.0,YR,,M,Y,95.0,KG,20200110.0,,PH,GB,GB,2020,Q1,Elderly
172551131,17255113,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,,GB-AUROBINDO-AUR-APL-2020-001434,AUROBINDO,,75.0,YR,,M,Y,95.0,KG,20200110.0,,PH,GB,GB,2020,Q1,Elderly
172551131,17255113,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,,GB-AUROBINDO-AUR-APL-2020-001434,AUROBINDO,,75.0,YR,,M,Y,95.0,KG,20200110.0,,PH,GB,GB,2020,Q1,Elderly
172551131,17255113,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,20191217.0,20200101.0,20200109,20200109,EXP,,GB-AUROBINDO-AUR-APL-2020-001434,AUROBINDO,,75.0,YR,,M,Y,95.0,KG,20200110.0,,PH,GB,GB,2020,Q1,Elderly
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Burning sensation,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Candida infection,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Fournier's gangrene,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Gangrene,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Haemorrhage,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Pain,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Skin disorder,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Skin fissures,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Skin infection,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Ulcer,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172571821,17257182,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Vulval disorder,,2020,Q1,1,I,20191217.0,,20200109,20200109,DIR,,,FDA-CTU,,36.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172573281,17257328,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q1,Cholelithiasis,,2020,Q1,1,I,20191228.0,,20200109,20200109,DIR,,,FDA-CTU,,64.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172573281,17257328,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191228.0,,20200109,20200109,DIR,,,FDA-CTU,,64.0,YR,,F,N,,,20200109.0,N,PH,US,US,2020,Q1,Adult
172580651,17258065,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Fall,,2020,Q1,1,I,20191021.0,20200108.0,20200110,20200110,EXP,DE-ADRED-04278-01,DE-PFIZER INC-2020008682,PFIZER,,80.0,YR,,M,Y,,,20200110.0,,MD,DE,DE,2020,Q1,Elderly
172580651,17258065,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,1,I,20191021.0,20200108.0,20200110,20200110,EXP,DE-ADRED-04278-01,DE-PFIZER INC-2020008682,PFIZER,,80.0,YR,,M,Y,,,20200110.0,,MD,DE,DE,2020,Q1,Elderly
172580651,17258065,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Haematoma,,2020,Q1,1,I,20191021.0,20200108.0,20200110,20200110,EXP,DE-ADRED-04278-01,DE-PFIZER INC-2020008682,PFIZER,,80.0,YR,,M,Y,,,20200110.0,,MD,DE,DE,2020,Q1,Elderly
172580651,17258065,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Musculoskeletal pain,,2020,Q1,1,I,20191021.0,20200108.0,20200110,20200110,EXP,DE-ADRED-04278-01,DE-PFIZER INC-2020008682,PFIZER,,80.0,YR,,M,Y,,,20200110.0,,MD,DE,DE,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Cervical spinal stenosis,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Deafness neurosensory,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Gout,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Hypertension,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Hypoaesthesia,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Lacunar infarction,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Malaise,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Nausea,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Sensory disturbance,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Spinal osteoarthritis,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172583982,17258398,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Vomiting,,2020,Q1,2,F,20190210.0,20200221.0,20200110,20200227,EXP,,JP-009507513-1910JPN001516J,MERCK,,67.0,YR,,M,Y,64.0,KG,20200227.0,,CN,JP,JP,2020,Q1,Elderly
172602341,17260234,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20191217.0,20200101.0,20200112,20200112,EXP,GB-MHRA-ADR 24462428,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0031,EMCURE,,75.0,YR,,M,Y,95.0,KG,20200112.0,,PH,GB,GB,2020,Q1,Elderly
172602341,17260234,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,,2020,Q1,Blood glucose abnormal,,2020,Q1,1,I,20191217.0,20200101.0,20200112,20200112,EXP,GB-MHRA-ADR 24462428,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0031,EMCURE,,75.0,YR,,M,Y,95.0,KG,20200112.0,,PH,GB,GB,2020,Q1,Elderly
172602341,17260234,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191217.0,20200101.0,20200112,20200112,EXP,GB-MHRA-ADR 24462428,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0031,EMCURE,,75.0,YR,,M,Y,95.0,KG,20200112.0,,PH,GB,GB,2020,Q1,Elderly
172602341,17260234,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191217.0,20200101.0,20200112,20200112,EXP,GB-MHRA-ADR 24462428,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0031,EMCURE,,75.0,YR,,M,Y,95.0,KG,20200112.0,,PH,GB,GB,2020,Q1,Elderly
172602341,17260234,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,,2020,Q1,Pneumonia,,2020,Q1,1,I,20191217.0,20200101.0,20200112,20200112,EXP,GB-MHRA-ADR 24462428,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0031,EMCURE,,75.0,YR,,M,Y,95.0,KG,20200112.0,,PH,GB,GB,2020,Q1,Elderly
172614192,17261419,10,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q1,Fall,,2020,Q1,2,F,,20191230.0,20200113,20200113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-232969,RANBAXY,,80.0,YR,,M,Y,,,20200113.0,,HP,NL,DE,2020,Q1,Elderly
172614192,17261419,10,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q1,Haematoma,,2020,Q1,2,F,,20191230.0,20200113,20200113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-232969,RANBAXY,,80.0,YR,,M,Y,,,20200113.0,,HP,NL,DE,2020,Q1,Elderly
172614192,17261419,10,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q1,Musculoskeletal pain,,2020,Q1,2,F,,20191230.0,20200113,20200113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-232969,RANBAXY,,80.0,YR,,M,Y,,,20200113.0,,HP,NL,DE,2020,Q1,Elderly
172641231,17264123,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20191217.0,20200103.0,20200113,20200113,EXP,GB-MHRA-EYC 00215154,GB-BAUSCH-BL-2020-000255,BAUSCH AND LOMB,,75.0,YR,,M,Y,95.0,KG,20200113.0,,PH,GB,GB,2020,Q1,Elderly
172641231,17264123,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Blood glucose abnormal,,2020,Q1,1,I,20191217.0,20200103.0,20200113,20200113,EXP,GB-MHRA-EYC 00215154,GB-BAUSCH-BL-2020-000255,BAUSCH AND LOMB,,75.0,YR,,M,Y,95.0,KG,20200113.0,,PH,GB,GB,2020,Q1,Elderly
172641231,17264123,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191217.0,20200103.0,20200113,20200113,EXP,GB-MHRA-EYC 00215154,GB-BAUSCH-BL-2020-000255,BAUSCH AND LOMB,,75.0,YR,,M,Y,95.0,KG,20200113.0,,PH,GB,GB,2020,Q1,Elderly
172641231,17264123,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191217.0,20200103.0,20200113,20200113,EXP,GB-MHRA-EYC 00215154,GB-BAUSCH-BL-2020-000255,BAUSCH AND LOMB,,75.0,YR,,M,Y,95.0,KG,20200113.0,,PH,GB,GB,2020,Q1,Elderly
172641231,17264123,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,20191217.0,20200103.0,20200113,20200113,EXP,GB-MHRA-EYC 00215154,GB-BAUSCH-BL-2020-000255,BAUSCH AND LOMB,,75.0,YR,,M,Y,95.0,KG,20200113.0,,PH,GB,GB,2020,Q1,Elderly
172683051,17268305,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Disorientation,,2020,Q1,1,I,20191022.0,,20191223,20191223,DIR,,,FDA-CTU,,77.0,YR,,M,N,,,20191218.0,N,PH,US,US,2020,Q1,Elderly
172683051,17268305,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Mental status changes,,2020,Q1,1,I,20191022.0,,20191223,20191223,DIR,,,FDA-CTU,,77.0,YR,,M,N,,,20191218.0,N,PH,US,US,2020,Q1,Elderly
172686841,17268684,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q1,Electrocardiogram T wave inversion,,2020,Q1,1,I,,20200110.0,20200114,20200114,EXP,DK-DKMA-WBS-0024237,DK-OTSUKA-2020_001076,OTSUKA,,25.0,YR,,F,Y,,,20200114.0,,MD,DK,DK,2020,Q1,Young Adult
172686841,17268684,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,1,I,,20200110.0,20200114,20200114,EXP,DK-DKMA-WBS-0024237,DK-OTSUKA-2020_001076,OTSUKA,,25.0,YR,,F,Y,,,20200114.0,,MD,DK,DK,2020,Q1,Young Adult
172686841,17268684,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q1,Product use in unapproved indication,,2020,Q1,1,I,,20200110.0,20200114,20200114,EXP,DK-DKMA-WBS-0024237,DK-OTSUKA-2020_001076,OTSUKA,,25.0,YR,,F,Y,,,20200114.0,,MD,DK,DK,2020,Q1,Young Adult
172709411,17270941,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20191217.0,20200113.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-009507513-2001GBR004340,MERCK,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172709411,17270941,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Blood glucose abnormal,,2020,Q1,1,I,20191217.0,20200113.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-009507513-2001GBR004340,MERCK,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172709411,17270941,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191217.0,20200113.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-009507513-2001GBR004340,MERCK,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172709411,17270941,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191217.0,20200113.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-009507513-2001GBR004340,MERCK,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172709411,17270941,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,20191217.0,20200113.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-009507513-2001GBR004340,MERCK,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172725281,17272528,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,D,,,,,10.0,MG,,,2020,Q1,Hypotension,,2020,Q1,1,I,20191119.0,,20191223,20191223,DIR,,,FDA-CTU,,74.0,YR,,M,N,97.0,KG,20191219.0,N,PH,US,US,2020,Q1,Elderly
172725281,17272528,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,D,,,,,10.0,MG,,,2020,Q1,Sepsis,,2020,Q1,1,I,20191119.0,,20191223,20191223,DIR,,,FDA-CTU,,74.0,YR,,M,N,97.0,KG,20191219.0,N,PH,US,US,2020,Q1,Elderly
172725281,17272528,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,D,,,,,10.0,MG,,,2020,Q1,Urinary tract infection,,2020,Q1,1,I,20191119.0,,20191223,20191223,DIR,,,FDA-CTU,,74.0,YR,,M,N,97.0,KG,20191219.0,N,PH,US,US,2020,Q1,Elderly
172725461,17272546,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20191217.0,20200106.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-EMD SERONO-E2B_90073952,EMD SERONO INC,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172725461,17272546,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Blood glucose abnormal,,2020,Q1,1,I,20191217.0,20200106.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-EMD SERONO-E2B_90073952,EMD SERONO INC,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172725461,17272546,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191217.0,20200106.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-EMD SERONO-E2B_90073952,EMD SERONO INC,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172725461,17272546,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191217.0,20200106.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-EMD SERONO-E2B_90073952,EMD SERONO INC,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172725461,17272546,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,20191217.0,20200106.0,20200115,20200115,EXP,GB-MHRA-EYC 00215154,GB-EMD SERONO-E2B_90073952,EMD SERONO INC,,75.0,YR,,M,Y,95.0,KG,20200115.0,,PH,GB,GB,2020,Q1,Elderly
172737041,17273704,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,,,,QD,2020,Q1,Anion gap increased,,2020,Q1,1,I,20191102.0,,20200115,20200115,DIR,,,FDA-CTU,,64.0,YR,,M,N,87.5,KG,20200115.0,Y,PH,US,US,2020,Q1,Adult
172737041,17273704,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,,,,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,20191102.0,,20200115,20200115,DIR,,,FDA-CTU,,64.0,YR,,M,N,87.5,KG,20200115.0,Y,PH,US,US,2020,Q1,Adult
172759231,17275923,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,Acute kidney injury,2020,Q1,1,I,20191217.0,20200103.0,20200116,20200116,EXP,GB-MHRA-EYC 00215154,GB-ALVOGEN-2020-ALVOGEN-102351,ALVOGEN,,75.0,YR,,M,Y,95.0,KG,20200116.0,,CN,GB,GB,2020,Q1,Elderly
172759231,17275923,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Blood glucose abnormal,Blood glucose abnormal,2020,Q1,1,I,20191217.0,20200103.0,20200116,20200116,EXP,GB-MHRA-EYC 00215154,GB-ALVOGEN-2020-ALVOGEN-102351,ALVOGEN,,75.0,YR,,M,Y,95.0,KG,20200116.0,,CN,GB,GB,2020,Q1,Elderly
172759231,17275923,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Dyspnoea,Dyspnoea,2020,Q1,1,I,20191217.0,20200103.0,20200116,20200116,EXP,GB-MHRA-EYC 00215154,GB-ALVOGEN-2020-ALVOGEN-102351,ALVOGEN,,75.0,YR,,M,Y,95.0,KG,20200116.0,,CN,GB,GB,2020,Q1,Elderly
172759231,17275923,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Metabolic acidosis,Metabolic acidosis,2020,Q1,1,I,20191217.0,20200103.0,20200116,20200116,EXP,GB-MHRA-EYC 00215154,GB-ALVOGEN-2020-ALVOGEN-102351,ALVOGEN,,75.0,YR,,M,Y,95.0,KG,20200116.0,,CN,GB,GB,2020,Q1,Elderly
172759231,17275923,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Pneumonia,Pneumonia,2020,Q1,1,I,20191217.0,20200103.0,20200116,20200116,EXP,GB-MHRA-EYC 00215154,GB-ALVOGEN-2020-ALVOGEN-102351,ALVOGEN,,75.0,YR,,M,Y,95.0,KG,20200116.0,,CN,GB,GB,2020,Q1,Elderly
172792741,17279274,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,U,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Blood bilirubin increased,,2020,Q1,1,I,20161026.0,20170712.0,20200116,20200116,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004045",BOEHRINGER INGELHEIM,,81.0,YR,,M,Y,62.9,KG,20200116.0,,MD,JP,JP,2020,Q1,Elderly
172792741,17279274,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,U,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Hepatic cancer,,2020,Q1,1,I,20161026.0,20170712.0,20200116,20200116,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004045",BOEHRINGER INGELHEIM,,81.0,YR,,M,Y,62.9,KG,20200116.0,,MD,JP,JP,2020,Q1,Elderly
172796311,17279631,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,1,I,20191004.0,20200110.0,20200116,20200116,EXP,GB-MHRA-EYC 00215650,GB-ELI_LILLY_AND_COMPANY-GB202001005053,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20200116.0,,CN,GB,GB,2020,Q1,Elderly
172796311,17279631,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Chest discomfort,,2020,Q1,1,I,20191004.0,20200110.0,20200116,20200116,EXP,GB-MHRA-EYC 00215650,GB-ELI_LILLY_AND_COMPANY-GB202001005053,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20200116.0,,CN,GB,GB,2020,Q1,Elderly
172796311,17279631,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,20191004.0,20200110.0,20200116,20200116,EXP,GB-MHRA-EYC 00215650,GB-ELI_LILLY_AND_COMPANY-GB202001005053,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20200116.0,,CN,GB,GB,2020,Q1,Elderly
172796311,17279631,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191004.0,20200110.0,20200116,20200116,EXP,GB-MHRA-EYC 00215650,GB-ELI_LILLY_AND_COMPANY-GB202001005053,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20200116.0,,CN,GB,GB,2020,Q1,Elderly
172809961,17280996,3,C,Empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,1,I,,20200113.0,20200117,20200117,EXP,,AU-TEVA-2020-AU-1171185,TEVA,"LEE AYS, SMITH AJF, KRUMMENACHER M, HUGHES TL. AN UNUSUAL CASE OF LOPERAMIDE ANAPHYLAXIS. ANN-ALLERGY-ASTHMA-IMMUNOL 2020;124(1):93-94.",75.0,YR,,M,Y,,,20200117.0,,MD,AU,AU,2020,Q1,Elderly
172898381,17289838,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,FILM-COATED TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20190101.0,20200106.0,20200120,20200120,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-125289,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,103.0,KG,20200120.0,,HP,US,US,2020,Q1,Elderly
172898381,17289838,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,FILM-COATED TABLET,,2020,Q1,Cardiac failure congestive,,2020,Q1,1,I,20190101.0,20200106.0,20200120,20200120,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-125289,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,103.0,KG,20200120.0,,HP,US,US,2020,Q1,Elderly
172899861,17289986,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,FILM-COATED TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20180906.0,20200106.0,20200120,20200120,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-125288,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,232.18,KG,20200120.0,,HP,US,US,2020,Q1,Elderly
172899861,17289986,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,FILM-COATED TABLET,,2020,Q1,Chronic obstructive pulmonary disease,,2020,Q1,1,I,20180906.0,20200106.0,20200120,20200120,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-125288,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,232.18,KG,20200120.0,,HP,US,US,2020,Q1,Elderly
172899861,17289986,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,FILM-COATED TABLET,,2020,Q1,Peripheral ischaemia,,2020,Q1,1,I,20180906.0,20200106.0,20200120,20200120,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-125288,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,232.18,KG,20200120.0,,HP,US,US,2020,Q1,Elderly
172930941,17293094,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,Y,, UNKNOWN,,,25.0,MG,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20191217.0,20200113.0,20200121,20200121,EXP,GB-MHRA-EYC 00215154,GB-TEVA-2020-GB-1170105,TEVA,,75.0,YR,,M,Y,95.0,KG,20200121.0,,PH,GB,GB,2020,Q1,Elderly
172930941,17293094,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,Y,, UNKNOWN,,,25.0,MG,,,2020,Q1,Blood glucose abnormal,,2020,Q1,1,I,20191217.0,20200113.0,20200121,20200121,EXP,GB-MHRA-EYC 00215154,GB-TEVA-2020-GB-1170105,TEVA,,75.0,YR,,M,Y,95.0,KG,20200121.0,,PH,GB,GB,2020,Q1,Elderly
172930941,17293094,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,Y,, UNKNOWN,,,25.0,MG,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191217.0,20200113.0,20200121,20200121,EXP,GB-MHRA-EYC 00215154,GB-TEVA-2020-GB-1170105,TEVA,,75.0,YR,,M,Y,95.0,KG,20200121.0,,PH,GB,GB,2020,Q1,Elderly
172930941,17293094,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,Y,, UNKNOWN,,,25.0,MG,,,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191217.0,20200113.0,20200121,20200121,EXP,GB-MHRA-EYC 00215154,GB-TEVA-2020-GB-1170105,TEVA,,75.0,YR,,M,Y,95.0,KG,20200121.0,,PH,GB,GB,2020,Q1,Elderly
172930941,17293094,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,Y,, UNKNOWN,,,25.0,MG,,,2020,Q1,Pneumonia,,2020,Q1,1,I,20191217.0,20200113.0,20200121,20200121,EXP,GB-MHRA-EYC 00215154,GB-TEVA-2020-GB-1170105,TEVA,,75.0,YR,,M,Y,95.0,KG,20200121.0,,PH,GB,GB,2020,Q1,Elderly
172993962,17299396,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Diabetic foot,,2020,Q1,2,F,20190303.0,20200302.0,20200122,20200303,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-003746",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,73.4,KG,20200303.0,,MD,JP,JP,2020,Q1,Adult
172993962,17299396,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Diabetic foot,,2020,Q1,2,F,20190303.0,20200302.0,20200122,20200303,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-003746",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,73.4,KG,20200303.0,,MD,JP,JP,2020,Q1,Adult
173064691,17306469,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,MORNING,150.0,MG,Y,,,,,10.0,MG,,QD,2020,Q1,Blood lactic acid increased,,2020,Q1,1,I,20191203.0,20200117.0,20200123,20200123,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-EMD SERONO-E2B_90074299,EMD SERONO INC,,55.0,YR,,M,Y,,,20200123.0,,PH,GB,GB,2020,Q1,Adult
173064691,17306469,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,MORNING,150.0,MG,Y,,,,,10.0,MG,,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191203.0,20200117.0,20200123,20200123,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-EMD SERONO-E2B_90074299,EMD SERONO INC,,55.0,YR,,M,Y,,,20200123.0,,PH,GB,GB,2020,Q1,Adult
173079161,17307916,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q1,Urinary tract infection,,2020,Q1,1,I,20191001.0,,20200106,20200106,DIR,,,FDA-CTU,,69.0,YR,,M,N,79.83,KG,20191218.0,N,PH,US,US,2020,Q1,Elderly
173143021,17314302,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,,QD,2020,Q1,Drug ineffective for unapproved indication,,2020,Q1,1,I,,20200114.0,20200124,20200124,EXP,,CA-AUROBINDO-AUR-APL-2020-003606,AUROBINDO,,59.0,YR,,M,Y,,,20200124.0,,HP,CA,CA,2020,Q1,Adult
173143021,17314302,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,,QD,2020,Q1,Off label use,,2020,Q1,1,I,,20200114.0,20200124,20200124,EXP,,CA-AUROBINDO-AUR-APL-2020-003606,AUROBINDO,,59.0,YR,,M,Y,,,20200124.0,,HP,CA,CA,2020,Q1,Adult
173143021,17314302,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,,QD,2020,Q1,Urosepsis,,2020,Q1,1,I,,20200114.0,20200124,20200124,EXP,,CA-AUROBINDO-AUR-APL-2020-003606,AUROBINDO,,59.0,YR,,M,Y,,,20200124.0,,HP,CA,CA,2020,Q1,Adult
173146191,17314619,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Anion gap increased,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Blood urea decreased,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Glucose urine present,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Herpes zoster,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Urine ketone body present,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173170011,17317001,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,FILM-COATED TABLET,,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,1,I,20190510.0,20200116.0,20200124,20200124,PER,,US-JNJFOC-20200131933,JOHNSON AND JOHNSON,,67.0,YR,,M,Y,95.3,KG,20200124.0,,MD,US,US,2020,Q1,Elderly
173182031,17318203,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,MORNING,150.0,MG,Y,,,,,10.0,MG,TABLET,QD,2020,Q1,Blood lactic acid increased,,2020,Q1,1,I,20191203.0,20200116.0,20200124,20200124,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-BAUSCH-BL-2020-001627,BAUSCH AND LOMB,,55.0,YR,,M,Y,,,20200124.0,,PH,GB,GB,2020,Q1,Adult
173182031,17318203,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,MORNING,150.0,MG,Y,,,,,10.0,MG,TABLET,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191203.0,20200116.0,20200124,20200124,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-BAUSCH-BL-2020-001627,BAUSCH AND LOMB,,55.0,YR,,M,Y,,,20200124.0,,PH,GB,GB,2020,Q1,Adult
173182601,17318260,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,1,I,20190510.0,20200116.0,20200124,20200124,EXP,,US-BAYER-2020-013917,BAYER,,67.0,YR,E,M,Y,95.3,KG,20200124.0,,HP,US,US,2020,Q1,Elderly
173237341,17323734,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM,DAILY (MORNING)",150.0,MG,Y,, UNKNOWN,,,10.0,MG,TABLET,,2020,Q1,Blood lactic acid increased,,2020,Q1,1,I,20191203.0,20200114.0,20200127,20200127,EXP,GB-MHRA-ADR 24464395,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0074,EMCURE,,55.0,YR,,M,Y,,,20200127.0,,PH,GB,GB,2020,Q1,Adult
173237341,17323734,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM,DAILY (MORNING)",150.0,MG,Y,, UNKNOWN,,,10.0,MG,TABLET,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191203.0,20200114.0,20200127,20200127,EXP,GB-MHRA-ADR 24464395,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0074,EMCURE,,55.0,YR,,M,Y,,,20200127.0,,PH,GB,GB,2020,Q1,Adult
173247841,17324784,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20190810.0,,20200109,20200109,DIR,,,FDA-CTU,,70.0,YR,,M,N,126.0,KG,20200108.0,N,PH,US,US,2020,Q1,Elderly
173247841,17324784,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q1,Drug intolerance,,2020,Q1,1,I,20190810.0,,20200109,20200109,DIR,,,FDA-CTU,,70.0,YR,,M,N,126.0,KG,20200108.0,N,PH,US,US,2020,Q1,Elderly
173247841,17324784,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q1,Therapy cessation,,2020,Q1,1,I,20190810.0,,20200109,20200109,DIR,,,FDA-CTU,,70.0,YR,,M,N,126.0,KG,20200108.0,N,PH,US,US,2020,Q1,Elderly
173251301,17325130,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,20191209.0,,20200126,20200126,DIR,,,FDA-CTU,,55.0,YR,,F,N,69.8,KG,20200126.0,N,PH,US,US,2020,Q1,Adult
173251301,17325130,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20191209.0,,20200126,20200126,DIR,,,FDA-CTU,,55.0,YR,,F,N,69.8,KG,20200126.0,N,PH,US,US,2020,Q1,Adult
173251301,17325130,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2020,Q1,Mental status changes,,2020,Q1,1,I,20191209.0,,20200126,20200126,DIR,,,FDA-CTU,,55.0,YR,,F,N,69.8,KG,20200126.0,N,PH,US,US,2020,Q1,Adult
173251301,17325130,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2020,Q1,Polydipsia,,2020,Q1,1,I,20191209.0,,20200126,20200126,DIR,,,FDA-CTU,,55.0,YR,,F,N,69.8,KG,20200126.0,N,PH,US,US,2020,Q1,Adult
173251301,17325130,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2020,Q1,Polyuria,,2020,Q1,1,I,20191209.0,,20200126,20200126,DIR,,,FDA-CTU,,55.0,YR,,F,N,69.8,KG,20200126.0,N,PH,US,US,2020,Q1,Adult
173259921,17325992,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,TABLET,QD,2020,Q1,Dysuria,,2020,Q1,1,I,20191108.0,,20200109,20200109,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20200109.0,N,PH,US,US,2020,Q1,Elderly
173259921,17325992,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,TABLET,QD,2020,Q1,Genital pain,,2020,Q1,1,I,20191108.0,,20200109,20200109,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20200109.0,N,PH,US,US,2020,Q1,Elderly
173259921,17325992,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,TABLET,QD,2020,Q1,Pruritus genital,,2020,Q1,1,I,20191108.0,,20200109,20200109,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20200109.0,N,PH,US,US,2020,Q1,Elderly
173287891,17328789,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q1,Abdominal pain,,2020,Q1,1,I,20190320.0,,20200110,20200110,DIR,,,FDA-CTU,,64.0,YR,,M,N,109.77,KG,20190410.0,N,PH,AU,AU,2020,Q1,Adult
173287891,17328789,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20190320.0,,20200110,20200110,DIR,,,FDA-CTU,,64.0,YR,,M,N,109.77,KG,20190410.0,N,PH,AU,AU,2020,Q1,Adult
173287891,17328789,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q1,Asthenia,,2020,Q1,1,I,20190320.0,,20200110,20200110,DIR,,,FDA-CTU,,64.0,YR,,M,N,109.77,KG,20190410.0,N,PH,AU,AU,2020,Q1,Adult
173287891,17328789,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q1,Hypotension,,2020,Q1,1,I,20190320.0,,20200110,20200110,DIR,,,FDA-CTU,,64.0,YR,,M,N,109.77,KG,20190410.0,N,PH,AU,AU,2020,Q1,Adult
173287891,17328789,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q1,Nausea,,2020,Q1,1,I,20190320.0,,20200110,20200110,DIR,,,FDA-CTU,,64.0,YR,,M,N,109.77,KG,20190410.0,N,PH,AU,AU,2020,Q1,Adult
173287891,17328789,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q1,Sepsis,,2020,Q1,1,I,20190320.0,,20200110,20200110,DIR,,,FDA-CTU,,64.0,YR,,M,N,109.77,KG,20190410.0,N,PH,AU,AU,2020,Q1,Adult
173287891,17328789,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q1,Urinary tract infection fungal,,2020,Q1,1,I,20190320.0,,20200110,20200110,DIR,,,FDA-CTU,,64.0,YR,,M,N,109.77,KG,20190410.0,N,PH,AU,AU,2020,Q1,Adult
173375971,17337597,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG,150.0,MG,Y,, UNKNOWN,,,10.0,MG,TABLET,,2020,Q1,Blood lactic acid increased,,2020,Q1,1,I,20191203.0,20200122.0,20200129,20200129,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-TEVA-2020-GB-1175625,TEVA,,55.0,YR,,M,Y,,,20200129.0,,PH,GB,GB,2020,Q1,Adult
173375971,17337597,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG,150.0,MG,Y,, UNKNOWN,,,10.0,MG,TABLET,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191203.0,20200122.0,20200129,20200129,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-TEVA-2020-GB-1175625,TEVA,,55.0,YR,,M,Y,,,20200129.0,,PH,GB,GB,2020,Q1,Adult
173388611,17338861,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,D,,,,1000.0,MG,,QD,2020,Q1,Acidosis,,2020,Q1,1,I,20200127.0,,20200128,20200128,DIR,,,FDA-CTU,,55.0,YR,,F,N,117.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
173388611,17338861,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,D,,,,1000.0,MG,,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,20200127.0,,20200128,20200128,DIR,,,FDA-CTU,,55.0,YR,,F,N,117.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
173388611,17338861,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,D,,,,1000.0,MG,,QD,2020,Q1,Dehydration,,2020,Q1,1,I,20200127.0,,20200128,20200128,DIR,,,FDA-CTU,,55.0,YR,,F,N,117.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
173388611,17338861,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,D,,,,1000.0,MG,,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200127.0,,20200128,20200128,DIR,,,FDA-CTU,,55.0,YR,,F,N,117.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
173388611,17338861,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,D,,,,1000.0,MG,,QD,2020,Q1,Feeling abnormal,,2020,Q1,1,I,20200127.0,,20200128,20200128,DIR,,,FDA-CTU,,55.0,YR,,F,N,117.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
173388611,17338861,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,D,,,,1000.0,MG,,QD,2020,Q1,Nausea,,2020,Q1,1,I,20200127.0,,20200128,20200128,DIR,,,FDA-CTU,,55.0,YR,,F,N,117.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
173388611,17338861,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,D,,,,1000.0,MG,,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20200127.0,,20200128,20200128,DIR,,,FDA-CTU,,55.0,YR,,F,N,117.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
173389701,17338970,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Angioedema,,2020,Q1,1,I,20191209.0,,20200113,20200113,DIR,,,FDA-CTU,,52.0,YR,,F,N,82.0,KG,20200113.0,N,PH,US,US,2020,Q1,Adult
173391681,17339168,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,, 960214/956954,20220131.0,,125.0,MG,,QD,2020,Q1,Haematuria,,2020,Q1,1,I,20191114.0,,20200113,20200113,DIR,,,FDA-CTU,,72.0,YR,,M,N,102.0,KG,20200113.0,N,PH,US,US,2020,Q1,Elderly
173392861,17339286,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Pollakiuria,,2020,Q1,1,I,20191210.0,,20200113,20200113,DIR,,,FDA-CTU,,68.0,YR,,M,N,80.0,KG,20200113.0,N,PH,US,US,2020,Q1,Elderly
173393561,17339356,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,19640108.0,,20200128,20200128,DIR,,,FDA-CTU,,55.0,YR,,M,N,73.8,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
173394461,17339446,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,12.5,MG,,,2020,Q1,Necrotising soft tissue infection,,2020,Q1,1,I,20200108.0,,20200113,20200113,DIR,,,FDA-CTU,,60.0,YR,,M,N,110.0,KG,20200110.0,N,PH,US,US,2020,Q1,Adult
173494431,17349443,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Dizziness,,2020,Q1,1,I,20191101.0,,20200115,20200115,DIR,,,FDA-CTU,,71.0,YR,,M,N,95.0,KG,20200114.0,N,PH,US,US,2020,Q1,Elderly
173494431,17349443,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20191101.0,,20200115,20200115,DIR,,,FDA-CTU,,71.0,YR,,M,N,95.0,KG,20200114.0,N,PH,US,US,2020,Q1,Elderly
173494431,17349443,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Orthostatic hypotension,,2020,Q1,1,I,20191101.0,,20200115,20200115,DIR,,,FDA-CTU,,71.0,YR,,M,N,95.0,KG,20200114.0,N,PH,US,US,2020,Q1,Elderly
173538741,17353874,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,1.0,DF,TABLET,QD,2020,Q1,Blood creatinine increased,,2020,Q1,1,I,20191205.0,,20200115,20200115,DIR,,,FDA-CTU,,69.0,YR,,M,N,119.0,KG,20200115.0,N,PH,US,US,2020,Q1,Elderly
173538741,17353874,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,1.0,DF,TABLET,QD,2020,Q1,Blood urea increased,,2020,Q1,1,I,20191205.0,,20200115,20200115,DIR,,,FDA-CTU,,69.0,YR,,M,N,119.0,KG,20200115.0,N,PH,US,US,2020,Q1,Elderly
173538741,17353874,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,1.0,DF,TABLET,QD,2020,Q1,Glomerular filtration rate decreased,,2020,Q1,1,I,20191205.0,,20200115,20200115,DIR,,,FDA-CTU,,69.0,YR,,M,N,119.0,KG,20200115.0,N,PH,US,US,2020,Q1,Elderly
173649731,17364973,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY;,,,U,,,,,25.0,MG,,QD,2020,Q1,Drug ineffective for unapproved indication,,2020,Q1,1,I,,20200129.0,20200204,20200204,EXP,,CA-TEVA-2020-CA-1178494,TEVA,,59.0,YR,,M,Y,,,20200204.0,,HP,CA,CA,2020,Q1,Adult
173649731,17364973,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY;,,,U,,,,,25.0,MG,,QD,2020,Q1,Off label use,,2020,Q1,1,I,,20200129.0,20200204,20200204,EXP,,CA-TEVA-2020-CA-1178494,TEVA,,59.0,YR,,M,Y,,,20200204.0,,HP,CA,CA,2020,Q1,Adult
173649731,17364973,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY;,,,U,,,,,25.0,MG,,QD,2020,Q1,Urosepsis,,2020,Q1,1,I,,20200129.0,20200204,20200204,EXP,,CA-TEVA-2020-CA-1178494,TEVA,,59.0,YR,,M,Y,,,20200204.0,,HP,CA,CA,2020,Q1,Adult
173660173,17366017,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,D,,,,,10.0,MG,,QD,2020,Q1,Blood pressure fluctuation,,2020,Q1,3,F,2014.0,20200319.0,20200204,20200331,EXP,,RU-EMD SERONO-9143268,EMD SERONO INC,"AMETOV A, NEVOLNIKOVA A, TERTYCHNAYA E. 10.24411/2304-9529-2019-13011; 10 YEARS OF EXPERIENCE WITH VILDAGLIPTIN IN RUSSIAN MEDICAL PRACTICE: CLINICAL EXAMPLES OF NEW POSSIBILITIES. ENDOCRINOLOGY: NEWS, OPINIONS, TRAINING. 2019;8 (3). APPENDIX: 20P:2-19.",58.0,YR,,F,Y,64.0,KG,20200331.0,,MD,RU,RU,2020,Q1,Adult
173660173,17366017,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,D,,,,,10.0,MG,,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,3,F,2014.0,20200319.0,20200204,20200331,EXP,,RU-EMD SERONO-9143268,EMD SERONO INC,"AMETOV A, NEVOLNIKOVA A, TERTYCHNAYA E. 10.24411/2304-9529-2019-13011; 10 YEARS OF EXPERIENCE WITH VILDAGLIPTIN IN RUSSIAN MEDICAL PRACTICE: CLINICAL EXAMPLES OF NEW POSSIBILITIES. ENDOCRINOLOGY: NEWS, OPINIONS, TRAINING. 2019;8 (3). APPENDIX: 20P:2-19.",58.0,YR,,F,Y,64.0,KG,20200331.0,,MD,RU,RU,2020,Q1,Adult
173660173,17366017,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,D,,,,,10.0,MG,,QD,2020,Q1,Dry mouth,,2020,Q1,3,F,2014.0,20200319.0,20200204,20200331,EXP,,RU-EMD SERONO-9143268,EMD SERONO INC,"AMETOV A, NEVOLNIKOVA A, TERTYCHNAYA E. 10.24411/2304-9529-2019-13011; 10 YEARS OF EXPERIENCE WITH VILDAGLIPTIN IN RUSSIAN MEDICAL PRACTICE: CLINICAL EXAMPLES OF NEW POSSIBILITIES. ENDOCRINOLOGY: NEWS, OPINIONS, TRAINING. 2019;8 (3). APPENDIX: 20P:2-19.",58.0,YR,,F,Y,64.0,KG,20200331.0,,MD,RU,RU,2020,Q1,Adult
173660173,17366017,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,D,,,,,10.0,MG,,QD,2020,Q1,Myocardial infarction,,2020,Q1,3,F,2014.0,20200319.0,20200204,20200331,EXP,,RU-EMD SERONO-9143268,EMD SERONO INC,"AMETOV A, NEVOLNIKOVA A, TERTYCHNAYA E. 10.24411/2304-9529-2019-13011; 10 YEARS OF EXPERIENCE WITH VILDAGLIPTIN IN RUSSIAN MEDICAL PRACTICE: CLINICAL EXAMPLES OF NEW POSSIBILITIES. ENDOCRINOLOGY: NEWS, OPINIONS, TRAINING. 2019;8 (3). APPENDIX: 20P:2-19.",58.0,YR,,F,Y,64.0,KG,20200331.0,,MD,RU,RU,2020,Q1,Adult
173660173,17366017,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,D,,,,,10.0,MG,,QD,2020,Q1,Pollakiuria,,2020,Q1,3,F,2014.0,20200319.0,20200204,20200331,EXP,,RU-EMD SERONO-9143268,EMD SERONO INC,"AMETOV A, NEVOLNIKOVA A, TERTYCHNAYA E. 10.24411/2304-9529-2019-13011; 10 YEARS OF EXPERIENCE WITH VILDAGLIPTIN IN RUSSIAN MEDICAL PRACTICE: CLINICAL EXAMPLES OF NEW POSSIBILITIES. ENDOCRINOLOGY: NEWS, OPINIONS, TRAINING. 2019;8 (3). APPENDIX: 20P:2-19.",58.0,YR,,F,Y,64.0,KG,20200331.0,,MD,RU,RU,2020,Q1,Adult
173660173,17366017,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,D,,,,,10.0,MG,,QD,2020,Q1,Pruritus,,2020,Q1,3,F,2014.0,20200319.0,20200204,20200331,EXP,,RU-EMD SERONO-9143268,EMD SERONO INC,"AMETOV A, NEVOLNIKOVA A, TERTYCHNAYA E. 10.24411/2304-9529-2019-13011; 10 YEARS OF EXPERIENCE WITH VILDAGLIPTIN IN RUSSIAN MEDICAL PRACTICE: CLINICAL EXAMPLES OF NEW POSSIBILITIES. ENDOCRINOLOGY: NEWS, OPINIONS, TRAINING. 2019;8 (3). APPENDIX: 20P:2-19.",58.0,YR,,F,Y,64.0,KG,20200331.0,,MD,RU,RU,2020,Q1,Adult
173670131,17367013,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",2050.0,MG,Y,U,,,,25.0,MG,,QD,2020,Q1,Dehydration,,2020,Q1,1,I,20190831.0,20200129.0,20200204,20200204,EXP,GB-MHRA-EYC 00207470,GB-MYLANLABS-2020M1012155,MYLAN,,64.0,YR,,M,Y,,,20200204.0,,HP,GB,GB,2020,Q1,Adult
173670131,17367013,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",2050.0,MG,Y,U,,,,25.0,MG,,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,20190831.0,20200129.0,20200204,20200204,EXP,GB-MHRA-EYC 00207470,GB-MYLANLABS-2020M1012155,MYLAN,,64.0,YR,,M,Y,,,20200204.0,,HP,GB,GB,2020,Q1,Adult
173670131,17367013,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",2050.0,MG,Y,U,,,,25.0,MG,,QD,2020,Q1,Lactic acidosis,,2020,Q1,1,I,20190831.0,20200129.0,20200204,20200204,EXP,GB-MHRA-EYC 00207470,GB-MYLANLABS-2020M1012155,MYLAN,,64.0,YR,,M,Y,,,20200204.0,,HP,GB,GB,2020,Q1,Adult
173749581,17374958,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,10.0,MG,,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173749581,17374958,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,10.0,MG,,QD,2020,Q1,Mental status changes,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173749581,17374958,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,10.0,MG,,QD,2020,Q1,Myocardial infarction,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173749581,17374958,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,10.0,MG,,QD,2020,Q1,Therapy cessation,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173762031,17376203,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,,25.0,MG,TABLET,,2020,Q1,Acidosis,,2020,Q1,1,I,20200116.0,20200131.0,20200206,20200206,EXP,GB-MHRA-ADR 24469814,GB-ACCORD-171755,ACCORD,,74.0,YR,,M,Y,61.1,KG,20200206.0,,PH,GB,GB,2020,Q1,Elderly
173762031,17376203,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,,25.0,MG,TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200116.0,20200131.0,20200206,20200206,EXP,GB-MHRA-ADR 24469814,GB-ACCORD-171755,ACCORD,,74.0,YR,,M,Y,61.1,KG,20200206.0,,PH,GB,GB,2020,Q1,Elderly
173762031,17376203,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,,25.0,MG,TABLET,,2020,Q1,Cardiac arrest,,2020,Q1,1,I,20200116.0,20200131.0,20200206,20200206,EXP,GB-MHRA-ADR 24469814,GB-ACCORD-171755,ACCORD,,74.0,YR,,M,Y,61.1,KG,20200206.0,,PH,GB,GB,2020,Q1,Elderly
173762031,17376203,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,,25.0,MG,TABLET,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20200116.0,20200131.0,20200206,20200206,EXP,GB-MHRA-ADR 24469814,GB-ACCORD-171755,ACCORD,,74.0,YR,,M,Y,61.1,KG,20200206.0,,PH,GB,GB,2020,Q1,Elderly
173762031,17376203,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,,25.0,MG,TABLET,,2020,Q1,Hyperlactacidaemia,,2020,Q1,1,I,20200116.0,20200131.0,20200206,20200206,EXP,GB-MHRA-ADR 24469814,GB-ACCORD-171755,ACCORD,,74.0,YR,,M,Y,61.1,KG,20200206.0,,PH,GB,GB,2020,Q1,Elderly
173762031,17376203,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,,25.0,MG,TABLET,,2020,Q1,Malaise,,2020,Q1,1,I,20200116.0,20200131.0,20200206,20200206,EXP,GB-MHRA-ADR 24469814,GB-ACCORD-171755,ACCORD,,74.0,YR,,M,Y,61.1,KG,20200206.0,,PH,GB,GB,2020,Q1,Elderly
173762031,17376203,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,,25.0,MG,TABLET,,2020,Q1,Vomiting,,2020,Q1,1,I,20200116.0,20200131.0,20200206,20200206,EXP,GB-MHRA-ADR 24469814,GB-ACCORD-171755,ACCORD,,74.0,YR,,M,Y,61.1,KG,20200206.0,,PH,GB,GB,2020,Q1,Elderly
173766481,17376648,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Osteonecrosis of jaw,,2020,Q1,1,I,20180605.0,20191225.0,20200206,20200206,EXP,,ES-MYLANLABS-2019M1131462,MYLAN,,66.0,YR,,F,Y,78.0,KG,20200206.0,,HP,ES,ES,2020,Q1,Elderly
173905871,17390587,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q1,Genital discomfort,,2020,Q1,1,I,20191113.0,,20200124,20200124,DIR,,,FDA-CTU,,77.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q1,Elderly
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Azotaemia,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Chest pain,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Chronic kidney disease,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Decreased appetite,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Fatigue,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Lung infiltration,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Myocardial infarction,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Nausea,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Renal impairment,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Supraventricular tachycardia,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173935762,17393576,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Vomiting,,2020,Q1,2,F,20180404.0,20200128.0,20200208,20200208,EXP,,NVSC2020US027726,NOVARTIS,,57.0,YR,,F,Y,87.4,KG,20200209.0,,CN,DE,US,2020,Q1,Adult
173954401,17395440,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Fungal infection,,2020,Q1,1,I,20190827.0,,20200124,20200124,DIR,,,FDA-CTU,,39.0,YR,,F,N,115.0,KG,20191218.0,N,PH,US,US,2020,Q1,Adult
173961661,17396166,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,N,,,,,25.0,MG,,QD,2020,Q1,Acidosis,,2020,Q1,1,I,20200116.0,20200204.0,20200210,20200210,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-009507513-2002GBR001582,MERCK,,74.0,YR,,M,Y,61.1,KG,20200210.0,,PH,GB,GB,2020,Q1,Elderly
173961661,17396166,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,N,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200116.0,20200204.0,20200210,20200210,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-009507513-2002GBR001582,MERCK,,74.0,YR,,M,Y,61.1,KG,20200210.0,,PH,GB,GB,2020,Q1,Elderly
173961661,17396166,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,N,,,,,25.0,MG,,QD,2020,Q1,Cardiac arrest,,2020,Q1,1,I,20200116.0,20200204.0,20200210,20200210,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-009507513-2002GBR001582,MERCK,,74.0,YR,,M,Y,61.1,KG,20200210.0,,PH,GB,GB,2020,Q1,Elderly
173961661,17396166,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,N,,,,,25.0,MG,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20200116.0,20200204.0,20200210,20200210,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-009507513-2002GBR001582,MERCK,,74.0,YR,,M,Y,61.1,KG,20200210.0,,PH,GB,GB,2020,Q1,Elderly
173961661,17396166,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,N,,,,,25.0,MG,,QD,2020,Q1,Hyperlactacidaemia,,2020,Q1,1,I,20200116.0,20200204.0,20200210,20200210,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-009507513-2002GBR001582,MERCK,,74.0,YR,,M,Y,61.1,KG,20200210.0,,PH,GB,GB,2020,Q1,Elderly
173961661,17396166,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,N,,,,,25.0,MG,,QD,2020,Q1,Malaise,,2020,Q1,1,I,20200116.0,20200204.0,20200210,20200210,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-009507513-2002GBR001582,MERCK,,74.0,YR,,M,Y,61.1,KG,20200210.0,,PH,GB,GB,2020,Q1,Elderly
173961661,17396166,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,N,,,,,25.0,MG,,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20200116.0,20200204.0,20200210,20200210,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-009507513-2002GBR001582,MERCK,,74.0,YR,,M,Y,61.1,KG,20200210.0,,PH,GB,GB,2020,Q1,Elderly
173995631,17399563,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191119.0,,20200124,20200124,DIR,,,FDA-CTU,,60.0,YR,,M,N,112.0,KG,20200117.0,N,PH,US,US,2020,Q1,Adult
174038931,17403893,3,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Daydreaming,,2020,Q1,1,I,,20200210.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1015970,MYLAN,,60.0,YR,,F,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174038931,17403893,3,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Disorientation,,2020,Q1,1,I,,20200210.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1015970,MYLAN,,60.0,YR,,F,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174038931,17403893,3,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Vitamin B12 deficiency,,2020,Q1,1,I,,20200210.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1015970,MYLAN,,60.0,YR,,F,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174055551,17405555,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,,, UNKNOWN,,,25.0,MG,TABLET,,2020,Q1,Acidosis,,2020,Q1,1,I,20200116.0,20200209.0,20200212,20200212,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-TEVA-2020-GB-1184399,TEVA,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174055551,17405555,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,,, UNKNOWN,,,25.0,MG,TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200116.0,20200209.0,20200212,20200212,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-TEVA-2020-GB-1184399,TEVA,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174055551,17405555,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,,, UNKNOWN,,,25.0,MG,TABLET,,2020,Q1,Cardiac arrest,,2020,Q1,1,I,20200116.0,20200209.0,20200212,20200212,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-TEVA-2020-GB-1184399,TEVA,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174055551,17405555,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,,, UNKNOWN,,,25.0,MG,TABLET,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20200116.0,20200209.0,20200212,20200212,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-TEVA-2020-GB-1184399,TEVA,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174055551,17405555,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,,, UNKNOWN,,,25.0,MG,TABLET,,2020,Q1,Hyperlactacidaemia,,2020,Q1,1,I,20200116.0,20200209.0,20200212,20200212,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-TEVA-2020-GB-1184399,TEVA,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174055551,17405555,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,,, UNKNOWN,,,25.0,MG,TABLET,,2020,Q1,Malaise,,2020,Q1,1,I,20200116.0,20200209.0,20200212,20200212,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-TEVA-2020-GB-1184399,TEVA,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174055551,17405555,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,,,,, UNKNOWN,,,25.0,MG,TABLET,,2020,Q1,Vomiting,,2020,Q1,1,I,20200116.0,20200209.0,20200212,20200212,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-TEVA-2020-GB-1184399,TEVA,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174069281,17406928,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,TABLET,QD,2020,Q1,Acidosis,,2020,Q1,1,I,20200116.0,20200131.0,20200212,20200212,EXP,,GB-AUROBINDO-AUR-APL-2020-006607,AUROBINDO,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174069281,17406928,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,TABLET,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200116.0,20200131.0,20200212,20200212,EXP,,GB-AUROBINDO-AUR-APL-2020-006607,AUROBINDO,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174069281,17406928,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,TABLET,QD,2020,Q1,Cardiac arrest,,2020,Q1,1,I,20200116.0,20200131.0,20200212,20200212,EXP,,GB-AUROBINDO-AUR-APL-2020-006607,AUROBINDO,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174069281,17406928,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,TABLET,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20200116.0,20200131.0,20200212,20200212,EXP,,GB-AUROBINDO-AUR-APL-2020-006607,AUROBINDO,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174069281,17406928,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,TABLET,QD,2020,Q1,Hyperlactacidaemia,,2020,Q1,1,I,20200116.0,20200131.0,20200212,20200212,EXP,,GB-AUROBINDO-AUR-APL-2020-006607,AUROBINDO,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174069281,17406928,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,TABLET,QD,2020,Q1,Malaise,,2020,Q1,1,I,20200116.0,20200131.0,20200212,20200212,EXP,,GB-AUROBINDO-AUR-APL-2020-006607,AUROBINDO,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174069281,17406928,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,D,,,,,25.0,MG,TABLET,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20200116.0,20200131.0,20200212,20200212,EXP,,GB-AUROBINDO-AUR-APL-2020-006607,AUROBINDO,,74.0,YR,,M,Y,61.1,KG,20200212.0,,PH,GB,GB,2020,Q1,Elderly
174113961,17411396,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Dehydration,,2020,Q1,1,I,20200113.0,,20200128,20200128,DIR,,,FDA-CTU,,62.0,YR,,M,N,141.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
174113961,17411396,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Dizziness,,2020,Q1,1,I,20200113.0,,20200128,20200128,DIR,,,FDA-CTU,,62.0,YR,,M,N,141.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
174113961,17411396,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Palpitations,,2020,Q1,1,I,20200113.0,,20200128,20200128,DIR,,,FDA-CTU,,62.0,YR,,M,N,141.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
174113961,17411396,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Sinus tachycardia,,2020,Q1,1,I,20200113.0,,20200128,20200128,DIR,,,FDA-CTU,,62.0,YR,,M,N,141.0,KG,20200128.0,N,PH,US,US,2020,Q1,Adult
174122521,17412252,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, DAILY",,,N,,,,,25.0,MG,TABLET,,2020,Q1,Acidosis,,2020,Q1,1,I,20200116.0,20200131.0,20200213,20200213,EXP,GB-MHRA-ADR 24469814,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0142,EMCURE,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174122521,17412252,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, DAILY",,,N,,,,,25.0,MG,TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200116.0,20200131.0,20200213,20200213,EXP,GB-MHRA-ADR 24469814,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0142,EMCURE,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174122521,17412252,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, DAILY",,,N,,,,,25.0,MG,TABLET,,2020,Q1,Cardiac arrest,,2020,Q1,1,I,20200116.0,20200131.0,20200213,20200213,EXP,GB-MHRA-ADR 24469814,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0142,EMCURE,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174122521,17412252,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, DAILY",,,N,,,,,25.0,MG,TABLET,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20200116.0,20200131.0,20200213,20200213,EXP,GB-MHRA-ADR 24469814,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0142,EMCURE,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174122521,17412252,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, DAILY",,,N,,,,,25.0,MG,TABLET,,2020,Q1,Hyperlactacidaemia,,2020,Q1,1,I,20200116.0,20200131.0,20200213,20200213,EXP,GB-MHRA-ADR 24469814,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0142,EMCURE,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174122521,17412252,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, DAILY",,,N,,,,,25.0,MG,TABLET,,2020,Q1,Malaise,,2020,Q1,1,I,20200116.0,20200131.0,20200213,20200213,EXP,GB-MHRA-ADR 24469814,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0142,EMCURE,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174122521,17412252,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, DAILY",,,N,,,,,25.0,MG,TABLET,,2020,Q1,Vomiting,,2020,Q1,1,I,20200116.0,20200131.0,20200213,20200213,EXP,GB-MHRA-ADR 24469814,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0142,EMCURE,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174137251,17413725,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200108.0,,20200130,20200130,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Elderly
174137251,17413725,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q1,Rash,,2020,Q1,1,I,20200108.0,,20200130,20200130,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Elderly
174137251,17413725,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200108.0,,20200130,20200130,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Elderly
174137251,17413725,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Rash,,2020,Q1,1,I,20200108.0,,20200130,20200130,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Elderly
174137291,17413729,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200108.0,,20200130,20200130,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Elderly
174137291,17413729,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Rash,,2020,Q1,1,I,20200108.0,,20200130,20200130,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Elderly
174137291,17413729,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200108.0,,20200130,20200130,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Elderly
174137291,17413729,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q1,Rash,,2020,Q1,1,I,20200108.0,,20200130,20200130,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Elderly
174137341,17413734,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200106.0,,20200130,20200130,DIR,,,FDA-CTU,,83.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Elderly
174137401,17413740,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,,,,,12.5,MG,,,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200116.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200130.0,N,PH,US,US,2020,Q1,Adult
174137981,17413798,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Anal abscess,,2020,Q1,1,I,20191017.0,,20200130,20200130,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200127.0,N,PH,US,US,2020,Q1,Adult
174142071,17414207,13,C,LINAGLIPTIN/EMPAGLIFLOZIN,,2,Oral,,,,,,,,,,,TABLET,QD,2020,Q1,Cytokine release syndrome,,2020,Q1,1,I,20181027.0,20200131.0,20200213,20200213,EXP,,US-FRESENIUS KABI-FK202001290,FRESENIUS KABI,,47.0,YR,,M,Y,93.8,KG,20200213.0,,MD,US,US,2020,Q1,Adult
174142071,17414207,13,C,LINAGLIPTIN/EMPAGLIFLOZIN,,2,Oral,,,,,,,,,,,TABLET,QD,2020,Q1,Febrile neutropenia,,2020,Q1,1,I,20181027.0,20200131.0,20200213,20200213,EXP,,US-FRESENIUS KABI-FK202001290,FRESENIUS KABI,,47.0,YR,,M,Y,93.8,KG,20200213.0,,MD,US,US,2020,Q1,Adult
174158291,17415829,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Acidosis,,2020,Q1,1,I,20200116.0,20200202.0,20200213,20200213,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-BAUSCH-BL-2020-003576,BAUSCH AND LOMB,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174158291,17415829,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200116.0,20200202.0,20200213,20200213,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-BAUSCH-BL-2020-003576,BAUSCH AND LOMB,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174158291,17415829,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Cardiac arrest,,2020,Q1,1,I,20200116.0,20200202.0,20200213,20200213,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-BAUSCH-BL-2020-003576,BAUSCH AND LOMB,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174158291,17415829,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20200116.0,20200202.0,20200213,20200213,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-BAUSCH-BL-2020-003576,BAUSCH AND LOMB,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174158291,17415829,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Hyperlactacidaemia,,2020,Q1,1,I,20200116.0,20200202.0,20200213,20200213,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-BAUSCH-BL-2020-003576,BAUSCH AND LOMB,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174158291,17415829,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Malaise,,2020,Q1,1,I,20200116.0,20200202.0,20200213,20200213,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-BAUSCH-BL-2020-003576,BAUSCH AND LOMB,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174158291,17415829,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20200116.0,20200202.0,20200213,20200213,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-BAUSCH-BL-2020-003576,BAUSCH AND LOMB,,74.0,YR,,M,Y,61.1,KG,20200213.0,,PH,GB,GB,2020,Q1,Elderly
174160192,17416019,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Fall,,2020,Q1,2,F,,20200210.0,20200213,20200217,EXP,,DE-MYLANLABS-2020M1015889,MYLAN,,80.0,YR,,M,Y,,,20200217.0,,MD,DE,DE,2020,Q1,Elderly
174160192,17416019,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Haematoma,,2020,Q1,2,F,,20200210.0,20200213,20200217,EXP,,DE-MYLANLABS-2020M1015889,MYLAN,,80.0,YR,,M,Y,,,20200217.0,,MD,DE,DE,2020,Q1,Elderly
174160192,17416019,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q1,Musculoskeletal pain,,2020,Q1,2,F,,20200210.0,20200213,20200217,EXP,,DE-MYLANLABS-2020M1015889,MYLAN,,80.0,YR,,M,Y,,,20200217.0,,MD,DE,DE,2020,Q1,Elderly
174160292,17416029,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Cardiac failure chronic,,2020,Q1,2,F,,20200109.0,20200213,20200320,EXP,,NVSC2020CZ031078,NOVARTIS,HRNCLROVA L. TREATING A PATIENT WITH CHRONIC HEART FAILURE AND DECREASED EJECTION FRACTION. ACTA MEDICINAE. 2019;8(15):60-3,60.0,YR,,M,Y,,,20200320.0,,HP,CZ,CZ,2020,Q1,Adult
174160292,17416029,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Disease progression,,2020,Q1,2,F,,20200109.0,20200213,20200320,EXP,,NVSC2020CZ031078,NOVARTIS,HRNCLROVA L. TREATING A PATIENT WITH CHRONIC HEART FAILURE AND DECREASED EJECTION FRACTION. ACTA MEDICINAE. 2019;8(15):60-3,60.0,YR,,M,Y,,,20200320.0,,HP,CZ,CZ,2020,Q1,Adult
174160292,17416029,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Therapeutic product effect incomplete,,2020,Q1,2,F,,20200109.0,20200213,20200320,EXP,,NVSC2020CZ031078,NOVARTIS,HRNCLROVA L. TREATING A PATIENT WITH CHRONIC HEART FAILURE AND DECREASED EJECTION FRACTION. ACTA MEDICINAE. 2019;8(15):60-3,60.0,YR,,M,Y,,,20200320.0,,HP,CZ,CZ,2020,Q1,Adult
174172151,17417215,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,N,,,,10.0,MG,,,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20200210.0,20200214,20200214,EXP,,BE-MYLANLABS-2020M1017711,MYLAN,"SCHEEN AJ, PAQUOT N. [WHICH INJECTABLE THERAPY AFTER FAILURE OF ORAL ANTIDIABETIC AGENTS IN TYPE 2 DIABETES ?]. [FRENCH]. REV-MED-LIEGE 2020;75(1):60-66.",65.0,YR,,M,Y,,,20200214.0,,HP,BE,BE,2020,Q1,Elderly
174172151,17417215,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,N,,,,10.0,MG,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200210.0,20200214,20200214,EXP,,BE-MYLANLABS-2020M1017711,MYLAN,"SCHEEN AJ, PAQUOT N. [WHICH INJECTABLE THERAPY AFTER FAILURE OF ORAL ANTIDIABETIC AGENTS IN TYPE 2 DIABETES ?]. [FRENCH]. REV-MED-LIEGE 2020;75(1):60-66.",65.0,YR,,M,Y,,,20200214.0,,HP,BE,BE,2020,Q1,Elderly
174182041,17418204,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Anal abscess,,2020,Q1,1,I,20191017.0,,20200130,20200130,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200127.0,N,PH,US,US,2020,Q1,Adult
174182041,17418204,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q1,Therapy cessation,,2020,Q1,1,I,20191017.0,,20200130,20200130,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200127.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Abdominal pain upper,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Chest pain,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Decreased appetite,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Dysphagia,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Fatigue,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Feeding disorder,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Hiatus hernia,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Intentional dose omission,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Nodule,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174182551,17418255,1,PS,empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,,D,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20191116.0,,20200214,20200214,DIR,,,FDA-CTU,,53.0,YR,,M,N,100.8,KG,20200214.0,N,PH,US,US,2020,Q1,Adult
174187291,17418729,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Acidosis,,2020,Q1,1,I,20200116.0,20200205.0,20200214,20200214,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-EMD SERONO-E2B_90074787,EMD SERONO INC,,74.0,YR,,M,Y,61.0,KG,20200214.0,,PH,GB,GB,2020,Q1,Elderly
174187291,17418729,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200116.0,20200205.0,20200214,20200214,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-EMD SERONO-E2B_90074787,EMD SERONO INC,,74.0,YR,,M,Y,61.0,KG,20200214.0,,PH,GB,GB,2020,Q1,Elderly
174187291,17418729,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Cardiac arrest,,2020,Q1,1,I,20200116.0,20200205.0,20200214,20200214,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-EMD SERONO-E2B_90074787,EMD SERONO INC,,74.0,YR,,M,Y,61.0,KG,20200214.0,,PH,GB,GB,2020,Q1,Elderly
174187291,17418729,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20200116.0,20200205.0,20200214,20200214,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-EMD SERONO-E2B_90074787,EMD SERONO INC,,74.0,YR,,M,Y,61.0,KG,20200214.0,,PH,GB,GB,2020,Q1,Elderly
174187291,17418729,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Hyperlactacidaemia,,2020,Q1,1,I,20200116.0,20200205.0,20200214,20200214,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-EMD SERONO-E2B_90074787,EMD SERONO INC,,74.0,YR,,M,Y,61.0,KG,20200214.0,,PH,GB,GB,2020,Q1,Elderly
174187291,17418729,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Malaise,,2020,Q1,1,I,20200116.0,20200205.0,20200214,20200214,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-EMD SERONO-E2B_90074787,EMD SERONO INC,,74.0,YR,,M,Y,61.0,KG,20200214.0,,PH,GB,GB,2020,Q1,Elderly
174187291,17418729,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20200116.0,20200205.0,20200214,20200214,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-EMD SERONO-E2B_90074787,EMD SERONO INC,,74.0,YR,,M,Y,61.0,KG,20200214.0,,PH,GB,GB,2020,Q1,Elderly
174194771,17419477,9,C,empagliflozin linagliptin 10/5,,2,,,,,,,,,,,,,,2020,Q1,Anaemia,,2020,Q1,1,I,20191008.0,,20200214,20200214,DIR,,,FDA-CTU,,65.0,YR,,F,N,116.0,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
174194771,17419477,9,C,empagliflozin linagliptin 10/5,,2,,,,,,,,,,,,,,2020,Q1,Asthenia,,2020,Q1,1,I,20191008.0,,20200214,20200214,DIR,,,FDA-CTU,,65.0,YR,,F,N,116.0,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
174194771,17419477,9,C,empagliflozin linagliptin 10/5,,2,,,,,,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191008.0,,20200214,20200214,DIR,,,FDA-CTU,,65.0,YR,,F,N,116.0,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
174194771,17419477,9,C,empagliflozin linagliptin 10/5,,2,,,,,,,,,,,,,,2020,Q1,Faeces discoloured,,2020,Q1,1,I,20191008.0,,20200214,20200214,DIR,,,FDA-CTU,,65.0,YR,,F,N,116.0,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
174194771,17419477,9,C,empagliflozin linagliptin 10/5,,2,,,,,,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,1,I,20191008.0,,20200214,20200214,DIR,,,FDA-CTU,,65.0,YR,,F,N,116.0,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
174194771,17419477,9,C,empagliflozin linagliptin 10/5,,2,,,,,,,,,,,,,,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,1,I,20191008.0,,20200214,20200214,DIR,,,FDA-CTU,,65.0,YR,,F,N,116.0,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
174194771,17419477,9,C,empagliflozin linagliptin 10/5,,2,,,,,,,,,,,,,,2020,Q1,Haemoglobin decreased,,2020,Q1,1,I,20191008.0,,20200214,20200214,DIR,,,FDA-CTU,,65.0,YR,,F,N,116.0,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
174194771,17419477,9,C,empagliflozin linagliptin 10/5,,2,,,,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,20191008.0,,20200214,20200214,DIR,,,FDA-CTU,,65.0,YR,,F,N,116.0,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
174247671,17424767,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Acidosis,Acidosis,2020,Q1,1,I,20200116.0,20200204.0,20200217,20200217,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-ALVOGEN-2020-ALVOGEN-107600,ALVOGEN,,74.0,YR,,M,Y,61.1,KG,20200217.0,,PH,GB,GB,2020,Q1,Elderly
174247671,17424767,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Acute kidney injury,Acute kidney injury,2020,Q1,1,I,20200116.0,20200204.0,20200217,20200217,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-ALVOGEN-2020-ALVOGEN-107600,ALVOGEN,,74.0,YR,,M,Y,61.1,KG,20200217.0,,PH,GB,GB,2020,Q1,Elderly
174247671,17424767,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Cardiac arrest,Cardiac arrest,2020,Q1,1,I,20200116.0,20200204.0,20200217,20200217,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-ALVOGEN-2020-ALVOGEN-107600,ALVOGEN,,74.0,YR,,M,Y,61.1,KG,20200217.0,,PH,GB,GB,2020,Q1,Elderly
174247671,17424767,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Hyperglycaemia,Hyperglycaemia,2020,Q1,1,I,20200116.0,20200204.0,20200217,20200217,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-ALVOGEN-2020-ALVOGEN-107600,ALVOGEN,,74.0,YR,,M,Y,61.1,KG,20200217.0,,PH,GB,GB,2020,Q1,Elderly
174247671,17424767,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Hyperlactacidaemia,Hyperlactacidaemia,2020,Q1,1,I,20200116.0,20200204.0,20200217,20200217,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-ALVOGEN-2020-ALVOGEN-107600,ALVOGEN,,74.0,YR,,M,Y,61.1,KG,20200217.0,,PH,GB,GB,2020,Q1,Elderly
174247671,17424767,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Malaise,Malaise,2020,Q1,1,I,20200116.0,20200204.0,20200217,20200217,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-ALVOGEN-2020-ALVOGEN-107600,ALVOGEN,,74.0,YR,,M,Y,61.1,KG,20200217.0,,PH,GB,GB,2020,Q1,Elderly
174247671,17424767,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Vomiting,Vomiting,2020,Q1,1,I,20200116.0,20200204.0,20200217,20200217,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-ALVOGEN-2020-ALVOGEN-107600,ALVOGEN,,74.0,YR,,M,Y,61.1,KG,20200217.0,,PH,GB,GB,2020,Q1,Elderly
174293231,17429323,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200209.0,20200218,20200218,EXP,,AU-ASTRAZENECA-2020SE22770,ASTRAZENECA,,61.0,YR,,M,Y,,,20200218.0,,HP,AU,AU,2020,Q1,Adult
174310342,17431034,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q1,Vertigo,,2020,Q1,2,F,20200102.0,20200218.0,20200218,20200221,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008770",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,83.4,KG,20200221.0,,MD,DE,DE,2020,Q1,Elderly
174314961,17431496,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,10.0,MG,,QD,2020,Q1,Asthma,,2020,Q1,1,I,,20200213.0,20200218,20200218,EXP,,CA-TEVA-2020-CA-1187304,TEVA,,50.0,YR,,M,Y,83.0,KG,20200218.0,,CN,CA,CA,2020,Q1,Adult
174314961,17431496,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,10.0,MG,,QD,2020,Q1,Blood count abnormal,,2020,Q1,1,I,,20200213.0,20200218,20200218,EXP,,CA-TEVA-2020-CA-1187304,TEVA,,50.0,YR,,M,Y,83.0,KG,20200218.0,,CN,CA,CA,2020,Q1,Adult
174314961,17431496,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,10.0,MG,,QD,2020,Q1,Chest discomfort,,2020,Q1,1,I,,20200213.0,20200218,20200218,EXP,,CA-TEVA-2020-CA-1187304,TEVA,,50.0,YR,,M,Y,83.0,KG,20200218.0,,CN,CA,CA,2020,Q1,Adult
174314961,17431496,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,10.0,MG,,QD,2020,Q1,Drug intolerance,,2020,Q1,1,I,,20200213.0,20200218,20200218,EXP,,CA-TEVA-2020-CA-1187304,TEVA,,50.0,YR,,M,Y,83.0,KG,20200218.0,,CN,CA,CA,2020,Q1,Adult
174314961,17431496,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,10.0,MG,,QD,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200213.0,20200218,20200218,EXP,,CA-TEVA-2020-CA-1187304,TEVA,,50.0,YR,,M,Y,83.0,KG,20200218.0,,CN,CA,CA,2020,Q1,Adult
174314961,17431496,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,10.0,MG,,QD,2020,Q1,Tremor,,2020,Q1,1,I,,20200213.0,20200218,20200218,EXP,,CA-TEVA-2020-CA-1187304,TEVA,,50.0,YR,,M,Y,83.0,KG,20200218.0,,CN,CA,CA,2020,Q1,Adult
174339901,17433990,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,14.5,MG,,,2020,Q1,Culture urine positive,,2020,Q1,1,I,20191105.0,,20200203,20200203,DIR,,,FDA-CTU,,73.0,YR,,M,N,119.75,KG,20200201.0,N,PH,US,US,2020,Q1,Elderly
174339901,17433990,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,14.5,MG,,,2020,Q1,Escherichia infection,,2020,Q1,1,I,20191105.0,,20200203,20200203,DIR,,,FDA-CTU,,73.0,YR,,M,N,119.75,KG,20200201.0,N,PH,US,US,2020,Q1,Elderly
174339901,17433990,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,14.5,MG,,,2020,Q1,Haematuria,,2020,Q1,1,I,20191105.0,,20200203,20200203,DIR,,,FDA-CTU,,73.0,YR,,M,N,119.75,KG,20200201.0,N,PH,US,US,2020,Q1,Elderly
174339901,17433990,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,14.5,MG,,,2020,Q1,Urinary tract infection,,2020,Q1,1,I,20191105.0,,20200203,20200203,DIR,,,FDA-CTU,,73.0,YR,,M,N,119.75,KG,20200201.0,N,PH,US,US,2020,Q1,Elderly
174386521,17438652,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,General physical health deterioration,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013922,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,,,20200220.0,,MD,DE,DE,2020,Q1,Elderly
174386521,17438652,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013922,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,,,20200220.0,,MD,DE,DE,2020,Q1,Elderly
174386521,17438652,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Polydipsia,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013922,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,,,20200220.0,,MD,DE,DE,2020,Q1,Elderly
174386521,17438652,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q1,Polyuria,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013922,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,,,20200220.0,,MD,DE,DE,2020,Q1,Elderly
174388191,17438819,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,1 DOSAGE FORMS,,,,, UNKNOWN,,,1.0,DF,,,2020,Q1,"Hallucinations, mixed",,2020,Q1,1,I,,20200217.0,20200220,20200220,EXP,GB-MHRA-TPP20841205C6791539YC1580403457547,GB-TEVA-2020-GB-1188401,TEVA,,65.0,YR,,M,Y,88.0,KG,20200220.0,,MD,GB,GB,2020,Q1,Elderly
174413081,17441308,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q1,Abdominal pain,,2020,Q1,1,I,20190317.0,20190319.0,20200220,20200220,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-012615",BOEHRINGER INGELHEIM,,73.0,YR,,F,Y,,,20200220.0,,MD,US,US,2020,Q1,Elderly
174413081,17441308,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20190317.0,20190319.0,20200220,20200220,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-012615",BOEHRINGER INGELHEIM,,73.0,YR,,F,Y,,,20200220.0,,MD,US,US,2020,Q1,Elderly
174413081,17441308,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q1,Nephropathy,,2020,Q1,1,I,20190317.0,20190319.0,20200220,20200220,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-012615",BOEHRINGER INGELHEIM,,73.0,YR,,F,Y,,,20200220.0,,MD,US,US,2020,Q1,Elderly
174464271,17446427,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20191217.0,20200219.0,20200221,20200221,EXP,GB-MHRA-EYC 00215154,GB-MYLANLABS-2020M1019862,MYLAN,,75.0,YR,,M,Y,95.0,KG,20200221.0,,PH,GB,GB,2020,Q1,Elderly
174464271,17446427,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Blood glucose abnormal,,2020,Q1,1,I,20191217.0,20200219.0,20200221,20200221,EXP,GB-MHRA-EYC 00215154,GB-MYLANLABS-2020M1019862,MYLAN,,75.0,YR,,M,Y,95.0,KG,20200221.0,,PH,GB,GB,2020,Q1,Elderly
174464271,17446427,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191217.0,20200219.0,20200221,20200221,EXP,GB-MHRA-EYC 00215154,GB-MYLANLABS-2020M1019862,MYLAN,,75.0,YR,,M,Y,95.0,KG,20200221.0,,PH,GB,GB,2020,Q1,Elderly
174464271,17446427,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191217.0,20200219.0,20200221,20200221,EXP,GB-MHRA-EYC 00215154,GB-MYLANLABS-2020M1019862,MYLAN,,75.0,YR,,M,Y,95.0,KG,20200221.0,,PH,GB,GB,2020,Q1,Elderly
174464271,17446427,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,U,,,,25.0,MG,,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,20191217.0,20200219.0,20200221,20200221,EXP,GB-MHRA-EYC 00215154,GB-MYLANLABS-2020M1019862,MYLAN,,75.0,YR,,M,Y,95.0,KG,20200221.0,,PH,GB,GB,2020,Q1,Elderly
174468452,17446845,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q1,Thyroid cancer,,2020,Q1,2,F,20190924.0,20200228.0,20200221,20200306,EXP,,IT-ASTRAZENECA-2019SF40248,ASTRAZENECA,,70.0,YR,,M,Y,,,20200306.0,,MD,IT,IT,2020,Q1,Elderly
174472111,17447211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20200127.0,20200210.0,20200221,20200221,EXP,GB-MHRA-EYC 00217477,GB-ELI_LILLY_AND_COMPANY-GB202002004733,ELI LILLY AND CO,,70.0,YR,,M,Y,75.0,KG,20200221.0,,CN,GB,GB,2020,Q1,Elderly
174472111,17447211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,20200127.0,20200210.0,20200221,20200221,EXP,GB-MHRA-EYC 00217477,GB-ELI_LILLY_AND_COMPANY-GB202002004733,ELI LILLY AND CO,,70.0,YR,,M,Y,75.0,KG,20200221.0,,CN,GB,GB,2020,Q1,Elderly
174472111,17447211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,1,I,20200127.0,20200210.0,20200221,20200221,EXP,GB-MHRA-EYC 00217477,GB-ELI_LILLY_AND_COMPANY-GB202002004733,ELI LILLY AND CO,,70.0,YR,,M,Y,75.0,KG,20200221.0,,CN,GB,GB,2020,Q1,Elderly
174472111,17447211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Heart rate increased,,2020,Q1,1,I,20200127.0,20200210.0,20200221,20200221,EXP,GB-MHRA-EYC 00217477,GB-ELI_LILLY_AND_COMPANY-GB202002004733,ELI LILLY AND CO,,70.0,YR,,M,Y,75.0,KG,20200221.0,,CN,GB,GB,2020,Q1,Elderly
174472111,17447211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,20200127.0,20200210.0,20200221,20200221,EXP,GB-MHRA-EYC 00217477,GB-ELI_LILLY_AND_COMPANY-GB202002004733,ELI LILLY AND CO,,70.0,YR,,M,Y,75.0,KG,20200221.0,,CN,GB,GB,2020,Q1,Elderly
174472111,17447211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20200127.0,20200210.0,20200221,20200221,EXP,GB-MHRA-EYC 00217477,GB-ELI_LILLY_AND_COMPANY-GB202002004733,ELI LILLY AND CO,,70.0,YR,,M,Y,75.0,KG,20200221.0,,CN,GB,GB,2020,Q1,Elderly
174488241,17448824,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, DAILY",,,,,,,,25.0,MG,,QD,2020,Q1,Abdominal pain upper,,2020,Q1,1,I,202001.0,20200217.0,20200224,20200224,PER,,US-ELI_LILLY_AND_COMPANY-US202002008115,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20200224.0,,CN,US,US,2020,Q1,Adult
174488241,17448824,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, DAILY",,,,,,,,25.0,MG,,QD,2020,Q1,Decreased appetite,,2020,Q1,1,I,202001.0,20200217.0,20200224,20200224,PER,,US-ELI_LILLY_AND_COMPANY-US202002008115,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20200224.0,,CN,US,US,2020,Q1,Adult
174488241,17448824,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, DAILY",,,,,,,,25.0,MG,,QD,2020,Q1,Eructation,,2020,Q1,1,I,202001.0,20200217.0,20200224,20200224,PER,,US-ELI_LILLY_AND_COMPANY-US202002008115,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20200224.0,,CN,US,US,2020,Q1,Adult
174488241,17448824,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, DAILY",,,,,,,,25.0,MG,,QD,2020,Q1,Flatulence,,2020,Q1,1,I,202001.0,20200217.0,20200224,20200224,PER,,US-ELI_LILLY_AND_COMPANY-US202002008115,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20200224.0,,CN,US,US,2020,Q1,Adult
174488241,17448824,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, DAILY",,,,,,,,25.0,MG,,QD,2020,Q1,Muscle spasms,,2020,Q1,1,I,202001.0,20200217.0,20200224,20200224,PER,,US-ELI_LILLY_AND_COMPANY-US202002008115,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20200224.0,,CN,US,US,2020,Q1,Adult
174488241,17448824,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, DAILY",,,,,,,,25.0,MG,,QD,2020,Q1,Nausea,,2020,Q1,1,I,202001.0,20200217.0,20200224,20200224,PER,,US-ELI_LILLY_AND_COMPANY-US202002008115,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20200224.0,,CN,US,US,2020,Q1,Adult
174488241,17448824,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, DAILY",,,,,,,,25.0,MG,,QD,2020,Q1,Vomiting,,2020,Q1,1,I,202001.0,20200217.0,20200224,20200224,PER,,US-ELI_LILLY_AND_COMPANY-US202002008115,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20200224.0,,CN,US,US,2020,Q1,Adult
174492671,17449267,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Hypotension,,2020,Q1,1,I,20190129.0,20200213.0,20200224,20200224,EXP,,US-TEVA-2020-US-1188218,TEVA,,60.0,YR,,M,Y,106.5,KG,20200224.0,,MD,US,US,2020,Q1,Adult
174492671,17449267,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,FILM-COATED TABLET,,2020,Q1,Hypotension,,2020,Q1,1,I,20190129.0,20200213.0,20200224,20200224,EXP,,US-TEVA-2020-US-1188218,TEVA,,60.0,YR,,M,Y,106.5,KG,20200224.0,,MD,US,US,2020,Q1,Adult
174513891,17451389,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Orchitis,,2020,Q1,1,I,20191226.0,,20200210,20200210,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200209.0,N,PH,US,US,2020,Q1,Elderly
174546351,17454635,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Blister rupture,,2020,Q1,1,I,,20200219.0,20200225,20200225,EXP,GB-MHRA-EYC 00217971,GB-TAKEDA-2020TEU001981,TAKEDA,,69.0,YR,,F,Y,87.2,KG,20200225.0,,HP,GB,GB,2020,Q1,Elderly
174546351,17454635,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Pain,,2020,Q1,1,I,,20200219.0,20200225,20200225,EXP,GB-MHRA-EYC 00217971,GB-TAKEDA-2020TEU001981,TAKEDA,,69.0,YR,,F,Y,87.2,KG,20200225.0,,HP,GB,GB,2020,Q1,Elderly
174546351,17454635,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Pemphigoid,,2020,Q1,1,I,,20200219.0,20200225,20200225,EXP,GB-MHRA-EYC 00217971,GB-TAKEDA-2020TEU001981,TAKEDA,,69.0,YR,,F,Y,87.2,KG,20200225.0,,HP,GB,GB,2020,Q1,Elderly
174546351,17454635,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200219.0,20200225,20200225,EXP,GB-MHRA-EYC 00217971,GB-TAKEDA-2020TEU001981,TAKEDA,,69.0,YR,,F,Y,87.2,KG,20200225.0,,HP,GB,GB,2020,Q1,Elderly
174546351,17454635,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q1,Rash,,2020,Q1,1,I,,20200219.0,20200225,20200225,EXP,GB-MHRA-EYC 00217971,GB-TAKEDA-2020TEU001981,TAKEDA,,69.0,YR,,F,Y,87.2,KG,20200225.0,,HP,GB,GB,2020,Q1,Elderly
174569311,17456931,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Complicated appendicitis,,2020,Q1,1,I,20190313.0,20200221.0,20200225,20200225,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-011043",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.9,KG,20200225.0,,MD,JP,JP,2020,Q1,Adult
174569311,17456931,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Diabetes mellitus,,2020,Q1,1,I,20190313.0,20200221.0,20200225,20200225,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-011043",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.9,KG,20200225.0,,MD,JP,JP,2020,Q1,Adult
174642621,17464262,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,204629.0,10.0,MG,TABLET,QD,2020,Q1,Hepatic cirrhosis,,2020,Q1,1,I,20161025.0,20191020.0,20200226,20200226,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-109455",BOEHRINGER INGELHEIM,,53.0,YR,,F,Y,,,20200226.0,,MD,JP,JP,2020,Q1,Adult
174642621,17464262,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,204629.0,25.0,MG,TABLET,QD,2020,Q1,Hepatic cirrhosis,,2020,Q1,1,I,20161025.0,20191020.0,20200226,20200226,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-109455",BOEHRINGER INGELHEIM,,53.0,YR,,F,Y,,,20200226.0,,MD,JP,JP,2020,Q1,Adult
174705751,17470575,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Arteriosclerosis coronary artery,,2020,Q1,1,I,,20200213.0,20200227,20200227,EXP,,IT-NOVOPROD-713425,NOVO NORDISK,,74.0,YR,,M,Y,,,20200227.0,,MD,IT,IT,2020,Q1,Elderly
174705751,17470575,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Coronary artery stenosis,,2020,Q1,1,I,,20200213.0,20200227,20200227,EXP,,IT-NOVOPROD-713425,NOVO NORDISK,,74.0,YR,,M,Y,,,20200227.0,,MD,IT,IT,2020,Q1,Elderly
174705751,17470575,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200213.0,20200227,20200227,EXP,,IT-NOVOPROD-713425,NOVO NORDISK,,74.0,YR,,M,Y,,,20200227.0,,MD,IT,IT,2020,Q1,Elderly
174705751,17470575,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200213.0,20200227,20200227,EXP,,IT-NOVOPROD-713425,NOVO NORDISK,,74.0,YR,,M,Y,,,20200227.0,,MD,IT,IT,2020,Q1,Elderly
174705751,17470575,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2020,Q1,Weight increased,,2020,Q1,1,I,,20200213.0,20200227,20200227,EXP,,IT-NOVOPROD-713425,NOVO NORDISK,,74.0,YR,,M,Y,,,20200227.0,,MD,IT,IT,2020,Q1,Elderly
174715261,17471526,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,,,,,10.0,MG,,,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20200224.0,20200228,20200228,EXP,,BE-009507513-2002BEL009180,MERCK,SCHEEN AJ. WHICH INJECTABLE THERAPY AFTER FAILURE OF ORAL ANTIDIABETIC AGENTS IN TYPE 2 DIABETES ?. REV-MED-LIEGE. 2020;75(1):60-6,65.0,YR,,M,Y,,,20200228.0,,HP,BE,BE,2020,Q1,Elderly
174715261,17471526,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,,,,,10.0,MG,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200224.0,20200228,20200228,EXP,,BE-009507513-2002BEL009180,MERCK,SCHEEN AJ. WHICH INJECTABLE THERAPY AFTER FAILURE OF ORAL ANTIDIABETIC AGENTS IN TYPE 2 DIABETES ?. REV-MED-LIEGE. 2020;75(1):60-6,65.0,YR,,M,Y,,,20200228.0,,HP,BE,BE,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,7,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q1,Syncope,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174806761,17480676,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,25.0,MG,TABLET,,2020,Q1,Lung neoplasm malignant,,2020,Q1,1,I,20180625.0,20200227.0,20200301,20200301,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-011807",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,43.2,KG,20200301.0,,MD,JP,JP,2020,Q1,Elderly
174834521,17483452,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q1,Rash,,2020,Q1,1,I,20190711.0,,20200218,20200218,DIR,,,FDA-CTU,,73.0,YR,,M,N,106.0,KG,20190918.0,N,PH,US,US,2020,Q1,Elderly
174870411,17487041,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Balanoposthitis,,2020,Q1,1,I,20191114.0,,20200219,20200219,DIR,,,FDA-CTU,,75.0,YR,,M,N,84.37,KG,20200218.0,N,PH,US,US,2020,Q1,Elderly
174870411,17487041,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Blood creatinine increased,,2020,Q1,1,I,20191114.0,,20200219,20200219,DIR,,,FDA-CTU,,75.0,YR,,M,N,84.37,KG,20200218.0,N,PH,US,US,2020,Q1,Elderly
174870411,17487041,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Blood urea increased,,2020,Q1,1,I,20191114.0,,20200219,20200219,DIR,,,FDA-CTU,,75.0,YR,,M,N,84.37,KG,20200218.0,N,PH,US,US,2020,Q1,Elderly
174896971,17489697,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"TABLET, 10 MG (MILLIGRAM), 1 KEER PER DAG, 1",,,,,,,204629.0,10.0,MG,TABLET,QD,2020,Q1,Candida infection,,2020,Q1,1,I,20200106.0,20200228.0,20200303,20200303,EXP,NL-LRB-00379081,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-011879",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,60.8,KG,20200303.0,,MD,NL,NL,2020,Q1,Elderly
174896971,17489697,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"TABLET, 10 MG (MILLIGRAM), 1 KEER PER DAG, 1",,,,,,,204629.0,10.0,MG,TABLET,QD,2020,Q1,Endophthalmitis,,2020,Q1,1,I,20200106.0,20200228.0,20200303,20200303,EXP,NL-LRB-00379081,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-011879",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,60.8,KG,20200303.0,,MD,NL,NL,2020,Q1,Elderly
174896971,17489697,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"TABLET, 10 MG (MILLIGRAM), 1 KEER PER DAG, 1",,,,,,,204629.0,10.0,MG,TABLET,QD,2020,Q1,Urosepsis,,2020,Q1,1,I,20200106.0,20200228.0,20200303,20200303,EXP,NL-LRB-00379081,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-011879",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,60.8,KG,20200303.0,,MD,NL,NL,2020,Q1,Elderly
174918531,17491853,8,C,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,QD (HALF TABLET),,,U,U,,,,,,,QD,2020,Q1,Arrhythmia,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,8,C,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,QD (HALF TABLET),,,U,U,,,,,,,QD,2020,Q1,Arthritis,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,8,C,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,QD (HALF TABLET),,,U,U,,,,,,,QD,2020,Q1,Asthma,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,8,C,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,QD (HALF TABLET),,,U,U,,,,,,,QD,2020,Q1,Chronic sinusitis,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,8,C,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,QD (HALF TABLET),,,U,U,,,,,,,QD,2020,Q1,Cough,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,8,C,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,QD (HALF TABLET),,,U,U,,,,,,,QD,2020,Q1,Intraductal proliferative breast lesion,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,8,C,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,QD (HALF TABLET),,,U,U,,,,,,,QD,2020,Q1,Sleep apnoea syndrome,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,8,C,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,QD (HALF TABLET),,,U,U,,,,,,,QD,2020,Q1,Snoring,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,8,C,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,QD (HALF TABLET),,,U,U,,,,,,,QD,2020,Q1,Upper respiratory tract infection,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174929991,17492999,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2020,Q1,Body mass index increased,,2020,Q1,1,I,,20200220.0,20200303,20200303,EXP,,AT-ELI_LILLY_AND_COMPANY-AT202002013549,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20200303.0,,MD,AT,AT,2020,Q1,Adult
174929991,17492999,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2020,Q1,Coronary artery stenosis,,2020,Q1,1,I,,20200220.0,20200303,20200303,EXP,,AT-ELI_LILLY_AND_COMPANY-AT202002013549,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20200303.0,,MD,AT,AT,2020,Q1,Adult
174929991,17492999,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2020,Q1,Glomerular filtration rate decreased,,2020,Q1,1,I,,20200220.0,20200303,20200303,EXP,,AT-ELI_LILLY_AND_COMPANY-AT202002013549,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20200303.0,,MD,AT,AT,2020,Q1,Adult
174929991,17492999,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,,20200220.0,20200303,20200303,EXP,,AT-ELI_LILLY_AND_COMPANY-AT202002013549,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20200303.0,,MD,AT,AT,2020,Q1,Adult
174929991,17492999,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2020,Q1,Hyperlipidaemia,,2020,Q1,1,I,,20200220.0,20200303,20200303,EXP,,AT-ELI_LILLY_AND_COMPANY-AT202002013549,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20200303.0,,MD,AT,AT,2020,Q1,Adult
174929991,17492999,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2020,Q1,Hypertension,,2020,Q1,1,I,,20200220.0,20200303,20200303,EXP,,AT-ELI_LILLY_AND_COMPANY-AT202002013549,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20200303.0,,MD,AT,AT,2020,Q1,Adult
174952221,17495222,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,, 956954,20220131.0,,12.5,MG,,QD,2020,Q1,Genital infection fungal,,2020,Q1,1,I,20200207.0,,20200221,20200221,DIR,,,FDA-CTU,,76.0,YR,,M,N,119.0,KG,20200220.0,N,PH,US,US,2020,Q1,Elderly
174952221,17495222,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,, 956954,20220131.0,,12.5,MG,,QD,2020,Q1,Rash,,2020,Q1,1,I,20200207.0,,20200221,20200221,DIR,,,FDA-CTU,,76.0,YR,,M,N,119.0,KG,20200220.0,N,PH,US,US,2020,Q1,Elderly
174953341,17495334,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q1,Pollakiuria,,2020,Q1,1,I,20191204.0,,20200221,20200221,DIR,,,FDA-CTU,,69.0,YR,,M,N,86.18,KG,20200201.0,N,PH,US,US,2020,Q1,Elderly
174972561,17497256,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2020,Q1,Taste disorder,,2020,Q1,1,I,20200210.0,,20200304,20200304,DIR,,,FDA-CTU,,72.0,YR,,M,N,84.37,KG,20200304.0,N,,US,US,2020,Q1,Elderly
175006321,17500632,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,3726.0417,MG,Y,,,,,25.0,MG,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200109.0,20200229.0,20200305,20200305,EXP,GB-MHRA-ADR 24470084,GB-ACCORD-174681,ACCORD,,68.0,YR,,F,Y,74.8,KG,20200305.0,,MD,GB,GB,2020,Q1,Elderly
175078651,17507865,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",257.042,DF,,,,,,1.0,DF,,QD,2020,Q1,Retinal haemorrhage,,2020,Q1,1,I,20200203.0,20200224.0,20200306,20200306,EXP,GB-MHRA-TPP9147716C6284380YC1581021932089,GB-NOVOPROD-714726,NOVO NORDISK,,57.0,YR,,F,Y,124.0,KG,20200306.0,,HP,GB,GB,2020,Q1,Adult
175078651,17507865,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",257.042,DF,,,,,,1.0,DF,,QD,2020,Q1,Vitreous haemorrhage,,2020,Q1,1,I,20200203.0,20200224.0,20200306,20200306,EXP,GB-MHRA-TPP9147716C6284380YC1581021932089,GB-NOVOPROD-714726,NOVO NORDISK,,57.0,YR,,F,Y,124.0,KG,20200306.0,,HP,GB,GB,2020,Q1,Adult
175081031,17508103,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Urinary tract infection,,2020,Q1,1,I,20200121.0,,20200225,20200225,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175092481,17509248,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175092481,17509248,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175092481,17509248,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175092481,17509248,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175092481,17509248,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175100471,17510047,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Urinary tract infection,,2020,Q1,1,I,20200121.0,,20200226,20200226,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175102351,17510235,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,, 957551,20220430,,25.0,MG,,QD,2020,Q1,Fungal infection,,2020,Q1,1,I,20200207.0,,20200226,20200226,DIR,,,FDA-CTU,,68.0,YR,,M,N,121.0,KG,20200225.0,N,PH,US,US,2020,Q1,Elderly
175102351,17510235,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,, 957551,20220430,,25.0,MG,,QD,2020,Q1,Genital rash,,2020,Q1,1,I,20200207.0,,20200226,20200226,DIR,,,FDA-CTU,,68.0,YR,,M,N,121.0,KG,20200225.0,N,PH,US,US,2020,Q1,Elderly
175102351,17510235,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,, 957551,20220430,,25.0,MG,,QD,2020,Q1,Urinary tract infection,,2020,Q1,1,I,20200207.0,,20200226,20200226,DIR,,,FDA-CTU,,68.0,YR,,M,N,121.0,KG,20200225.0,N,PH,US,US,2020,Q1,Elderly
175106751,17510675,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Chills,,2020,Q1,1,I,,20200228.0,20200306,20200306,EXP,,CA-CELGENEUS-CAN-20200210550,CELGENE,,66.0,YR,,M,Y,,,20200306.0,,HP,CA,CA,2020,Q1,Elderly
175106751,17510675,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Sepsis,,2020,Q1,1,I,,20200228.0,20200306,20200306,EXP,,CA-CELGENEUS-CAN-20200210550,CELGENE,,66.0,YR,,M,Y,,,20200306.0,,HP,CA,CA,2020,Q1,Elderly
175106751,17510675,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Vomiting,,2020,Q1,1,I,,20200228.0,20200306,20200306,EXP,,CA-CELGENEUS-CAN-20200210550,CELGENE,,66.0,YR,,M,Y,,,20200306.0,,HP,CA,CA,2020,Q1,Elderly
175110841,17511084,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,10.0,MG,,,2020,Q1,Dizziness,,2020,Q1,1,I,20190106.0,,20200226,20200226,DIR,,,FDA-CTU,,59.0,YR,,M,N,112.04,KG,20190716.0,N,PH,US,US,2020,Q1,Adult
175110841,17511084,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,10.0,MG,,,2020,Q1,Hypotension,,2020,Q1,1,I,20190106.0,,20200226,20200226,DIR,,,FDA-CTU,,59.0,YR,,M,N,112.04,KG,20190716.0,N,PH,US,US,2020,Q1,Adult
175110841,17511084,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,10.0,MG,,,2020,Q1,Syncope,,2020,Q1,1,I,20190106.0,,20200226,20200226,DIR,,,FDA-CTU,,59.0,YR,,M,N,112.04,KG,20190716.0,N,PH,US,US,2020,Q1,Adult
175110841,17511084,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q1,Dizziness,,2020,Q1,1,I,20190106.0,,20200226,20200226,DIR,,,FDA-CTU,,59.0,YR,,M,N,112.04,KG,20190716.0,N,PH,US,US,2020,Q1,Adult
175110841,17511084,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q1,Hypotension,,2020,Q1,1,I,20190106.0,,20200226,20200226,DIR,,,FDA-CTU,,59.0,YR,,M,N,112.04,KG,20190716.0,N,PH,US,US,2020,Q1,Adult
175110841,17511084,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q1,Syncope,,2020,Q1,1,I,20190106.0,,20200226,20200226,DIR,,,FDA-CTU,,59.0,YR,,M,N,112.04,KG,20190716.0,N,PH,US,US,2020,Q1,Adult
175112731,17511273,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2020,Q1,Pollakiuria,,2020,Q1,1,I,20191209.0,,20200226,20200226,DIR,,,FDA-CTU,,85.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q1,Elderly
175112731,17511273,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2020,Q1,Rash,,2020,Q1,1,I,20191209.0,,20200226,20200226,DIR,,,FDA-CTU,,85.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q1,Elderly
175115471,17511547,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Cardiac arrest,,2020,Q1,1,I,20190204.0,20200225.0,20200307,20200307,EXP,,GB-AUROBINDO-AUR-APL-2020-011112,AUROBINDO,,83.0,YR,,F,Y,,,20200307.0,,PH,GB,GB,2020,Q1,Elderly
175115471,17511547,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Malaise,,2020,Q1,1,I,20190204.0,20200225.0,20200307,20200307,EXP,,GB-AUROBINDO-AUR-APL-2020-011112,AUROBINDO,,83.0,YR,,F,Y,,,20200307.0,,PH,GB,GB,2020,Q1,Elderly
175115471,17511547,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Sinus node dysfunction,,2020,Q1,1,I,20190204.0,20200225.0,20200307,20200307,EXP,,GB-AUROBINDO-AUR-APL-2020-011112,AUROBINDO,,83.0,YR,,F,Y,,,20200307.0,,PH,GB,GB,2020,Q1,Elderly
175121661,17512166,3,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,,,2020,Q1,Daydreaming,,2020,Q1,1,I,,20200304.0,20200308,20200308,EXP,,NVSC2020ES062765,NOVARTIS,,60.0,YR,,F,Y,,,20200308.0,,HP,ES,ES,2020,Q1,Adult
175121661,17512166,3,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,,,2020,Q1,Disorientation,,2020,Q1,1,I,,20200304.0,20200308,20200308,EXP,,NVSC2020ES062765,NOVARTIS,,60.0,YR,,F,Y,,,20200308.0,,HP,ES,ES,2020,Q1,Adult
175121661,17512166,3,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,,,2020,Q1,Vitamin B12 deficiency,,2020,Q1,1,I,,20200304.0,20200308,20200308,EXP,,NVSC2020ES062765,NOVARTIS,,60.0,YR,,F,Y,,,20200308.0,,HP,ES,ES,2020,Q1,Adult
175143911,17514391,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,1,I,20200123.0,,20200226,20200226,DIR,,,FDA-CTU,,71.0,YR,,F,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175143911,17514391,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Asthenia,,2020,Q1,1,I,20200123.0,,20200226,20200226,DIR,,,FDA-CTU,,71.0,YR,,F,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175144011,17514401,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200101.0,,20200226,20200226,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175144011,17514401,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20200101.0,,20200226,20200226,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175144011,17514401,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20200101.0,,20200226,20200226,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175144011,17514401,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20200101.0,,20200226,20200226,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Blood creatinine increased,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Blood urea increased,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Confusional state,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Diarrhoea,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Fatigue,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Hyponatraemia,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Hypotension,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Hypovolaemia,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175166381,17516638,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N," 960183,960182,960184",20220630.0,,12.5,MG,,QD,2020,Q1,Weight decreased,,2020,Q1,1,I,20200211.0,,20200306,20200306,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200227.0,N,PH,US,US,2020,Q1,Elderly
175204451,17520445,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200108.0,,20200302,20200302,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200228.0,N,PH,US,US,2020,Q1,Elderly
175207361,17520736,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,, 957395,20220401.0,,12.5,MG,,,2020,Q1,Genital pain,,2020,Q1,1,I,20200127.0,,20200302,20200302,DIR,,,FDA-CTU,,70.0,YR,,M,N,125.0,KG,20200229.0,N,PH,US,US,2020,Q1,Elderly
175210101,17521010,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200108.0,,20200302,20200302,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200228.0,N,PH,US,US,2020,Q1,Elderly
175210841,17521084,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Acidosis,,2020,Q1,1,I,20200116.0,20200229.0,20200310,20200310,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-MYLANLABS-2020M1024277,MYLAN,,74.0,YR,,M,Y,61.1,KG,20200310.0,,PH,GB,GB,2020,Q1,Elderly
175210841,17521084,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200116.0,20200229.0,20200310,20200310,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-MYLANLABS-2020M1024277,MYLAN,,74.0,YR,,M,Y,61.1,KG,20200310.0,,PH,GB,GB,2020,Q1,Elderly
175210841,17521084,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Cardiac arrest,,2020,Q1,1,I,20200116.0,20200229.0,20200310,20200310,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-MYLANLABS-2020M1024277,MYLAN,,74.0,YR,,M,Y,61.1,KG,20200310.0,,PH,GB,GB,2020,Q1,Elderly
175210841,17521084,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20200116.0,20200229.0,20200310,20200310,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-MYLANLABS-2020M1024277,MYLAN,,74.0,YR,,M,Y,61.1,KG,20200310.0,,PH,GB,GB,2020,Q1,Elderly
175210841,17521084,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Hyperlactacidaemia,,2020,Q1,1,I,20200116.0,20200229.0,20200310,20200310,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-MYLANLABS-2020M1024277,MYLAN,,74.0,YR,,M,Y,61.1,KG,20200310.0,,PH,GB,GB,2020,Q1,Elderly
175210841,17521084,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Malaise,,2020,Q1,1,I,20200116.0,20200229.0,20200310,20200310,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-MYLANLABS-2020M1024277,MYLAN,,74.0,YR,,M,Y,61.1,KG,20200310.0,,PH,GB,GB,2020,Q1,Elderly
175210841,17521084,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,N,,,,,25.0,MG,TABLET,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20200116.0,20200229.0,20200310,20200310,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,GB-MYLANLABS-2020M1024277,MYLAN,,74.0,YR,,M,Y,61.1,KG,20200310.0,,PH,GB,GB,2020,Q1,Elderly
175211071,17521107,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,, 957395,20220401.0,,12.5,MG,,,2020,Q1,Genital pain,,2020,Q1,1,I,20200127.0,,20200302,20200302,DIR,,,FDA-CTU,,70.0,YR,,M,N,125.0,KG,20200229.0,N,PH,US,US,2020,Q1,Elderly
175211221,17521122,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,, 957395,20220401.0,,12.5,MG,,,2020,Q1,Dehydration,,2020,Q1,1,I,20200121.0,,20200302,20200302,DIR,,,FDA-CTU,,52.0,YR,,M,N,124.74,KG,20200229.0,N,PH,US,US,2020,Q1,Adult
175211221,17521122,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,, 957395,20220401.0,,12.5,MG,,,2020,Q1,Dizziness,,2020,Q1,1,I,20200121.0,,20200302,20200302,DIR,,,FDA-CTU,,52.0,YR,,M,N,124.74,KG,20200229.0,N,PH,US,US,2020,Q1,Adult
175211221,17521122,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,, 957395,20220401.0,,12.5,MG,,,2020,Q1,Hypotension,,2020,Q1,1,I,20200121.0,,20200302,20200302,DIR,,,FDA-CTU,,52.0,YR,,M,N,124.74,KG,20200229.0,N,PH,US,US,2020,Q1,Adult
175211221,17521122,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,, 957395,20220401.0,,12.5,MG,,,2020,Q1,Syncope,,2020,Q1,1,I,20200121.0,,20200302,20200302,DIR,,,FDA-CTU,,52.0,YR,,M,N,124.74,KG,20200229.0,N,PH,US,US,2020,Q1,Adult
175254371,17525437,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,3726.0417,MG,Y,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200109.0,20200302.0,20200310,20200310,EXP,GB-MHRA-EYC 00217015,GB-BAUSCH-BL-2020-007137,BAUSCH AND LOMB,,68.0,YR,,F,Y,74.8,KG,20200310.0,,MD,GB,GB,2020,Q1,Elderly
175262351,17526235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,3726.0417,MG,Y,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200109.0,20200305.0,20200310,20200310,EXP,GB-MHRA-EYC 00217015,GB-EMD SERONO-E2B_90075691,EMD SERONO INC,,68.0,YR,,F,Y,75.0,KG,20200310.0,,MD,GB,GB,2020,Q1,Elderly
175285071,17528507,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",3726.042,MG,Y,U,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200109.0,20200229.0,20200312,20200312,EXP,,GB-AUROBINDO-AUR-APL-2020-011982,AUROBINDO,,68.0,YR,,F,Y,74.8,KG,20200312.0,,MD,GB,GB,2020,Q1,Elderly
175300451,17530045,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG,3726.0417,MG,Y,, UNKNOWN,,,25.0,MG,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200109.0,20200304.0,20200312,20200312,EXP,GB-MHRA-EYC 00217015,GB-TEVA-2020-GB-1198170,TEVA,,68.0,YR,,F,Y,74.8,KG,20200312.0,,MD,GB,GB,2020,Q1,Elderly
175307681,17530768,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Cellulitis,,2020,Q1,1,I,20190721.0,,20200304,20200304,DIR,,,FDA-CTU,,61.0,YR,,M,N,167.38,KG,20200303.0,N,PH,US,US,2020,Q1,Adult
175307681,17530768,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Fournier's gangrene,,2020,Q1,1,I,20190721.0,,20200304,20200304,DIR,,,FDA-CTU,,61.0,YR,,M,N,167.38,KG,20200303.0,N,PH,US,US,2020,Q1,Adult
175307681,17530768,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Pemphigoid,,2020,Q1,1,I,20190721.0,,20200304,20200304,DIR,,,FDA-CTU,,61.0,YR,,M,N,167.38,KG,20200303.0,N,PH,US,US,2020,Q1,Adult
175315621,17531562,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,3726.0417,MG,Y,,,,,25.0,MG,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200109.0,20200306.0,20200312,20200312,EXP,GB-MHRA-EYC 00217015,GB-MICRO LABS LIMITED-ML2020-00682,MICRO LABS,,68.0,YR,,F,Y,74.8,KG,20200312.0,,MD,GB,GB,2020,Q1,Elderly
175357751,17535775,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",3726.042,MG,Y,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200109.0,20200305.0,20200313,20200313,EXP,GB-MHRA-EYC 00217015,GB-SA-2020SA059295,SANOFI AVENTIS,,68.0,YR,E,F,Y,74.8,KG,20200313.0,,MD,GB,GB,2020,Q1,Elderly
175369841,17536984,2,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,10.0,MG,,,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200302.0,20200313,20200313,EXP,,JP-BION-008608,BIONPHARMA,MIYAUCHI T. VALPROATE INTOXICATION IN A PATIENT WITH BIPOLAR I DISORDER DUE TO SGLT2 INHIBITOR-INDUCED WEIGHT REDUCTION. DARU. 2020 FEB 26.,67.0,YR,E,M,Y,78.3,KG,20200313.0,,HP,JP,JP,2020,Q1,Elderly
175369841,17536984,2,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,10.0,MG,,,2020,Q1,Drug level increased,,2020,Q1,1,I,,20200302.0,20200313,20200313,EXP,,JP-BION-008608,BIONPHARMA,MIYAUCHI T. VALPROATE INTOXICATION IN A PATIENT WITH BIPOLAR I DISORDER DUE TO SGLT2 INHIBITOR-INDUCED WEIGHT REDUCTION. DARU. 2020 FEB 26.,67.0,YR,E,M,Y,78.3,KG,20200313.0,,HP,JP,JP,2020,Q1,Elderly
175369841,17536984,2,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,10.0,MG,,,2020,Q1,Treatment failure,,2020,Q1,1,I,,20200302.0,20200313,20200313,EXP,,JP-BION-008608,BIONPHARMA,MIYAUCHI T. VALPROATE INTOXICATION IN A PATIENT WITH BIPOLAR I DISORDER DUE TO SGLT2 INHIBITOR-INDUCED WEIGHT REDUCTION. DARU. 2020 FEB 26.,67.0,YR,E,M,Y,78.3,KG,20200313.0,,HP,JP,JP,2020,Q1,Elderly
175369841,17536984,2,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,10.0,MG,,,2020,Q1,Tremor,,2020,Q1,1,I,,20200302.0,20200313,20200313,EXP,,JP-BION-008608,BIONPHARMA,MIYAUCHI T. VALPROATE INTOXICATION IN A PATIENT WITH BIPOLAR I DISORDER DUE TO SGLT2 INHIBITOR-INDUCED WEIGHT REDUCTION. DARU. 2020 FEB 26.,67.0,YR,E,M,Y,78.3,KG,20200313.0,,HP,JP,JP,2020,Q1,Elderly
175393061,17539306,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q1,Breast cancer metastatic,,2020,Q1,1,I,,20200310.0,20200313,20200313,EXP,,CO-EMD SERONO-9151652,EMD SERONO INC,,66.0,YR,,F,Y,76.0,KG,20200312.0,,CN,CO,CO,2020,Q1,Elderly
175444121,17544412,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM PER DAY,3726.042,MG,Y,,,,,25.0,MG,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200109.0,20200302.0,20200316,20200316,EXP,GB-MHRA-ADR 24470084,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-000304,EMCURE,,68.0,YR,,F,Y,74.8,KG,20200316.0,,MD,GB,GB,2020,Q1,Elderly
175449891,17544989,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,, 957551,20220530.0,,12.5,MG,,QD,2020,Q1,Candida infection,,2020,Q1,1,I,20200219.0,,20200306,20200306,DIR,,,FDA-CTU,,75.0,YR,,M,N,126.0,KG,20200304.0,N,PH,US,US,2020,Q1,Elderly
175449891,17544989,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,, 957551,20220530.0,,12.5,MG,,QD,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200219.0,,20200306,20200306,DIR,,,FDA-CTU,,75.0,YR,,M,N,126.0,KG,20200304.0,N,PH,US,US,2020,Q1,Elderly
175468331,17546833,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,10.0,MG,,,2020,Q1,Balanitis candida,,2020,Q1,1,I,,,20200306,20200306,DIR,,,FDA-CTU,,68.0,YR,,M,N,115.0,KG,20200304.0,N,PH,US,US,2020,Q1,Elderly
175487821,17548782,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,, 957553,20220630.0,,12.5,MG,,QD,2020,Q1,Penile pain,,2020,Q1,1,I,20200221.0,,20200306,20200306,DIR,,,FDA-CTU,,69.0,YR,,M,N,81.0,KG,20200305.0,N,PH,US,US,2020,Q1,Elderly
175487821,17548782,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,, 957553,20220630.0,,12.5,MG,,QD,2020,Q1,Pruritus genital,,2020,Q1,1,I,20200221.0,,20200306,20200306,DIR,,,FDA-CTU,,69.0,YR,,M,N,81.0,KG,20200305.0,N,PH,US,US,2020,Q1,Elderly
175487871,17548787,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 5MG TAB),EMPAGLIFLOZIN,1,Oral,,,,N,D,,,,5.0,MG,,BID,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,1,I,20200214.0,,20200306,20200306,DIR,,,FDA-CTU,,75.0,YR,,M,N,62.55,KG,20200228.0,N,PH,US,US,2020,Q1,Elderly
175487871,17548787,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 5MG TAB),EMPAGLIFLOZIN,1,,,,,N,D,,,,,,,,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,1,I,20200214.0,,20200306,20200306,DIR,,,FDA-CTU,,75.0,YR,,M,N,62.55,KG,20200228.0,N,PH,US,US,2020,Q1,Elderly
175511651,17551165,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Constipation,,2020,Q1,1,I,20190701.0,,20200310,20200310,DIR,,,FDA-CTU,,65.0,YR,,M,N,114.76,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
175511651,17551165,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Decreased appetite,,2020,Q1,1,I,20190701.0,,20200310,20200310,DIR,,,FDA-CTU,,65.0,YR,,M,N,114.76,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
175511651,17551165,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Gastrointestinal pain,,2020,Q1,1,I,20190701.0,,20200310,20200310,DIR,,,FDA-CTU,,65.0,YR,,M,N,114.76,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
175511651,17551165,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Groin pain,,2020,Q1,1,I,20190701.0,,20200310,20200310,DIR,,,FDA-CTU,,65.0,YR,,M,N,114.76,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
175511651,17551165,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Nausea,,2020,Q1,1,I,20190701.0,,20200310,20200310,DIR,,,FDA-CTU,,65.0,YR,,M,N,114.76,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
175511651,17551165,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20190701.0,,20200310,20200310,DIR,,,FDA-CTU,,65.0,YR,,M,N,114.76,KG,20200214.0,N,PH,US,US,2020,Q1,Elderly
175524192,17552419,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,20 MG MILLGRAM(S) EVERY DAYS 2 SEPARATED DOSES,,,Y,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,2,F,20200122.0,20200324.0,20200317,20200327,EXP,,DE-ASTRAZENECA-2020SE37636,ASTRAZENECA,,73.0,YR,,M,Y,80.0,KG,20200327.0,,MD,DE,DE,2020,Q1,Elderly
175524192,17552419,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,20 MG MILLGRAM(S) EVERY DAYS 2 SEPARATED DOSES,,,Y,,,,,,,,,2020,Q1,Duplicate therapy error,,2020,Q1,2,F,20200122.0,20200324.0,20200317,20200327,EXP,,DE-ASTRAZENECA-2020SE37636,ASTRAZENECA,,73.0,YR,,M,Y,80.0,KG,20200327.0,,MD,DE,DE,2020,Q1,Elderly
175524192,17552419,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,20 MG MILLGRAM(S) EVERY DAYS 2 SEPARATED DOSES,,,Y,,,,,,,,,2020,Q1,Ketoacidosis,,2020,Q1,2,F,20200122.0,20200324.0,20200317,20200327,EXP,,DE-ASTRAZENECA-2020SE37636,ASTRAZENECA,,73.0,YR,,M,Y,80.0,KG,20200327.0,,MD,DE,DE,2020,Q1,Elderly
175524192,17552419,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,20 MG MILLGRAM(S) EVERY DAYS 2 SEPARATED DOSES,,,Y,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,2,F,20200122.0,20200324.0,20200317,20200327,EXP,,DE-ASTRAZENECA-2020SE37636,ASTRAZENECA,,73.0,YR,,M,Y,80.0,KG,20200327.0,,MD,DE,DE,2020,Q1,Elderly
175524192,17552419,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,20 MG MILLGRAM(S) EVERY DAYS 2 SEPARATED DOSES,,,Y,,,,,,,,,2020,Q1,Polyuria,,2020,Q1,2,F,20200122.0,20200324.0,20200317,20200327,EXP,,DE-ASTRAZENECA-2020SE37636,ASTRAZENECA,,73.0,YR,,M,Y,80.0,KG,20200327.0,,MD,DE,DE,2020,Q1,Elderly
175524192,17552419,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,20 MG MILLGRAM(S) EVERY DAYS 2 SEPARATED DOSES,,,Y,,,,,,,,,2020,Q1,Product prescribing error,,2020,Q1,2,F,20200122.0,20200324.0,20200317,20200327,EXP,,DE-ASTRAZENECA-2020SE37636,ASTRAZENECA,,73.0,YR,,M,Y,80.0,KG,20200327.0,,MD,DE,DE,2020,Q1,Elderly
175562741,17556274,1,PS,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Oral,,,,N,D,,,,,,,QD,2020,Q1,Necrotising fasciitis,,2020,Q1,1,I,20200312.0,,20200318,20200318,DIR,,,FDA-CTU,,63.0,YR,,M,N,53.0,KG,20200318.0,N,PH,US,US,2020,Q1,Adult
175578791,17557879,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Anion gap increased,,2020,Q1,1,I,20200223.0,,20200311,20200311,DIR,,,FDA-CTU,,50.0,YR,,M,N,,,20200311.0,N,PH,US,US,2020,Q1,Adult
175578791,17557879,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Diabetic ketosis,,2020,Q1,1,I,20200223.0,,20200311,20200311,DIR,,,FDA-CTU,,50.0,YR,,M,N,,,20200311.0,N,PH,US,US,2020,Q1,Adult
175609391,17560939,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Haematuria,,2020,Q1,1,I,20200202.0,,20200312,20200312,DIR,,,FDA-CTU,,60.0,YR,,M,N,160.0,KG,20200311.0,N,PH,US,US,2020,Q1,Adult
175609391,17560939,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q1,Pollakiuria,,2020,Q1,1,I,20200202.0,,20200312,20200312,DIR,,,FDA-CTU,,60.0,YR,,M,N,160.0,KG,20200311.0,N,PH,US,US,2020,Q1,Adult
175610541,17561054,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20200220.0,,20200312,20200312,DIR,,,FDA-CTU,,67.0,YR,,M,N,88.45,KG,20200311.0,N,PH,US,US,2020,Q1,Elderly
175610911,17561091,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q1,Atrial fibrillation,,2020,Q1,1,I,20190120.0,,20200312,20200312,DIR,,,FDA-CTU,,60.0,YR,,M,N,94.0,KG,20190418.0,N,PH,US,US,2020,Q1,Adult
175610911,17561091,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20190120.0,,20200312,20200312,DIR,,,FDA-CTU,,60.0,YR,,M,N,94.0,KG,20190418.0,N,PH,US,US,2020,Q1,Adult
175610911,17561091,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q1,Gastroenteritis,,2020,Q1,1,I,20190120.0,,20200312,20200312,DIR,,,FDA-CTU,,60.0,YR,,M,N,94.0,KG,20190418.0,N,PH,US,US,2020,Q1,Adult
175613011,17561301,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,,,,,10.0,MG,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20190120.0,,20200312,20200312,DIR,,,FDA-CTU,,60.0,YR,,M,N,94.0,KG,20190418.0,N,PH,US,US,2020,Q1,Adult
175625121,17562512,2,C,EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE,,2,Oral,,,,,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,20200210.0,20200224.0,20200319,20200319,PER,,US-ASTRAZENECA-2020SE30427,ASTRAZENECA,,21768.0,DY,,M,Y,64.4,KG,20200319.0,,CN,US,US,2020,Q1,Elderly
175625121,17562512,2,C,EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE,,2,Oral,,,,,,,,,,,,,2020,Q1,Injection site extravasation,,2020,Q1,1,I,20200210.0,20200224.0,20200319,20200319,PER,,US-ASTRAZENECA-2020SE30427,ASTRAZENECA,,21768.0,DY,,M,Y,64.4,KG,20200319.0,,CN,US,US,2020,Q1,Elderly
175661881,17566188,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20191217.0,20200318.0,20200320,20200320,EXP,GB-MHRA-EYC 00215154,NVSC2020GB078642,NOVARTIS,,75.0,YR,,M,Y,95.0,KG,20200320.0,,HP,GB,GB,2020,Q1,Elderly
175661881,17566188,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Blood glucose abnormal,,2020,Q1,1,I,20191217.0,20200318.0,20200320,20200320,EXP,GB-MHRA-EYC 00215154,NVSC2020GB078642,NOVARTIS,,75.0,YR,,M,Y,95.0,KG,20200320.0,,HP,GB,GB,2020,Q1,Elderly
175661881,17566188,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191217.0,20200318.0,20200320,20200320,EXP,GB-MHRA-EYC 00215154,NVSC2020GB078642,NOVARTIS,,75.0,YR,,M,Y,95.0,KG,20200320.0,,HP,GB,GB,2020,Q1,Elderly
175661881,17566188,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,20191217.0,20200318.0,20200320,20200320,EXP,GB-MHRA-EYC 00215154,NVSC2020GB078642,NOVARTIS,,75.0,YR,,M,Y,95.0,KG,20200320.0,,HP,GB,GB,2020,Q1,Elderly
175661881,17566188,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,Y,,,,,25.0,MG,,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,20191217.0,20200318.0,20200320,20200320,EXP,GB-MHRA-EYC 00215154,NVSC2020GB078642,NOVARTIS,,75.0,YR,,M,Y,95.0,KG,20200320.0,,HP,GB,GB,2020,Q1,Elderly
175692151,17569215,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,, 956951,20211031.0,,12.5,MG,,,2020,Q1,Polyuria,,2020,Q1,1,I,20190924.0,,20200316,20200316,DIR,,,FDA-CTU,,81.0,YR,,M,N,79.83,KG,20200314.0,N,PH,US,US,2020,Q1,Elderly
175721451,17572145,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q1,Angina pectoris,,2020,Q1,1,I,,20200317.0,20200323,20200323,EXP,,NVSC2020DE082083,NOVARTIS,"WIECHELT J, BRAUN A, BEUTEL-SIEBERTZ J. POLYPHARMACY IN GERIATRIC PATIENTS - TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE. SCHMERZMEDIZIN. 2020;36(2)",78.0,YR,,F,Y,55.0,KG,20200323.0,,HP,DE,DE,2020,Q1,Elderly
175721451,17572145,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q1,Dehydration,,2020,Q1,1,I,,20200317.0,20200323,20200323,EXP,,NVSC2020DE082083,NOVARTIS,"WIECHELT J, BRAUN A, BEUTEL-SIEBERTZ J. POLYPHARMACY IN GERIATRIC PATIENTS - TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE. SCHMERZMEDIZIN. 2020;36(2)",78.0,YR,,F,Y,55.0,KG,20200323.0,,HP,DE,DE,2020,Q1,Elderly
175721451,17572145,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q1,Urinary tract infection,,2020,Q1,1,I,,20200317.0,20200323,20200323,EXP,,NVSC2020DE082083,NOVARTIS,"WIECHELT J, BRAUN A, BEUTEL-SIEBERTZ J. POLYPHARMACY IN GERIATRIC PATIENTS - TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE. SCHMERZMEDIZIN. 2020;36(2)",78.0,YR,,F,Y,55.0,KG,20200323.0,,HP,DE,DE,2020,Q1,Elderly
175774961,17577496,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q1,Malaise,,2020,Q1,1,I,20191206.0,20200319.0,20200324,20200324,EXP,,IT-EMD SERONO-9153740,EMD SERONO INC,,69.0,YR,,F,Y,,,20200324.0,,PH,IT,IT,2020,Q1,Elderly
175796881,17579688,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Disorientation,,2020,Q1,1,I,20191126.0,20200319.0,20200325,20200325,EXP,DE-AMK-240569,DE-LUPIN PHARMACEUTICALS INC.-2020-01480,LUPIN,,68.0,YR,,F,Y,,,20200325.0,,CN,GB,DE,2020,Q1,Elderly
175796881,17579688,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,20191126.0,20200319.0,20200325,20200325,EXP,DE-AMK-240569,DE-LUPIN PHARMACEUTICALS INC.-2020-01480,LUPIN,,68.0,YR,,F,Y,,,20200325.0,,CN,GB,DE,2020,Q1,Elderly
175796881,17579688,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Epilepsy,,2020,Q1,1,I,20191126.0,20200319.0,20200325,20200325,EXP,DE-AMK-240569,DE-LUPIN PHARMACEUTICALS INC.-2020-01480,LUPIN,,68.0,YR,,F,Y,,,20200325.0,,CN,GB,DE,2020,Q1,Elderly
175796881,17579688,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Psychomotor hyperactivity,,2020,Q1,1,I,20191126.0,20200319.0,20200325,20200325,EXP,DE-AMK-240569,DE-LUPIN PHARMACEUTICALS INC.-2020-01480,LUPIN,,68.0,YR,,F,Y,,,20200325.0,,CN,GB,DE,2020,Q1,Elderly
175818041,17581804,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",3726.042,MG,Y,U,,,,25.0,MG,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200109.0,20200317.0,20200325,20200325,EXP,GB-MHRA-EYC 00217015,GB-MYLANLABS-2020M1030676,MYLAN,,68.0,YR,,F,Y,74.8,KG,20200325.0,,MD,GB,GB,2020,Q1,Elderly
175820001,17582000,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,QD,2020,Q1,Arterial occlusive disease,,2020,Q1,1,I,20190205.0,20200319.0,20200325,20200325,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-016083",BOEHRINGER INGELHEIM,,75.0,YR,,M,Y,71.5,KG,20200325.0,,MD,JP,JP,2020,Q1,Elderly
175847721,17584772,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,, 960182,20220630.0,,25.0,MG,,QD,2020,Q1,Genital discomfort,,2020,Q1,1,I,20200214.0,,20200324,20200324,DIR,,,FDA-CTU,,65.0,YR,,M,N,84.0,KG,20200323.0,N,PH,US,US,2020,Q1,Elderly
175847721,17584772,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,, 960182,20220630.0,,25.0,MG,,QD,2020,Q1,Pruritus,,2020,Q1,1,I,20200214.0,,20200324,20200324,DIR,,,FDA-CTU,,65.0,YR,,M,N,84.0,KG,20200323.0,N,PH,US,US,2020,Q1,Elderly
175903411,17590341,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191119.0,,20200325,20200325,DIR,,,FDA-CTU,,60.0,YR,,M,N,112.0,KG,20200117.0,N,PH,US,US,2020,Q1,Adult
175908391,17590839,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Nausea,,2020,Q1,1,I,20191127.0,,20200325,20200325,DIR,,,FDA-CTU,,64.0,YR,,M,N,79.0,KG,20200117.0,N,PH,US,US,2020,Q1,Adult
175908391,17590839,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q1,Vomiting,,2020,Q1,1,I,20191127.0,,20200325,20200325,DIR,,,FDA-CTU,,64.0,YR,,M,N,79.0,KG,20200117.0,N,PH,US,US,2020,Q1,Adult
175946061,17594606,2,C,EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE,,2,Oral,TWO TIMES A DAY,,,,,,,,,,,,2020,Q1,Injection site extravasation,,2020,Q1,1,I,20200217.0,20200224.0,20200327,20200327,PER,,US-ASTRAZENECA-2020SE30633,ASTRAZENECA,,21775.0,DY,,M,Y,64.4,KG,20200327.0,,CN,US,US,2020,Q1,Elderly
175966641,17596664,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,204629.0,,,,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,20200306.0,20200327.0,20200330,20200330,EXP,GB-MHRA-EYC 00220651,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-016969",BOEHRINGER INGELHEIM,,49.0,YR,,F,Y,,,20200330.0,,PH,GB,GB,2020,Q1,Adult
175981111,17598111,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q1,Disorientation,,2020,Q1,1,I,20191126.0,20200319.0,20200330,20200330,EXP,DE-BFARM-20003273,DE-ACCORD-177473,ACCORD,,68.0,YR,E,F,Y,,,20200330.0,,PH,DE,DE,2020,Q1,Elderly
175981111,17598111,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,20191126.0,20200319.0,20200330,20200330,EXP,DE-BFARM-20003273,DE-ACCORD-177473,ACCORD,,68.0,YR,E,F,Y,,,20200330.0,,PH,DE,DE,2020,Q1,Elderly
175981111,17598111,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q1,Epilepsy,,2020,Q1,1,I,20191126.0,20200319.0,20200330,20200330,EXP,DE-BFARM-20003273,DE-ACCORD-177473,ACCORD,,68.0,YR,E,F,Y,,,20200330.0,,PH,DE,DE,2020,Q1,Elderly
175981111,17598111,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q1,Psychomotor hyperactivity,,2020,Q1,1,I,20191126.0,20200319.0,20200330,20200330,EXP,DE-BFARM-20003273,DE-ACCORD-177473,ACCORD,,68.0,YR,E,F,Y,,,20200330.0,,PH,DE,DE,2020,Q1,Elderly
176009251,17600925,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,0.5,DF,TABLET,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20190701.0,20200325.0,20200331,20200331,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-016954",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,63.0,KG,20200331.0,,MD,JP,JP,2020,Q1,Elderly
176009251,17600925,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20190701.0,20200325.0,20200331,20200331,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-016954",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,63.0,KG,20200331.0,,MD,JP,JP,2020,Q1,Elderly
176036781,17603678,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",210.938,MG,Y,U,,,,25.0,MG,,QD,2020,Q1,Malaise,,2020,Q1,1,I,20191206.0,20200319.0,20200331,20200331,EXP,,IT-AUROBINDO-AUR-APL-2020-015757,AUROBINDO,,69.0,YR,,F,Y,,,20200331.0,,PH,IT,IT,2020,Q1,Elderly
176036921,17603692,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Disorientation,,2020,Q1,1,I,20191126.0,20200319.0,20200331,20200331,EXP,,DE-AUROBINDO-AUR-APL-2020-015795,AUROBINDO,,68.0,YR,,F,Y,,,20200331.0,,PH,DE,DE,2020,Q1,Elderly
176036921,17603692,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,20191126.0,20200319.0,20200331,20200331,EXP,,DE-AUROBINDO-AUR-APL-2020-015795,AUROBINDO,,68.0,YR,,F,Y,,,20200331.0,,PH,DE,DE,2020,Q1,Elderly
176036921,17603692,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Epilepsy,,2020,Q1,1,I,20191126.0,20200319.0,20200331,20200331,EXP,,DE-AUROBINDO-AUR-APL-2020-015795,AUROBINDO,,68.0,YR,,F,Y,,,20200331.0,,PH,DE,DE,2020,Q1,Elderly
176036921,17603692,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Psychomotor hyperactivity,,2020,Q1,1,I,20191126.0,20200319.0,20200331,20200331,EXP,,DE-AUROBINDO-AUR-APL-2020-015795,AUROBINDO,,68.0,YR,,F,Y,,,20200331.0,,PH,DE,DE,2020,Q1,Elderly
176082771,17608277,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,25.0,MG,,QD,2020,Q1,Hiccups,,2020,Q1,1,I,,20200220.0,20200331,20200331,PER,,US-ASTRAZENECA-2020SE26349,ASTRAZENECA,,68.0,YR,,M,Y,131.5,KG,20200331.0,,HP,US,US,2020,Q1,Elderly
176085431,17608543,2,SS,Empagliflozin;Linagliptin,EMPAGLIFLOZIN\LINAGLIPTIN,1,Oral,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,FILM COATED TABLET,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,20200316.0,20200324.0,20200331,20200331,EXP,,AT-AUROBINDO-AUR-APL-2020-015980,AUROBINDO,,77.0,YR,,F,Y,,,20200401.0,,MD,AT,AT,2020,Q1,Elderly
176101911,17610191,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q1,Urosepsis,,2020,Q1,1,I,20200302.0,,20200330,20200330,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200325.0,N,PH,US,US,2020,Q1,Elderly
176104431,17610443,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Dysuria,,2020,Q1,1,I,20200224.0,,20200330,20200330,DIR,,,FDA-CTU,,71.0,YR,,M,N,174.0,KG,20200325.0,N,PH,US,US,2020,Q1,Elderly
176104431,17610443,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q1,Genital rash,,2020,Q1,1,I,20200224.0,,20200330,20200330,DIR,,,FDA-CTU,,71.0,YR,,M,N,174.0,KG,20200325.0,N,PH,US,US,2020,Q1,Elderly
136486458,13648645,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Hyperphosphatasaemia,,2020,Q2,8,F,20161117.0,20200612.0,20170613,20200618,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-003274",BOEHRINGER INGELHEIM,,51.0,YR,,M,Y,87.9,KG,20200618.0,,MD,JP,JP,2020,Q2,Adult
136486458,13648645,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Urine ketone body present,,2020,Q2,8,F,20161117.0,20200612.0,20170613,20200618,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-003274",BOEHRINGER INGELHEIM,,51.0,YR,,M,Y,87.9,KG,20200618.0,,MD,JP,JP,2020,Q2,Adult
143137987,14313798,23,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q2,Angina unstable,,2020,Q2,7,F,20171203.0,20200501.0,20171221,20200508,EXP,,DE-CELGENEUS-DEU-20171204818,CELGENE,,77.0,YR,,F,Y,,,20200508.0,,HP,DE,DE,2020,Q2,Elderly
143137987,14313798,23,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q2,Cholecystitis,,2020,Q2,7,F,20171203.0,20200501.0,20171221,20200508,EXP,,DE-CELGENEUS-DEU-20171204818,CELGENE,,77.0,YR,,F,Y,,,20200508.0,,HP,DE,DE,2020,Q2,Elderly
143137987,14313798,23,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q2,Infection,,2020,Q2,7,F,20171203.0,20200501.0,20171221,20200508,EXP,,DE-CELGENEUS-DEU-20171204818,CELGENE,,77.0,YR,,F,Y,,,20200508.0,,HP,DE,DE,2020,Q2,Elderly
143137987,14313798,23,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q2,Multiple organ dysfunction syndrome,,2020,Q2,7,F,20171203.0,20200501.0,20171221,20200508,EXP,,DE-CELGENEUS-DEU-20171204818,CELGENE,,77.0,YR,,F,Y,,,20200508.0,,HP,DE,DE,2020,Q2,Elderly
143137987,14313798,23,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q2,Urosepsis,,2020,Q2,7,F,20171203.0,20200501.0,20171221,20200508,EXP,,DE-CELGENEUS-DEU-20171204818,CELGENE,,77.0,YR,,F,Y,,,20200508.0,,HP,DE,DE,2020,Q2,Elderly
152455576,15245557,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,U,,,,10.0,MG,,,2020,Q2,Acute myocardial infarction,,2020,Q2,6,F,200508.0,20200527.0,20180806,20200529,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
152455576,15245557,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,U,,,,10.0,MG,,,2020,Q2,Diabetes mellitus,,2020,Q2,6,F,200508.0,20200527.0,20180806,20200529,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
152455576,15245557,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,U,,,,10.0,MG,,,2020,Q2,Drug ineffective,,2020,Q2,6,F,200508.0,20200527.0,20180806,20200529,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
152455576,15245557,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,U,,,,10.0,MG,,,2020,Q2,Glycosylated haemoglobin decreased,,2020,Q2,6,F,200508.0,20200527.0,20180806,20200529,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
152455576,15245557,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,U,,,,10.0,MG,,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,6,F,200508.0,20200527.0,20180806,20200529,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
152455576,15245557,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,U,,,,10.0,MG,,,2020,Q2,Hyperlipidaemia,,2020,Q2,6,F,200508.0,20200527.0,20180806,20200529,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
152455576,15245557,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,U,,,,10.0,MG,,,2020,Q2,Hypertension,,2020,Q2,6,F,200508.0,20200527.0,20180806,20200529,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
152455576,15245557,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,U,,,,10.0,MG,,,2020,Q2,Myocardial infarction,,2020,Q2,6,F,200508.0,20200527.0,20180806,20200529,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
152455576,15245557,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,U,,,,10.0,MG,,,2020,Q2,Weight increased,,2020,Q2,6,F,200508.0,20200527.0,20180806,20200529,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
154577692,15457769,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Urine ketone body present,,2020,Q2,2,F,20180126.0,20200330.0,20181003,20200401,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-005183",BOEHRINGER INGELHEIM,,30.0,YR,,M,Y,91.0,KG,20200402.0,,MD,JP,JP,2020,Q2,Young Adult
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Anaemia,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Blood cholesterol increased,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Blood glucose increased,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Blood pressure fluctuation,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Blood uric acid increased,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Cardiomegaly,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Carotid arteriosclerosis,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Chest discomfort,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Decreased ventricular preload,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Dyspnoea exertional,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Electrocardiogram abnormal,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Hepatic lesion,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Ischaemia,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Myocardial ischaemia,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Renal impairment,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
155382763,15538276,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,U,,,,1.0,DF,TABLET,QD,2020,Q2,Transient ischaemic attack,,2020,Q2,3,F,,20200413.0,20181022,20200415,EXP,,HU-MYLANLABS-2018M1078419,MYLAN,SZLADEK H.. PRACTICAL EXPERIENCES IN INTEGRATING COMBINATION THERAPY TO EXISTING TREATMENT.. HAZIORVOS TOVABBKEPZO SZEMLE.. 2018;23:243-245,65.0,YR,,M,Y,,,20200415.0,,HP,HU,HU,2020,Q2,Elderly
156936532,15693653,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,FILM-COATED TABLET,,2020,Q2,Benign prostatic hyperplasia,,2020,Q2,2,F,,20181129.0,20181206,20200428,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-113188,BRISTOL MYERS SQUIBB,,80.0,YR,,M,Y,111.6,KG,20200428.0,,HP,US,US,2020,Q2,Elderly
156936532,15693653,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,FILM-COATED TABLET,,2020,Q2,Chronic kidney disease,,2020,Q2,2,F,,20181129.0,20181206,20200428,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-113188,BRISTOL MYERS SQUIBB,,80.0,YR,,M,Y,111.6,KG,20200428.0,,HP,US,US,2020,Q2,Elderly
156936532,15693653,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,FILM-COATED TABLET,,2020,Q2,Haematuria,,2020,Q2,2,F,,20181129.0,20181206,20200428,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-113188,BRISTOL MYERS SQUIBB,,80.0,YR,,M,Y,111.6,KG,20200428.0,,HP,US,US,2020,Q2,Elderly
156936532,15693653,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,FILM-COATED TABLET,,2020,Q2,Intentional product use issue,,2020,Q2,2,F,,20181129.0,20181206,20200428,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-113188,BRISTOL MYERS SQUIBB,,80.0,YR,,M,Y,111.6,KG,20200428.0,,HP,US,US,2020,Q2,Elderly
156936532,15693653,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,FILM-COATED TABLET,,2020,Q2,Off label use,,2020,Q2,2,F,,20181129.0,20181206,20200428,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-113188,BRISTOL MYERS SQUIBB,,80.0,YR,,M,Y,111.6,KG,20200428.0,,HP,US,US,2020,Q2,Elderly
157608383,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
157608383,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
157608383,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Hypoglycaemia,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
157608383,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Seasonal allergy,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
157608383,15760838,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Urine ketone body present,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
157608383,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
157608383,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
157608383,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q2,Hypoglycaemia,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
157608383,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q2,Seasonal allergy,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
157608383,15760838,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q2,Urine ketone body present,,2020,Q2,3,F,20160531.0,20200525.0,20181226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-006647",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,60.5,KG,20200602.0,,MD,JP,JP,2020,Q2,Adult
159955832,15995583,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Abdominal pain upper,,2020,Q2,2,F,20190215.0,20190213.0,20190222,20200629,EXP,,PHHY2018CO163899,NOVARTIS,,67.0,YR,,M,Y,55.0,KG,20200629.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q2,Elderly
159955832,15995583,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Cardiac disorder,,2020,Q2,2,F,20190215.0,20190213.0,20190222,20200629,EXP,,PHHY2018CO163899,NOVARTIS,,67.0,YR,,M,Y,55.0,KG,20200629.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q2,Elderly
159955832,15995583,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Choking,,2020,Q2,2,F,20190215.0,20190213.0,20190222,20200629,EXP,,PHHY2018CO163899,NOVARTIS,,67.0,YR,,M,Y,55.0,KG,20200629.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q2,Elderly
159955832,15995583,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Death,,2020,Q2,2,F,20190215.0,20190213.0,20190222,20200629,EXP,,PHHY2018CO163899,NOVARTIS,,67.0,YR,,M,Y,55.0,KG,20200629.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q2,Elderly
159955832,15995583,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,2,F,20190215.0,20190213.0,20190222,20200629,EXP,,PHHY2018CO163899,NOVARTIS,,67.0,YR,,M,Y,55.0,KG,20200629.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q2,Elderly
159955832,15995583,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Insomnia,,2020,Q2,2,F,20190215.0,20190213.0,20190222,20200629,EXP,,PHHY2018CO163899,NOVARTIS,,67.0,YR,,M,Y,55.0,KG,20200629.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q2,Elderly
159955832,15995583,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Phlebitis,,2020,Q2,2,F,20190215.0,20190213.0,20190222,20200629,EXP,,PHHY2018CO163899,NOVARTIS,,67.0,YR,,M,Y,55.0,KG,20200629.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q2,Elderly
159955832,15995583,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Renal disorder,,2020,Q2,2,F,20190215.0,20190213.0,20190222,20200629,EXP,,PHHY2018CO163899,NOVARTIS,,67.0,YR,,M,Y,55.0,KG,20200629.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q2,Elderly
159955832,15995583,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,2,F,20190215.0,20190213.0,20190222,20200629,EXP,,PHHY2018CO163899,NOVARTIS,,67.0,YR,,M,Y,55.0,KG,20200629.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q2,Elderly
160059322,16005932,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Cardiac arrest,,2020,Q2,2,F,20190204.0,20200511.0,20190226,20200512,EXP,GB-MHRA-EYC 00194595,PHHY2019GB041213,NOVARTIS,,83.0,YR,,F,Y,,,20200513.0,,HP,GB,GB,2020,Q2,Elderly
160059322,16005932,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Malaise,,2020,Q2,2,F,20190204.0,20200511.0,20190226,20200512,EXP,GB-MHRA-EYC 00194595,PHHY2019GB041213,NOVARTIS,,83.0,YR,,F,Y,,,20200513.0,,HP,GB,GB,2020,Q2,Elderly
160059322,16005932,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Sinus node dysfunction,,2020,Q2,2,F,20190204.0,20200511.0,20190226,20200512,EXP,GB-MHRA-EYC 00194595,PHHY2019GB041213,NOVARTIS,,83.0,YR,,F,Y,,,20200513.0,,HP,GB,GB,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Arrhythmia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Atrial fibrillation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Bradycardia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Dehydration,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Haematocrit increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Haemoglobin increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Heart rate irregular,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Hypovolaemia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Left atrial dilatation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Mucosal dryness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Presyncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Pulmonary congestion,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Renal disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Skin disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,14,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q2,Syncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Acute kidney injury,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Arrhythmia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Atrial fibrillation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Bradycardia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Dehydration,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Dizziness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Drug interaction,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Haematocrit increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Haemoglobin increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Heart rate irregular,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Hypotension,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Hypovolaemia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Left atrial dilatation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Mucosal dryness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Oedema peripheral,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Presyncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Pulmonary congestion,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Renal disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Skin disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,15,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,QD,2020,Q2,Syncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
1615119814,16151198,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q2,Urosepsis,,2020,Q2,14,F,20190316.0,20200528.0,20190403,20200529,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-013915",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,91.0,KG,20200530.0,,MD,DE,DE,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Acidosis,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,C-reactive protein increased,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Food intolerance,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Glycosuria,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Hypophosphataemia,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Ketonuria,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Leukocytosis,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Nausea,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Neutrophilia,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
164604575,16460457,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Cerebral infarction,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Cholangitis acute,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Cholelithiasis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Dermatitis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Fall,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Humerus fracture,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Cerebral infarction,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Cholangitis acute,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Cholelithiasis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Dermatitis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Fall,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,TABLET,,2020,Q2,Humerus fracture,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Cerebral infarction,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Cholangitis acute,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Cholelithiasis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Dermatitis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Fall,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Humerus fracture,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Cerebral infarction,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Cholangitis acute,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Cholelithiasis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Dermatitis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Fall,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Humerus fracture,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Cerebral infarction,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Cholangitis acute,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Cholelithiasis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Dermatitis,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Fall,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
164604575,16460457,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,TABLET,,2020,Q2,Humerus fracture,,2020,Q2,5,F,20170322.0,20200621.0,20190620,20200626,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-004537",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,71.9,KG,20200626.0,,MD,JP,JP,2020,Q2,Elderly
167100289,16710028,8,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,TABLETS,,2020,Q2,Intestinal haemorrhage,,2020,Q2,9,F,20190805.0,20200601.0,20190816,20200603,EXP,,JP-CELGENEUS-JPN-20190804062,CELGENE,,76.0,YR,,M,Y,64.4,KG,20200603.0,,MD,JP,JP,2020,Q2,Elderly
167102499,16710249,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,Y,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Oedema peripheral,Oedema peripheral,2020,Q2,9,F,20180426.0,20200408.0,20190816,20200413,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-033227",BOEHRINGER INGELHEIM,,55.0,YR,,M,Y,83.0,KG,20200413.0,,MD,MX,MX,2020,Q2,Adult
167102499,16710249,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,Y,,,204629.0,,,FILM-COATED TABLET,,2020,Q2,Oedema peripheral,Oedema peripheral,2020,Q2,9,F,20180426.0,20200408.0,20190816,20200413,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-033227",BOEHRINGER INGELHEIM,,55.0,YR,,M,Y,83.0,KG,20200413.0,,MD,MX,MX,2020,Q2,Adult
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Acidosis,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,C-reactive protein increased,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Food intolerance,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Glycosuria,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Hypophosphataemia,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Ketonuria,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Leukocytosis,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Nausea,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Neutrophilia,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Vomiting,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
1687739311,16877393,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Ascites,,2020,Q2,11,F,20190301.0,20200603.0,20191002,20200605,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-104458",BOEHRINGER INGELHEIM,,77.0,YR,,M,Y,62.4,KG,20200605.0,,MD,AR,AR,2020,Q2,Elderly
1687739311,16877393,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Liver disorder,,2020,Q2,11,F,20190301.0,20200603.0,20191002,20200605,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-104458",BOEHRINGER INGELHEIM,,77.0,YR,,M,Y,62.4,KG,20200605.0,,MD,AR,AR,2020,Q2,Elderly
169630014,16963001,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, EVERY 1 DAY",,,U,,,,,10.0,MG,,,2020,Q2,Chronic kidney disease,,2020,Q2,4,F,20181222.0,20200409.0,20191025,20200415,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-101486,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,50.0,KG,20200415.0,,HP,ES,ES,2020,Q2,Elderly
169630014,16963001,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, EVERY 1 DAY",,,U,,,,,10.0,MG,,,2020,Q2,Metabolic acidosis,,2020,Q2,4,F,20181222.0,20200409.0,20191025,20200415,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-101486,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,50.0,KG,20200415.0,,HP,ES,ES,2020,Q2,Elderly
169630014,16963001,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, EVERY 1 DAY",,,U,,,,,10.0,MG,,,2020,Q2,Sepsis,,2020,Q2,4,F,20181222.0,20200409.0,20191025,20200415,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-101486,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,50.0,KG,20200415.0,,HP,ES,ES,2020,Q2,Elderly
169832443,16983244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q2,Lower limb fracture,,2020,Q2,3,F,20191016.0,20200330.0,20191101,20200406,EXP,,DE-CELGENEUS-DEU-20191010472,CELGENE,,77.0,YR,,M,Y,104.5,KG,20200406.0,,HP,DE,DE,2020,Q2,Elderly
169832443,16983244,27,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Lower limb fracture,,2020,Q2,3,F,20191016.0,20200330.0,20191101,20200406,EXP,,DE-CELGENEUS-DEU-20191010472,CELGENE,,77.0,YR,,M,Y,104.5,KG,20200406.0,,HP,DE,DE,2020,Q2,Elderly
170361712,17036171,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Hospitalisation,,2020,Q2,2,F,201908.0,20200422.0,20191115,20200616,EXP,,US-MERZ PHARMACEUTICALS GMBH-19-04530,MERZ,,67.0,YR,E,M,Y,95.0,KG,20200617.0,,PH,US,US,2020,Q2,Elderly
170361712,17036171,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,2,F,201908.0,20200422.0,20191115,20200616,EXP,,US-MERZ PHARMACEUTICALS GMBH-19-04530,MERZ,,67.0,YR,E,M,Y,95.0,KG,20200617.0,,PH,US,US,2020,Q2,Elderly
171627933,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Anhedonia,,2020,Q2,3,F,20161018.0,20200428.0,20191217,20200514,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200514.0,,LW,US,US,2020,Q2,Adult
171627933,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Anxiety,,2020,Q2,3,F,20161018.0,20200428.0,20191217,20200514,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200514.0,,LW,US,US,2020,Q2,Adult
171627933,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,3,F,20161018.0,20200428.0,20191217,20200514,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200514.0,,LW,US,US,2020,Q2,Adult
171627933,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Economic problem,,2020,Q2,3,F,20161018.0,20200428.0,20191217,20200514,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200514.0,,LW,US,US,2020,Q2,Adult
171627933,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Emotional distress,,2020,Q2,3,F,20161018.0,20200428.0,20191217,20200514,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200514.0,,LW,US,US,2020,Q2,Adult
171627933,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Glomerulonephritis membranous,,2020,Q2,3,F,20161018.0,20200428.0,20191217,20200514,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200514.0,,LW,US,US,2020,Q2,Adult
171627933,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,3,F,20161018.0,20200428.0,20191217,20200514,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200514.0,,LW,US,US,2020,Q2,Adult
171627933,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,3,F,20161018.0,20200428.0,20191217,20200514,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200514.0,,LW,US,US,2020,Q2,Adult
171627933,17162793,31,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Tooth loss,,2020,Q2,3,F,20161018.0,20200428.0,20191217,20200514,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,,,20200514.0,,LW,US,US,2020,Q2,Adult
171695564,17169556,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,4,F,20180529.0,20200525.0,20191218,20200527,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-120395",BOEHRINGER INGELHEIM,,62.0,YR,,F,Y,82.7,KG,20200528.0,,MD,JP,JP,2020,Q2,Adult
171695564,17169556,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Ketoacidosis,,2020,Q2,4,F,20180529.0,20200525.0,20191218,20200527,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-120395",BOEHRINGER INGELHEIM,,62.0,YR,,F,Y,82.7,KG,20200528.0,,MD,JP,JP,2020,Q2,Adult
171839016,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Acute kidney injury,,2020,Q2,6,F,20190313.0,20200609.0,20191220,20200611,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200611.0,,MD,IT,IT,2020,Q2,Elderly
171839016,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Anaemia,,2020,Q2,6,F,20190313.0,20200609.0,20191220,20200611,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200611.0,,MD,IT,IT,2020,Q2,Elderly
171839016,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Intentional self-injury,,2020,Q2,6,F,20190313.0,20200609.0,20191220,20200611,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200611.0,,MD,IT,IT,2020,Q2,Elderly
171839016,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Pulmonary sepsis,,2020,Q2,6,F,20190313.0,20200609.0,20191220,20200611,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200611.0,,MD,IT,IT,2020,Q2,Elderly
171839016,17183901,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Respiratory acidosis,,2020,Q2,6,F,20190313.0,20200609.0,20191220,20200611,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-024902",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,49.0,KG,20200611.0,,MD,IT,IT,2020,Q2,Elderly
172259943,17225994,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Cardiac failure,,2020,Q2,3,F,20191219.0,20200327.0,20200102,20200403,EXP,,"NL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-122749",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,81.0,KG,20200403.0,,MD,NL,NL,2020,Q2,Elderly
172637344,17263734,19,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Influenza,,2020,Q2,4,F,20200104.0,20200617.0,20200113,20200619,EXP,,US-CELGENEUS-USA-20200102462,CELGENE,,72.0,YR,,M,Y,87.62,KG,20200619.0,,MD,US,US,2020,Q2,Elderly
172637344,17263734,19,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Pneumonia bacterial,,2020,Q2,4,F,20200104.0,20200617.0,20200113,20200619,EXP,,US-CELGENEUS-USA-20200102462,CELGENE,,72.0,YR,,M,Y,87.62,KG,20200619.0,,MD,US,US,2020,Q2,Elderly
172809962,17280996,3,C,Empagliflozin/metformin,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Anaphylactic reaction,,2020,Q2,2,F,,20200601.0,20200117,20200604,EXP,,AU-TEVA-2020-AU-1171185,TEVA,LEE A. CASE REPORT OF ANAPHYLAXIS TO LOPERAMIDE HYDROCHLORIDE. INTERNAL MEDICINE JOURNAL. 2019 SEP;49(4):14-15.,75.0,YR,,M,Y,,,20200604.0,,MD,AU,AU,2020,Q2,Elderly
172993964,17299396,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Diabetic foot,,2020,Q2,4,F,20190303.0,20200603.0,20200122,20200608,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-003746",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,73.4,KG,20200608.0,,MD,JP,JP,2020,Q2,Adult
172993964,17299396,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Diabetic foot,,2020,Q2,4,F,20190303.0,20200603.0,20200122,20200608,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-003746",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,73.4,KG,20200608.0,,MD,JP,JP,2020,Q2,Adult
174258215,17425821,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q2,Diverticulitis,,2020,Q2,5,F,20200103.0,20200406.0,20200217,20200408,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001362",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,47.3,KG,20200408.0,,MD,JP,JP,2020,Q2,Adult
174605712,17460571,11,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,2,F,20190124.0,20200330.0,20200225,20200406,EXP,,CZ-AUROBINDO-AUR-APL-2020-004511,AUROBINDO,HRNCLROVA L. TREATING A PATIENT WITH CHRONIC HEART FAILURE AND DECREASED EJECTION FRACTION. ACTA MEDICINAE. 2019;8(15):60-3,60.0,YR,,M,Y,,,20200406.0,,HP,CZ,CZ,2020,Q2,Adult
174605712,17460571,11,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Extrasystoles,,2020,Q2,2,F,20190124.0,20200330.0,20200225,20200406,EXP,,CZ-AUROBINDO-AUR-APL-2020-004511,AUROBINDO,HRNCLROVA L. TREATING A PATIENT WITH CHRONIC HEART FAILURE AND DECREASED EJECTION FRACTION. ACTA MEDICINAE. 2019;8(15):60-3,60.0,YR,,M,Y,,,20200406.0,,HP,CZ,CZ,2020,Q2,Adult
174605712,17460571,11,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,2,F,20190124.0,20200330.0,20200225,20200406,EXP,,CZ-AUROBINDO-AUR-APL-2020-004511,AUROBINDO,HRNCLROVA L. TREATING A PATIENT WITH CHRONIC HEART FAILURE AND DECREASED EJECTION FRACTION. ACTA MEDICINAE. 2019;8(15):60-3,60.0,YR,,M,Y,,,20200406.0,,HP,CZ,CZ,2020,Q2,Adult
174605712,17460571,11,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Sinus tachycardia,,2020,Q2,2,F,20190124.0,20200330.0,20200225,20200406,EXP,,CZ-AUROBINDO-AUR-APL-2020-004511,AUROBINDO,HRNCLROVA L. TREATING A PATIENT WITH CHRONIC HEART FAILURE AND DECREASED EJECTION FRACTION. ACTA MEDICINAE. 2019;8(15):60-3,60.0,YR,,M,Y,,,20200406.0,,HP,CZ,CZ,2020,Q2,Adult
174605712,17460571,11,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Ventricular dyssynchrony,,2020,Q2,2,F,20190124.0,20200330.0,20200225,20200406,EXP,,CZ-AUROBINDO-AUR-APL-2020-004511,AUROBINDO,HRNCLROVA L. TREATING A PATIENT WITH CHRONIC HEART FAILURE AND DECREASED EJECTION FRACTION. ACTA MEDICINAE. 2019;8(15):60-3,60.0,YR,,M,Y,,,20200406.0,,HP,CZ,CZ,2020,Q2,Adult
174616897,17461689,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,,,FILM-COATED TABLET,,2020,Q2,Renal failure,,2020,Q2,7,F,20191105.0,20200430.0,20200226,20200505,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-010758",BOEHRINGER INGELHEIM,,72.0,YR,,M,Y,99.3,KG,20200506.0,,MD,PL,PL,2020,Q2,Elderly
174616897,17461689,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,,,FILM-COATED TABLET,,2020,Q2,Urinary tract infection,,2020,Q2,7,F,20191105.0,20200430.0,20200226,20200505,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-010758",BOEHRINGER INGELHEIM,,72.0,YR,,M,Y,99.3,KG,20200506.0,,MD,PL,PL,2020,Q2,Elderly
174818842,17481884,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Abdominal pain upper,,2020,Q2,2,F,20200213.0,20200421.0,20200302,20200424,EXP,,AU-SA-2020SA050531,SANOFI AVENTIS,,63.0,YR,A,M,Y,72.0,KG,20200424.0,,MD,AU,AU,2020,Q2,Adult
174818842,17481884,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Hepatic cancer,,2020,Q2,2,F,20200213.0,20200421.0,20200302,20200424,EXP,,AU-SA-2020SA050531,SANOFI AVENTIS,,63.0,YR,A,M,Y,72.0,KG,20200424.0,,MD,AU,AU,2020,Q2,Adult
174818842,17481884,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Liver function test abnormal,,2020,Q2,2,F,20200213.0,20200421.0,20200302,20200424,EXP,,AU-SA-2020SA050531,SANOFI AVENTIS,,63.0,YR,A,M,Y,72.0,KG,20200424.0,,MD,AU,AU,2020,Q2,Adult
175539604,17553960,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q2,Blood pressure increased,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q2,Diabetic nephropathy,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q2,Hypertension,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q2,Oedema,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q2,Oedema peripheral,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q2,Protein urine present,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q2,Renal impairment,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,11,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,UNK,,,,,,,,,,,QD,2020,Q2,Blood pressure increased,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,11,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,UNK,,,,,,,,,,,QD,2020,Q2,Diabetic nephropathy,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,11,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,UNK,,,,,,,,,,,QD,2020,Q2,Hypertension,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,11,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,UNK,,,,,,,,,,,QD,2020,Q2,Oedema,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,11,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,UNK,,,,,,,,,,,QD,2020,Q2,Oedema peripheral,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,11,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,UNK,,,,,,,,,,,QD,2020,Q2,Protein urine present,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,11,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,UNK,,,,,,,,,,,QD,2020,Q2,Renal impairment,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175721452,17572145,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Angina pectoris,,2020,Q2,2,F,,20200617.0,20200323,20200624,EXP,,NVSC2020DE082083,NOVARTIS,,78.0,YR,,F,Y,55.0,KG,20200624.0,,HP,DE,DE,2020,Q2,Elderly
175721452,17572145,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Dehydration,,2020,Q2,2,F,,20200617.0,20200323,20200624,EXP,,NVSC2020DE082083,NOVARTIS,,78.0,YR,,F,Y,55.0,KG,20200624.0,,HP,DE,DE,2020,Q2,Elderly
175721452,17572145,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Renal impairment,,2020,Q2,2,F,,20200617.0,20200323,20200624,EXP,,NVSC2020DE082083,NOVARTIS,,78.0,YR,,F,Y,55.0,KG,20200624.0,,HP,DE,DE,2020,Q2,Elderly
175721452,17572145,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,2,F,,20200617.0,20200323,20200624,EXP,,NVSC2020DE082083,NOVARTIS,,78.0,YR,,F,Y,55.0,KG,20200624.0,,HP,DE,DE,2020,Q2,Elderly
175796882,17579688,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Disorientation,,2020,Q2,2,F,20191126.0,20200421.0,20200325,20200428,EXP,DE-AMK-240569,DE-LUPIN PHARMACEUTICALS INC.-2020-01480,LUPIN,,68.0,YR,,F,Y,,,20200428.0,,CN,GB,DE,2020,Q2,Elderly
175796882,17579688,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,2,F,20191126.0,20200421.0,20200325,20200428,EXP,DE-AMK-240569,DE-LUPIN PHARMACEUTICALS INC.-2020-01480,LUPIN,,68.0,YR,,F,Y,,,20200428.0,,CN,GB,DE,2020,Q2,Elderly
175796882,17579688,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Epilepsy,,2020,Q2,2,F,20191126.0,20200421.0,20200325,20200428,EXP,DE-AMK-240569,DE-LUPIN PHARMACEUTICALS INC.-2020-01480,LUPIN,,68.0,YR,,F,Y,,,20200428.0,,CN,GB,DE,2020,Q2,Elderly
175796882,17579688,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Psychomotor hyperactivity,,2020,Q2,2,F,20191126.0,20200421.0,20200325,20200428,EXP,DE-AMK-240569,DE-LUPIN PHARMACEUTICALS INC.-2020-01480,LUPIN,,68.0,YR,,F,Y,,,20200428.0,,CN,GB,DE,2020,Q2,Elderly
175820002,17582000,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,QD,2020,Q2,Arterial occlusive disease,,2020,Q2,2,F,20190129.0,20200526.0,20200325,20200527,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-016083",BOEHRINGER INGELHEIM,,75.0,YR,,M,Y,71.5,KG,20200527.0,,MD,JP,JP,2020,Q2,Elderly
175935383,17593538,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Bone density decreased,,2020,Q2,3,F,201908.0,20200506.0,20200327,20200602,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200602.0,,LW,US,US,2020,Q2,Adult
175935383,17593538,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,3,F,201908.0,20200506.0,20200327,20200602,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200602.0,,LW,US,US,2020,Q2,Adult
175935383,17593538,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Osteopenia,,2020,Q2,3,F,201908.0,20200506.0,20200327,20200602,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200602.0,,LW,US,US,2020,Q2,Adult
175981112,17598111,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q2,Disorientation,,2020,Q2,2,F,20191126.0,20200505.0,20200330,20200514,EXP,DE-BFARM-20003273,DE-ACCORD-177473,ACCORD,,68.0,YR,E,F,Y,,,20200514.0,,PH,DE,DE,2020,Q2,Elderly
175981112,17598111,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,2,F,20191126.0,20200505.0,20200330,20200514,EXP,DE-BFARM-20003273,DE-ACCORD-177473,ACCORD,,68.0,YR,E,F,Y,,,20200514.0,,PH,DE,DE,2020,Q2,Elderly
175981112,17598111,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q2,Epilepsy,,2020,Q2,2,F,20191126.0,20200505.0,20200330,20200514,EXP,DE-BFARM-20003273,DE-ACCORD-177473,ACCORD,,68.0,YR,E,F,Y,,,20200514.0,,PH,DE,DE,2020,Q2,Elderly
175981112,17598111,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q2,Psychomotor hyperactivity,,2020,Q2,2,F,20191126.0,20200505.0,20200330,20200514,EXP,DE-BFARM-20003273,DE-ACCORD-177473,ACCORD,,68.0,YR,E,F,Y,,,20200514.0,,PH,DE,DE,2020,Q2,Elderly
175998162,17599816,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2020,Q2,Blood glucose increased,,2020,Q2,2,F,2012.0,20200401.0,20200330,20200408,EXP,,RU-EMD SERONO-9153913,EMD SERONO INC,"ZANOZINA O, SOROKINA Y, SARATOVSKAYA V. 10.33978:EXPERIENCE IN THE USE OF FIXED COMBINATION INSULIN GLARGINE 100 U/ML AND LIXISENATIDE IN PATIENTS WITH TYPE 2 DIABETES WHO DID NOT REACH THE TARGETS AFTER USING ORAL HYPOGLYCEMIC DRUGS. EFFECTIVE PHARMACOTHERAPY. 2019;15 (41):28-31. DOI:10.33978 / 2307-3586-2019-15-41-28-31",63.0,YR,,F,Y,85.0,KG,20200408.0,,MD,RU,RU,2020,Q2,Adult
175998162,17599816,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2020,Q2,Drug ineffective,,2020,Q2,2,F,2012.0,20200401.0,20200330,20200408,EXP,,RU-EMD SERONO-9153913,EMD SERONO INC,"ZANOZINA O, SOROKINA Y, SARATOVSKAYA V. 10.33978:EXPERIENCE IN THE USE OF FIXED COMBINATION INSULIN GLARGINE 100 U/ML AND LIXISENATIDE IN PATIENTS WITH TYPE 2 DIABETES WHO DID NOT REACH THE TARGETS AFTER USING ORAL HYPOGLYCEMIC DRUGS. EFFECTIVE PHARMACOTHERAPY. 2019;15 (41):28-31. DOI:10.33978 / 2307-3586-2019-15-41-28-31",63.0,YR,,F,Y,85.0,KG,20200408.0,,MD,RU,RU,2020,Q2,Adult
175998162,17599816,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,2012.0,20200401.0,20200330,20200408,EXP,,RU-EMD SERONO-9153913,EMD SERONO INC,"ZANOZINA O, SOROKINA Y, SARATOVSKAYA V. 10.33978:EXPERIENCE IN THE USE OF FIXED COMBINATION INSULIN GLARGINE 100 U/ML AND LIXISENATIDE IN PATIENTS WITH TYPE 2 DIABETES WHO DID NOT REACH THE TARGETS AFTER USING ORAL HYPOGLYCEMIC DRUGS. EFFECTIVE PHARMACOTHERAPY. 2019;15 (41):28-31. DOI:10.33978 / 2307-3586-2019-15-41-28-31",63.0,YR,,F,Y,85.0,KG,20200408.0,,MD,RU,RU,2020,Q2,Adult
176036922,17603692,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Disorientation,,2020,Q2,2,F,20191126.0,20200422.0,20200331,20200429,EXP,,DE-AUROBINDO-AUR-APL-2020-015795,AUROBINDO,,68.0,YR,,F,Y,,,20200429.0,,PH,DE,DE,2020,Q2,Elderly
176036922,17603692,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,2,F,20191126.0,20200422.0,20200331,20200429,EXP,,DE-AUROBINDO-AUR-APL-2020-015795,AUROBINDO,,68.0,YR,,F,Y,,,20200429.0,,PH,DE,DE,2020,Q2,Elderly
176036922,17603692,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Epilepsy,,2020,Q2,2,F,20191126.0,20200422.0,20200331,20200429,EXP,,DE-AUROBINDO-AUR-APL-2020-015795,AUROBINDO,,68.0,YR,,F,Y,,,20200429.0,,PH,DE,DE,2020,Q2,Elderly
176036922,17603692,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Psychomotor hyperactivity,,2020,Q2,2,F,20191126.0,20200422.0,20200331,20200429,EXP,,DE-AUROBINDO-AUR-APL-2020-015795,AUROBINDO,,68.0,YR,,F,Y,,,20200429.0,,PH,DE,DE,2020,Q2,Elderly
176076162,17607616,2,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,UNKNOWN,,2020,Q2,Disorientation,,2020,Q2,2,F,20191126.0,20200427.0,20200401,20200506,EXP,DE-AMK-240569,DE-BIOGEN-2020BI00855353,BIOGEN,,68.0,YR,,F,Y,,,20200506.0,,PH,DE,DE,2020,Q2,Elderly
176076162,17607616,2,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,UNKNOWN,,2020,Q2,Drug interaction,,2020,Q2,2,F,20191126.0,20200427.0,20200401,20200506,EXP,DE-AMK-240569,DE-BIOGEN-2020BI00855353,BIOGEN,,68.0,YR,,F,Y,,,20200506.0,,PH,DE,DE,2020,Q2,Elderly
176076162,17607616,2,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,UNKNOWN,,2020,Q2,Epilepsy,,2020,Q2,2,F,20191126.0,20200427.0,20200401,20200506,EXP,DE-AMK-240569,DE-BIOGEN-2020BI00855353,BIOGEN,,68.0,YR,,F,Y,,,20200506.0,,PH,DE,DE,2020,Q2,Elderly
176076162,17607616,2,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,UNKNOWN,,2020,Q2,Psychomotor hyperactivity,,2020,Q2,2,F,20191126.0,20200427.0,20200401,20200506,EXP,DE-AMK-240569,DE-BIOGEN-2020BI00855353,BIOGEN,,68.0,YR,,F,Y,,,20200506.0,,PH,DE,DE,2020,Q2,Elderly
176097812,17609781,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Disorientation,,2020,Q2,2,F,20191126.0,20200506.0,20200401,20200508,EXP,DE-AMK-240569,DE-PFIZER INC-2020133134,PFIZER,,68.0,YR,,F,Y,,,20200508.0,,PH,DE,DE,2020,Q2,Elderly
176097812,17609781,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,2,F,20191126.0,20200506.0,20200401,20200508,EXP,DE-AMK-240569,DE-PFIZER INC-2020133134,PFIZER,,68.0,YR,,F,Y,,,20200508.0,,PH,DE,DE,2020,Q2,Elderly
176097812,17609781,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Encephalitis,,2020,Q2,2,F,20191126.0,20200506.0,20200401,20200508,EXP,DE-AMK-240569,DE-PFIZER INC-2020133134,PFIZER,,68.0,YR,,F,Y,,,20200508.0,,PH,DE,DE,2020,Q2,Elderly
176097812,17609781,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Epilepsy,,2020,Q2,2,F,20191126.0,20200506.0,20200401,20200508,EXP,DE-AMK-240569,DE-PFIZER INC-2020133134,PFIZER,,68.0,YR,,F,Y,,,20200508.0,,PH,DE,DE,2020,Q2,Elderly
176097812,17609781,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Oxygen saturation decreased,,2020,Q2,2,F,20191126.0,20200506.0,20200401,20200508,EXP,DE-AMK-240569,DE-PFIZER INC-2020133134,PFIZER,,68.0,YR,,F,Y,,,20200508.0,,PH,DE,DE,2020,Q2,Elderly
176097812,17609781,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,PO2 decreased,,2020,Q2,2,F,20191126.0,20200506.0,20200401,20200508,EXP,DE-AMK-240569,DE-PFIZER INC-2020133134,PFIZER,,68.0,YR,,F,Y,,,20200508.0,,PH,DE,DE,2020,Q2,Elderly
176097812,17609781,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Psychomotor hyperactivity,,2020,Q2,2,F,20191126.0,20200506.0,20200401,20200508,EXP,DE-AMK-240569,DE-PFIZER INC-2020133134,PFIZER,,68.0,YR,,F,Y,,,20200508.0,,PH,DE,DE,2020,Q2,Elderly
176105972,17610597,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Pneumonia,,2020,Q2,2,F,20200325.0,20200408.0,20200401,20200410,EXP,,MX-CELGENEUS-MEX-20200310414,CELGENE,,68.0,YR,,M,Y,,,20200410.0,,HP,MX,MX,2020,Q2,Elderly
176113172,17611317,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2020,Q2,Cardiac arrest,,2020,Q2,2,F,20200228.0,20200526.0,20200401,20200529,EXP,,CA-HLS-202000272,HLS THERAPEUTICS,,75.0,YR,E,M,Y,,,20200529.0,,MD,CA,CA,2020,Q2,Elderly
176113172,17611317,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2020,Q2,Constipation,,2020,Q2,2,F,20200228.0,20200526.0,20200401,20200529,EXP,,CA-HLS-202000272,HLS THERAPEUTICS,,75.0,YR,E,M,Y,,,20200529.0,,MD,CA,CA,2020,Q2,Elderly
176113172,17611317,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2020,Q2,Depressed level of consciousness,,2020,Q2,2,F,20200228.0,20200526.0,20200401,20200529,EXP,,CA-HLS-202000272,HLS THERAPEUTICS,,75.0,YR,E,M,Y,,,20200529.0,,MD,CA,CA,2020,Q2,Elderly
176113172,17611317,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2020,Q2,Intestinal obstruction,,2020,Q2,2,F,20200228.0,20200526.0,20200401,20200529,EXP,,CA-HLS-202000272,HLS THERAPEUTICS,,75.0,YR,E,M,Y,,,20200529.0,,MD,CA,CA,2020,Q2,Elderly
176113172,17611317,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2020,Q2,Pneumonia aspiration,,2020,Q2,2,F,20200228.0,20200526.0,20200401,20200529,EXP,,CA-HLS-202000272,HLS THERAPEUTICS,,75.0,YR,E,M,Y,,,20200529.0,,MD,CA,CA,2020,Q2,Elderly
176114381,17611438,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,, UNKNOWN,,,25.0,MG,,QD,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,20200401.0,,20200401,20200401,DIR,,,FDA-CTU,,69.0,YR,,M,N,80.0,KG,20200401.0,N,PH,US,US,2020,Q2,Elderly
176149323,17614932,1,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,,,,,,2020,Q2,Disorientation,,2020,Q2,3,F,20191126.0,20200510.0,20200402,20200515,EXP,DE-AMK-240569,DE-TORRENT-00017115,TORRENT,,68.0,YR,E,F,Y,,,20200515.0,,PH,DE,DE,2020,Q2,Elderly
176149323,17614932,1,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,3,F,20191126.0,20200510.0,20200402,20200515,EXP,DE-AMK-240569,DE-TORRENT-00017115,TORRENT,,68.0,YR,E,F,Y,,,20200515.0,,PH,DE,DE,2020,Q2,Elderly
176149323,17614932,1,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,,,,,,2020,Q2,Epilepsy,,2020,Q2,3,F,20191126.0,20200510.0,20200402,20200515,EXP,DE-AMK-240569,DE-TORRENT-00017115,TORRENT,,68.0,YR,E,F,Y,,,20200515.0,,PH,DE,DE,2020,Q2,Elderly
176149323,17614932,1,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,,,,,,2020,Q2,Psychomotor hyperactivity,,2020,Q2,3,F,20191126.0,20200510.0,20200402,20200515,EXP,DE-AMK-240569,DE-TORRENT-00017115,TORRENT,,68.0,YR,E,F,Y,,,20200515.0,,PH,DE,DE,2020,Q2,Elderly
176208111,17620811,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200114.0,,20200401,20200401,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20200319.0,N,PH,US,US,2020,Q2,Elderly
176254882,17625488,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,(),,,,,,,,,,,,2020,Q2,Disorientation,,2020,Q2,2,F,20191126.0,20200428.0,20200403,20200511,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-242733,RANBAXY,,68.0,YR,,F,Y,,,20200511.0,,HP,NL,DE,2020,Q2,Elderly
176254882,17625488,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,(),,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,2,F,20191126.0,20200428.0,20200403,20200511,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-242733,RANBAXY,,68.0,YR,,F,Y,,,20200511.0,,HP,NL,DE,2020,Q2,Elderly
176254882,17625488,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,(),,,,,,,,,,,,2020,Q2,Epilepsy,,2020,Q2,2,F,20191126.0,20200428.0,20200403,20200511,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-242733,RANBAXY,,68.0,YR,,F,Y,,,20200511.0,,HP,NL,DE,2020,Q2,Elderly
176254882,17625488,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,(),,,,,,,,,,,,2020,Q2,Psychomotor hyperactivity,,2020,Q2,2,F,20191126.0,20200428.0,20200403,20200511,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-242733,RANBAXY,,68.0,YR,,F,Y,,,20200511.0,,HP,NL,DE,2020,Q2,Elderly
176290131,17629013,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20181204.0,,20200402,20200402,DIR,,,FDA-CTU,,47.0,YR,,F,N,79.83,KG,20200319.0,N,PH,US,US,2020,Q2,Adult
176301331,17630133,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Back pain,,2020,Q2,1,I,20200119.0,,20200402,20200402,DIR,,,FDA-CTU,,60.0,YR,,M,N,146.96,KG,20200319.0,N,PH,US,US,2020,Q2,Adult
176301331,17630133,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Nausea,,2020,Q2,1,I,20200119.0,,20200402,20200402,DIR,,,FDA-CTU,,60.0,YR,,M,N,146.96,KG,20200319.0,N,PH,US,US,2020,Q2,Adult
176301331,17630133,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Vomiting,,2020,Q2,1,I,20200119.0,,20200402,20200402,DIR,,,FDA-CTU,,60.0,YR,,M,N,146.96,KG,20200319.0,N,PH,US,US,2020,Q2,Adult
176316441,17631644,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,,20200331.0,20200406,20200406,EXP,,AU-EMD SERONO-9155459,EMD SERONO INC,"CHACKO B, WHITLEY M, BECKMANN U, MURRAY K, ROWLEY M. POSTOPERATIVE EUGLYCAEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH SODIUM- GLUCOSE COTRANSPORTER-2 INHIBITORS (GLIFLOZINS): A REPORT OF TWO CASES AND REVIEW OF THE LITERATURE.. ANAESTHESIA AND INTENSIVE CARE. 2018 MAR 01;46(2):215-219.",55.0,YR,,M,Y,,,20200406.0,,MD,AU,AU,2020,Q2,Adult
176321581,17632158,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,,20200331.0,20200406,20200406,EXP,,AU-EMD SERONO-9155690,EMD SERONO INC,"CHACKO B, WHITLEY M, BECKMANN U, ROWLEY M, MURRAY K. POSTOPERATIVE EUGLYCAEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH SODIUM- GLUCOSE COTRANSPORTER-2 INHIBITORS (GLIFLOZINS): A REPORT OF TWO CASES AND REVIEW OF THE LITERATURE.. ANAESTHESIA AND INTENSIVE CARE. 2018 MAR 01;46(2):215-219.",66.0,YR,,F,Y,,,20200406.0,,MD,AU,AU,2020,Q2,Elderly
176381031,17638103,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q2,Pruritus,,2020,Q2,1,I,20200304.0,,20200407,20200407,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20200407.0,N,PH,US,US,2020,Q2,Adult
176381031,17638103,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q2,Urticaria,,2020,Q2,1,I,20200304.0,,20200407,20200407,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20200407.0,N,PH,US,US,2020,Q2,Adult
176457201,17645720,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,FOR SEVERAL YEAR,,,Y,U,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,,20200331.0,20200408,20200408,EXP,,AU-MYLANLABS-2020M1035670,MYLAN,"CHACKO B, WHITLEY M, BECKMANN U, ROWLEY M, MURRAY K.. POSTOPERATIVE EUGLYCAEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH SODIUM- GLUCOSE COTRANSPORTER-2 INHIBITORS (GLIFLOZINS): A REPORT OF TWO CASES AND REVIEW OF THE LITERATURE.. ANAESTHESIA AND INTENSIVE CARE.. 2018;46(2):215-219",66.0,YR,,F,Y,,,20200408.0,,HP,AU,AU,2020,Q2,Elderly
176457211,17645721,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,,20200331.0,20200408,20200408,EXP,,AU-MYLANLABS-2020M1035671,MYLAN,"CHACKO B, WHITLEY M, BECKMANN U, MURRAY K, ROWLEY M. POSTOPERATIVE EUGLYCAEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH SODIUM- GLUCOSE COTRANSPORTER-2 INHIBITORS (GLIFLOZINS): A REPORT OF TWO CASES AND. ANAESTHESIA AND INTENSIVE CARE. 2018;46(2):215-219",55.0,YR,,M,Y,,,20200408.0,,HP,AU,AU,2020,Q2,Adult
176467573,17646757,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1X/DAY (1-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Angina pectoris,,2020,Q2,3,F,,20200416.0,20200408,20200423,EXP,,DE-PFIZER INC-2020140827,PFIZER,"WIECHELT, J.. POLYPHARMACY IN GERIATRIC PATIENTS - TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE.. SCHMERZMEDIZIN. 2020;36(2)",78.0,YR,,F,Y,55.0,KG,20200423.0,,HP,DE,DE,2020,Q2,Elderly
176467573,17646757,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1X/DAY (1-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Dehydration,,2020,Q2,3,F,,20200416.0,20200408,20200423,EXP,,DE-PFIZER INC-2020140827,PFIZER,"WIECHELT, J.. POLYPHARMACY IN GERIATRIC PATIENTS - TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE.. SCHMERZMEDIZIN. 2020;36(2)",78.0,YR,,F,Y,55.0,KG,20200423.0,,HP,DE,DE,2020,Q2,Elderly
176467573,17646757,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1X/DAY (1-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,3,F,,20200416.0,20200408,20200423,EXP,,DE-PFIZER INC-2020140827,PFIZER,"WIECHELT, J.. POLYPHARMACY IN GERIATRIC PATIENTS - TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE.. SCHMERZMEDIZIN. 2020;36(2)",78.0,YR,,F,Y,55.0,KG,20200423.0,,HP,DE,DE,2020,Q2,Elderly
176485271,17648527,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,QD,2020,Q2,Angina pectoris,,2020,Q2,1,I,,20200327.0,20200408,20200408,EXP,,DE-BAUSCH-BL-2020-009680,BAUSCH AND LOMB,"J W, J B, A B. POLYPHARMACY IN GERIATRIC PATIENTS TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE. SCHMERZMEDIZIN. 2020;36(2):.",78.0,YR,,F,Y,55.0,KG,20200408.0,,HP,DE,DE,2020,Q2,Elderly
176485271,17648527,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,QD,2020,Q2,Dehydration,,2020,Q2,1,I,,20200327.0,20200408,20200408,EXP,,DE-BAUSCH-BL-2020-009680,BAUSCH AND LOMB,"J W, J B, A B. POLYPHARMACY IN GERIATRIC PATIENTS TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE. SCHMERZMEDIZIN. 2020;36(2):.",78.0,YR,,F,Y,55.0,KG,20200408.0,,HP,DE,DE,2020,Q2,Elderly
176485271,17648527,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,1,I,,20200327.0,20200408,20200408,EXP,,DE-BAUSCH-BL-2020-009680,BAUSCH AND LOMB,"J W, J B, A B. POLYPHARMACY IN GERIATRIC PATIENTS TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE. SCHMERZMEDIZIN. 2020;36(2):.",78.0,YR,,F,Y,55.0,KG,20200408.0,,HP,DE,DE,2020,Q2,Elderly
176501591,17650159,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER DOSE:12.5MG;OTHER FREQUENCY:AM;?,,,,,,,,,,,,2020,Q2,Pollakiuria,,2020,Q2,1,I,20200302.0,,20200408,20200408,DIR,,,FDA-CTU,,36.0,YR,,M,N,80.29,KG,20200408.0,N,PH,US,US,2020,Q2,Adult
176544302,17654430,8,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,U,,,,,10.0,MG,,QD,2020,Q2,Angina pectoris,,2020,Q2,2,F,,20200422.0,20200410,20200502,EXP,,DE-AUROBINDO-AUR-APL-2020-016924,AUROBINDO,,78.0,YR,,F,Y,55.0,KG,20200502.0,,HP,DE,DE,2020,Q2,Elderly
176544302,17654430,8,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,U,,,,,10.0,MG,,QD,2020,Q2,Dehydration,,2020,Q2,2,F,,20200422.0,20200410,20200502,EXP,,DE-AUROBINDO-AUR-APL-2020-016924,AUROBINDO,,78.0,YR,,F,Y,55.0,KG,20200502.0,,HP,DE,DE,2020,Q2,Elderly
176544302,17654430,8,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,U,,,,,10.0,MG,,QD,2020,Q2,Renal impairment,,2020,Q2,2,F,,20200422.0,20200410,20200502,EXP,,DE-AUROBINDO-AUR-APL-2020-016924,AUROBINDO,,78.0,YR,,F,Y,55.0,KG,20200502.0,,HP,DE,DE,2020,Q2,Elderly
176544302,17654430,8,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,U,,,,,10.0,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,2,F,,20200422.0,20200410,20200502,EXP,,DE-AUROBINDO-AUR-APL-2020-016924,AUROBINDO,,78.0,YR,,F,Y,55.0,KG,20200502.0,,HP,DE,DE,2020,Q2,Elderly
176643691,17664369,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,, 960183,20220601.0,,25.0,MG,,QD,2020,Q2,Erythema,,2020,Q2,1,I,20200316.0,,20200413,20200413,DIR,,,FDA-CTU,,73.0,YR,,M,N,89.36,KG,20200409.0,N,PH,US,US,2020,Q2,Elderly
176643691,17664369,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,, 960183,20220601.0,,25.0,MG,,QD,2020,Q2,Incorrect dose administered,,2020,Q2,1,I,20200316.0,,20200413,20200413,DIR,,,FDA-CTU,,73.0,YR,,M,N,89.36,KG,20200409.0,N,PH,US,US,2020,Q2,Elderly
176643691,17664369,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,, 960183,20220601.0,,25.0,MG,,QD,2020,Q2,Pruritus,,2020,Q2,1,I,20200316.0,,20200413,20200413,DIR,,,FDA-CTU,,73.0,YR,,M,N,89.36,KG,20200409.0,N,PH,US,US,2020,Q2,Elderly
176643691,17664369,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,, 960183,20220601.0,,25.0,MG,,QD,2020,Q2,Urticaria,,2020,Q2,1,I,20200316.0,,20200413,20200413,DIR,,,FDA-CTU,,73.0,YR,,M,N,89.36,KG,20200409.0,N,PH,US,US,2020,Q2,Elderly
176645841,17664584,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Asthenia,,2020,Q2,1,I,20200405.0,,20200413,20200413,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200410.0,N,PH,US,US,2020,Q2,Adult
176645841,17664584,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Decubitus ulcer,,2020,Q2,1,I,20200405.0,,20200413,20200413,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200410.0,N,PH,US,US,2020,Q2,Adult
176645841,17664584,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20200405.0,,20200413,20200413,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200410.0,N,PH,US,US,2020,Q2,Adult
176645841,17664584,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,20200405.0,,20200413,20200413,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200410.0,N,PH,US,US,2020,Q2,Adult
176645841,17664584,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,20200405.0,,20200413,20200413,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200410.0,N,PH,US,US,2020,Q2,Adult
176645841,17664584,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,1,I,20200405.0,,20200413,20200413,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200410.0,N,PH,US,US,2020,Q2,Adult
176645841,17664584,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20200405.0,,20200413,20200413,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20200410.0,N,PH,US,US,2020,Q2,Adult
176651421,17665142,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,, 960183,20220601.0,,12.5,MG,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,20200301.0,,20200413,20200413,DIR,,,FDA-CTU,,62.0,YR,,M,N,78.0,KG,20200409.0,N,PH,US,US,2020,Q2,Adult
176653021,17665302,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER DOSE:12.5MG;OTHER FREQUENCY:AM;?,,,,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,20200316.0,,20200413,20200413,DIR,,,FDA-CTU,,73.0,YR,,M,N,92.53,KG,20200409.0,N,PH,US,US,2020,Q2,Elderly
176664221,17666422,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Colon cancer,,2020,Q2,1,I,20191201.0,20200412.0,20200414,20200414,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-019509",BOEHRINGER INGELHEIM,,68.0,YR,,M,Y,72.6,KG,20200414.0,,MD,JP,JP,2020,Q2,Elderly
176676243,17667624,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,131597.0,,,FILM-COATED TABLET,,2020,Q2,Cardiac failure,,2020,Q2,3,F,20200408.0,20200529.0,20200414,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-018919",BOEHRINGER INGELHEIM,,80.0,YR,,M,Y,66.9,KG,20200602.0,,MD,JP,JP,2020,Q2,Elderly
176709071,17670907,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20190922.0,,20200414,20200414,DIR,,,FDA-CTU,,73.0,YR,,M,N,195.0,KG,20200319.0,N,PH,US,US,2020,Q2,Elderly
176709071,17670907,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q2,Confusional state,,2020,Q2,1,I,20190922.0,,20200414,20200414,DIR,,,FDA-CTU,,73.0,YR,,M,N,195.0,KG,20200319.0,N,PH,US,US,2020,Q2,Elderly
176709071,17670907,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20190922.0,,20200414,20200414,DIR,,,FDA-CTU,,73.0,YR,,M,N,195.0,KG,20200319.0,N,PH,US,US,2020,Q2,Elderly
176709071,17670907,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,20190922.0,,20200414,20200414,DIR,,,FDA-CTU,,73.0,YR,,M,N,195.0,KG,20200319.0,N,PH,US,US,2020,Q2,Elderly
176709071,17670907,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q2,Liver function test decreased,,2020,Q2,1,I,20190922.0,,20200414,20200414,DIR,,,FDA-CTU,,73.0,YR,,M,N,195.0,KG,20200319.0,N,PH,US,US,2020,Q2,Elderly
176709071,17670907,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20190922.0,,20200414,20200414,DIR,,,FDA-CTU,,73.0,YR,,M,N,195.0,KG,20200319.0,N,PH,US,US,2020,Q2,Elderly
176709071,17670907,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,10.0,MG,,,2020,Q2,Urosepsis,,2020,Q2,1,I,20190922.0,,20200414,20200414,DIR,,,FDA-CTU,,73.0,YR,,M,N,195.0,KG,20200319.0,N,PH,US,US,2020,Q2,Elderly
176768142,17676814,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Disorientation,,2020,Q2,2,F,20191126.0,20200506.0,20200416,20200512,EXP,DE-AMK-240569,DE-MYLANLABS-2020M1037984,MYLAN,,68.0,YR,,F,Y,,,20200512.0,,PH,DE,DE,2020,Q2,Elderly
176768142,17676814,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,2,F,20191126.0,20200506.0,20200416,20200512,EXP,DE-AMK-240569,DE-MYLANLABS-2020M1037984,MYLAN,,68.0,YR,,F,Y,,,20200512.0,,PH,DE,DE,2020,Q2,Elderly
176768142,17676814,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Epilepsy,,2020,Q2,2,F,20191126.0,20200506.0,20200416,20200512,EXP,DE-AMK-240569,DE-MYLANLABS-2020M1037984,MYLAN,,68.0,YR,,F,Y,,,20200512.0,,PH,DE,DE,2020,Q2,Elderly
176768142,17676814,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Psychomotor hyperactivity,,2020,Q2,2,F,20191126.0,20200506.0,20200416,20200512,EXP,DE-AMK-240569,DE-MYLANLABS-2020M1037984,MYLAN,,68.0,YR,,F,Y,,,20200512.0,,PH,DE,DE,2020,Q2,Elderly
176773981,17677398,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",200.417,MG,U,,,,,10.0,MG,,QD,2020,Q2,Cardiac failure,,2020,Q2,1,I,20181019.0,20200415.0,20200416,20200416,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,NVSC2020GB102411,NOVARTIS,,68.0,YR,,F,Y,82.0,KG,20200416.0,,HP,GB,GB,2020,Q2,Elderly
176773981,17677398,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",200.417,MG,U,,,,,10.0,MG,,QD,2020,Q2,Dyspnoea,,2020,Q2,1,I,20181019.0,20200415.0,20200416,20200416,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,NVSC2020GB102411,NOVARTIS,,68.0,YR,,F,Y,82.0,KG,20200416.0,,HP,GB,GB,2020,Q2,Elderly
176773981,17677398,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",200.417,MG,U,,,,,10.0,MG,,QD,2020,Q2,Fluid retention,,2020,Q2,1,I,20181019.0,20200415.0,20200416,20200416,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,NVSC2020GB102411,NOVARTIS,,68.0,YR,,F,Y,82.0,KG,20200416.0,,HP,GB,GB,2020,Q2,Elderly
176773981,17677398,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",200.417,MG,U,,,,,10.0,MG,,QD,2020,Q2,Pericardial effusion,,2020,Q2,1,I,20181019.0,20200415.0,20200416,20200416,EXP,GB-MHRA-INP0B459061-F824-4180-9480-DB82B517A0BD,NVSC2020GB102411,NOVARTIS,,68.0,YR,,F,Y,82.0,KG,20200416.0,,HP,GB,GB,2020,Q2,Elderly
176805751,17680575,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Dry mouth,,2020,Q2,1,I,20200305.0,,20200417,20200417,DIR,,,FDA-CTU,,52.0,YR,,M,N,,,20200310.0,N,PH,US,US,2020,Q2,Adult
176824321,17682432,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",,,Y,U,,,,10.0,MG,TABLET,QD,2020,Q2,Dysuria,,2020,Q2,1,I,,20200409.0,20200418,20200418,EXP,,GB-AUROBINDO-AUR-APL-2020-018955,AUROBINDO,,66.0,YR,,M,Y,,,20200418.0,,PH,GB,GB,2020,Q2,Elderly
176824321,17682432,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",,,Y,U,,,,10.0,MG,TABLET,QD,2020,Q2,Urinary tract infection,,2020,Q2,1,I,,20200409.0,20200418,20200418,EXP,,GB-AUROBINDO-AUR-APL-2020-018955,AUROBINDO,,66.0,YR,,M,Y,,,20200418.0,,PH,GB,GB,2020,Q2,Elderly
176874602,17687460,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"ONE AT 12PM, ONE AFTER DINNER",,,,,,,,5.0,MG,,BID,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,2,F,,20200505.0,20200421,20200507,EXP,GB-MHRA-EYC 00221319,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-020565",BOEHRINGER INGELHEIM,,76.0,YR,,F,Y,,,20200507.0,,MD,GB,GB,2020,Q2,Elderly
176874602,17687460,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"ONE AT 12PM, ONE AFTER DINNER",,,,,,,,5.0,MG,,BID,2020,Q2,Hypophagia,,2020,Q2,2,F,,20200505.0,20200421,20200507,EXP,GB-MHRA-EYC 00221319,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-020565",BOEHRINGER INGELHEIM,,76.0,YR,,F,Y,,,20200507.0,,MD,GB,GB,2020,Q2,Elderly
176876524,17687652,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,5.0,MG,,QD,2020,Q2,Diabetic ketoacidosis,,2020,Q2,4,F,201705.0,20200430.0,20200421,20200505,EXP,,"CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-019653",BOEHRINGER INGELHEIM,BARTASKOVA D. A COTTAGE HIDDEN IN THE WOODS -A CASE SHOWING THE KEY ROLE OF CORRECT INDICATION FOR GLIFLOZIN THERAPY IN THE PREVENTION OF DIABETIC KETOACIDOSIS IN TYPE 1DIABETES. DIABETES CLINIC.,70.0,YR,,F,Y,71.0,KG,20200505.0,,MD,CZ,CZ,2020,Q2,Elderly
176876524,17687652,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,5.0,MG,,QD,2020,Q2,Localised infection,,2020,Q2,4,F,201705.0,20200430.0,20200421,20200505,EXP,,"CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-019653",BOEHRINGER INGELHEIM,BARTASKOVA D. A COTTAGE HIDDEN IN THE WOODS -A CASE SHOWING THE KEY ROLE OF CORRECT INDICATION FOR GLIFLOZIN THERAPY IN THE PREVENTION OF DIABETIC KETOACIDOSIS IN TYPE 1DIABETES. DIABETES CLINIC.,70.0,YR,,F,Y,71.0,KG,20200505.0,,MD,CZ,CZ,2020,Q2,Elderly
176876524,17687652,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,5.0,MG,,QD,2020,Q2,Off label use,,2020,Q2,4,F,201705.0,20200430.0,20200421,20200505,EXP,,"CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-019653",BOEHRINGER INGELHEIM,BARTASKOVA D. A COTTAGE HIDDEN IN THE WOODS -A CASE SHOWING THE KEY ROLE OF CORRECT INDICATION FOR GLIFLOZIN THERAPY IN THE PREVENTION OF DIABETIC KETOACIDOSIS IN TYPE 1DIABETES. DIABETES CLINIC.,70.0,YR,,F,Y,71.0,KG,20200505.0,,MD,CZ,CZ,2020,Q2,Elderly
176889281,17688928,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Candida infection,,2020,Q2,1,I,20190816.0,,20200420,20200420,DIR,,,FDA-CTU,,63.0,YR,,F,N,78.93,KG,20200417.0,N,PH,US,US,2020,Q2,Adult
176889281,17688928,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20190816.0,,20200420,20200420,DIR,,,FDA-CTU,,63.0,YR,,F,N,78.93,KG,20200417.0,N,PH,US,US,2020,Q2,Adult
176889281,17688928,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Vaginitis gardnerella,,2020,Q2,1,I,20190816.0,,20200420,20200420,DIR,,,FDA-CTU,,63.0,YR,,F,N,78.93,KG,20200417.0,N,PH,US,US,2020,Q2,Adult
176924931,17692493,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2020,Q2,Blood urea increased,,2020,Q2,1,I,20200221.0,,20200420,20200420,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Adult
176924931,17692493,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2020,Q2,Myalgia,,2020,Q2,1,I,20200221.0,,20200420,20200420,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Adult
176932911,17693291,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q2,Pruritus,,2020,Q2,1,I,20200221.0,,20200421,20200421,DIR,,,FDA-CTU,,67.0,YR,,M,N,85.0,KG,20200417.0,N,PH,US,US,2020,Q2,Elderly
176932911,17693291,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q2,Urticaria,,2020,Q2,1,I,20200221.0,,20200421,20200421,DIR,,,FDA-CTU,,67.0,YR,,M,N,85.0,KG,20200417.0,N,PH,US,US,2020,Q2,Elderly
176934201,17693420,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20200203.0,,20200421,20200421,DIR,,,FDA-CTU,,72.0,YR,,M,N,102.0,KG,20200417.0,N,PH,US,US,2020,Q2,Elderly
176939501,17693950,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q2,Atrial fibrillation,,2020,Q2,1,I,20200203.0,,20200421,20200421,DIR,,,FDA-CTU,,71.0,YR,,M,N,89.0,KG,20200417.0,N,PH,US,US,2020,Q2,Elderly
177017143,17701714,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Bladder neoplasm,,2020,Q2,3,F,201911.0,20200428.0,20200423,20200429,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-120891",BOEHRINGER INGELHEIM,,57.0,YR,,M,Y,83.0,KG,20200429.0,,MD,PL,PL,2020,Q2,Adult
177017143,17701714,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Dysuria,,2020,Q2,3,F,201911.0,20200428.0,20200423,20200429,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-120891",BOEHRINGER INGELHEIM,,57.0,YR,,M,Y,83.0,KG,20200429.0,,MD,PL,PL,2020,Q2,Adult
177044451,17704445,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Angina pectoris,,2020,Q2,1,I,,20200415.0,20200424,20200424,EXP,,DE-MYLANLABS-2020M1038906,MYLAN,"WIECHELT J, BRAUN A, BEUTEL-SIEBERTZ J.. POLYPHARMACY IN GERIATRIC PATIENTS - TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE.. SCHMERZMEDIZIN. 2020;36(2)",78.0,YR,,F,Y,55.0,KG,20200424.0,,HP,DE,DE,2020,Q2,Elderly
177044451,17704445,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Dehydration,,2020,Q2,1,I,,20200415.0,20200424,20200424,EXP,,DE-MYLANLABS-2020M1038906,MYLAN,"WIECHELT J, BRAUN A, BEUTEL-SIEBERTZ J.. POLYPHARMACY IN GERIATRIC PATIENTS - TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE.. SCHMERZMEDIZIN. 2020;36(2)",78.0,YR,,F,Y,55.0,KG,20200424.0,,HP,DE,DE,2020,Q2,Elderly
177044451,17704445,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,1,I,,20200415.0,20200424,20200424,EXP,,DE-MYLANLABS-2020M1038906,MYLAN,"WIECHELT J, BRAUN A, BEUTEL-SIEBERTZ J.. POLYPHARMACY IN GERIATRIC PATIENTS - TIPS FOR SAFE AND EFFICIENT DRUG THERAPY IN OLD AGE.. SCHMERZMEDIZIN. 2020;36(2)",78.0,YR,,F,Y,55.0,KG,20200424.0,,HP,DE,DE,2020,Q2,Elderly
177049831,17704983,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200205.0,,20200423,20200423,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Elderly
177049831,17704983,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Blood glucose abnormal,,2020,Q2,1,I,20200205.0,,20200423,20200423,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Elderly
177049831,17704983,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Blood urea increased,,2020,Q2,1,I,20200205.0,,20200423,20200423,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Elderly
177049831,17704983,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Dehydration,,2020,Q2,1,I,20200205.0,,20200423,20200423,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Elderly
177049831,17704983,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Pollakiuria,,2020,Q2,1,I,20200205.0,,20200423,20200423,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Elderly
177123121,17712312,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,20200211.0,,20200427,20200427,DIR,,,FDA-CTU,,74.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Elderly
177123121,17712312,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,20200211.0,,20200427,20200427,DIR,,,FDA-CTU,,74.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Elderly
177124181,17712418,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200226.0,,20200427,20200427,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Elderly
177128524,17712852,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Anaemia,,2020,Q2,4,F,20200320.0,20200626.0,20200427,20200630,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-020097",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,60.0,KG,20200630.0,,MD,MX,MX,2020,Q2,Elderly
177128524,17712852,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Gastric ulcer,,2020,Q2,4,F,20200320.0,20200626.0,20200427,20200630,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-020097",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,60.0,KG,20200630.0,,MD,MX,MX,2020,Q2,Elderly
177135871,17713587,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,, 957553,20220630.0,,12.5,MG,,,2020,Q2,Blood glucose fluctuation,,2020,Q2,1,I,20191104.0,,20200427,20200427,DIR,,,FDA-CTU,,74.0,YR,,M,N,93.0,KG,20200424.0,N,PH,US,US,2020,Q2,Elderly
177135871,17713587,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,, 957553,20220630.0,,12.5,MG,,,2020,Q2,Pollakiuria,,2020,Q2,1,I,20191104.0,,20200427,20200427,DIR,,,FDA-CTU,,74.0,YR,,M,N,93.0,KG,20200424.0,N,PH,US,US,2020,Q2,Elderly
177156534,17715653,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q2,Cardiac failure,,2020,Q2,4,F,20200205.0,20200522.0,20200427,20200527,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-020880",BOEHRINGER INGELHEIM,,61.0,YR,,F,Y,89.2,KG,20200527.0,,MD,BR,BR,2020,Q2,Adult
177192581,17719258,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Acidosis,,2020,Q2,1,I,20200116.0,20200427.0,20200428,20200428,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,NVSC2020GB114406,NOVARTIS,,74.0,YR,,M,Y,61.1,KG,20200428.0,,HP,COUNTRY NOT SPECIFIED,GB,2020,Q2,Elderly
177192581,17719258,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200116.0,20200427.0,20200428,20200428,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,NVSC2020GB114406,NOVARTIS,,74.0,YR,,M,Y,61.1,KG,20200428.0,,HP,COUNTRY NOT SPECIFIED,GB,2020,Q2,Elderly
177192581,17719258,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Cardiac arrest,,2020,Q2,1,I,20200116.0,20200427.0,20200428,20200428,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,NVSC2020GB114406,NOVARTIS,,74.0,YR,,M,Y,61.1,KG,20200428.0,,HP,COUNTRY NOT SPECIFIED,GB,2020,Q2,Elderly
177192581,17719258,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,20200116.0,20200427.0,20200428,20200428,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,NVSC2020GB114406,NOVARTIS,,74.0,YR,,M,Y,61.1,KG,20200428.0,,HP,COUNTRY NOT SPECIFIED,GB,2020,Q2,Elderly
177192581,17719258,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Hyperlactacidaemia,,2020,Q2,1,I,20200116.0,20200427.0,20200428,20200428,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,NVSC2020GB114406,NOVARTIS,,74.0,YR,,M,Y,61.1,KG,20200428.0,,HP,COUNTRY NOT SPECIFIED,GB,2020,Q2,Elderly
177192581,17719258,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Malaise,,2020,Q2,1,I,20200116.0,20200427.0,20200428,20200428,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,NVSC2020GB114406,NOVARTIS,,74.0,YR,,M,Y,61.1,KG,20200428.0,,HP,COUNTRY NOT SPECIFIED,GB,2020,Q2,Elderly
177192581,17719258,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Vomiting,,2020,Q2,1,I,20200116.0,20200427.0,20200428,20200428,EXP,GB-MHRA-MIDB-18C56AD3-2560-4EFD-8C46-50B2451121CC,NVSC2020GB114406,NOVARTIS,,74.0,YR,,M,Y,61.1,KG,20200428.0,,HP,COUNTRY NOT SPECIFIED,GB,2020,Q2,Elderly
177256652,17725665,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q2,Cardiac failure,,2020,Q2,2,F,202002.0,20200428.0,20200429,20200504,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-021407",BOEHRINGER INGELHEIM,,39.0,YR,,M,Y,127.5,KG,20200504.0,,MD,BR,BR,2020,Q2,Adult
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Anal haemorrhage,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Back pain,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Blood test abnormal,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Blood urine present,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Burning sensation,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Chromaturia,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Confusional state,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Depressed mood,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Dizziness,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Fall,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Fatigue,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Flank pain,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Gait disturbance,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Haemorrhoids,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Hepatic pain,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Malaise,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Night sweats,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Off label use,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Post-traumatic stress disorder,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Rectal haemorrhage,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Renal disorder,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Renal pain,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Somnolence,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Thermal burn,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Urine analysis abnormal,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177286413,17728641,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q2,Wrong technique in product usage process,,2020,Q2,3,F,20200415.0,20200610.0,20200430,20200618,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033773,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,122.47,KG,20200618.0,,CN,US,US,2020,Q2,Elderly
177338051,17733805,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Cough,,2020,Q2,1,I,20191224.0,,20200430,20200430,DIR,,,FDA-CTU,,82.0,YR,,M,N,76.0,KG,20200217.0,N,PH,US,US,2020,Q2,Elderly
177338051,17733805,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Diarrhoea,,2020,Q2,1,I,20191224.0,,20200430,20200430,DIR,,,FDA-CTU,,82.0,YR,,M,N,76.0,KG,20200217.0,N,PH,US,US,2020,Q2,Elderly
177338051,17733805,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Weight decreased,,2020,Q2,1,I,20191224.0,,20200430,20200430,DIR,,,FDA-CTU,,82.0,YR,,M,N,76.0,KG,20200217.0,N,PH,US,US,2020,Q2,Elderly
177338141,17733814,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,1X,2020,Q2,Renal impairment,,2020,Q2,1,I,20181205.0,,20200430,20200430,DIR,,,FDA-CTU,,70.0,YR,,M,N,108.0,KG,20190215.0,N,PH,US,US,2020,Q2,Elderly
177343071,17734307,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Insulin resistance,,2020,Q2,1,I,,20200428.0,20200501,20200501,EXP,,HK-PFIZER INC-2020172928,PFIZER,"CHAN, N.. OPTIMIZING LIPID MANAGEMENT IN A HIGH-RISK DIABETES PATIENT. MIMS DOCTOR. 2020;16-17",76.0,YR,,M,Y,,,20200501.0,,MD,HK,HK,2020,Q2,Elderly
177343071,17734307,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Muscle atrophy,,2020,Q2,1,I,,20200428.0,20200501,20200501,EXP,,HK-PFIZER INC-2020172928,PFIZER,"CHAN, N.. OPTIMIZING LIPID MANAGEMENT IN A HIGH-RISK DIABETES PATIENT. MIMS DOCTOR. 2020;16-17",76.0,YR,,M,Y,,,20200501.0,,MD,HK,HK,2020,Q2,Elderly
177389511,17738951,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q2,Genital infection fungal,,2020,Q2,1,I,20200320.0,,20200501,20200501,DIR,,,FDA-CTU,,73.0,YR,,M,N,100.0,KG,20200430.0,N,PH,US,US,2020,Q2,Elderly
177404331,17740433,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q2,Dehydration,,2020,Q2,1,I,20200325.0,,20200501,20200501,DIR,,,FDA-CTU,,66.0,YR,,M,N,84.0,KG,20200430.0,N,PH,US,US,2020,Q2,Elderly
177404331,17740433,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,,,2020,Q2,Muscle spasms,,2020,Q2,1,I,20200325.0,,20200501,20200501,DIR,,,FDA-CTU,,66.0,YR,,M,N,84.0,KG,20200430.0,N,PH,US,US,2020,Q2,Elderly
177421431,17742143,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,,2020,Q2,Dysuria,,2020,Q2,1,I,,20200428.0,20200504,20200504,EXP,GB-MHRA-ADR 24488113,GB-ACCORD-180597,ACCORD,,66.0,YR,,M,Y,,,20200504.0,,PH,GB,GB,2020,Q2,Elderly
177421431,17742143,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,,2020,Q2,Urinary tract infection,,2020,Q2,1,I,,20200428.0,20200504,20200504,EXP,GB-MHRA-ADR 24488113,GB-ACCORD-180597,ACCORD,,66.0,YR,,M,Y,,,20200504.0,,PH,GB,GB,2020,Q2,Elderly
177455121,17745512,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20200310.0,,20200505,20200505,DIR,,,FDA-CTU,,56.0,YR,,M,N,72.57,KG,20200428.0,N,PH,US,US,2020,Q2,Adult
177455121,17745512,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,20200310.0,,20200505,20200505,DIR,,,FDA-CTU,,56.0,YR,,M,N,72.57,KG,20200428.0,N,PH,US,US,2020,Q2,Adult
177455121,17745512,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Nausea,,2020,Q2,1,I,20200310.0,,20200505,20200505,DIR,,,FDA-CTU,,56.0,YR,,M,N,72.57,KG,20200428.0,N,PH,US,US,2020,Q2,Adult
177455121,17745512,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Pyrexia,,2020,Q2,1,I,20200310.0,,20200505,20200505,DIR,,,FDA-CTU,,56.0,YR,,M,N,72.57,KG,20200428.0,N,PH,US,US,2020,Q2,Adult
177455121,17745512,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Vomiting,,2020,Q2,1,I,20200310.0,,20200505,20200505,DIR,,,FDA-CTU,,56.0,YR,,M,N,72.57,KG,20200428.0,N,PH,US,US,2020,Q2,Adult
177456901,17745690,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q2,Haematuria,,2020,Q2,1,I,20200429.0,,20200505,20200505,DIR,,,FDA-CTU,,53.0,YR,,F,N,,,20200505.0,N,PH,US,US,2020,Q2,Adult
177456901,17745690,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q2,Hypersensitivity,,2020,Q2,1,I,20200429.0,,20200505,20200505,DIR,,,FDA-CTU,,53.0,YR,,F,N,,,20200505.0,N,PH,US,US,2020,Q2,Adult
177456901,17745690,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20200429.0,,20200505,20200505,DIR,,,FDA-CTU,,53.0,YR,,F,N,,,20200505.0,N,PH,US,US,2020,Q2,Adult
177456901,17745690,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q2,Urosepsis,,2020,Q2,1,I,20200429.0,,20200505,20200505,DIR,,,FDA-CTU,,53.0,YR,,F,N,,,20200505.0,N,PH,US,US,2020,Q2,Adult
177456901,17745690,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q2,Vaginal haemorrhage,,2020,Q2,1,I,20200429.0,,20200505,20200505,DIR,,,FDA-CTU,,53.0,YR,,F,N,,,20200505.0,N,PH,US,US,2020,Q2,Adult
177469431,17746943,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",225.0,MG,Y,U,,,,25.0,MG,,QD,2020,Q2,Malaise,,2020,Q2,1,I,20191206.0,20200429.0,20200505,20200505,EXP,IT-MINISAL02-597217,IT-MYLANLABS-2020M1043452,MYLAN,,69.0,YR,,F,Y,,,20200505.0,,PH,IT,IT,2020,Q2,Elderly
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Acute abdomen,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Biliary colic,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Dacryostenosis acquired,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Diabetes mellitus,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Diabetic retinopathy,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Incisional hernia,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Influenza,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Periarthritis,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Posterior capsule opacification,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177475442,17747544,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Tinea infection,,2020,Q2,2,F,20170630.0,20200530.0,20200505,20200605,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-001902",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,84.0,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
177476441,17747644,12,C,empagliflozin (+) metformin hydrochloride,,2,,"12,5/850MG; 1 TABLET AT 12.00 A.M. AND 1 TABLET AT 6.00 P.M.",,,,,,,,,,,BID,2020,Q2,Acute generalised exanthematous pustulosis,,2020,Q2,1,I,202004.0,20200430.0,20200505,20200505,EXP,,IT-009507513-2005ITA000480,MERCK,,66.0,YR,,M,Y,100.0,KG,20200505.0,,CN,IT,IT,2020,Q2,Elderly
177476441,17747644,12,C,empagliflozin (+) metformin hydrochloride,,2,,"12,5/850MG; 1 TABLET AT 12.00 A.M. AND 1 TABLET AT 6.00 P.M.",,,,,,,,,,,BID,2020,Q2,Drug reaction with eosinophilia and systemic symptoms,,2020,Q2,1,I,202004.0,20200430.0,20200505,20200505,EXP,,IT-009507513-2005ITA000480,MERCK,,66.0,YR,,M,Y,100.0,KG,20200505.0,,CN,IT,IT,2020,Q2,Elderly
177476441,17747644,12,C,empagliflozin (+) metformin hydrochloride,,2,,"12,5/850MG; 1 TABLET AT 12.00 A.M. AND 1 TABLET AT 6.00 P.M.",,,,,,,,,,,BID,2020,Q2,Immune-mediated dermatitis,,2020,Q2,1,I,202004.0,20200430.0,20200505,20200505,EXP,,IT-009507513-2005ITA000480,MERCK,,66.0,YR,,M,Y,100.0,KG,20200505.0,,CN,IT,IT,2020,Q2,Elderly
177476441,17747644,12,C,empagliflozin (+) metformin hydrochloride,,2,,"12,5/850MG; 1 TABLET AT 12.00 A.M. AND 1 TABLET AT 6.00 P.M.",,,,,,,,,,,BID,2020,Q2,Vasculitis,,2020,Q2,1,I,202004.0,20200430.0,20200505,20200505,EXP,,IT-009507513-2005ITA000480,MERCK,,66.0,YR,,M,Y,100.0,KG,20200505.0,,CN,IT,IT,2020,Q2,Elderly
177548591,17754859,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q2,Chest wall haematoma,,2020,Q2,1,I,,20200504.0,20200507,20200507,EXP,,DE-DRREDDYS-GER/GER/20/0122591,DR REDDYS,,83.0,YR,E,F,Y,60.0,KG,20200507.0,,PH,DE,DE,2020,Q2,Elderly
177548591,17754859,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q2,Fall,,2020,Q2,1,I,,20200504.0,20200507,20200507,EXP,,DE-DRREDDYS-GER/GER/20/0122591,DR REDDYS,,83.0,YR,E,F,Y,60.0,KG,20200507.0,,PH,DE,DE,2020,Q2,Elderly
177548591,17754859,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q2,Fracture,,2020,Q2,1,I,,20200504.0,20200507,20200507,EXP,,DE-DRREDDYS-GER/GER/20/0122591,DR REDDYS,,83.0,YR,E,F,Y,60.0,KG,20200507.0,,PH,DE,DE,2020,Q2,Elderly
177548591,17754859,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q2,Periorbital haematoma,,2020,Q2,1,I,,20200504.0,20200507,20200507,EXP,,DE-DRREDDYS-GER/GER/20/0122591,DR REDDYS,,83.0,YR,E,F,Y,60.0,KG,20200507.0,,PH,DE,DE,2020,Q2,Elderly
177548591,17754859,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q2,Presyncope,,2020,Q2,1,I,,20200504.0,20200507,20200507,EXP,,DE-DRREDDYS-GER/GER/20/0122591,DR REDDYS,,83.0,YR,E,F,Y,60.0,KG,20200507.0,,PH,DE,DE,2020,Q2,Elderly
177562191,17756219,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,25 MG AM PO,,,N,D,,,,25.0,MG,,,2020,Q2,Necrotising fasciitis,,2020,Q2,1,I,20200401.0,,20200507,20200507,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200414.0,N,PH,US,US,2020,Q2,Elderly
177562241,17756224,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q2,Pollakiuria,,2020,Q2,1,I,20191019.0,,20200507,20200507,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200427.0,N,PH,US,US,2020,Q2,Elderly
177584012,17758401,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,TABLET,QD,2020,Q2,Cholecystitis,,2020,Q2,2,F,20200221.0,20200513.0,20200507,20200522,EXP,,US-INTERCEPT-CT2020001016,INTERCEPT PHARMACEUTICALS,,63.0,YR,,F,Y,85.0,KG,20200522.0,,MD,US,US,2020,Q2,Adult
177659491,17765949,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Genital rash,,2020,Q2,1,I,20200423.0,,20200508,20200508,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20200507.0,N,PH,US,US,2020,Q2,Elderly
177659491,17765949,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Rash,,2020,Q2,1,I,20200423.0,,20200508,20200508,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20200507.0,N,PH,US,US,2020,Q2,Elderly
177659601,17765960,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20200422.0,,20200508,20200508,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20200507.0,N,PH,US,US,2020,Q2,Elderly
177688111,17768811,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q2,Chest wall haematoma,,2020,Q2,1,I,,20200502.0,20200512,20200512,EXP,,DE-AUROBINDO-AUR-APL-2020-022423,AUROBINDO,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177688111,17768811,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q2,Fall,,2020,Q2,1,I,,20200502.0,20200512,20200512,EXP,,DE-AUROBINDO-AUR-APL-2020-022423,AUROBINDO,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177688111,17768811,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200502.0,20200512,20200512,EXP,,DE-AUROBINDO-AUR-APL-2020-022423,AUROBINDO,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177688111,17768811,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q2,Periorbital haematoma,,2020,Q2,1,I,,20200502.0,20200512,20200512,EXP,,DE-AUROBINDO-AUR-APL-2020-022423,AUROBINDO,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177688111,17768811,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q2,Presyncope,,2020,Q2,1,I,,20200502.0,20200512,20200512,EXP,,DE-AUROBINDO-AUR-APL-2020-022423,AUROBINDO,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177708881,17770888,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Chest wall haematoma,,2020,Q2,1,I,20190922.0,20200506.0,20200512,20200512,EXP,,DE-PFIZER INC-2020187123,PFIZER,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177708881,17770888,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Fall,,2020,Q2,1,I,20190922.0,20200506.0,20200512,20200512,EXP,,DE-PFIZER INC-2020187123,PFIZER,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177708881,17770888,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Fracture,,2020,Q2,1,I,20190922.0,20200506.0,20200512,20200512,EXP,,DE-PFIZER INC-2020187123,PFIZER,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177708881,17770888,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,20190922.0,20200506.0,20200512,20200512,EXP,,DE-PFIZER INC-2020187123,PFIZER,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177708881,17770888,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Periorbital haematoma,,2020,Q2,1,I,20190922.0,20200506.0,20200512,20200512,EXP,,DE-PFIZER INC-2020187123,PFIZER,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177708881,17770888,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1X/DAY, (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Presyncope,,2020,Q2,1,I,20190922.0,20200506.0,20200512,20200512,EXP,,DE-PFIZER INC-2020187123,PFIZER,,83.0,YR,,F,Y,60.0,KG,20200512.0,,PH,DE,DE,2020,Q2,Elderly
177720261,17772026,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20200420.0,20200501.0,20200512,20200512,EXP,GB-MHRA-EYC 00222007,GB-NOVOPROD-726537,NOVO NORDISK,,67.0,YR,,M,Y,,,20200512.0,,PH,GB,GB,2020,Q2,Elderly
177720261,17772026,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Vomiting projectile,,2020,Q2,1,I,20200420.0,20200501.0,20200512,20200512,EXP,GB-MHRA-EYC 00222007,GB-NOVOPROD-726537,NOVO NORDISK,,67.0,YR,,M,Y,,,20200512.0,,PH,GB,GB,2020,Q2,Elderly
177725371,17772537,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,2019.0,20200325.0,20200512,20200512,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0245,BIODELIVERY SCIENCES INTERNATIONAL,,68.0,YR,E,F,Y,90.8,KG,20200512.0,,CN,US,US,2020,Q2,Elderly
177737521,17773752,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Pancreatitis acute,,2020,Q2,1,I,20180529.0,20200429.0,20200513,20200513,EXP,,PT-RECORDATI RARE DISEASES-2083732,RECORDATI,,46.0,YR,,F,Y,,,20200513.0,,MD,PT,PT,2020,Q2,Adult
177824761,17782476,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Chest wall haematoma,,2020,Q2,1,I,,20200506.0,20200514,20200514,EXP,,DE-TEVA-2020-DE-1234555,TEVA,,83.0,YR,,F,Y,60.0,KG,20200514.0,,PH,DE,DE,2020,Q2,Elderly
177824761,17782476,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Fall,,2020,Q2,1,I,,20200506.0,20200514,20200514,EXP,,DE-TEVA-2020-DE-1234555,TEVA,,83.0,YR,,F,Y,60.0,KG,20200514.0,,PH,DE,DE,2020,Q2,Elderly
177824761,17782476,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Fracture,,2020,Q2,1,I,,20200506.0,20200514,20200514,EXP,,DE-TEVA-2020-DE-1234555,TEVA,,83.0,YR,,F,Y,60.0,KG,20200514.0,,PH,DE,DE,2020,Q2,Elderly
177824761,17782476,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Periorbital haematoma,,2020,Q2,1,I,,20200506.0,20200514,20200514,EXP,,DE-TEVA-2020-DE-1234555,TEVA,,83.0,YR,,F,Y,60.0,KG,20200514.0,,PH,DE,DE,2020,Q2,Elderly
177824761,17782476,6,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Presyncope,,2020,Q2,1,I,,20200506.0,20200514,20200514,EXP,,DE-TEVA-2020-DE-1234555,TEVA,,83.0,YR,,F,Y,60.0,KG,20200514.0,,PH,DE,DE,2020,Q2,Elderly
177924274,17792427,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Back pain,,2020,Q2,4,F,20200316.0,20200615.0,20200515,20200624,EXP,,"BE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-016524",BOEHRINGER INGELHEIM,,73.0,YR,,M,Y,82.6,KG,20200623.0,,MD,BE,BE,2020,Q2,Elderly
177962201,17796220,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",3726.042,MG,Y,,,,,25.0,MG,,QD,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200109.0,20200513.0,20200517,20200517,EXP,GB-MHRA-EYC 00217015,NVSC2020GB131451,NOVARTIS,,68.0,YR,,F,Y,74.8,KG,20200518.0,,HP,GB,GB,2020,Q2,Elderly
177992341,17799234,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Chest wall haematoma,,2020,Q2,1,I,,20200512.0,20200518,20200518,EXP,,DE-MYLANLABS-2020M1048531,MYLAN,,83.0,YR,,F,Y,60.0,KG,20200518.0,,PH,DE,DE,2020,Q2,Elderly
177992341,17799234,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Fall,,2020,Q2,1,I,,20200512.0,20200518,20200518,EXP,,DE-MYLANLABS-2020M1048531,MYLAN,,83.0,YR,,F,Y,60.0,KG,20200518.0,,PH,DE,DE,2020,Q2,Elderly
177992341,17799234,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Fracture,,2020,Q2,1,I,,20200512.0,20200518,20200518,EXP,,DE-MYLANLABS-2020M1048531,MYLAN,,83.0,YR,,F,Y,60.0,KG,20200518.0,,PH,DE,DE,2020,Q2,Elderly
177992341,17799234,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Periorbital haematoma,,2020,Q2,1,I,,20200512.0,20200518,20200518,EXP,,DE-MYLANLABS-2020M1048531,MYLAN,,83.0,YR,,F,Y,60.0,KG,20200518.0,,PH,DE,DE,2020,Q2,Elderly
177992341,17799234,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Presyncope,,2020,Q2,1,I,,20200512.0,20200518,20200518,EXP,,DE-MYLANLABS-2020M1048531,MYLAN,,83.0,YR,,F,Y,60.0,KG,20200518.0,,PH,DE,DE,2020,Q2,Elderly
178008453,17800845,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,D,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Pulmonary oedema,,2020,Q2,3,F,20191107.0,20200526.0,20200518,20200527,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-016434",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,112.4,KG,20200528.0,,MD,GB,GB,2020,Q2,Elderly
178018151,17801815,16,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,1,I,20200515.0,,20200518,20200518,DIR,,,FDA-CTU,,67.0,YR,,F,N,72.6,KG,20200518.0,Y,PH,US,US,2020,Q2,Elderly
178018151,17801815,16,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Swelling,,2020,Q2,1,I,20200515.0,,20200518,20200518,DIR,,,FDA-CTU,,67.0,YR,,F,N,72.6,KG,20200518.0,Y,PH,US,US,2020,Q2,Elderly
178018151,17801815,16,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Throat irritation,,2020,Q2,1,I,20200515.0,,20200518,20200518,DIR,,,FDA-CTU,,67.0,YR,,F,N,72.6,KG,20200518.0,Y,PH,US,US,2020,Q2,Elderly
178037752,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Abscess drainage,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178037752,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Appendicitis,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178037752,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Gastric polyps,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178037752,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Iron deficiency anaemia,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178037752,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Weight increased,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178060631,17806063,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Chest wall haematoma,,2020,Q2,1,I,,20200512.0,20200520,20200520,EXP,DE-BFARM-20005208,DE-ACCORD-182410,ACCORD,,83.0,YR,E,F,Y,60.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
178060631,17806063,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,,20200512.0,20200520,20200520,EXP,DE-BFARM-20005208,DE-ACCORD-182410,ACCORD,,83.0,YR,E,F,Y,60.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
178060631,17806063,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200512.0,20200520,20200520,EXP,DE-BFARM-20005208,DE-ACCORD-182410,ACCORD,,83.0,YR,E,F,Y,60.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
178060631,17806063,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Periorbital haematoma,,2020,Q2,1,I,,20200512.0,20200520,20200520,EXP,DE-BFARM-20005208,DE-ACCORD-182410,ACCORD,,83.0,YR,E,F,Y,60.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
178060631,17806063,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Presyncope,,2020,Q2,1,I,,20200512.0,20200520,20200520,EXP,DE-BFARM-20005208,DE-ACCORD-182410,ACCORD,,83.0,YR,E,F,Y,60.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
178096282,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Atrial fibrillation,,2020,Q2,2,F,20180204.0,20200616.0,20200520,20200618,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200618.0,,CN,US,US,2020,Q2,Adult
178096282,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Coronary artery disease,,2020,Q2,2,F,20180204.0,20200616.0,20200520,20200618,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200618.0,,CN,US,US,2020,Q2,Adult
178096282,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Hyperkalaemia,,2020,Q2,2,F,20180204.0,20200616.0,20200520,20200618,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200618.0,,CN,US,US,2020,Q2,Adult
178096282,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Mitral valve incompetence,,2020,Q2,2,F,20180204.0,20200616.0,20200520,20200618,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200618.0,,CN,US,US,2020,Q2,Adult
178096282,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q2,Myocardial infarction,,2020,Q2,2,F,20180204.0,20200616.0,20200520,20200618,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200618.0,,CN,US,US,2020,Q2,Adult
178215781,17821578,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,204629.0,,,,,2020,Q2,Orchitis,,2020,Q2,1,I,20200202.0,20200317.0,20200525,20200525,EXP,,"RO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015888",BOEHRINGER INGELHEIM,,59.0,YR,,M,Y,,,20200525.0,,MD,RO,RO,2020,Q2,Adult
178215781,17821578,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,204629.0,,,,,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20200202.0,20200317.0,20200525,20200525,EXP,,"RO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015888",BOEHRINGER INGELHEIM,,59.0,YR,,M,Y,,,20200525.0,,MD,RO,RO,2020,Q2,Adult
178240381,17824038,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,, 955539,20211031.0,,25.0,MG,,QD,2020,Q2,Fall,,2020,Q2,1,I,20200330.0,,20200522,20200522,DIR,,,FDA-CTU,,74.0,YR,,M,N,99.0,KG,20200521.0,N,PH,US,US,2020,Q2,Elderly
178240381,17824038,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,, 955539,20211031.0,,25.0,MG,,QD,2020,Q2,Therapy change,,2020,Q2,1,I,20200330.0,,20200522,20200522,DIR,,,FDA-CTU,,74.0,YR,,M,N,99.0,KG,20200521.0,N,PH,US,US,2020,Q2,Elderly
178240381,17824038,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,, 955539,20211031.0,,25.0,MG,,QD,2020,Q2,Vision blurred,,2020,Q2,1,I,20200330.0,,20200522,20200522,DIR,,,FDA-CTU,,74.0,YR,,M,N,99.0,KG,20200521.0,N,PH,US,US,2020,Q2,Elderly
178293241,17829324,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,TABLET,,2020,Q2,Pollakiuria,,2020,Q2,1,I,20200330.0,,20200527,20200527,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Adult
178308151,17830815,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DAILY DOSE: 25 MG MILLGRAM(S) EVERY DAYS,,,,,,,,25.0,MG,,QD,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200414.0,20200523.0,20200527,20200527,EXP,DE-DCGMA-20184960,DE-BAUSCH-BL-2020-015340,BAUSCH AND LOMB,,78.0,YR,,M,Y,72.0,KG,20200527.0,,PH,DE,DE,2020,Q2,Elderly
178308151,17830815,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DAILY DOSE: 25 MG MILLGRAM(S) EVERY DAYS,,,,,,,,25.0,MG,,QD,2020,Q2,Lactic acidosis,,2020,Q2,1,I,20200414.0,20200523.0,20200527,20200527,EXP,DE-DCGMA-20184960,DE-BAUSCH-BL-2020-015340,BAUSCH AND LOMB,,78.0,YR,,M,Y,72.0,KG,20200527.0,,PH,DE,DE,2020,Q2,Elderly
178314751,17831475,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2020,Q2,Hemiparesis,,2020,Q2,1,I,20191114.0,20200504.0,20200527,20200527,EXP,,GB-NOVOPROD-728703,NOVO NORDISK,,61.0,YR,,F,Y,92.0,KG,20200527.0,,MD,GB,GB,2020,Q2,Adult
178314751,17831475,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2020,Q2,Swelling,,2020,Q2,1,I,20191114.0,20200504.0,20200527,20200527,EXP,,GB-NOVOPROD-728703,NOVO NORDISK,,61.0,YR,,F,Y,92.0,KG,20200527.0,,MD,GB,GB,2020,Q2,Adult
178341432,17834143,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DAILY DOSE: 25 MG MILLGRAM(S) EVERY DAYS,,,,,,,,25.0,MG,,QD,2020,Q2,Acute kidney injury,,2020,Q2,2,F,20200414.0,20200528.0,20200528,20200603,EXP,,DE-EMD SERONO-E2B_90077735,EMD SERONO INC,,78.0,YR,,M,Y,72.0,KG,20200603.0,,PH,DE,DE,2020,Q2,Elderly
178341432,17834143,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DAILY DOSE: 25 MG MILLGRAM(S) EVERY DAYS,,,,,,,,25.0,MG,,QD,2020,Q2,Lactic acidosis,,2020,Q2,2,F,20200414.0,20200528.0,20200528,20200603,EXP,,DE-EMD SERONO-E2B_90077735,EMD SERONO INC,,78.0,YR,,M,Y,72.0,KG,20200603.0,,PH,DE,DE,2020,Q2,Elderly
178345181,17834518,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Pollakiuria,,2020,Q2,1,I,20200323.0,,20200528,20200528,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Adult
178345691,17834569,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20200331.0,,20200528,20200528,DIR,,,FDA-CTU,,55.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Adult
178358822,17835882,18,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,2,F,20200515.0,20200623.0,20200528,20200626,EXP,,US-GILEAD-2020-0468290,GILEAD,,67.0,YR,E,F,Y,72.6,KG,20200626.0,,PH,US,US,2020,Q2,Elderly
178358822,17835882,18,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Swelling,,2020,Q2,2,F,20200515.0,20200623.0,20200528,20200626,EXP,,US-GILEAD-2020-0468290,GILEAD,,67.0,YR,E,F,Y,72.6,KG,20200626.0,,PH,US,US,2020,Q2,Elderly
178358822,17835882,18,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Throat irritation,,2020,Q2,2,F,20200515.0,20200623.0,20200528,20200626,EXP,,US-GILEAD-2020-0468290,GILEAD,,67.0,YR,E,F,Y,72.6,KG,20200626.0,,PH,US,US,2020,Q2,Elderly
178428931,17842893,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",225.0,MG,Y,,,,,25.0,MG,,QD,2020,Q2,Malaise,,2020,Q2,1,I,20191206.0,20200527.0,20200530,20200530,EXP,IT-MINISAL02-597217,NVSC2020IT148030,NOVARTIS,,69.0,YR,,F,Y,,,20200530.0,,HP,IT,IT,2020,Q2,Elderly
178429231,17842923,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY (DAILY DOSE: 25 MG MILLGRAM(S) EVERY DAYS)",,,,,,,,25.0,MG,,QD,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200414.0,20200521.0,20200530,20200530,EXP,,DE-AUROBINDO-AUR-APL-2020-026500,AUROBINDO,,78.0,YR,,M,Y,72.0,KG,20200530.0,,PH,DE,DE,2020,Q2,Elderly
178429231,17842923,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY (DAILY DOSE: 25 MG MILLGRAM(S) EVERY DAYS)",,,,,,,,25.0,MG,,QD,2020,Q2,Lactic acidosis,,2020,Q2,1,I,20200414.0,20200521.0,20200530,20200530,EXP,,DE-AUROBINDO-AUR-APL-2020-026500,AUROBINDO,,78.0,YR,,M,Y,72.0,KG,20200530.0,,PH,DE,DE,2020,Q2,Elderly
178486192,17848619,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,QD,2020,Q2,Blood glucose increased,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,QD,2020,Q2,Decreased appetite,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,QD,2020,Q2,Nausea,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,QD,2020,Q2,Treatment noncompliance,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,QD,2020,Q2,Weight decreased,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178499221,17849922,3,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY;,,,,,,,,25.0,MG,,QD,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200414.0,20200526.0,20200602,20200602,EXP,,DE-TEVA-2020-DE-1242693,TEVA,,78.0,YR,,M,Y,72.0,KG,20200602.0,,PH,DE,DE,2020,Q2,Elderly
178499221,17849922,3,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY;,,,,,,,,25.0,MG,,QD,2020,Q2,Lactic acidosis,,2020,Q2,1,I,20200414.0,20200526.0,20200602,20200602,EXP,,DE-TEVA-2020-DE-1242693,TEVA,,78.0,YR,,M,Y,72.0,KG,20200602.0,,PH,DE,DE,2020,Q2,Elderly
178502471,17850247,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Decreased appetite,,2020,Q2,1,I,20200515.0,,20200602,20200602,DIR,,,FDA-CTU,,53.0,YR,,M,N,62.1,KG,20200602.0,N,PH,US,US,2020,Q2,Adult
178502471,17850247,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20200515.0,,20200602,20200602,DIR,,,FDA-CTU,,53.0,YR,,M,N,62.1,KG,20200602.0,N,PH,US,US,2020,Q2,Adult
178502471,17850247,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q2,Malaise,,2020,Q2,1,I,20200515.0,,20200602,20200602,DIR,,,FDA-CTU,,53.0,YR,,M,N,62.1,KG,20200602.0,N,PH,US,US,2020,Q2,Adult
178551701,17855170,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,AM,,,D,D,,,,12.5,MG,,,2020,Q2,Asthenia,,2020,Q2,1,I,20191216.0,,20200602,20200602,DIR,,,FDA-CTU,,58.0,YR,,M,N,60.78,KG,20200601.0,N,PH,US,US,2020,Q2,Adult
178551701,17855170,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,AM,,,D,D,,,,12.5,MG,,,2020,Q2,Therapy cessation,,2020,Q2,1,I,20191216.0,,20200602,20200602,DIR,,,FDA-CTU,,58.0,YR,,M,N,60.78,KG,20200601.0,N,PH,US,US,2020,Q2,Adult
178551701,17855170,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,AM,,,D,D,,,,12.5,MG,,,2020,Q2,Weight decreased,,2020,Q2,1,I,20191216.0,,20200602,20200602,DIR,,,FDA-CTU,,58.0,YR,,M,N,60.78,KG,20200601.0,N,PH,US,US,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Anaemia,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Anuria,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Cerebral haemorrhage,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Febrile neutropenia,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Malaise,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Sepsis,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Tachycardia,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178590381,17859038,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Thrombocytopenia,,2020,Q2,1,I,20190815.0,20200528.0,20200604,20200604,EXP,,DE-TEVA-2020-DE-1243284,TEVA,,56.0,YR,,F,Y,87.0,KG,20200604.0,,HP,DE,DE,2020,Q2,Adult
178606101,17860610,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q2,Vulvovaginal candidiasis,,2020,Q2,1,I,20200603.0,,20200604,20200604,DIR,,,FDA-CTU,,51.0,YR,,F,N,135.6,KG,20200604.0,N,PH,US,US,2020,Q2,Adult
178729802,17872980,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,5.0,MG,TABLET,QD,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,5.0,MG,TABLET,QD,2020,Q2,Eczema asteatotic,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,5.0,MG,TABLET,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,5.0,MG,TABLET,QD,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,QD,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,QD,2020,Q2,Eczema asteatotic,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,TABLET,QD,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178744311,17874431,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,85.958336,DF,,,,,,1.0,DF,,,2020,Q2,Back pain,,2020,Q2,1,I,20200522.0,20200603.0,20200609,20200609,EXP,GB-MHRA-ADR 24498559,GB-ACCORD-184639,ACCORD,,51.0,YR,,M,Y,90.0,KG,20200609.0,,PH,GB,GB,2020,Q2,Adult
178835951,17883595,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,TABLET,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200115.0,20200607.0,20200611,20200611,EXP,,DE-BAUSCH-BL-2020-016573,BAUSCH AND LOMB,,77.0,YR,,M,Y,,,20200611.0,,MD,DE,DE,2020,Q2,Elderly
178835951,17883595,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,TABLET,QD,2020,Q2,Product administration error,,2020,Q2,1,I,20200115.0,20200607.0,20200611,20200611,EXP,,DE-BAUSCH-BL-2020-016573,BAUSCH AND LOMB,,77.0,YR,,M,Y,,,20200611.0,,MD,DE,DE,2020,Q2,Elderly
178924191,17892419,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY (1-0-0-0)",,,U,U,,,,10.0,MG,TABLET,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200115.0,20200605.0,20200613,20200613,EXP,,DE-AUROBINDO-AUR-APL-2020-028642,AUROBINDO,,77.0,YR,,M,Y,,,20200613.0,,MD,DE,DE,2020,Q2,Elderly
178924191,17892419,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY (1-0-0-0)",,,U,U,,,,10.0,MG,TABLET,QD,2020,Q2,Product administration error,,2020,Q2,1,I,20200115.0,20200605.0,20200613,20200613,EXP,,DE-AUROBINDO-AUR-APL-2020-028642,AUROBINDO,,77.0,YR,,M,Y,,,20200613.0,,MD,DE,DE,2020,Q2,Elderly
178924552,17892455,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q2,Loss of consciousness,,2020,Q2,2,F,20200403.0,20200618.0,20200612,20200622,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029601",BOEHRINGER INGELHEIM,,72.0,YR,,F,Y,64.0,KG,20200622.0,,MD,MX,MX,2020,Q2,Elderly
178982931,17898293,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,1 DOSAGEFORM,85.958336,DF,,, UNKNOWN,,,1.0,DF,,,2020,Q2,Back pain,,2020,Q2,1,I,20200522.0,20200608.0,20200616,20200616,EXP,GB-MHRA-TPP17804545C5479028YC1590141483817,GB-TEVA-2020-GB-1247818,TEVA,,51.0,YR,,M,Y,90.0,KG,20200616.0,,PH,GB,GB,2020,Q2,Adult
179001211,17900121,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Haematuria,,2020,Q2,1,I,,20200609.0,20200616,20200616,EXP,DE-BFARM-20006222,DE-ACCORD-185357,ACCORD,,80.0,YR,E,M,Y,78.0,KG,20200616.0,,PH,DE,DE,2020,Q2,Elderly
179001211,17900121,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Urinary hesitation,,2020,Q2,1,I,,20200609.0,20200616,20200616,EXP,DE-BFARM-20006222,DE-ACCORD-185357,ACCORD,,80.0,YR,E,M,Y,78.0,KG,20200616.0,,PH,DE,DE,2020,Q2,Elderly
179010461,17901046,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,1 DF,701.0,DF,,, UNKNOWN,,,1.0,DF,,,2020,Q2,Rash pruritic,,2020,Q2,1,I,20200521.0,20200608.0,20200616,20200616,EXP,GB-MHRA-TPP16422299C4584903YC1590055362834,GB-TEVA-2020-GB-1247880,TEVA,,57.0,YR,,M,Y,93.0,KG,20200616.0,,HP,GB,GB,2020,Q2,Adult
179015671,17901567,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"1 DF, 1X/DAY",85.958,DF,,, UNKNOWN,,,1.0,DF,,QD,2020,Q2,Back pain,,2020,Q2,1,I,20200522.0,20200612.0,20200616,20200616,EXP,GB-MHRA-TPP17804545C5479028YC1590141483817,GB-PFIZER INC-2020230132,PFIZER,,51.0,YR,,M,Y,90.0,KG,20200616.0,,PH,GB,GB,2020,Q2,Adult
179018441,17901844,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0, TABLETTEN",,,U,,,,,10.0,MG,TABLET,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200115.0,20200610.0,20200616,20200616,EXP,,DE-EMD SERONO-E2B_90078050,EMD SERONO INC,,77.0,YR,,M,Y,,,20200616.0,,MD,DE,DE,2020,Q2,Elderly
179018441,17901844,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0, TABLETTEN",,,U,,,,,10.0,MG,TABLET,QD,2020,Q2,Product administration error,,2020,Q2,1,I,20200115.0,20200610.0,20200616,20200616,EXP,,DE-EMD SERONO-E2B_90078050,EMD SERONO INC,,77.0,YR,,M,Y,,,20200616.0,,MD,DE,DE,2020,Q2,Elderly
179024921,17902492,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,,,,204629.0,25.0,MG,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200610.0,20200617,20200617,EXP,,"RO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029524",BOEHRINGER INGELHEIM,"DUMITRU A, POSEA M. EUGLYCEMIC KETOACIDOSIS DIAGNOSIS AND TREATMENT PROTOCOL IN TYPE 1 DIABETES PATIENT. ROMANIAN JOURNAL OF DIABETES NUTRITION + METABOLIC DISEASES. 2019;VOL. 26(3):.",39.0,YR,,F,Y,68.0,KG,20200617.0,,MD,RO,RO,2020,Q2,Adult
179024921,17902492,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,,,,204629.0,25.0,MG,,QD,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,,20200610.0,20200617,20200617,EXP,,"RO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029524",BOEHRINGER INGELHEIM,"DUMITRU A, POSEA M. EUGLYCEMIC KETOACIDOSIS DIAGNOSIS AND TREATMENT PROTOCOL IN TYPE 1 DIABETES PATIENT. ROMANIAN JOURNAL OF DIABETES NUTRITION + METABOLIC DISEASES. 2019;VOL. 26(3):.",39.0,YR,,F,Y,68.0,KG,20200617.0,,MD,RO,RO,2020,Q2,Adult
179024921,17902492,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,,,,204629.0,25.0,MG,,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200610.0,20200617,20200617,EXP,,"RO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029524",BOEHRINGER INGELHEIM,"DUMITRU A, POSEA M. EUGLYCEMIC KETOACIDOSIS DIAGNOSIS AND TREATMENT PROTOCOL IN TYPE 1 DIABETES PATIENT. ROMANIAN JOURNAL OF DIABETES NUTRITION + METABOLIC DISEASES. 2019;VOL. 26(3):.",39.0,YR,,F,Y,68.0,KG,20200617.0,,MD,RO,RO,2020,Q2,Adult
179036431,17903643,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (DOSAGE TEXT: 1-0-0-0),,,,,,,,10.0,MG,,,2020,Q2,Haematuria,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,DE-AUROBINDO-AUR-APL-2020-029131,AUROBINDO,,80.0,YR,,M,Y,78.0,KG,20200617.0,,PH,DE,DE,2020,Q2,Elderly
179036431,17903643,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (DOSAGE TEXT: 1-0-0-0),,,,,,,,10.0,MG,,,2020,Q2,Urinary hesitation,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,DE-AUROBINDO-AUR-APL-2020-029131,AUROBINDO,,80.0,YR,,M,Y,78.0,KG,20200617.0,,PH,DE,DE,2020,Q2,Elderly
179061831,17906183,7,C,empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q2,Haematuria,,2020,Q2,1,I,,20200612.0,20200617,20200617,EXP,DE-ADRED-05020-01,DE-TORRENT-00017753,TORRENT,,80.0,YR,E,M,Y,78.0,KG,20200617.0,,PH,DE,DE,2020,Q2,Elderly
179061831,17906183,7,C,empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q2,Urinary hesitation,,2020,Q2,1,I,,20200612.0,20200617,20200617,EXP,DE-ADRED-05020-01,DE-TORRENT-00017753,TORRENT,,80.0,YR,E,M,Y,78.0,KG,20200617.0,,PH,DE,DE,2020,Q2,Elderly
179072131,17907213,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN (TABLET)",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200612.0,20200617,20200617,EXP,,DE-DRREDDYS-GER/GER/20/0124119,DR REDDYS,,67.0,YR,E,M,Y,,,20200617.0,,MD,DE,DE,2020,Q2,Elderly
179072131,17907213,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN (TABLET)",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q2,Cough,,2020,Q2,1,I,,20200612.0,20200617,20200617,EXP,,DE-DRREDDYS-GER/GER/20/0124119,DR REDDYS,,67.0,YR,E,M,Y,,,20200617.0,,MD,DE,DE,2020,Q2,Elderly
179072131,17907213,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN (TABLET)",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200612.0,20200617,20200617,EXP,,DE-DRREDDYS-GER/GER/20/0124119,DR REDDYS,,67.0,YR,E,M,Y,,,20200617.0,,MD,DE,DE,2020,Q2,Elderly
179072131,17907213,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN (TABLET)",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200612.0,20200617,20200617,EXP,,DE-DRREDDYS-GER/GER/20/0124119,DR REDDYS,,67.0,YR,E,M,Y,,,20200617.0,,MD,DE,DE,2020,Q2,Elderly
179094081,17909408,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY (1-0-0-0)",,,U,U,,,,10.0,MG,,QD,2020,Q2,Anaemia,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029330,AUROBINDO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179094081,17909408,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY (1-0-0-0)",,,U,U,,,,10.0,MG,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029330,AUROBINDO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179094081,17909408,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY (1-0-0-0)",,,U,U,,,,10.0,MG,,QD,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029330,AUROBINDO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179094081,17909408,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY (1-0-0-0)",,,U,U,,,,10.0,MG,,QD,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029330,AUROBINDO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179094081,17909408,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY (1-0-0-0)",,,U,U,,,,10.0,MG,,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029330,AUROBINDO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179094081,17909408,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY (1-0-0-0)",,,U,U,,,,10.0,MG,,QD,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029330,AUROBINDO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179094081,17909408,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY (1-0-0-0)",,,U,U,,,,10.0,MG,,QD,2020,Q2,Pallor,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029330,AUROBINDO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179130551,17913055,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,DE-BFARM-20006229,DE-ACCORD-185540,ACCORD,,56.0,YR,A,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179130551,17913055,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,DE-BFARM-20006229,DE-ACCORD-185540,ACCORD,,56.0,YR,A,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179130551,17913055,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,DE-BFARM-20006229,DE-ACCORD-185540,ACCORD,,56.0,YR,A,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179130551,17913055,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,DE-BFARM-20006229,DE-ACCORD-185540,ACCORD,,56.0,YR,A,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179130551,17913055,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,DE-BFARM-20006229,DE-ACCORD-185540,ACCORD,,56.0,YR,A,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179130551,17913055,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,DE-BFARM-20006229,DE-ACCORD-185540,ACCORD,,56.0,YR,A,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179130551,17913055,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q2,Pallor,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,DE-BFARM-20006229,DE-ACCORD-185540,ACCORD,,56.0,YR,A,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179139981,17913998,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY  (1-0-0-0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029550,AUROBINDO,,67.0,YR,,M,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Elderly
179139981,17913998,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY  (1-0-0-0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q2,Cough,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029550,AUROBINDO,,67.0,YR,,M,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Elderly
179139981,17913998,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY  (1-0-0-0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029550,AUROBINDO,,67.0,YR,,M,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Elderly
179139981,17913998,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY  (1-0-0-0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029550,AUROBINDO,,67.0,YR,,M,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Elderly
179142621,17914262,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Anaemia,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05010-01,DE-BAUSCH-BL-2020-017101,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179142621,17914262,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05010-01,DE-BAUSCH-BL-2020-017101,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179142621,17914262,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05010-01,DE-BAUSCH-BL-2020-017101,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179142621,17914262,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05010-01,DE-BAUSCH-BL-2020-017101,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179142621,17914262,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05010-01,DE-BAUSCH-BL-2020-017101,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179142621,17914262,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05010-01,DE-BAUSCH-BL-2020-017101,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179142621,17914262,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Pallor,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05010-01,DE-BAUSCH-BL-2020-017101,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179148841,17914884,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2020,Q2,Anaemia,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005127,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179148841,17914884,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005127,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179148841,17914884,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005127,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179148841,17914884,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005127,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179148841,17914884,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005127,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179148841,17914884,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005127,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179148841,17914884,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2020,Q2,Pallor,,2020,Q2,1,I,,20200610.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005127,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Adult
179178981,17917898,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Anaemia,,2020,Q2,1,I,,20200610.0,20200619,20200619,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02864,LUPIN,,56.0,YR,,F,Y,,,20200619.0,,CN,NL,DE,2020,Q2,Adult
179178981,17917898,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200610.0,20200619,20200619,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02864,LUPIN,,56.0,YR,,F,Y,,,20200619.0,,CN,NL,DE,2020,Q2,Adult
179178981,17917898,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200610.0,20200619,20200619,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02864,LUPIN,,56.0,YR,,F,Y,,,20200619.0,,CN,NL,DE,2020,Q2,Adult
179178981,17917898,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200610.0,20200619,20200619,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02864,LUPIN,,56.0,YR,,F,Y,,,20200619.0,,CN,NL,DE,2020,Q2,Adult
179178981,17917898,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200610.0,20200619,20200619,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02864,LUPIN,,56.0,YR,,F,Y,,,20200619.0,,CN,NL,DE,2020,Q2,Adult
179178981,17917898,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200610.0,20200619,20200619,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02864,LUPIN,,56.0,YR,,F,Y,,,20200619.0,,CN,NL,DE,2020,Q2,Adult
179178981,17917898,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD (1-0-0-0)",,,,,,,,10.0,MG,,QD,2020,Q2,Pallor,,2020,Q2,1,I,,20200610.0,20200619,20200619,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02864,LUPIN,,56.0,YR,,F,Y,,,20200619.0,,CN,NL,DE,2020,Q2,Adult
179197911,17919791,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q2,Pancreatitis acute,,2020,Q2,1,I,20191023.0,20191209.0,20200619,20200619,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-119365",BOEHRINGER INGELHEIM,,63.0,YR,,F,Y,76.0,KG,20200620.0,,MD,CO,CO,2020,Q2,Adult
179200571,17920057,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q2,Anaemia,,2020,Q2,1,I,,20200610.0,20200620,20200620,EXP,DE-BFARM-20006229,DE-EMCURE PHARMACEUTICALS LTD-2020-EPL-000772,EMCURE,,56.0,YR,,F,Y,,,20200620.0,,MD,DE,DE,2020,Q2,Adult
179200571,17920057,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200610.0,20200620,20200620,EXP,DE-BFARM-20006229,DE-EMCURE PHARMACEUTICALS LTD-2020-EPL-000772,EMCURE,,56.0,YR,,F,Y,,,20200620.0,,MD,DE,DE,2020,Q2,Adult
179200571,17920057,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200610.0,20200620,20200620,EXP,DE-BFARM-20006229,DE-EMCURE PHARMACEUTICALS LTD-2020-EPL-000772,EMCURE,,56.0,YR,,F,Y,,,20200620.0,,MD,DE,DE,2020,Q2,Adult
179200571,17920057,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200610.0,20200620,20200620,EXP,DE-BFARM-20006229,DE-EMCURE PHARMACEUTICALS LTD-2020-EPL-000772,EMCURE,,56.0,YR,,F,Y,,,20200620.0,,MD,DE,DE,2020,Q2,Adult
179200571,17920057,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200610.0,20200620,20200620,EXP,DE-BFARM-20006229,DE-EMCURE PHARMACEUTICALS LTD-2020-EPL-000772,EMCURE,,56.0,YR,,F,Y,,,20200620.0,,MD,DE,DE,2020,Q2,Adult
179200571,17920057,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200610.0,20200620,20200620,EXP,DE-BFARM-20006229,DE-EMCURE PHARMACEUTICALS LTD-2020-EPL-000772,EMCURE,,56.0,YR,,F,Y,,,20200620.0,,MD,DE,DE,2020,Q2,Adult
179200571,17920057,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q2,Pallor,,2020,Q2,1,I,,20200610.0,20200620,20200620,EXP,DE-BFARM-20006229,DE-EMCURE PHARMACEUTICALS LTD-2020-EPL-000772,EMCURE,,56.0,YR,,F,Y,,,20200620.0,,MD,DE,DE,2020,Q2,Adult
179227431,17922743,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20200301.0,,20200621,20200621,DIR,,,FDA-CTU,,95.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Elderly
179228201,17922820,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q2,Pollakiuria,,2020,Q2,1,I,20191112.0,,20200621,20200621,DIR,,,FDA-CTU,,66.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179228201,17922820,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q2,Therapy cessation,,2020,Q2,1,I,20191112.0,,20200621,20200621,DIR,,,FDA-CTU,,66.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179228201,17922820,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q2,Urinary retention,,2020,Q2,1,I,20191112.0,,20200621,20200621,DIR,,,FDA-CTU,,66.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179232551,17923255,7,C,empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Haematuria,,2020,Q2,1,I,,20200614.0,20200622,20200622,EXP,,DE-TEVA-2020-DE-1789144,TEVA,,80.0,YR,,M,Y,78.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179232551,17923255,7,C,empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Urinary hesitation,,2020,Q2,1,I,,20200614.0,20200622,20200622,EXP,,DE-TEVA-2020-DE-1789144,TEVA,,80.0,YR,,M,Y,78.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179232961,17923296,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Fungal infection,,2020,Q2,1,I,20191114.0,,20200621,20200621,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179232961,17923296,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Genitourinary tract infection,,2020,Q2,1,I,20191114.0,,20200621,20200621,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179232961,17923296,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Pruritus,,2020,Q2,1,I,20191114.0,,20200621,20200621,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179232961,17923296,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Purulent discharge,,2020,Q2,1,I,20191114.0,,20200621,20200621,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179232961,17923296,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Rash erythematous,,2020,Q2,1,I,20191114.0,,20200621,20200621,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179261471,17926147,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,TABLET,,2020,Q2,Lung neoplasm malignant,,2020,Q2,1,I,20200306.0,20200621.0,20200623,20200623,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-031185",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,83.0,KG,20200623.0,,MD,JP,JP,2020,Q2,Elderly
179261471,17926147,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,25.0,MG,TABLET,,2020,Q2,Lung neoplasm malignant,,2020,Q2,1,I,20200306.0,20200621.0,20200623,20200623,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-031185",BOEHRINGER INGELHEIM,,71.0,YR,,M,Y,83.0,KG,20200623.0,,MD,JP,JP,2020,Q2,Elderly
179266571,17926657,6,C,empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q2,Skin ulcer,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,,DE-DRREDDYS-GER/GER/20/0124241,DR REDDYS,,83.0,YR,E,M,Y,75.0,KG,20200623.0,,MD,DE,DE,2020,Q2,Elderly
179266571,17926657,6,C,empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,, UNKNOWN,,,10.0,MG,,QD,2020,Q2,Wound,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,,DE-DRREDDYS-GER/GER/20/0124241,DR REDDYS,,83.0,YR,E,M,Y,75.0,KG,20200623.0,,MD,DE,DE,2020,Q2,Elderly
179269281,17926928,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q2,Fungal skin infection,,2020,Q2,1,I,20191126.0,,20200621,20200621,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179269281,17926928,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q2,Penile rash,,2020,Q2,1,I,20191126.0,,20200621,20200621,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179269291,17926929,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,25.0,MG,,QD,2020,Q2,Perineal rash,,2020,Q2,1,I,20190801.0,,20200621,20200621,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179269291,17926929,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,25.0,MG,,QD,2020,Q2,Rash,,2020,Q2,1,I,20190801.0,,20200621,20200621,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q2,Elderly
179278431,17927843,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q2,Fournier's gangrene,,2020,Q2,1,I,20200609.0,,20200621,20200621,DIR,,,FDA-CTU,,64.0,YR,,M,N,140.0,KG,20200615.0,N,PH,US,US,2020,Q2,Adult
179310171,17931017,1,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q2,Anaemia,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,DE-ADRED-05010-01,DE-TORRENT-00017800,TORRENT,,56.0,YR,A,F,Y,,,20200623.0,,MD,DE,DE,2020,Q2,Adult
179310171,17931017,1,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,DE-ADRED-05010-01,DE-TORRENT-00017800,TORRENT,,56.0,YR,A,F,Y,,,20200623.0,,MD,DE,DE,2020,Q2,Adult
179310171,17931017,1,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,DE-ADRED-05010-01,DE-TORRENT-00017800,TORRENT,,56.0,YR,A,F,Y,,,20200623.0,,MD,DE,DE,2020,Q2,Adult
179310171,17931017,1,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,DE-ADRED-05010-01,DE-TORRENT-00017800,TORRENT,,56.0,YR,A,F,Y,,,20200623.0,,MD,DE,DE,2020,Q2,Adult
179310171,17931017,1,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,DE-ADRED-05010-01,DE-TORRENT-00017800,TORRENT,,56.0,YR,A,F,Y,,,20200623.0,,MD,DE,DE,2020,Q2,Adult
179310171,17931017,1,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,DE-ADRED-05010-01,DE-TORRENT-00017800,TORRENT,,56.0,YR,A,F,Y,,,20200623.0,,MD,DE,DE,2020,Q2,Adult
179310171,17931017,1,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q2,Pallor,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,DE-ADRED-05010-01,DE-TORRENT-00017800,TORRENT,,56.0,YR,A,F,Y,,,20200623.0,,MD,DE,DE,2020,Q2,Adult
179315791,17931579,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Acute myocardial infarction,,2020,Q2,1,I,20190617.0,20200617.0,20200624,20200624,PER,,GB-AMGEN-GBRSP2020097731,AMGEN,,54.0,YR,A,F,Y,92.0,KG,20200623.0,,HP,GB,GB,2020,Q2,Adult
179318431,17931843,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Anaemia,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1789367,TEVA,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179318431,17931843,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1789367,TEVA,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179318431,17931843,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1789367,TEVA,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179318431,17931843,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1789367,TEVA,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179318431,17931843,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1789367,TEVA,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179318431,17931843,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1789367,TEVA,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179318431,17931843,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Pallor,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1789367,TEVA,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179351551,17935155,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Abdominal pain upper,,2020,Q2,1,I,20200622.0,,20200624,20200624,DIR,,,FDA-CTU,,66.0,YR,,F,N,55.35,KG,20200624.0,N,CN,US,US,2020,Q2,Elderly
179351551,17935155,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,20200622.0,,20200624,20200624,DIR,,,FDA-CTU,,66.0,YR,,F,N,55.35,KG,20200624.0,N,CN,US,US,2020,Q2,Elderly
179371291,17937129,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY; 1-0-0-0,,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200616.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1790472,TEVA,,67.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Elderly
179371291,17937129,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY; 1-0-0-0,,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q2,Cough,,2020,Q2,1,I,,20200616.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1790472,TEVA,,67.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Elderly
179371291,17937129,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY; 1-0-0-0,,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200616.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1790472,TEVA,,67.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Elderly
179371291,17937129,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY; 1-0-0-0,,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200616.0,20200624,20200624,EXP,,DE-TEVA-2020-DE-1790472,TEVA,,67.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Elderly
179383991,17938399,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Anaemia,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057311,MYLAN,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179383991,17938399,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057311,MYLAN,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179383991,17938399,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057311,MYLAN,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179383991,17938399,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057311,MYLAN,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179383991,17938399,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057311,MYLAN,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179383991,17938399,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057311,MYLAN,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179383991,17938399,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, 1-0-0-0",,,,,,,,10.0,MG,,QD,2020,Q2,Pallor,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057311,MYLAN,,56.0,YR,,F,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179384101,17938410,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q2,Haematuria,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057397,MYLAN,,80.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179384101,17938410,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,10.0,MG,,,2020,Q2,Urinary hesitation,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057397,MYLAN,,80.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179384481,17938448,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD, 1-0-0-0, TABLETTEN",,,,,,,,10.0,MG,TABLET,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057673,MYLAN,,67.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Elderly
179384481,17938448,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD, 1-0-0-0, TABLETTEN",,,,,,,,10.0,MG,TABLET,QD,2020,Q2,Cough,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057673,MYLAN,,67.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Elderly
179384481,17938448,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD, 1-0-0-0, TABLETTEN",,,,,,,,10.0,MG,TABLET,QD,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057673,MYLAN,,67.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Elderly
179384481,17938448,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD, 1-0-0-0, TABLETTEN",,,,,,,,10.0,MG,TABLET,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057673,MYLAN,,67.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Elderly
179389741,17938974,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Anaemia,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51592,HIKMA,,56.0,YR,,F,Y,,,20200625.0,,MD,DE,DE,2020,Q2,Adult
179389741,17938974,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51592,HIKMA,,56.0,YR,,F,Y,,,20200625.0,,MD,DE,DE,2020,Q2,Adult
179389741,17938974,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51592,HIKMA,,56.0,YR,,F,Y,,,20200625.0,,MD,DE,DE,2020,Q2,Adult
179389741,17938974,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51592,HIKMA,,56.0,YR,,F,Y,,,20200625.0,,MD,DE,DE,2020,Q2,Adult
179389741,17938974,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51592,HIKMA,,56.0,YR,,F,Y,,,20200625.0,,MD,DE,DE,2020,Q2,Adult
179389741,17938974,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51592,HIKMA,,56.0,YR,,F,Y,,,20200625.0,,MD,DE,DE,2020,Q2,Adult
179389741,17938974,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Pallor,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51592,HIKMA,,56.0,YR,,F,Y,,,20200625.0,,MD,DE,DE,2020,Q2,Adult
179441891,17944189,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,1.0,DF,,QD,2020,Q2,Otitis externa,,2020,Q2,1,I,,20200617.0,20200625,20200625,EXP,,GB-ASTRAZENECA-2020SE78096,ASTRAZENECA,,72.0,YR,,M,Y,120.0,KG,20200625.0,,,GB,GB,2020,Q2,Elderly
179456321,17945632,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,UNKNOWN,,2020,Q2,Anaemia,,2020,Q2,1,I,,20200617.0,20200625,20200625,EXP,,DE-FRESENIUS KABI-FK202006301,FRESENIUS KABI,,56.0,YR,,F,Y,,,20200625.0,,HP,NL,DE,2020,Q2,Adult
179456321,17945632,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,UNKNOWN,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200617.0,20200625,20200625,EXP,,DE-FRESENIUS KABI-FK202006301,FRESENIUS KABI,,56.0,YR,,F,Y,,,20200625.0,,HP,NL,DE,2020,Q2,Adult
179456321,17945632,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,UNKNOWN,,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200617.0,20200625,20200625,EXP,,DE-FRESENIUS KABI-FK202006301,FRESENIUS KABI,,56.0,YR,,F,Y,,,20200625.0,,HP,NL,DE,2020,Q2,Adult
179456321,17945632,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,UNKNOWN,,2020,Q2,Epistaxis,,2020,Q2,1,I,,20200617.0,20200625,20200625,EXP,,DE-FRESENIUS KABI-FK202006301,FRESENIUS KABI,,56.0,YR,,F,Y,,,20200625.0,,HP,NL,DE,2020,Q2,Adult
179456321,17945632,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,UNKNOWN,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200617.0,20200625,20200625,EXP,,DE-FRESENIUS KABI-FK202006301,FRESENIUS KABI,,56.0,YR,,F,Y,,,20200625.0,,HP,NL,DE,2020,Q2,Adult
179456321,17945632,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,UNKNOWN,,2020,Q2,Haematochezia,,2020,Q2,1,I,,20200617.0,20200625,20200625,EXP,,DE-FRESENIUS KABI-FK202006301,FRESENIUS KABI,,56.0,YR,,F,Y,,,20200625.0,,HP,NL,DE,2020,Q2,Adult
179456321,17945632,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0",,,,,,,,,,UNKNOWN,,2020,Q2,Pallor,,2020,Q2,1,I,,20200617.0,20200625,20200625,EXP,,DE-FRESENIUS KABI-FK202006301,FRESENIUS KABI,,56.0,YR,,F,Y,,,20200625.0,,HP,NL,DE,2020,Q2,Adult
179492501,17949250,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q2,Sepsis,,2020,Q2,1,I,20200115.0,,20200626,20200626,DIR,,,FDA-CTU,,72.0,YR,,M,N,146.0,KG,20200618.0,N,PH,US,US,2020,Q2,Elderly
179492501,17949250,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20200115.0,,20200626,20200626,DIR,,,FDA-CTU,,72.0,YR,,M,N,146.0,KG,20200618.0,N,PH,US,US,2020,Q2,Elderly
179496951,17949695,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Anorectal operation,,2020,Q2,1,I,202006.0,20200621.0,20200626,20200626,EXP,,IL-TAKEDA-2020TUS027732,TAKEDA,,71.0,YR,,M,Y,,,20200626.0,,CN,IL,IL,2020,Q2,Elderly
179496951,17949695,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q2,Weight decreased,,2020,Q2,1,I,202006.0,20200621.0,20200626,20200626,EXP,,IL-TAKEDA-2020TUS027732,TAKEDA,,71.0,YR,,M,Y,,,20200626.0,,CN,IL,IL,2020,Q2,Elderly
179513001,17951300,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20190120.0,20200615.0,20200626,20200626,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-047816,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,97.7,KG,20200626.0,,HP,US,US,2020,Q2,Elderly
179513001,17951300,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2020,Q2,Haematoma muscle,,2020,Q2,1,I,20190120.0,20200615.0,20200626,20200626,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-047816,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,97.7,KG,20200626.0,,HP,US,US,2020,Q2,Elderly
179513001,17951300,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2020,Q2,Rectal haemorrhage,,2020,Q2,1,I,20190120.0,20200615.0,20200626,20200626,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-047816,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,97.7,KG,20200626.0,,HP,US,US,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Acidosis,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,C-reactive protein increased,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Food intolerance,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Glycosuria,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypophosphataemia,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Ketonuria,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Leukocytosis,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Neutrophilia,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179534371,17953437,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200414.0,20200625.0,20200628,20200628,EXP,DE-BFARM-20005714,NVSC2020DE181230,NOVARTIS,,78.0,YR,,M,Y,72.0,KG,20200628.0,,HP,DE,DE,2020,Q2,Elderly
179534371,17953437,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q2,Lactic acidosis,,2020,Q2,1,I,20200414.0,20200625.0,20200628,20200628,EXP,DE-BFARM-20005714,NVSC2020DE181230,NOVARTIS,,78.0,YR,,M,Y,72.0,KG,20200628.0,,HP,DE,DE,2020,Q2,Elderly
179536361,17953636,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Eye haemorrhage,,2020,Q2,1,I,202002.0,20200616.0,20200628,20200628,EXP,,US-ABBVIE-20K-163-3447870-00,ABBVIE,,51.0,YR,,M,Y,77.18,KG,20200628.0,,CN,US,US,2020,Q2,Adult
179536361,17953636,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Rash,,2020,Q2,1,I,202002.0,20200616.0,20200628,20200628,EXP,,US-ABBVIE-20K-163-3447870-00,ABBVIE,,51.0,YR,,M,Y,77.18,KG,20200628.0,,CN,US,US,2020,Q2,Adult
179550691,17955069,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,TABLET,QD,2020,Q2,Diabetic complication,,2020,Q2,1,I,20200402.0,,20200626,20200626,DIR,,,FDA-CTU,,76.0,YR,,M,N,,,20200603.0,N,PH,US,US,2020,Q2,Elderly
179550691,17955069,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,TABLET,QD,2020,Q2,Osteomyelitis,,2020,Q2,1,I,20200402.0,,20200626,20200626,DIR,,,FDA-CTU,,76.0,YR,,M,N,,,20200603.0,N,PH,US,US,2020,Q2,Elderly
179550691,17955069,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,TABLET,QD,2020,Q2,Toe amputation,,2020,Q2,1,I,20200402.0,,20200626,20200626,DIR,,,FDA-CTU,,76.0,YR,,M,N,,,20200603.0,N,PH,US,US,2020,Q2,Elderly
179554771,17955477,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,,,,,12.5,MG,TABLET,QD,2020,Q2,Pollakiuria,,2020,Q2,1,I,20200407.0,,20200626,20200626,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20200407.0,N,PH,US,US,2020,Q2,Adult
179558121,17955812,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2020,Q2,Pollakiuria,,2020,Q2,1,I,20200422.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200618.0,N,PH,US,US,2020,Q2,Elderly
179559091,17955909,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,,,,,12.5,MG,,,2020,Q2,Pollakiuria,,2020,Q2,1,I,20200319.0,,20200626,20200626,DIR,,,FDA-CTU,,76.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Elderly
179559091,17955909,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,,,,,12.5,MG,,,2020,Q2,Rash,,2020,Q2,1,I,20200319.0,,20200626,20200626,DIR,,,FDA-CTU,,76.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Elderly
179559091,17955909,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,,,,,12.5,MG,,,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20200319.0,,20200626,20200626,DIR,,,FDA-CTU,,76.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Elderly
179576661,17957666,6,C,empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Skin ulcer,,2020,Q2,1,I,,20200621.0,20200629,20200629,EXP,,DE-TEVA-2020-DE-1791831,TEVA,,83.0,YR,,M,Y,75.0,KG,20200629.0,,MD,DE,DE,2020,Q2,Elderly
179576661,17957666,6,C,empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q2,Wound,,2020,Q2,1,I,,20200621.0,20200629,20200629,EXP,,DE-TEVA-2020-DE-1791831,TEVA,,83.0,YR,,M,Y,75.0,KG,20200629.0,,MD,DE,DE,2020,Q2,Elderly
179580721,17958072,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Chest wall haematoma,,2020,Q2,1,I,,20200622.0,20200629,20200629,EXP,,NVSC2020DE176072,NOVARTIS,,83.0,YR,,F,Y,60.0,KG,20200629.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q2,Elderly
179580721,17958072,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Fall,,2020,Q2,1,I,,20200622.0,20200629,20200629,EXP,,NVSC2020DE176072,NOVARTIS,,83.0,YR,,F,Y,60.0,KG,20200629.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q2,Elderly
179580721,17958072,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Fracture,,2020,Q2,1,I,,20200622.0,20200629,20200629,EXP,,NVSC2020DE176072,NOVARTIS,,83.0,YR,,F,Y,60.0,KG,20200629.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q2,Elderly
179580721,17958072,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Periorbital haematoma,,2020,Q2,1,I,,20200622.0,20200629,20200629,EXP,,NVSC2020DE176072,NOVARTIS,,83.0,YR,,F,Y,60.0,KG,20200629.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q2,Elderly
179580721,17958072,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q2,Presyncope,,2020,Q2,1,I,,20200622.0,20200629,20200629,EXP,,NVSC2020DE176072,NOVARTIS,,83.0,YR,,F,Y,60.0,KG,20200629.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q2,Elderly
179589881,17958988,7,C,empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1-0-0-0 ()",,,U,,,,,,,,,2020,Q2,Haematuria,,2020,Q2,1,I,,20200615.0,20200630,20200630,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-251862,RANBAXY,,80.0,YR,,M,Y,78.0,KG,20200630.0,,HP,NL,DE,2020,Q2,Elderly
179589881,17958988,7,C,empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1-0-0-0 ()",,,U,,,,,,,,,2020,Q2,Urinary hesitation,,2020,Q2,1,I,,20200615.0,20200630,20200630,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-251862,RANBAXY,,80.0,YR,,M,Y,78.0,KG,20200630.0,,HP,NL,DE,2020,Q2,Elderly
179598621,17959862,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2020,Q2,Urinary tract infection,,2020,Q2,1,I,20200427.0,,20200629,20200629,DIR,,,FDA-CTU,,50.0,YR,,M,N,,,20200618.0,N,PH,US,US,2020,Q2,Adult
179598671,17959867,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200421.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200618.0,N,PH,US,US,2020,Q2,Elderly
179598671,17959867,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200421.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200618.0,N,PH,US,US,2020,Q2,Elderly
179610131,17961013,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q2,Fungal infection,,2020,Q2,1,I,20200304.0,,20200629,20200629,DIR,,,FDA-CTU,,59.0,YR,,M,N,135.0,KG,20200327.0,N,PH,US,US,2020,Q2,Adult
179610251,17961025,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Osteomyelitis,,2020,Q2,1,I,20200423.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200501.0,N,PH,US,US,2020,Q2,Elderly
179610251,17961025,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,12.5,MG,,QD,2020,Q2,Toe amputation,,2020,Q2,1,I,20200423.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200501.0,N,PH,US,US,2020,Q2,Elderly
179612051,17961205,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Glucose urine,,2020,Q2,1,I,20200407.0,,20200629,20200629,DIR,,,FDA-CTU,,66.0,YR,,M,N,70.0,KG,20200504.0,N,PH,US,US,2020,Q2,Elderly
179612051,17961205,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Penile discomfort,,2020,Q2,1,I,20200407.0,,20200629,20200629,DIR,,,FDA-CTU,,66.0,YR,,M,N,70.0,KG,20200504.0,N,PH,US,US,2020,Q2,Elderly
179612051,17961205,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Pruritus,,2020,Q2,1,I,20200407.0,,20200629,20200629,DIR,,,FDA-CTU,,66.0,YR,,M,N,70.0,KG,20200504.0,N,PH,US,US,2020,Q2,Elderly
179612051,17961205,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q2,Urticaria,,2020,Q2,1,I,20200407.0,,20200629,20200629,DIR,,,FDA-CTU,,66.0,YR,,M,N,70.0,KG,20200504.0,N,PH,US,US,2020,Q2,Elderly
179613011,17961301,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20191229.0,,20200629,20200629,DIR,,,FDA-CTU,,38.0,YR,,M,N,,,20200110.0,N,PH,US,US,2020,Q2,Adult
179613691,17961369,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20190515.0,,20200630,20200630,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20200618.0,N,PH,US,US,2020,Q2,Elderly
179628681,17962868,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
179628681,17962868,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Haematuria,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
179628681,17962868,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Haemorrhage,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
179628681,17962868,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Labelled drug-drug interaction medication error,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
179628681,17962868,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q2,Product administration error,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
151038641,15103864,22,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Chills,,2020,Q3,1,I,20180530.0,20180607.0,20180703,20180703,EXP,,CA-CELGENEUS-CAN-20180602708,CELGENE,,66.0,YR,,M,Y,,,20180703.0,,HP,CA,CA,2020,Q3,Elderly
151038641,15103864,22,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Sepsis,,2020,Q3,1,I,20180530.0,20180607.0,20180703,20180703,EXP,,CA-CELGENEUS-CAN-20180602708,CELGENE,,66.0,YR,,M,Y,,,20180703.0,,HP,CA,CA,2020,Q3,Elderly
151038641,15103864,22,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Vomiting,,2020,Q3,1,I,20180530.0,20180607.0,20180703,20180703,EXP,,CA-CELGENEUS-CAN-20180602708,CELGENE,,66.0,YR,,M,Y,,,20180703.0,,HP,CA,CA,2020,Q3,Elderly
152455578,15245557,22,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,U,,,,10.0,MG,,,2020,Q3,Acute myocardial infarction,,2020,Q3,8,F,200508.0,20200918.0,20180806,20200922,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200922.0,,HP,SK,SK,2020,Q3,Elderly
152455578,15245557,22,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,U,,,,10.0,MG,,,2020,Q3,Diabetes mellitus,,2020,Q3,8,F,200508.0,20200918.0,20180806,20200922,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200922.0,,HP,SK,SK,2020,Q3,Elderly
152455578,15245557,22,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,U,,,,10.0,MG,,,2020,Q3,Drug ineffective,,2020,Q3,8,F,200508.0,20200918.0,20180806,20200922,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200922.0,,HP,SK,SK,2020,Q3,Elderly
152455578,15245557,22,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,U,,,,10.0,MG,,,2020,Q3,Glycosylated haemoglobin decreased,,2020,Q3,8,F,200508.0,20200918.0,20180806,20200922,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200922.0,,HP,SK,SK,2020,Q3,Elderly
152455578,15245557,22,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,U,,,,10.0,MG,,,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,8,F,200508.0,20200918.0,20180806,20200922,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200922.0,,HP,SK,SK,2020,Q3,Elderly
152455578,15245557,22,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,U,,,,10.0,MG,,,2020,Q3,Hyperlipidaemia,,2020,Q3,8,F,200508.0,20200918.0,20180806,20200922,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200922.0,,HP,SK,SK,2020,Q3,Elderly
152455578,15245557,22,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,U,,,,10.0,MG,,,2020,Q3,Hypertension,,2020,Q3,8,F,200508.0,20200918.0,20180806,20200922,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200922.0,,HP,SK,SK,2020,Q3,Elderly
152455578,15245557,22,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,U,,,,10.0,MG,,,2020,Q3,Myocardial infarction,,2020,Q3,8,F,200508.0,20200918.0,20180806,20200922,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200922.0,,HP,SK,SK,2020,Q3,Elderly
152455578,15245557,22,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,U,,,,10.0,MG,,,2020,Q3,Weight increased,,2020,Q3,8,F,200508.0,20200918.0,20180806,20200922,EXP,,PHHY2018SK058557,NOVARTIS,,66.0,YR,,M,Y,,,20200922.0,,HP,SK,SK,2020,Q3,Elderly
156614453,15661445,42,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,3,F,2018.0,20200715.0,20181127,20200831,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20200831.0,,LW,US,US,2020,Q3,Adult
156614453,15661445,42,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Anhedonia,,2020,Q3,3,F,2018.0,20200715.0,20181127,20200831,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20200831.0,,LW,US,US,2020,Q3,Adult
156614453,15661445,42,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Anxiety,,2020,Q3,3,F,2018.0,20200715.0,20181127,20200831,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20200831.0,,LW,US,US,2020,Q3,Adult
156614453,15661445,42,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Bone density decreased,,2020,Q3,3,F,2018.0,20200715.0,20181127,20200831,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20200831.0,,LW,US,US,2020,Q3,Adult
156614453,15661445,42,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Economic problem,,2020,Q3,3,F,2018.0,20200715.0,20181127,20200831,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20200831.0,,LW,US,US,2020,Q3,Adult
156614453,15661445,42,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Emotional distress,,2020,Q3,3,F,2018.0,20200715.0,20181127,20200831,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20200831.0,,LW,US,US,2020,Q3,Adult
156614453,15661445,42,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Pain,,2020,Q3,3,F,2018.0,20200715.0,20181127,20200831,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20200831.0,,LW,US,US,2020,Q3,Adult
156762353,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q3,Acute kidney injury,,2020,Q3,3,F,20180430.0,20200909.0,20181130,20200922,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.2,KG,20200922.0,,HP,US,US,2020,Q3,Elderly
156762353,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q3,Diabetes mellitus,,2020,Q3,3,F,20180430.0,20200909.0,20181130,20200922,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.2,KG,20200922.0,,HP,US,US,2020,Q3,Elderly
156762353,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q3,Giant cell arteritis,,2020,Q3,3,F,20180430.0,20200909.0,20181130,20200922,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.2,KG,20200922.0,,HP,US,US,2020,Q3,Elderly
156762353,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q3,Hypovolaemia,,2020,Q3,3,F,20180430.0,20200909.0,20181130,20200922,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.2,KG,20200922.0,,HP,US,US,2020,Q3,Elderly
156762353,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q3,Peripheral ischaemia,,2020,Q3,3,F,20180430.0,20200909.0,20181130,20200922,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.2,KG,20200922.0,,HP,US,US,2020,Q3,Elderly
156762353,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q3,Polyuria,,2020,Q3,3,F,20180430.0,20200909.0,20181130,20200922,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.2,KG,20200922.0,,HP,US,US,2020,Q3,Elderly
156762353,15676235,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,FILM-COATED TABLET,,2020,Q3,Splenic infarction,,2020,Q3,3,F,20180430.0,20200909.0,20181130,20200922,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110621,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,105.2,KG,20200922.0,,HP,US,US,2020,Q3,Elderly
159160652,15916065,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,JARDIANCE 10MG Q.D,,,,,,,204629.0,10.0,MG,COATED TABLET,QD,2020,Q3,Pollakiuria,,2020,Q3,2,F,201811.0,20200708.0,20190204,20200715,EXP,,"KR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-003741",BOEHRINGER INGELHEIM,,42.0,YR,,M,Y,158.0,KG,20200715.0,,MD,KR,KR,2020,Q3,Adult
161078914,16107891,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2020,Q3,Dyschromatopsia,,2020,Q3,4,F,20181206.0,20200918.0,20190322,20200922,EXP,,US-ALLERGAN-1912024US,ALLERGAN,,51.0,YR,,M,Y,105.7,KG,20200922.0,,HP,US,US,2020,Q3,Adult
161521155,16152115,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q3,Diabetic nephropathy,,2020,Q3,5,F,20190326.0,20200813.0,20190403,20200820,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-014846",BOEHRINGER INGELHEIM,,64.0,YR,,F,Y,91.8,KG,20200820.0,,MD,AR,AR,2020,Q3,Adult
162521897,16252189,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q3,Basal cell carcinoma,,2020,Q3,7,F,20181018.0,20190627.0,20190429,20190711,EXP,,AU-JNJFOC-20190433605,JOHNSON AND JOHNSON,,62.0,YR,,M,Y,106.0,KG,20190711.0,,MD,AU,AU,2020,Q3,Adult
162521897,16252189,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q3,Bowen's disease,,2020,Q3,7,F,20181018.0,20190627.0,20190429,20190711,EXP,,AU-JNJFOC-20190433605,JOHNSON AND JOHNSON,,62.0,YR,,M,Y,106.0,KG,20190711.0,,MD,AU,AU,2020,Q3,Adult
163112846,16311284,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,,,FILM-COATED TABLET,QD,2020,Q3,Dehydration,,2020,Q3,6,F,20190422.0,20190802.0,20190514,20190805,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-020046",BOEHRINGER INGELHEIM,,77.0,YR,,M,Y,49.4,KG,20190806.0,,MD,BR,BR,2020,Q3,Elderly
163112846,16311284,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,,,FILM-COATED TABLET,QD,2020,Q3,Hepatitis acute,,2020,Q3,6,F,20190422.0,20190802.0,20190514,20190805,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-020046",BOEHRINGER INGELHEIM,,77.0,YR,,M,Y,49.4,KG,20190806.0,,MD,BR,BR,2020,Q3,Elderly
163112846,16311284,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,,,FILM-COATED TABLET,QD,2020,Q3,Hypotension,,2020,Q3,6,F,20190422.0,20190802.0,20190514,20190805,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-020046",BOEHRINGER INGELHEIM,,77.0,YR,,M,Y,49.4,KG,20190806.0,,MD,BR,BR,2020,Q3,Elderly
168970154,16897015,33,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2020,Q3,Thyroid cancer,,2020,Q3,4,F,20190822.0,20200722.0,20191009,20200723,EXP,,IT-ROCHE-2429873,ROCHE,,66.0,YR,,M,Y,,,20200723.0,,MD,IT,IT,2020,Q3,Elderly
169576844,16957684,4,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,"12.5?1000,MG,DAILY",,,,,,,,,,,,2020,Q3,Malignant anorectal neoplasm,,2020,Q3,4,F,20191016.0,20200713.0,20191024,20200716,EXP,,US-GILEAD-2019-0433605,GILEAD,,66.0,YR,E,M,Y,84.8,KG,20200716.0,,MD,US,US,2020,Q3,Elderly
169576844,16957684,4,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,"12.5?1000,MG,DAILY",,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,4,F,20191016.0,20200713.0,20191024,20200716,EXP,,US-GILEAD-2019-0433605,GILEAD,,66.0,YR,E,M,Y,84.8,KG,20200716.0,,MD,US,US,2020,Q3,Elderly
169832444,16983244,25,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q3,Lower limb fracture,,2020,Q3,4,F,20191016.0,20200713.0,20191101,20200717,EXP,,DE-CELGENEUS-DEU-20191010472,CELGENE,,77.0,YR,,M,Y,104.5,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
169832444,16983244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Lower limb fracture,,2020,Q3,4,F,20191016.0,20200713.0,20191101,20200717,EXP,,DE-CELGENEUS-DEU-20191010472,CELGENE,,77.0,YR,,M,Y,104.5,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
170475987,17047598,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q3,Cardiac failure,,2020,Q3,7,F,20191112.0,20200729.0,20191119,20200731,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-114461",BOEHRINGER INGELHEIM,,82.0,YR,,F,Y,52.2,KG,20200731.0,,MD,BR,BR,2020,Q3,Elderly
172030277,17203027,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q3,Acute respiratory failure,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
172030277,17203027,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q3,Cardiac failure congestive,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
172030277,17203027,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q3,Hypoxia,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
172030277,17203027,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q3,Pneumonia,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
172030277,17203027,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q3,Streptococcus test positive,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
174147479,17414747,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Anaemia,,2020,Q3,9,F,20200127.0,20200917.0,20200213,20200922,EXP,,MX-CELGENEUS-MEX-20200202416,CELGENE,,68.0,YR,,M,Y,,,20200922.0,,HP,MX,MX,2020,Q3,Elderly
174147479,17414747,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Pneumonia,,2020,Q3,9,F,20200127.0,20200917.0,20200213,20200922,EXP,,MX-CELGENEUS-MEX-20200202416,CELGENE,,68.0,YR,,M,Y,,,20200922.0,,HP,MX,MX,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Adverse event,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Anaemia,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood albumin increased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood bilirubin increased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood chloride decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood creatinine increased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood glucose abnormal,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood glucose increased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood pressure decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood sodium decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood urea increased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Blood urea nitrogen/creatinine ratio increased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Body temperature decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Cardiac discomfort,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Dyspnoea,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Dyspnoea exertional,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Full blood count decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Haematocrit decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Haemoglobin decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Illness,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Lymphocyte count decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Mean cell haemoglobin increased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Neutrophil count increased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Oxygen saturation decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Platelet count decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Red blood cell count decreased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Red cell distribution width increased,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175731068,17573106,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, BID",,,,,,,,10.0,MG,,BID,2020,Q3,Transfusion,,2020,Q3,8,F,202003.0,20200817.0,20200323,20200824,EXP,,US-ACTELION-A-US2020-203279,ACTELION,,67.0,YR,,F,Y,75.0,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
175935384,17593538,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Bone density decreased,,2020,Q3,4,F,201908.0,20200515.0,20200327,20200813,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200813.0,,LW,US,US,2020,Q3,Adult
175935384,17593538,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,4,F,201908.0,20200515.0,20200327,20200813,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200813.0,,LW,US,US,2020,Q3,Adult
175935384,17593538,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Osteopenia,,2020,Q3,4,F,201908.0,20200515.0,20200327,20200813,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200813.0,,LW,US,US,2020,Q3,Adult
176254246,17625424,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Adrenal gland cancer metastatic,,2020,Q3,6,F,20200327.0,20200703.0,20200403,20200706,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-017198",BOEHRINGER INGELHEIM,,90.0,YR,,M,Y,47.5,KG,20200706.0,,MD,JP,JP,2020,Q3,Elderly
176254246,17625424,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Lung neoplasm malignant,,2020,Q3,6,F,20200327.0,20200703.0,20200403,20200706,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-017198",BOEHRINGER INGELHEIM,,90.0,YR,,M,Y,47.5,KG,20200706.0,,MD,JP,JP,2020,Q3,Elderly
177584013,17758401,19,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,TABLET,QD,2020,Q3,Cholecystitis chronic,,2020,Q3,3,F,20200221.0,20200904.0,20200507,20200915,EXP,,US-INTERCEPT-CT2020001016,INTERCEPT PHARMACEUTICALS,,63.0,YR,,F,Y,85.0,KG,20200915.0,,MD,US,US,2020,Q3,Adult
178037753,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q3,Abscess drainage,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q3,Appendicitis,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q3,Gastric polyps,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q3,Iron deficiency anaemia,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178096284,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q3,Atrial fibrillation,,2020,Q3,4,F,20180204.0,20200820.0,20200520,20200824,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200824.0,,CN,US,US,2020,Q3,Adult
178096284,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q3,Coronary artery disease,,2020,Q3,4,F,20180204.0,20200820.0,20200520,20200824,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200824.0,,CN,US,US,2020,Q3,Adult
178096284,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q3,Hyperkalaemia,,2020,Q3,4,F,20180204.0,20200820.0,20200520,20200824,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200824.0,,CN,US,US,2020,Q3,Adult
178096284,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q3,Mitral valve incompetence,,2020,Q3,4,F,20180204.0,20200820.0,20200520,20200824,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200824.0,,CN,US,US,2020,Q3,Adult
178096284,17809628,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,D,,,,,25.0,MG,,QD,2020,Q3,Myocardial infarction,,2020,Q3,4,F,20180204.0,20200820.0,20200520,20200824,EXP,,US-ABBVIE-18K-163-3095220-00,ABBVIE,,62.0,YR,,F,Y,61.7,KG,20200824.0,,CN,US,US,2020,Q3,Adult
178214532,17821453,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Endotracheal intubation,,2020,Q3,2,F,,20200626.0,20200525,20200703,EXP,,JP-ABBVIE-20K-087-3416198-00,ABBVIE,"SUGIMOTO R, KENZAKA T, FUJIKAWA M, ET AL.. A CASE OF SERIOUS COVID?19 PNEUMONIA WHICH INTUBATION TUBE OCCLUSION OCCURRED BY HIGH?VISCOSITY SPUTUM AND THE USAGE OF HUMIDIFIER AND THE ABDOMINAL POSITION TREATMENT WAS EFFECTIVE. 2020 MAY 19?.",65.0,YR,,M,Y,92.0,KG,20200703.0,,MD,COUNTRY NOT SPECIFIED,JP,2020,Q3,Elderly
178214532,17821453,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Mechanical ventilation,,2020,Q3,2,F,,20200626.0,20200525,20200703,EXP,,JP-ABBVIE-20K-087-3416198-00,ABBVIE,"SUGIMOTO R, KENZAKA T, FUJIKAWA M, ET AL.. A CASE OF SERIOUS COVID?19 PNEUMONIA WHICH INTUBATION TUBE OCCLUSION OCCURRED BY HIGH?VISCOSITY SPUTUM AND THE USAGE OF HUMIDIFIER AND THE ABDOMINAL POSITION TREATMENT WAS EFFECTIVE. 2020 MAY 19?.",65.0,YR,,M,Y,92.0,KG,20200703.0,,MD,COUNTRY NOT SPECIFIED,JP,2020,Q3,Elderly
178214532,17821453,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,2,F,,20200626.0,20200525,20200703,EXP,,JP-ABBVIE-20K-087-3416198-00,ABBVIE,"SUGIMOTO R, KENZAKA T, FUJIKAWA M, ET AL.. A CASE OF SERIOUS COVID?19 PNEUMONIA WHICH INTUBATION TUBE OCCLUSION OCCURRED BY HIGH?VISCOSITY SPUTUM AND THE USAGE OF HUMIDIFIER AND THE ABDOMINAL POSITION TREATMENT WAS EFFECTIVE. 2020 MAY 19?.",65.0,YR,,M,Y,92.0,KG,20200703.0,,MD,COUNTRY NOT SPECIFIED,JP,2020,Q3,Elderly
178214532,17821453,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,2,F,,20200626.0,20200525,20200703,EXP,,JP-ABBVIE-20K-087-3416198-00,ABBVIE,"SUGIMOTO R, KENZAKA T, FUJIKAWA M, ET AL.. A CASE OF SERIOUS COVID?19 PNEUMONIA WHICH INTUBATION TUBE OCCLUSION OCCURRED BY HIGH?VISCOSITY SPUTUM AND THE USAGE OF HUMIDIFIER AND THE ABDOMINAL POSITION TREATMENT WAS EFFECTIVE. 2020 MAY 19?.",65.0,YR,,M,Y,92.0,KG,20200703.0,,MD,COUNTRY NOT SPECIFIED,JP,2020,Q3,Elderly
178214532,17821453,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Productive cough,,2020,Q3,2,F,,20200626.0,20200525,20200703,EXP,,JP-ABBVIE-20K-087-3416198-00,ABBVIE,"SUGIMOTO R, KENZAKA T, FUJIKAWA M, ET AL.. A CASE OF SERIOUS COVID?19 PNEUMONIA WHICH INTUBATION TUBE OCCLUSION OCCURRED BY HIGH?VISCOSITY SPUTUM AND THE USAGE OF HUMIDIFIER AND THE ABDOMINAL POSITION TREATMENT WAS EFFECTIVE. 2020 MAY 19?.",65.0,YR,,M,Y,92.0,KG,20200703.0,,MD,COUNTRY NOT SPECIFIED,JP,2020,Q3,Elderly
178314752,17831475,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2020,Q3,Cerebral infarction,,2020,Q3,2,F,20191114.0,20200528.0,20200527,20200721,EXP,,GB-NOVOPROD-728703,NOVO NORDISK,,61.0,YR,,F,Y,92.0,KG,20200721.0,,MD,GB,GB,2020,Q3,Adult
178676353,17867635,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Arthralgia,,2020,Q3,3,F,201705.0,20200720.0,20200605,20200802,EXP,,GB-NOVOPROD-731084,NOVO NORDISK,,63.0,YR,,M,Y,,,20200803.0,,CN,GB,GB,2020,Q3,Adult
178676353,17867635,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,3,F,201705.0,20200720.0,20200605,20200802,EXP,,GB-NOVOPROD-731084,NOVO NORDISK,,63.0,YR,,M,Y,,,20200803.0,,CN,GB,GB,2020,Q3,Adult
178676353,17867635,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Interstitial lung disease,,2020,Q3,3,F,201705.0,20200720.0,20200605,20200802,EXP,,GB-NOVOPROD-731084,NOVO NORDISK,,63.0,YR,,M,Y,,,20200803.0,,CN,GB,GB,2020,Q3,Adult
178676353,17867635,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Plasma cell myeloma,,2020,Q3,3,F,201705.0,20200720.0,20200605,20200802,EXP,,GB-NOVOPROD-731084,NOVO NORDISK,,63.0,YR,,M,Y,,,20200803.0,,CN,GB,GB,2020,Q3,Adult
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Anaemia,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Dizziness,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Dyspnoea,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Fluid overload,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Haematocrit decreased,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Haemoglobin decreased,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Hypotension,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Incorrect dose administered,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Internal haemorrhage,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Mineral supplementation,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Muscle spasms,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Pain in extremity,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Red blood cell count decreased,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QAM",,,,,,,,25.0,MG,,QD,2020,Q3,Transfusion,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178847992,17884799,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Aortic stenosis,,2020,Q3,2,F,20081229.0,20200709.0,20200611,20200720,EXP,,GB-NOVOPROD-732158,NOVO NORDISK,,72.0,YR,,M,Y,,,20200720.0,,CN,GB,GB,2020,Q3,Elderly
178847992,17884799,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,2,F,20081229.0,20200709.0,20200611,20200720,EXP,,GB-NOVOPROD-732158,NOVO NORDISK,,72.0,YR,,M,Y,,,20200720.0,,CN,GB,GB,2020,Q3,Elderly
178847992,17884799,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,20081229.0,20200709.0,20200611,20200720,EXP,,GB-NOVOPROD-732158,NOVO NORDISK,,72.0,YR,,M,Y,,,20200720.0,,CN,GB,GB,2020,Q3,Elderly
178847992,17884799,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Loss of consciousness,,2020,Q3,2,F,20081229.0,20200709.0,20200611,20200720,EXP,,GB-NOVOPROD-732158,NOVO NORDISK,,72.0,YR,,M,Y,,,20200720.0,,CN,GB,GB,2020,Q3,Elderly
178847992,17884799,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Myocardial ischaemia,,2020,Q3,2,F,20081229.0,20200709.0,20200611,20200720,EXP,,GB-NOVOPROD-732158,NOVO NORDISK,,72.0,YR,,M,Y,,,20200720.0,,CN,GB,GB,2020,Q3,Elderly
178847992,17884799,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Syncope,,2020,Q3,2,F,20081229.0,20200709.0,20200611,20200720,EXP,,GB-NOVOPROD-732158,NOVO NORDISK,,72.0,YR,,M,Y,,,20200720.0,,CN,GB,GB,2020,Q3,Elderly
178924553,17892455,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q3,Loss of consciousness,,2020,Q3,3,F,20200403.0,20200724.0,20200612,20200728,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029601",BOEHRINGER INGELHEIM,,72.0,YR,,F,Y,65.0,KG,20200728.0,,MD,MX,MX,2020,Q3,Elderly
178924553,17892455,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q3,Ventricular tachycardia,,2020,Q3,3,F,20200403.0,20200724.0,20200612,20200728,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029601",BOEHRINGER INGELHEIM,,72.0,YR,,F,Y,65.0,KG,20200728.0,,MD,MX,MX,2020,Q3,Elderly
179120935,17912093,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, BID",,,,,,,,25.0,MG,,BID,2020,Q3,Haematuria,,2020,Q3,5,F,20200601.0,20200924.0,20200618,20200930,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-047354,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,115.0,KG,20200930.0,,MD,SK,SK,2020,Q3,Elderly
179120935,17912093,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, BID",,,,,,,,25.0,MG,,BID,2020,Q3,Renal impairment,,2020,Q3,5,F,20200601.0,20200924.0,20200618,20200930,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-047354,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,115.0,KG,20200930.0,,MD,SK,SK,2020,Q3,Elderly
179120935,17912093,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, BID",,,,,,,,25.0,MG,,BID,2020,Q3,Urinary retention,,2020,Q3,5,F,20200601.0,20200924.0,20200618,20200930,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-047354,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,115.0,KG,20200930.0,,MD,SK,SK,2020,Q3,Elderly
179135882,17913588,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,2,F,2018.0,20200629.0,20200618,20200702,EXP,,SK-EMD SERONO-9169345,EMD SERONO INC,"MOKOSOVA A, RYBAROVA O, SCHRONER Z. THERAPY WITH SGLT2 INHIBITORS:CASE REPORTS. DIABETAS A OBEZITA. 2020?20(39):57?59.",63.0,YR,,M,Y,98.0,KG,20200702.0,,MD,SK,SK,2020,Q3,Adult
179135882,17913588,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Diabetic neuropathy,,2020,Q3,2,F,2018.0,20200629.0,20200618,20200702,EXP,,SK-EMD SERONO-9169345,EMD SERONO INC,"MOKOSOVA A, RYBAROVA O, SCHRONER Z. THERAPY WITH SGLT2 INHIBITORS:CASE REPORTS. DIABETAS A OBEZITA. 2020?20(39):57?59.",63.0,YR,,M,Y,98.0,KG,20200702.0,,MD,SK,SK,2020,Q3,Adult
179197912,17919791,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Pancreatitis acute,,2020,Q3,2,F,20191023.0,20200720.0,20200619,20200724,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-119365",BOEHRINGER INGELHEIM,,63.0,YR,,F,Y,76.0,KG,20200724.0,,MD,CO,CO,2020,Q3,Adult
179293782,17929378,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q3,Product residue present,,2020,Q3,2,F,,20200608.0,20200623,20200707,PER,,US-GRANULES INDIA LIMITED-2086544,GRANULES INDIA,N/AP,74.0,YR,,M,Y,,,20200707.0,,PH,US,US,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Abdominal lymphadenopathy,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Abdominal pain lower,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Abnormal faeces,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Back pain,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Biliary obstruction,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Bilirubin urine present,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Bladder discomfort,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Blood albumin decreased,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Blood urine present,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Cholelithiasis,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Constipation,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Flatulence,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Gallbladder enlargement,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Glucose urine present,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Hepatic enzyme abnormal,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Hepatic function abnormal,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Hepatic lesion,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Hepatitis C,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Hypophagia,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Ileus,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Intestinal dilatation,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Jaundice,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Lymphadenopathy mediastinal,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Megacolon,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Obesity,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Ocular icterus,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Oedema peripheral,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Pancreatic carcinoma metastatic,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Pancreatic neoplasm,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Pancreatitis,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Pulmonary fibrosis,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Retroperitoneal lymphadenopathy,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Spinal osteoarthritis,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179498352,17949835,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,EVERY BEDTIME,,,,,,,,10.0,MG,,,2020,Q3,Toxicity to various agents,,2020,Q3,2,F,2020.0,20200717.0,20200625,20200723,EXP,,CA-ABBVIE-20K-028-3460019-00,ABBVIE,,68.0,YR,,F,Y,,,20200723.0,,MD,CA,CA,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Acidosis,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,C-reactive protein increased,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Food intolerance,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Glycosuria,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Hypophosphataemia,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Ketonuria,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Leukocytosis,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Metabolic acidosis,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Nausea,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Neutrophilia,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,7,C,EMPAGLIFLOZIN/EMPAGLIFLOZIN/EMPAGLIFLOZIN,,2,,,,,U,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Anion gap increased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Blood creatine increased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Blood electrolytes abnormal,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Blood triglycerides increased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Blood urea abnormal,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Full blood count abnormal,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Haematocrit decreased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Haemoglobin decreased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,High density lipoprotein decreased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Mean cell haemoglobin decreased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Mean cell volume decreased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Red cell distribution width increased,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179677671,17967767,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,1,I,20200612.0,20200612.0,20200701,20200701,EXP,,AU-MYLANLABS-2020M1056839,MYLAN,,52.0,YR,,M,Y,,,20200701.0,,HP,AU,AU,2020,Q3,Adult
179686791,17968679,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1?0?0?0",,,,,,,,10.0,MG,,QD,2020,Q3,Skin ulcer,,2020,Q3,1,I,,20200622.0,20200701,20200701,EXP,,DE-MYLANLABS-2020M1059214,MYLAN,,83.0,YR,,M,Y,75.0,KG,20200701.0,,MD,DE,DE,2020,Q3,Elderly
179686791,17968679,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1?0?0?0",,,,,,,,10.0,MG,,QD,2020,Q3,Wound,,2020,Q3,1,I,,20200622.0,20200701,20200701,EXP,,DE-MYLANLABS-2020M1059214,MYLAN,,83.0,YR,,M,Y,75.0,KG,20200701.0,,MD,DE,DE,2020,Q3,Elderly
179849461,17984946,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD(1?0?0?0, TABLETTEN)",,,U,U,,,,10.0,MG,TABLET,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200115.0,20200630.0,20200706,20200706,EXP,,NVSC2020DE185331,NOVARTIS,,77.0,YR,,M,Y,,,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179849461,17984946,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD(1?0?0?0, TABLETTEN)",,,U,U,,,,10.0,MG,TABLET,QD,2020,Q3,Product administration error,,2020,Q3,1,I,20200115.0,20200630.0,20200706,20200706,EXP,,NVSC2020DE185331,NOVARTIS,,77.0,YR,,M,Y,,,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179959234,17995923,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q3,Cerebral haematoma,,2020,Q3,4,F,20200124.0,20200803.0,20200708,20200810,EXP,,"HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033561",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,52.0,KG,20200811.0,,MD,HU,HU,2020,Q3,Elderly
179959234,17995923,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q3,Paraneoplastic syndrome,,2020,Q3,4,F,20200124.0,20200803.0,20200708,20200810,EXP,,"HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033561",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,52.0,KG,20200811.0,,MD,HU,HU,2020,Q3,Elderly
179959234,17995923,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q3,Vulval cancer,,2020,Q3,4,F,20200124.0,20200803.0,20200708,20200810,EXP,,"HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033561",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,52.0,KG,20200811.0,,MD,HU,HU,2020,Q3,Elderly
179970701,17997070,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1?0?0?0",,,U,,,,,,,,,2020,Q3,Haematuria,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,NVSC2020DE187245,NOVARTIS,,80.0,YR,,M,Y,78.0,KG,20200708.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
179970701,17997070,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 1?0?0?0",,,U,,,,,,,,,2020,Q3,Urinary hesitation,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,NVSC2020DE187245,NOVARTIS,,80.0,YR,,M,Y,78.0,KG,20200708.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
180048071,18004807,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,FILM-COATED TABLET,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20191002.0,20200701.0,20200710,20200710,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-251652,RANBAXY,,67.0,YR,,M,Y,,,20200710.0,,CN,DE,US,2020,Q3,Elderly
180048071,18004807,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,FILM-COATED TABLET,,2020,Q3,Hypotension,,2020,Q3,1,I,20191002.0,20200701.0,20200710,20200710,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-251652,RANBAXY,,67.0,YR,,M,Y,,,20200710.0,,CN,DE,US,2020,Q3,Elderly
180048071,18004807,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,FILM-COATED TABLET,,2020,Q3,Ketoacidosis,,2020,Q3,1,I,20191002.0,20200701.0,20200710,20200710,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-251652,RANBAXY,,67.0,YR,,M,Y,,,20200710.0,,CN,DE,US,2020,Q3,Elderly
180048071,18004807,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,FILM-COATED TABLET,,2020,Q3,Metabolic acidosis,,2020,Q3,1,I,20191002.0,20200701.0,20200710,20200710,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-251652,RANBAXY,,67.0,YR,,M,Y,,,20200710.0,,CN,DE,US,2020,Q3,Elderly
180048071,18004807,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,FILM-COATED TABLET,,2020,Q3,Syncope,,2020,Q3,1,I,20191002.0,20200701.0,20200710,20200710,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-251652,RANBAXY,,67.0,YR,,M,Y,,,20200710.0,,CN,DE,US,2020,Q3,Elderly
180107071,18010707,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (10 MG, 1?0?0?0)",,,U,,,,,10.0,MG,,QD,2020,Q3,Skin ulcer,,2020,Q3,1,I,,20200706.0,20200710,20200710,EXP,,NVSC2020DE191245,NOVARTIS,,83.0,YR,,M,Y,75.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180107071,18010707,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (10 MG, 1?0?0?0)",,,U,,,,,10.0,MG,,QD,2020,Q3,Wound,,2020,Q3,1,I,,20200706.0,20200710,20200710,EXP,,NVSC2020DE191245,NOVARTIS,,83.0,YR,,M,Y,75.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180109196,18010919,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Chronic kidney disease,,2020,Q3,6,F,20200604.0,20200813.0,20200710,20200817,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-030331",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,82.6,KG,20200817.0,,MD,CO,CO,2020,Q3,Elderly
180109196,18010919,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Urinary tract infection,,2020,Q3,6,F,20200604.0,20200813.0,20200710,20200817,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-030331",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,82.6,KG,20200817.0,,MD,CO,CO,2020,Q3,Elderly
180109441,18010944,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD (1?0?0?0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,,NVSC2020DE188779,NOVARTIS,,67.0,YR,,M,Y,,,20200711.0,,HP,DE,DE,2020,Q3,Elderly
180109441,18010944,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD (1?0?0?0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q3,Cough,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,,NVSC2020DE188779,NOVARTIS,,67.0,YR,,M,Y,,,20200711.0,,HP,DE,DE,2020,Q3,Elderly
180109441,18010944,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD (1?0?0?0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,,NVSC2020DE188779,NOVARTIS,,67.0,YR,,M,Y,,,20200711.0,,HP,DE,DE,2020,Q3,Elderly
180109441,18010944,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD (1?0?0?0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,,NVSC2020DE188779,NOVARTIS,,67.0,YR,,M,Y,,,20200711.0,,HP,DE,DE,2020,Q3,Elderly
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Anxiety,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Arterial stenosis,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Blood creatinine increased,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Cardiac failure,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Cellulitis,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Diabetic gastroparesis,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Dyspepsia,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Gastrooesophageal reflux disease,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Impaired healing,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Injury,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Nausea,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Osteomyelitis,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Retinopathy,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Selective eating disorder,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Skin ulcer,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Urinary tract infection,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Urosepsis,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180172692,18017269,14,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 5 MG/500 MG/D,,,U,,,,,2.0,DF,,BID,2020,Q3,Weight decreased,,2020,Q3,2,F,,20200805.0,20200713,20200812,EXP,,CH-009507513-2007CHE002280,MERCK,,53.0,YR,,F,Y,,,20200812.0,,MD,CH,CH,2020,Q3,Adult
180193992,18019399,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,2,F,2017.0,20200729.0,20200714,20200807,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202007001377,ELI LILLY AND CO,,50.0,YR,,F,Y,93.0,KG,20200807.0,,MD,JP,JP,2020,Q3,Adult
180246062,18024606,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Ejection fraction decreased,,2020,Q3,2,F,202004.0,20200716.0,20200714,20200722,EXP,,IT-ABBVIE-20K-083-3482020-00,ABBVIE,,69.0,YR,,M,Y,80.0,KG,20200722.0,,MD,IT,IT,2020,Q3,Elderly
180246062,18024606,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Pneumonia cytomegaloviral,,2020,Q3,2,F,202004.0,20200716.0,20200714,20200722,EXP,,IT-ABBVIE-20K-083-3482020-00,ABBVIE,,69.0,YR,,M,Y,80.0,KG,20200722.0,,MD,IT,IT,2020,Q3,Elderly
180247991,18024799,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,Y,,,,12.5,MG,,QD,2020,Q3,Abdominal pain,,2020,Q3,1,I,20200320.0,,20200714,20200714,DIR,,,FDA-CTU,,58.0,YR,,F,N,96.62,KG,20200403.0,N,PH,US,US,2020,Q3,Adult
180248261,18024826,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,20191007.0,,20200714,20200714,DIR,,,FDA-CTU,,70.0,YR,,F,N,,,20191115.0,N,PH,US,US,2020,Q3,Elderly
180248261,18024826,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,20191007.0,,20200714,20200714,DIR,,,FDA-CTU,,70.0,YR,,F,N,,,20191115.0,N,PH,US,US,2020,Q3,Elderly
180248261,18024826,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Hypocapnia,,2020,Q3,1,I,20191007.0,,20200714,20200714,DIR,,,FDA-CTU,,70.0,YR,,F,N,,,20191115.0,N,PH,US,US,2020,Q3,Elderly
180248261,18024826,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Metabolic acidosis,,2020,Q3,1,I,20191007.0,,20200714,20200714,DIR,,,FDA-CTU,,70.0,YR,,F,N,,,20191115.0,N,PH,US,US,2020,Q3,Elderly
180248261,18024826,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Starvation ketoacidosis,,2020,Q3,1,I,20191007.0,,20200714,20200714,DIR,,,FDA-CTU,,70.0,YR,,F,N,,,20191115.0,N,PH,US,US,2020,Q3,Elderly
180361461,18036146,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Hypotension,,2020,Q3,1,I,20190425.0,,20200716,20200716,DIR,,,FDA-CTU,,77.0,YR,,M,N,69.0,KG,20190914.0,N,PH,US,US,2020,Q3,Elderly
180361461,18036146,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Syncope,,2020,Q3,1,I,20190425.0,,20200716,20200716,DIR,,,FDA-CTU,,77.0,YR,,M,N,69.0,KG,20190914.0,N,PH,US,US,2020,Q3,Elderly
180361511,18036151,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Cellulitis of male external genital organ,,2020,Q3,1,I,20190806.0,,20200716,20200716,DIR,,,FDA-CTU,,61.0,YR,,M,N,129.0,KG,20190914.0,N,PH,US,US,2020,Q3,Adult
180361511,18036151,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Rash,,2020,Q3,1,I,20190806.0,,20200716,20200716,DIR,,,FDA-CTU,,61.0,YR,,M,N,129.0,KG,20190914.0,N,PH,US,US,2020,Q3,Adult
180361561,18036156,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,0.5,MG,,QD,2020,Q3,Agitation,,2020,Q3,1,I,20190719.0,,20200716,20200716,DIR,,,FDA-CTU,,80.0,YR,,M,N,95.0,KG,20190822.0,N,PH,US,US,2020,Q3,Elderly
180361561,18036156,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,0.5,MG,,QD,2020,Q3,Depression,,2020,Q3,1,I,20190719.0,,20200716,20200716,DIR,,,FDA-CTU,,80.0,YR,,M,N,95.0,KG,20190822.0,N,PH,US,US,2020,Q3,Elderly
180402762,18040276,11,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,,,,,,10.0,MG,UNKNOWN,QD,2020,Q3,Coronary artery disease,,2020,Q3,2,F,20200709.0,20200728.0,20200717,20200803,EXP,,AU-CELGENEUS-AUS-20200703197,CELGENE,,72.0,YR,,M,Y,75.7,KG,20200803.0,,HP,AU,AU,2020,Q3,Elderly
180515972,18051597,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,2,F,20200707.0,20200721.0,20200722,20200723,EXP,,US-ROCHE-2641552,ROCHE,,69.0,YR,,M,Y,,,20200723.0,,CN,US,US,2020,Q3,Elderly
180515972,18051597,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,2,F,20200707.0,20200721.0,20200722,20200723,EXP,,US-ROCHE-2641552,ROCHE,,69.0,YR,,M,Y,,,20200723.0,,CN,US,US,2020,Q3,Elderly
180515972,18051597,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Rib fracture,,2020,Q3,2,F,20200707.0,20200721.0,20200722,20200723,EXP,,US-ROCHE-2641552,ROCHE,,69.0,YR,,M,Y,,,20200723.0,,CN,US,US,2020,Q3,Elderly
180543782,18054378,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,201511.0,20200730.0,20200722,20200731,EXP,,NVSC2020CZ204204,NOVARTIS,,68.0,YR,,M,Y,,,20200731.0,,HP,CZ,CZ,2020,Q3,Elderly
180543782,18054378,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Congestive cardiomyopathy,,2020,Q3,2,F,201511.0,20200730.0,20200722,20200731,EXP,,NVSC2020CZ204204,NOVARTIS,,68.0,YR,,M,Y,,,20200731.0,,HP,CZ,CZ,2020,Q3,Elderly
180543782,18054378,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,2,F,201511.0,20200730.0,20200722,20200731,EXP,,NVSC2020CZ204204,NOVARTIS,,68.0,YR,,M,Y,,,20200731.0,,HP,CZ,CZ,2020,Q3,Elderly
180543782,18054378,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Ejection fraction decreased,,2020,Q3,2,F,201511.0,20200730.0,20200722,20200731,EXP,,NVSC2020CZ204204,NOVARTIS,,68.0,YR,,M,Y,,,20200731.0,,HP,CZ,CZ,2020,Q3,Elderly
180543782,18054378,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,2,F,201511.0,20200730.0,20200722,20200731,EXP,,NVSC2020CZ204204,NOVARTIS,,68.0,YR,,M,Y,,,20200731.0,,HP,CZ,CZ,2020,Q3,Elderly
180543782,18054378,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Myocardial hypoperfusion,,2020,Q3,2,F,201511.0,20200730.0,20200722,20200731,EXP,,NVSC2020CZ204204,NOVARTIS,,68.0,YR,,M,Y,,,20200731.0,,HP,CZ,CZ,2020,Q3,Elderly
180543782,18054378,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,2,F,201511.0,20200730.0,20200722,20200731,EXP,,NVSC2020CZ204204,NOVARTIS,,68.0,YR,,M,Y,,,20200731.0,,HP,CZ,CZ,2020,Q3,Elderly
180543782,18054378,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Treatment failure,,2020,Q3,2,F,201511.0,20200730.0,20200722,20200731,EXP,,NVSC2020CZ204204,NOVARTIS,,68.0,YR,,M,Y,,,20200731.0,,HP,CZ,CZ,2020,Q3,Elderly
180545091,18054509,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Mental status changes,,2020,Q3,1,I,20200520.0,,20200722,20200722,DIR,,,FDA-CTU,,66.0,YR,,F,N,,,20200718.0,N,PH,US,US,2020,Q3,Elderly
180545311,18054531,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200518.0,,20200722,20200722,DIR,,,FDA-CTU,,59.0,YR,,F,N,,,20200718.0,N,PH,US,US,2020,Q3,Adult
180545341,18054534,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20200506.0,,20200722,20200722,DIR,,,FDA-CTU,,66.0,YR,,M,N,,,20200718.0,N,PH,US,US,2020,Q3,Elderly
180546031,18054603,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Angina pectoris,,2020,Q3,1,I,20200716.0,,20200721,20200721,DIR,,,FDA-CTU,,66.0,YR,,M,N,83.0,KG,20200720.0,N,PH,US,US,2020,Q3,Elderly
180546031,18054603,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,20200716.0,,20200721,20200721,DIR,,,FDA-CTU,,66.0,YR,,M,N,83.0,KG,20200720.0,N,PH,US,US,2020,Q3,Elderly
180546031,18054603,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Fatigue,,2020,Q3,1,I,20200716.0,,20200721,20200721,DIR,,,FDA-CTU,,66.0,YR,,M,N,83.0,KG,20200720.0,N,PH,US,US,2020,Q3,Elderly
180583741,18058374,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200518.0,,20200722,20200722,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20200718.0,N,PH,US,US,2020,Q3,Elderly
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Candida infection,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Candida sepsis,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Coagulation test abnormal,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Coagulopathy,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Emphysematous pyelonephritis,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Oliguria,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Perinephric abscess,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Product use in unapproved indication,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Pyelonephritis fungal,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Systemic candida,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Therapy non-responder,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Urinary tract candidiasis,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Urinary tract infection enterococcal,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180590726,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q3,Vesicoureteric reflux,,2020,Q3,6,F,,20200911.0,20200723,20200914,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20200914.0,,HP,ES,ES,2020,Q3,Adult
180592611,18059261,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Abdominal pain,,2020,Q3,1,I,20200603.0,,20200722,20200722,DIR,,,FDA-CTU,,62.0,YR,,M,N,68.04,KG,20200713.0,N,PH,US,US,2020,Q3,Adult
180592611,18059261,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Defaecation urgency,,2020,Q3,1,I,20200603.0,,20200722,20200722,DIR,,,FDA-CTU,,62.0,YR,,M,N,68.04,KG,20200713.0,N,PH,US,US,2020,Q3,Adult
180592611,18059261,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Diarrhoea haemorrhagic,,2020,Q3,1,I,20200603.0,,20200722,20200722,DIR,,,FDA-CTU,,62.0,YR,,M,N,68.04,KG,20200713.0,N,PH,US,US,2020,Q3,Adult
180592611,18059261,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,20200603.0,,20200722,20200722,DIR,,,FDA-CTU,,62.0,YR,,M,N,68.04,KG,20200713.0,N,PH,US,US,2020,Q3,Adult
180592611,18059261,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,20200603.0,,20200722,20200722,DIR,,,FDA-CTU,,62.0,YR,,M,N,68.04,KG,20200713.0,N,PH,US,US,2020,Q3,Adult
180657581,18065758,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Asthenia,,2020,Q3,1,I,20200617.0,,20200724,20200724,DIR,,,FDA-CTU,,78.0,YR,,M,N,84.0,KG,20200721.0,N,PH,US,US,2020,Q3,Elderly
180657581,18065758,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Nausea,,2020,Q3,1,I,20200617.0,,20200724,20200724,DIR,,,FDA-CTU,,78.0,YR,,M,N,84.0,KG,20200721.0,N,PH,US,US,2020,Q3,Elderly
180657581,18065758,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Rash,,2020,Q3,1,I,20200617.0,,20200724,20200724,DIR,,,FDA-CTU,,78.0,YR,,M,N,84.0,KG,20200721.0,N,PH,US,US,2020,Q3,Elderly
180657581,18065758,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Skin disorder,,2020,Q3,1,I,20200617.0,,20200724,20200724,DIR,,,FDA-CTU,,78.0,YR,,M,N,84.0,KG,20200721.0,N,PH,US,US,2020,Q3,Elderly
180657581,18065758,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20200617.0,,20200724,20200724,DIR,,,FDA-CTU,,78.0,YR,,M,N,84.0,KG,20200721.0,N,PH,US,US,2020,Q3,Elderly
180774351,18077435,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q3,Diabetic foot,,2020,Q3,1,I,,20200723.0,20200728,20200728,EXP,,IT-EMD SERONO-9177077,EMD SERONO INC,,63.0,YR,A,M,Y,,,20200728.0,,CN,IT,IT,2020,Q3,Adult
180782921,18078292,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Diabetic foot,,2020,Q3,1,I,,20200727.0,20200727,20200727,EXP,,NVSC2020IT210013,NOVARTIS,,63.0,YR,,M,Y,,,20200728.0,,HP,IT,IT,2020,Q3,Adult
180801861,18080186,13,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,THERAPY START DATE: JUN 2018,,,Y,,,,,,,,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,13,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,THERAPY START DATE: JUN 2018,,,Y,,,,,,,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,13,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,THERAPY START DATE: JUN 2018,,,Y,,,,,,,,QD,2020,Q3,Weight increased,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180923431,18092343,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,TABLET,,2020,Q3,Genital rash,,2020,Q3,1,I,20200717.0,,20200730,20200730,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200729.0,N,PH,US,US,2020,Q3,Elderly
180923431,18092343,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,TABLET,,2020,Q3,Rash,,2020,Q3,1,I,20200717.0,,20200730,20200730,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200729.0,N,PH,US,US,2020,Q3,Elderly
180928901,18092890,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200721.0,20200730,20200730,EXP,,PL-MYLANLABS-2020M1067887,MYLAN,"SIWEK M, WORON J, GOROSTOWICZ A, WORDLICZEK J. ADVERSE EFFECTS OF INTERACTIONS BETWEEN ANTIPSYCHOTICS AND MEDICATIONS USED IN THE TREATMENT OF CARDIOVASCULAR DISORDERS. PHARMACOL?REP 2020?72(2):350?359.",68.0,YR,,M,Y,,,20200730.0,,HP,PL,PL,2020,Q3,Elderly
180928901,18092890,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200721.0,20200730,20200730,EXP,,PL-MYLANLABS-2020M1067887,MYLAN,"SIWEK M, WORON J, GOROSTOWICZ A, WORDLICZEK J. ADVERSE EFFECTS OF INTERACTIONS BETWEEN ANTIPSYCHOTICS AND MEDICATIONS USED IN THE TREATMENT OF CARDIOVASCULAR DISORDERS. PHARMACOL?REP 2020?72(2):350?359.",68.0,YR,,M,Y,,,20200730.0,,HP,PL,PL,2020,Q3,Elderly
180928901,18092890,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Head injury,,2020,Q3,1,I,,20200721.0,20200730,20200730,EXP,,PL-MYLANLABS-2020M1067887,MYLAN,"SIWEK M, WORON J, GOROSTOWICZ A, WORDLICZEK J. ADVERSE EFFECTS OF INTERACTIONS BETWEEN ANTIPSYCHOTICS AND MEDICATIONS USED IN THE TREATMENT OF CARDIOVASCULAR DISORDERS. PHARMACOL?REP 2020?72(2):350?359.",68.0,YR,,M,Y,,,20200730.0,,HP,PL,PL,2020,Q3,Elderly
180928901,18092890,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Hypotonia,,2020,Q3,1,I,,20200721.0,20200730,20200730,EXP,,PL-MYLANLABS-2020M1067887,MYLAN,"SIWEK M, WORON J, GOROSTOWICZ A, WORDLICZEK J. ADVERSE EFFECTS OF INTERACTIONS BETWEEN ANTIPSYCHOTICS AND MEDICATIONS USED IN THE TREATMENT OF CARDIOVASCULAR DISORDERS. PHARMACOL?REP 2020?72(2):350?359.",68.0,YR,,M,Y,,,20200730.0,,HP,PL,PL,2020,Q3,Elderly
180929883,18092988,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Septic shock,,2020,Q3,3,F,20200720.0,20200818.0,20200730,20200821,EXP,,"KR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037161",BOEHRINGER INGELHEIM,,78.0,YR,,F,Y,61.6,KG,20200821.0,,MD,KR,KR,2020,Q3,Elderly
180929883,18092988,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Urinary tract infection,,2020,Q3,3,F,20200720.0,20200818.0,20200730,20200821,EXP,,"KR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037161",BOEHRINGER INGELHEIM,,78.0,YR,,F,Y,61.6,KG,20200821.0,,MD,KR,KR,2020,Q3,Elderly
180930232,18093023,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,20200720.0,20200803.0,20200730,20200812,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037493",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,70.1,KG,20200813.0,,MD,BR,BR,2020,Q3,Elderly
180930232,18093023,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,20200720.0,20200803.0,20200730,20200812,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037493",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,70.1,KG,20200813.0,,MD,BR,BR,2020,Q3,Elderly
180947572,18094757,3,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q3,Diabetic foot,,2020,Q3,2,F,,20200810.0,20200731,20200821,EXP,,IT-AUROBINDO-AUR-APL-2020-036936,AUROBINDO,,63.0,YR,,M,Y,,,20200821.0,,CN,IT,IT,2020,Q3,Adult
180956161,18095616,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Cardiac failure chronic,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04007,ALKEM,,76.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Elderly
180956161,18095616,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Conjunctival pallor,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04007,ALKEM,,76.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Elderly
180956161,18095616,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Decreased appetite,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04007,ALKEM,,76.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Elderly
180956161,18095616,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04007,ALKEM,,76.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Elderly
180956161,18095616,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Fatigue,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04007,ALKEM,,76.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Elderly
180956161,18095616,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Iron deficiency anaemia,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04007,ALKEM,,76.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Elderly
180976081,18097608,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Candida infection,,2020,Q3,1,I,,20200721.0,20200731,20200731,EXP,,ES-MYLANLABS-2020M1067951,MYLAN,,56.0,YR,,F,Y,,,20200731.0,,HP,ES,ES,2020,Q3,Adult
180976081,18097608,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Candida sepsis,,2020,Q3,1,I,,20200721.0,20200731,20200731,EXP,,ES-MYLANLABS-2020M1067951,MYLAN,,56.0,YR,,F,Y,,,20200731.0,,HP,ES,ES,2020,Q3,Adult
180976081,18097608,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Coagulation test abnormal,,2020,Q3,1,I,,20200721.0,20200731,20200731,EXP,,ES-MYLANLABS-2020M1067951,MYLAN,,56.0,YR,,F,Y,,,20200731.0,,HP,ES,ES,2020,Q3,Adult
180976081,18097608,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200721.0,20200731,20200731,EXP,,ES-MYLANLABS-2020M1067951,MYLAN,,56.0,YR,,F,Y,,,20200731.0,,HP,ES,ES,2020,Q3,Adult
180976081,18097608,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Emphysematous pyelonephritis,,2020,Q3,1,I,,20200721.0,20200731,20200731,EXP,,ES-MYLANLABS-2020M1067951,MYLAN,,56.0,YR,,F,Y,,,20200731.0,,HP,ES,ES,2020,Q3,Adult
180976081,18097608,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Perinephric abscess,,2020,Q3,1,I,,20200721.0,20200731,20200731,EXP,,ES-MYLANLABS-2020M1067951,MYLAN,,56.0,YR,,F,Y,,,20200731.0,,HP,ES,ES,2020,Q3,Adult
180976081,18097608,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Pyelonephritis fungal,,2020,Q3,1,I,,20200721.0,20200731,20200731,EXP,,ES-MYLANLABS-2020M1067951,MYLAN,,56.0,YR,,F,Y,,,20200731.0,,HP,ES,ES,2020,Q3,Adult
180976081,18097608,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,,20200721.0,20200731,20200731,EXP,,ES-MYLANLABS-2020M1067951,MYLAN,,56.0,YR,,F,Y,,,20200731.0,,HP,ES,ES,2020,Q3,Adult
180976081,18097608,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Systemic candida,,2020,Q3,1,I,,20200721.0,20200731,20200731,EXP,,ES-MYLANLABS-2020M1067951,MYLAN,,56.0,YR,,F,Y,,,20200731.0,,HP,ES,ES,2020,Q3,Adult
181006741,18100674,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2020,Q3,Diabetic foot,,2020,Q3,1,I,,20200727.0,20200731,20200731,EXP,,IT-BAUSCH-BL-2020-021414,BAUSCH AND LOMB,,63.0,YR,,M,Y,,,20200731.0,,CN,IT,IT,2020,Q3,Adult
181028812,18102881,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Candida infection,,2020,Q3,2,F,20181217.0,20200808.0,20200803,20200813,EXP,,ES-ASTELLAS-2020US023850,ASTELLAS,,53.0,YR,,F,Y,,,20200813.0,,CN,GB,ES,2020,Q3,Adult
181028812,18102881,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Candida sepsis,,2020,Q3,2,F,20181217.0,20200808.0,20200803,20200813,EXP,,ES-ASTELLAS-2020US023850,ASTELLAS,,53.0,YR,,F,Y,,,20200813.0,,CN,GB,ES,2020,Q3,Adult
181028812,18102881,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Drug ineffective,,2020,Q3,2,F,20181217.0,20200808.0,20200803,20200813,EXP,,ES-ASTELLAS-2020US023850,ASTELLAS,,53.0,YR,,F,Y,,,20200813.0,,CN,GB,ES,2020,Q3,Adult
181028812,18102881,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Emphysematous pyelonephritis,,2020,Q3,2,F,20181217.0,20200808.0,20200803,20200813,EXP,,ES-ASTELLAS-2020US023850,ASTELLAS,,53.0,YR,,F,Y,,,20200813.0,,CN,GB,ES,2020,Q3,Adult
181028812,18102881,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Perinephric abscess,,2020,Q3,2,F,20181217.0,20200808.0,20200803,20200813,EXP,,ES-ASTELLAS-2020US023850,ASTELLAS,,53.0,YR,,F,Y,,,20200813.0,,CN,GB,ES,2020,Q3,Adult
181028812,18102881,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Septic shock,,2020,Q3,2,F,20181217.0,20200808.0,20200803,20200813,EXP,,ES-ASTELLAS-2020US023850,ASTELLAS,,53.0,YR,,F,Y,,,20200813.0,,CN,GB,ES,2020,Q3,Adult
181028812,18102881,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Urinary tract candidiasis,,2020,Q3,2,F,20181217.0,20200808.0,20200803,20200813,EXP,,ES-ASTELLAS-2020US023850,ASTELLAS,,53.0,YR,,F,Y,,,20200813.0,,CN,GB,ES,2020,Q3,Adult
181028812,18102881,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Urinary tract infection,,2020,Q3,2,F,20181217.0,20200808.0,20200803,20200813,EXP,,ES-ASTELLAS-2020US023850,ASTELLAS,,53.0,YR,,F,Y,,,20200813.0,,CN,GB,ES,2020,Q3,Adult
181028812,18102881,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Urinary tract infection enterococcal,,2020,Q3,2,F,20181217.0,20200808.0,20200803,20200813,EXP,,ES-ASTELLAS-2020US023850,ASTELLAS,,53.0,YR,,F,Y,,,20200813.0,,CN,GB,ES,2020,Q3,Adult
181040781,18104078,5,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,,,2020,Q3,Diabetic foot,,2020,Q3,1,I,,20200727.0,20200803,20200803,EXP,,IT-MYLANLABS-2020M1068014,MYLAN,,63.0,YR,,M,Y,,,20200803.0,,CN,IT,IT,2020,Q3,Adult
181069831,18106983,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,TBL FLM,,,Y,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Altered state of consciousness,,2020,Q3,1,I,20200626.0,20200731.0,20200803,20200803,EXP,SK-SUKLSK-20200469,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-039284",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,,,20200803.0,,MD,SK,SK,2020,Q3,Elderly
181069831,18106983,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,TBL FLM,,,Y,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200626.0,20200731.0,20200803,20200803,EXP,SK-SUKLSK-20200469,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-039284",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,,,20200803.0,,MD,SK,SK,2020,Q3,Elderly
181070461,18107046,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,25.0,MG,,QD,2020,Q3,Asthenia,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,25.0,MG,,QD,2020,Q3,Cough,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,25.0,MG,,QD,2020,Q3,Delirium,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,25.0,MG,,QD,2020,Q3,Dyspnoea,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,25.0,MG,,QD,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D, N/A,,,25.0,MG,,QD,2020,Q3,Tachypnoea,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181077591,18107759,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Anuria,,2020,Q3,1,I,20200513.0,,20200804,20200804,DIR,,,FDA-CTU,,72.0,YR,,M,N,81.19,KG,20200718.0,N,PH,US,US,2020,Q3,Elderly
181077591,18107759,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Constipation,,2020,Q3,1,I,20200513.0,,20200804,20200804,DIR,,,FDA-CTU,,72.0,YR,,M,N,81.19,KG,20200718.0,N,PH,US,US,2020,Q3,Elderly
181081733,18108173,10,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG DAILY,,,Y,U,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,COVID-19,,2020,Q3,3,F,20200309.0,20200919.0,20200803,20200929,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015702",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,99.0,KG,20200929.0,,MD,BR,BR,2020,Q3,Elderly
181081733,18108173,10,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG DAILY,,,Y,U,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,3,F,20200309.0,20200919.0,20200803,20200929,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015702",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,99.0,KG,20200929.0,,MD,BR,BR,2020,Q3,Elderly
181081733,18108173,10,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG DAILY,,,Y,U,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Metabolic acidosis,,2020,Q3,3,F,20200309.0,20200919.0,20200803,20200929,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015702",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,99.0,KG,20200929.0,,MD,BR,BR,2020,Q3,Elderly
181087161,18108716,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q3,Candida infection,,2020,Q3,1,I,,20200721.0,20200804,20200804,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2020-04059,LUPIN,,53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181087161,18108716,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q3,Candida sepsis,,2020,Q3,1,I,,20200721.0,20200804,20200804,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2020-04059,LUPIN,,53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181087161,18108716,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q3,Coagulation test abnormal,,2020,Q3,1,I,,20200721.0,20200804,20200804,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2020-04059,LUPIN,,53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181087161,18108716,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200721.0,20200804,20200804,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2020-04059,LUPIN,,53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181087161,18108716,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q3,Emphysematous pyelonephritis,,2020,Q3,1,I,,20200721.0,20200804,20200804,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2020-04059,LUPIN,,53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181087161,18108716,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q3,Perinephric abscess,,2020,Q3,1,I,,20200721.0,20200804,20200804,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2020-04059,LUPIN,,53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181087161,18108716,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q3,Pyelonephritis fungal,,2020,Q3,1,I,,20200721.0,20200804,20200804,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2020-04059,LUPIN,,53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181087161,18108716,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,,20200721.0,20200804,20200804,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2020-04059,LUPIN,,53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181087161,18108716,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q3,Systemic candida,,2020,Q3,1,I,,20200721.0,20200804,20200804,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2020-04059,LUPIN,,53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181091111,18109111,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Anti-neutrophil cytoplasmic antibody positive vasculitis,,2020,Q3,1,I,20200709.0,20200727.0,20200804,20200804,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-038620",BOEHRINGER INGELHEIM,,78.0,YR,,F,Y,,,20200804.0,,MD,DE,DE,2020,Q3,Elderly
181099391,18109939,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Emphysematous pyelonephritis,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,ES-MYLANLABS-2020M1068598,MYLAN,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R ET AL... FULMINANT EPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON CLINICAL PRACTICE. 2020?144(6):304?9",53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181099391,18109939,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Product use in unapproved indication,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,ES-MYLANLABS-2020M1068598,MYLAN,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R ET AL... FULMINANT EPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON CLINICAL PRACTICE. 2020?144(6):304?9",53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181099391,18109939,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,ES-MYLANLABS-2020M1068598,MYLAN,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R ET AL... FULMINANT EPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON CLINICAL PRACTICE. 2020?144(6):304?9",53.0,YR,,F,Y,,,20200804.0,,HP,ES,ES,2020,Q3,Adult
181117261,18111726,10,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Candida infection,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,ES-TEVA-2020-ES-1809860,TEVA,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT. NEPHRON 2020?144(6):304?309.",56.0,YR,A,F,Y,,,20200805.0,,MD,ES,ES,2020,Q3,Adult
181117261,18111726,10,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Candida sepsis,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,ES-TEVA-2020-ES-1809860,TEVA,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT. NEPHRON 2020?144(6):304?309.",56.0,YR,A,F,Y,,,20200805.0,,MD,ES,ES,2020,Q3,Adult
181117261,18111726,10,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Coagulation test abnormal,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,ES-TEVA-2020-ES-1809860,TEVA,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT. NEPHRON 2020?144(6):304?309.",56.0,YR,A,F,Y,,,20200805.0,,MD,ES,ES,2020,Q3,Adult
181117261,18111726,10,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,ES-TEVA-2020-ES-1809860,TEVA,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT. NEPHRON 2020?144(6):304?309.",56.0,YR,A,F,Y,,,20200805.0,,MD,ES,ES,2020,Q3,Adult
181117261,18111726,10,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Emphysematous pyelonephritis,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,ES-TEVA-2020-ES-1809860,TEVA,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT. NEPHRON 2020?144(6):304?309.",56.0,YR,A,F,Y,,,20200805.0,,MD,ES,ES,2020,Q3,Adult
181117261,18111726,10,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Perinephric abscess,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,ES-TEVA-2020-ES-1809860,TEVA,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT. NEPHRON 2020?144(6):304?309.",56.0,YR,A,F,Y,,,20200805.0,,MD,ES,ES,2020,Q3,Adult
181117261,18111726,10,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Pyelonephritis fungal,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,ES-TEVA-2020-ES-1809860,TEVA,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT. NEPHRON 2020?144(6):304?309.",56.0,YR,A,F,Y,,,20200805.0,,MD,ES,ES,2020,Q3,Adult
181117261,18111726,10,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,ES-TEVA-2020-ES-1809860,TEVA,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT. NEPHRON 2020?144(6):304?309.",56.0,YR,A,F,Y,,,20200805.0,,MD,ES,ES,2020,Q3,Adult
181117261,18111726,10,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Systemic candida,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,ES-TEVA-2020-ES-1809860,TEVA,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT. NEPHRON 2020?144(6):304?309.",56.0,YR,A,F,Y,,,20200805.0,,MD,ES,ES,2020,Q3,Adult
181242331,18124233,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,FILM-COATED TABLET,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20190219.0,20200731.0,20200807,20200807,EXP,,US-JNJFOC-20200802647,JOHNSON AND JOHNSON,,77.0,YR,E,F,Y,44.5,KG,20200807.0,,MD,US,US,2020,Q3,Elderly
181242331,18124233,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,FILM-COATED TABLET,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,20190219.0,20200731.0,20200807,20200807,EXP,,US-JNJFOC-20200802647,JOHNSON AND JOHNSON,,77.0,YR,E,F,Y,44.5,KG,20200807.0,,MD,US,US,2020,Q3,Elderly
181260011,18126001,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Staphylococcal infection,,2020,Q3,1,I,20200130.0,20200529.0,20200807,20200807,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-027352",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,86.0,KG,20200808.0,,MD,PL,PL,2020,Q3,Elderly
181278611,18127861,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Rash,,2020,Q3,1,I,20190909.0,,20200807,20200807,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20191118.0,N,PH,US,US,2020,Q3,Adult
181311101,18131110,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (2?0?0?0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,,20200807.0,20200810,20200810,EXP,,NVSC2020DE220543,NOVARTIS,,82.0,YR,,M,Y,,,20200810.0,,HP,DE,DE,2020,Q3,Elderly
181311101,18131110,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (2?0?0?0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q3,Erythema,,2020,Q3,1,I,,20200807.0,20200810,20200810,EXP,,NVSC2020DE220543,NOVARTIS,,82.0,YR,,M,Y,,,20200810.0,,HP,DE,DE,2020,Q3,Elderly
181311101,18131110,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (2?0?0?0)",,,U,,,,,10.0,MG,TABLET,QD,2020,Q3,Hot flush,,2020,Q3,1,I,,20200807.0,20200810,20200810,EXP,,NVSC2020DE220543,NOVARTIS,,82.0,YR,,M,Y,,,20200810.0,,HP,DE,DE,2020,Q3,Elderly
181343641,18134364,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Genital rash,,2020,Q3,1,I,20200423.0,,20200810,20200810,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20200507.0,N,PH,US,US,2020,Q3,Elderly
181393941,18139394,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q3,Cerebral infarction,,2020,Q3,1,I,,20200807.0,20200812,20200812,EXP,GB-MHRA-EYC 00226685,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-040824",BOEHRINGER INGELHEIM,,87.0,YR,,M,Y,,,20200812.0,,HP,GB,GB,2020,Q3,Elderly
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Candida infection,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Candida sepsis,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Coagulation test abnormal,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Coagulopathy,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Emphysematous pyelonephritis,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Hypotension,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Oliguria,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Perinephric abscess,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Pyelonephritis fungal,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Septic shock,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Systemic candida,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Urinary tract infection enterococcal,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181423282,18142328,8,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,, UNKNOWN,,,,,,,2020,Q3,Vesicoureteric reflux,,2020,Q3,2,F,,20200914.0,20200813,20200916,EXP,,ES-ROCHE-2657950,ROCHE,"CASES?CORONA C, SHABAKA A, GONZALEZ?LOPEZ A, MARTIN?SEGARRA O, MORENO DE LA HIGUERA MA, LUCENA R, ET AL. FULMINANT EMPHYSEMATOUS PYELONEPHRITIS BY CANDIDA GLABRATA IN A KIDNEY ALLOGRAFT.. NEPHRON. 2020?144(6):304?309.",56.0,YR,,F,Y,,,20200916.0,,HP,ES,ES,2020,Q3,Adult
181425331,18142533,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, TWO TIMES A DAY",,,U,,,,,10.0,MG,TABLET,BID,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,,20200805.0,20200813,20200813,EXP,,DE-AUROBINDO-AUR-APL-2020-038641,AUROBINDO,,82.0,YR,,M,Y,,,20200813.0,,MD,DE,DE,2020,Q3,Elderly
181425331,18142533,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, TWO TIMES A DAY",,,U,,,,,10.0,MG,TABLET,BID,2020,Q3,Erythema,,2020,Q3,1,I,,20200805.0,20200813,20200813,EXP,,DE-AUROBINDO-AUR-APL-2020-038641,AUROBINDO,,82.0,YR,,M,Y,,,20200813.0,,MD,DE,DE,2020,Q3,Elderly
181425331,18142533,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, TWO TIMES A DAY",,,U,,,,,10.0,MG,TABLET,BID,2020,Q3,Hot flush,,2020,Q3,1,I,,20200805.0,20200813,20200813,EXP,,DE-AUROBINDO-AUR-APL-2020-038641,AUROBINDO,,82.0,YR,,M,Y,,,20200813.0,,MD,DE,DE,2020,Q3,Elderly
181436191,18143619,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2020,Q3,Monoparesis,,2020,Q3,1,I,20200805.0,20200806.0,20200813,20200813,EXP,,DE-ROCHE-2655728,ROCHE,,72.0,YR,,F,Y,63.0,KG,20200813.0,,MD,DE,DE,2020,Q3,Elderly
181479821,18147982,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, UNKNOWN (1?0?0?0)",,,,,,,,10.0,MG,TABLET,,2020,Q3,Fall,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008001583,ELI LILLY AND CO,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181479821,18147982,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, UNKNOWN (1?0?0?0)",,,,,,,,10.0,MG,TABLET,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008001583,ELI LILLY AND CO,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181479821,18147982,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, UNKNOWN (1?0?0?0)",,,,,,,,10.0,MG,TABLET,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008001583,ELI LILLY AND CO,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181479821,18147982,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, UNKNOWN (1?0?0?0)",,,,,,,,10.0,MG,TABLET,,2020,Q3,Wound,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008001583,ELI LILLY AND CO,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181507441,18150744,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q3,Fournier's gangrene,,2020,Q3,1,I,20200219.0,,20200814,20200814,DIR,,,FDA-CTU,,62.0,YR,,F,N,127.0,KG,20200814.0,N,PH,US,US,2020,Q3,Adult
181507441,18150744,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q3,Perirectal abscess,,2020,Q3,1,I,20200219.0,,20200814,20200814,DIR,,,FDA-CTU,,62.0,YR,,F,N,127.0,KG,20200814.0,N,PH,US,US,2020,Q3,Adult
181536911,18153691,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD (25 MG, 1?0?0?0)",,,U,,,,,25.0,MG,,QD,2020,Q3,Gangrene,,2020,Q3,1,I,,20200810.0,20200816,20200816,EXP,DE-ADRED-05117-01,NVSC2020DE222574,NOVARTIS,,83.0,YR,,M,Y,,,20200816.0,,HP,DE,DE,2020,Q3,Elderly
181536911,18153691,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD (25 MG, 1?0?0?0)",,,U,,,,,25.0,MG,,QD,2020,Q3,Peripheral arterial occlusive disease,,2020,Q3,1,I,,20200810.0,20200816,20200816,EXP,DE-ADRED-05117-01,NVSC2020DE222574,NOVARTIS,,83.0,YR,,M,Y,,,20200816.0,,HP,DE,DE,2020,Q3,Elderly
181536911,18153691,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD (25 MG, 1?0?0?0)",,,U,,,,,25.0,MG,,QD,2020,Q3,Wound,,2020,Q3,1,I,,20200810.0,20200816,20200816,EXP,DE-ADRED-05117-01,NVSC2020DE222574,NOVARTIS,,83.0,YR,,M,Y,,,20200816.0,,HP,DE,DE,2020,Q3,Elderly
181556771,18155677,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,25.0,MG,,QD,2020,Q3,Fungal sepsis,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,25.0,MG,,QD,2020,Q3,Hydroureter,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,25.0,MG,,QD,2020,Q3,Nephrotic syndrome,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,25.0,MG,,QD,2020,Q3,Pyelonephritis,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,25.0,MG,,QD,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,25.0,MG,,QD,2020,Q3,Urinary tract obstruction,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181557031,18155703,6,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Accidental overdose,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181557031,18155703,6,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Blood lactic acid increased,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181557031,18155703,6,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Blood pH decreased,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181557031,18155703,6,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181557031,18155703,6,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181563331,18156333,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,,,,QD,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,20200812.0,,20200815,20200815,DIR,,,FDA-CTU,,40.0,YR,,M,N,147.0,KG,20200815.0,N,PH,US,US,2020,Q3,Adult
181571041,18157104,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200814.0,,20200817,20200817,DIR,,,FDA-CTU,,41.0,YR,,M,N,90.7,KG,20200817.0,N,PH,US,US,2020,Q3,Adult
181571041,18157104,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,20200814.0,,20200817,20200817,DIR,,,FDA-CTU,,41.0,YR,,M,N,90.7,KG,20200817.0,N,PH,US,US,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Candida infection,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Candida sepsis,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Coagulation test abnormal,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Coagulopathy,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Emphysematous pyelonephritis,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Oliguria,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Perinephric abscess,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Pyelonephritis fungal,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Systemic candida,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Urinary tract infection enterococcal,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181612592,18161259,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q3,Vesicoureteric reflux,,2020,Q3,2,F,,20200824.0,20200818,20200908,EXP,,ES-VELOXIS PHARMACEUTICALS-2020VELES-000698,VELOXIS PHARMACEUTICALS,,56.0,YR,,F,Y,,,20200908.0,,MD,ES,ES,2020,Q3,Adult
181656111,18165611,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 2?0?0?0, TABLET",,,,,,,,10.0,MG,TABLET,,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,,20200813.0,20200818,20200818,EXP,,DE-FRESENIUS KABI-FK202008402,FRESENIUS KABI,,82.0,YR,,M,Y,,,20200818.0,,HP,NL,DE,2020,Q3,Elderly
181656111,18165611,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 2?0?0?0, TABLET",,,,,,,,10.0,MG,TABLET,,2020,Q3,Erythema,,2020,Q3,1,I,,20200813.0,20200818,20200818,EXP,,DE-FRESENIUS KABI-FK202008402,FRESENIUS KABI,,82.0,YR,,M,Y,,,20200818.0,,HP,NL,DE,2020,Q3,Elderly
181656111,18165611,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, 2?0?0?0, TABLET",,,,,,,,10.0,MG,TABLET,,2020,Q3,Hot flush,,2020,Q3,1,I,,20200813.0,20200818,20200818,EXP,,DE-FRESENIUS KABI-FK202008402,FRESENIUS KABI,,82.0,YR,,M,Y,,,20200818.0,,HP,NL,DE,2020,Q3,Elderly
181665181,18166518,2,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MG, 1?0?0?0",,,,, UNKNOWN,,,25.0,MG,,QD,2020,Q3,Gangrene,,2020,Q3,1,I,,20200811.0,20200819,20200819,EXP,,DE-DRREDDYS-GER/GER/20/0125986,DR REDDYS,,83.0,YR,E,M,Y,,,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181665181,18166518,2,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MG, 1?0?0?0",,,,, UNKNOWN,,,25.0,MG,,QD,2020,Q3,Peripheral arterial occlusive disease,,2020,Q3,1,I,,20200811.0,20200819,20200819,EXP,,DE-DRREDDYS-GER/GER/20/0125986,DR REDDYS,,83.0,YR,E,M,Y,,,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181665181,18166518,2,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MG, 1?0?0?0",,,,, UNKNOWN,,,25.0,MG,,QD,2020,Q3,Wound,,2020,Q3,1,I,,20200811.0,20200819,20200819,EXP,,DE-DRREDDYS-GER/GER/20/0125986,DR REDDYS,,83.0,YR,E,M,Y,,,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181703051,18170305,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1?0?0?0, TABLETTEN",,,,U,,,,10.0,MG,TABLET,,2020,Q3,Fall,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071317,MYLAN,,82.0,YR,,M,Y,133.4,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703051,18170305,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1?0?0?0, TABLETTEN",,,,U,,,,10.0,MG,TABLET,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071317,MYLAN,,82.0,YR,,M,Y,133.4,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703051,18170305,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1?0?0?0, TABLETTEN",,,,U,,,,10.0,MG,TABLET,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071317,MYLAN,,82.0,YR,,M,Y,133.4,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703051,18170305,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1?0?0?0, TABLETTEN",,,,U,,,,10.0,MG,TABLET,,2020,Q3,Wound,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071317,MYLAN,,82.0,YR,,M,Y,133.4,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181722311,18172231,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Malaise,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,10,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181730061,18173006,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,2020.0,20200513.0,20200819,20200819,EXP,,GB-MYLANLABS-2020M1049261,MYLAN,,62.0,YR,,M,Y,,,20200819.0,,MD,GB,GB,2020,Q3,Adult
181730061,18173006,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,2020.0,20200513.0,20200819,20200819,EXP,,GB-MYLANLABS-2020M1049261,MYLAN,,62.0,YR,,M,Y,,,20200819.0,,MD,GB,GB,2020,Q3,Adult
181730061,18173006,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q3,Oxygen saturation abnormal,,2020,Q3,1,I,2020.0,20200513.0,20200819,20200819,EXP,,GB-MYLANLABS-2020M1049261,MYLAN,,62.0,YR,,M,Y,,,20200819.0,,MD,GB,GB,2020,Q3,Adult
181730061,18173006,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q3,Pyrexia,,2020,Q3,1,I,2020.0,20200513.0,20200819,20200819,EXP,,GB-MYLANLABS-2020M1049261,MYLAN,,62.0,YR,,M,Y,,,20200819.0,,MD,GB,GB,2020,Q3,Adult
181730061,18173006,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q3,Urosepsis,,2020,Q3,1,I,2020.0,20200513.0,20200819,20200819,EXP,,GB-MYLANLABS-2020M1049261,MYLAN,,62.0,YR,,M,Y,,,20200819.0,,MD,GB,GB,2020,Q3,Adult
181733671,18173367,8,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 2?0?0?0",,,U,,,,,10.0,MG,TABLET,,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,DE-ADRED-05314-01,DE-TORRENT-00018171,TORRENT,,82.0,YR,E,M,Y,,,20200820.0,,MD,DE,DE,2020,Q3,Elderly
181733671,18173367,8,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 2?0?0?0",,,U,,,,,10.0,MG,TABLET,,2020,Q3,Erythema,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,DE-ADRED-05314-01,DE-TORRENT-00018171,TORRENT,,82.0,YR,E,M,Y,,,20200820.0,,MD,DE,DE,2020,Q3,Elderly
181733671,18173367,8,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 2?0?0?0",,,U,,,,,10.0,MG,TABLET,,2020,Q3,Hot flush,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,DE-ADRED-05314-01,DE-TORRENT-00018171,TORRENT,,82.0,YR,E,M,Y,,,20200820.0,,MD,DE,DE,2020,Q3,Elderly
181736191,18173619,9,C,Empagliflozin,EMPAGLIFLOZIN,1,,"2 DOSAGE FORMS DAILY; 10 MG, 2?0?0?0",,,,, UNKNOWN,,,2.0,DF,TABLET,QD,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,DE-TEVA-2020-DE-1815610,TEVA,,82.0,YR,E,M,Y,,,20200820.0,,MD,DE,DE,2020,Q3,Elderly
181736191,18173619,9,C,Empagliflozin,EMPAGLIFLOZIN,1,,"2 DOSAGE FORMS DAILY; 10 MG, 2?0?0?0",,,,, UNKNOWN,,,2.0,DF,TABLET,QD,2020,Q3,Erythema,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,DE-TEVA-2020-DE-1815610,TEVA,,82.0,YR,E,M,Y,,,20200820.0,,MD,DE,DE,2020,Q3,Elderly
181736191,18173619,9,C,Empagliflozin,EMPAGLIFLOZIN,1,,"2 DOSAGE FORMS DAILY; 10 MG, 2?0?0?0",,,,, UNKNOWN,,,2.0,DF,TABLET,QD,2020,Q3,Hot flush,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,DE-TEVA-2020-DE-1815610,TEVA,,82.0,YR,E,M,Y,,,20200820.0,,MD,DE,DE,2020,Q3,Elderly
181759471,18175947,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2020,Q3,Candida infection,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,,ES-PFIZER INC-2020308112,PFIZER,,56.0,YR,,F,Y,,,20200820.0,,MD,ES,ES,2020,Q3,Adult
181759471,18175947,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2020,Q3,Candida sepsis,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,,ES-PFIZER INC-2020308112,PFIZER,,56.0,YR,,F,Y,,,20200820.0,,MD,ES,ES,2020,Q3,Adult
181759471,18175947,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2020,Q3,Coagulation test abnormal,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,,ES-PFIZER INC-2020308112,PFIZER,,56.0,YR,,F,Y,,,20200820.0,,MD,ES,ES,2020,Q3,Adult
181759471,18175947,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2020,Q3,Emphysematous pyelonephritis,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,,ES-PFIZER INC-2020308112,PFIZER,,56.0,YR,,F,Y,,,20200820.0,,MD,ES,ES,2020,Q3,Adult
181759471,18175947,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2020,Q3,Perinephric abscess,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,,ES-PFIZER INC-2020308112,PFIZER,,56.0,YR,,F,Y,,,20200820.0,,MD,ES,ES,2020,Q3,Adult
181759471,18175947,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2020,Q3,Pyelonephritis fungal,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,,ES-PFIZER INC-2020308112,PFIZER,,56.0,YR,,F,Y,,,20200820.0,,MD,ES,ES,2020,Q3,Adult
181759471,18175947,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,,ES-PFIZER INC-2020308112,PFIZER,,56.0,YR,,F,Y,,,20200820.0,,MD,ES,ES,2020,Q3,Adult
181759471,18175947,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2020,Q3,Systemic candida,,2020,Q3,1,I,,20200810.0,20200820,20200820,EXP,,ES-PFIZER INC-2020308112,PFIZER,,56.0,YR,,F,Y,,,20200820.0,,MD,ES,ES,2020,Q3,Adult
181815111,18181511,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD, 1?0?0?0",,,,,,,,25.0,MG,,QD,2020,Q3,Gangrene,,2020,Q3,1,I,,20200812.0,20200821,20200821,EXP,,DE-MYLANLABS-2020M1071743,MYLAN,,83.0,YR,,M,Y,,,20200821.0,,MD,DE,DE,2020,Q3,Elderly
181815111,18181511,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD, 1?0?0?0",,,,,,,,25.0,MG,,QD,2020,Q3,Peripheral arterial occlusive disease,,2020,Q3,1,I,,20200812.0,20200821,20200821,EXP,,DE-MYLANLABS-2020M1071743,MYLAN,,83.0,YR,,M,Y,,,20200821.0,,MD,DE,DE,2020,Q3,Elderly
181815111,18181511,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD, 1?0?0?0",,,,,,,,25.0,MG,,QD,2020,Q3,Wound,,2020,Q3,1,I,,20200812.0,20200821,20200821,EXP,,DE-MYLANLABS-2020M1071743,MYLAN,,83.0,YR,,M,Y,,,20200821.0,,MD,DE,DE,2020,Q3,Elderly
181857091,18185709,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20190813.0,20200824,20200824,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-217926,RANBAXY,"HERNANDEZ?QUILES C, RAMIREZ?DUQUE N, ACOSTA?DELGADO D. KETOACIDOSIS DUE TO EMPAGLIFLOZIN, A PARADIGM SHIFT: CASE REPORT AND REVIEW OF LITERATURE. CURR DIABET REV. 2019?15(4):259?262",52.0,YR,,M,Y,70.0,KG,20200824.0,,HP,ES,ES,2020,Q3,Adult
181857091,18185709,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,,20190813.0,20200824,20200824,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-217926,RANBAXY,"HERNANDEZ?QUILES C, RAMIREZ?DUQUE N, ACOSTA?DELGADO D. KETOACIDOSIS DUE TO EMPAGLIFLOZIN, A PARADIGM SHIFT: CASE REPORT AND REVIEW OF LITERATURE. CURR DIABET REV. 2019?15(4):259?262",52.0,YR,,M,Y,70.0,KG,20200824.0,,HP,ES,ES,2020,Q3,Adult
181857091,18185709,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Leukocytosis,,2020,Q3,1,I,,20190813.0,20200824,20200824,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-217926,RANBAXY,"HERNANDEZ?QUILES C, RAMIREZ?DUQUE N, ACOSTA?DELGADO D. KETOACIDOSIS DUE TO EMPAGLIFLOZIN, A PARADIGM SHIFT: CASE REPORT AND REVIEW OF LITERATURE. CURR DIABET REV. 2019?15(4):259?262",52.0,YR,,M,Y,70.0,KG,20200824.0,,HP,ES,ES,2020,Q3,Adult
181857091,18185709,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Neutrophilia,,2020,Q3,1,I,,20190813.0,20200824,20200824,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-217926,RANBAXY,"HERNANDEZ?QUILES C, RAMIREZ?DUQUE N, ACOSTA?DELGADO D. KETOACIDOSIS DUE TO EMPAGLIFLOZIN, A PARADIGM SHIFT: CASE REPORT AND REVIEW OF LITERATURE. CURR DIABET REV. 2019?15(4):259?262",52.0,YR,,M,Y,70.0,KG,20200824.0,,HP,ES,ES,2020,Q3,Adult
181905591,18190559,5,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200818.0,20200825,20200825,EXP,,CA-TEVA-2020-CA-1817791,TEVA,,61.0,YR,A,F,Y,,,20200825.0,,HP,CA,CA,2020,Q3,Adult
181905591,18190559,5,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200818.0,20200825,20200825,EXP,,CA-TEVA-2020-CA-1817791,TEVA,,61.0,YR,A,F,Y,,,20200825.0,,HP,CA,CA,2020,Q3,Adult
181905591,18190559,5,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,,20200818.0,20200825,20200825,EXP,,CA-TEVA-2020-CA-1817791,TEVA,,61.0,YR,A,F,Y,,,20200825.0,,HP,CA,CA,2020,Q3,Adult
181905591,18190559,5,C,EMPAGLIFLOZIN;LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200818.0,20200825,20200825,EXP,,CA-TEVA-2020-CA-1817791,TEVA,,61.0,YR,A,F,Y,,,20200825.0,,HP,CA,CA,2020,Q3,Adult
181989501,18198950,2,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY; 1?0?0?0,,,,,,,,25.0,MG,,QD,2020,Q3,Gangrene,,2020,Q3,1,I,,20200823.0,20200826,20200826,EXP,,DE-TEVA-2020-DE-1819708,TEVA,,83.0,YR,E,M,Y,,,20200826.0,,MD,DE,DE,2020,Q3,Elderly
181989501,18198950,2,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY; 1?0?0?0,,,,,,,,25.0,MG,,QD,2020,Q3,Peripheral arterial occlusive disease,,2020,Q3,1,I,,20200823.0,20200826,20200826,EXP,,DE-TEVA-2020-DE-1819708,TEVA,,83.0,YR,E,M,Y,,,20200826.0,,MD,DE,DE,2020,Q3,Elderly
181989501,18198950,2,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY; 1?0?0?0,,,,,,,,25.0,MG,,QD,2020,Q3,Wound,,2020,Q3,1,I,,20200823.0,20200826,20200826,EXP,,DE-TEVA-2020-DE-1819708,TEVA,,83.0,YR,E,M,Y,,,20200826.0,,MD,DE,DE,2020,Q3,Elderly
181990751,18199075,11,C,LINAGLIPTIN/EMPAGLIFLOZIN,,2,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,11,C,LINAGLIPTIN/EMPAGLIFLOZIN,,2,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,11,C,LINAGLIPTIN/EMPAGLIFLOZIN,,2,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,11,C,LINAGLIPTIN/EMPAGLIFLOZIN,,2,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Malaise,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,11,C,LINAGLIPTIN/EMPAGLIFLOZIN,,2,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,11,C,LINAGLIPTIN/EMPAGLIFLOZIN,,2,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
182017541,18201754,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"1 DOSAGE FORM, DAILY",171.958,DF,,,,,,1.0,DF,,,2020,Q3,Blood lactic acid increased,,2020,Q3,1,I,20200427.0,20200814.0,20200827,20200827,EXP,GB-MHRA-ADR 24493331,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-001181,EMCURE,,54.0,YR,,M,Y,104.0,KG,20200827.0,,HP,GB,GB,2020,Q3,Adult
182017541,18201754,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"1 DOSAGE FORM, DAILY",171.958,DF,,,,,,1.0,DF,,,2020,Q3,Endocrine disorder,,2020,Q3,1,I,20200427.0,20200814.0,20200827,20200827,EXP,GB-MHRA-ADR 24493331,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-001181,EMCURE,,54.0,YR,,M,Y,104.0,KG,20200827.0,,HP,GB,GB,2020,Q3,Adult
182026771,18202677,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Osteoporotic fracture,,2020,Q3,1,I,20190515.0,20200819.0,20200827,20200827,EXP,,DE-ABBVIE-20K-062-3542835-00,ABBVIE,,84.0,YR,,F,Y,76.0,KG,20200827.0,,MD,DE,DE,2020,Q3,Elderly
182125461,18212546,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,,QD,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,,20200827.0,20200831,20200831,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-044437",BOEHRINGER INGELHEIM,"O^NEILL R, TYACK L, FREEMAN M, HUSSEIN H, EUGLYCEMIC KETOACIDOSIS IN A PATIENT WITH METASTATIC NON?SMALL?CELL LUNG ADENOCARCINOMA AND CONCOMITANT PULMONARY EMBOLISM. CASE REPORTS IN ENDOCRINOLOGY. 2020? 2020:",71.0,YR,E,M,Y,75.3,KG,20200830.0,,HP,AU,AU,2020,Q3,Elderly
182125461,18212546,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,,QD,2020,Q3,Pneumonia,,2020,Q3,1,I,,20200827.0,20200831,20200831,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-044437",BOEHRINGER INGELHEIM,"O^NEILL R, TYACK L, FREEMAN M, HUSSEIN H, EUGLYCEMIC KETOACIDOSIS IN A PATIENT WITH METASTATIC NON?SMALL?CELL LUNG ADENOCARCINOMA AND CONCOMITANT PULMONARY EMBOLISM. CASE REPORTS IN ENDOCRINOLOGY. 2020? 2020:",71.0,YR,E,M,Y,75.3,KG,20200830.0,,HP,AU,AU,2020,Q3,Elderly
182133801,18213380,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Fournier's gangrene,,2020,Q3,1,I,20200701.0,,20200831,20200831,DIR,,,FDA-CTU,,71.0,YR,,M,N,99.0,KG,20200812.0,N,PH,US,US,2020,Q3,Elderly
182133801,18213380,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Scrotal gangrene,,2020,Q3,1,I,20200701.0,,20200831,20200831,DIR,,,FDA-CTU,,71.0,YR,,M,N,99.0,KG,20200812.0,N,PH,US,US,2020,Q3,Elderly
182140031,18214003,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200616.0,,20200831,20200831,DIR,,,FDA-CTU,,78.0,YR,,M,N,99.79,KG,20200825.0,N,PH,US,US,2020,Q3,Elderly
182140031,18214003,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Dehydration,,2020,Q3,1,I,20200616.0,,20200831,20200831,DIR,,,FDA-CTU,,78.0,YR,,M,N,99.79,KG,20200825.0,N,PH,US,US,2020,Q3,Elderly
182140031,18214003,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Dizziness,,2020,Q3,1,I,20200616.0,,20200831,20200831,DIR,,,FDA-CTU,,78.0,YR,,M,N,99.79,KG,20200825.0,N,PH,US,US,2020,Q3,Elderly
182140031,18214003,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200616.0,,20200831,20200831,DIR,,,FDA-CTU,,78.0,YR,,M,N,99.79,KG,20200825.0,N,PH,US,US,2020,Q3,Elderly
182140031,18214003,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Hypotension,,2020,Q3,1,I,20200616.0,,20200831,20200831,DIR,,,FDA-CTU,,78.0,YR,,M,N,99.79,KG,20200825.0,N,PH,US,US,2020,Q3,Elderly
182140031,18214003,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Syncope,,2020,Q3,1,I,20200616.0,,20200831,20200831,DIR,,,FDA-CTU,,78.0,YR,,M,N,99.79,KG,20200825.0,N,PH,US,US,2020,Q3,Elderly
182140451,18214045,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,, 962255,20221031.0,,12.5,MG,,QD,2020,Q3,Diabetic ketosis,,2020,Q3,1,I,20200610.0,,20200831,20200831,DIR,,,FDA-CTU,,53.0,YR,,F,N,125.0,KG,20200829.0,N,PH,US,US,2020,Q3,Adult
182168621,18216862,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200825.0,20200901,20200901,EXP,000912710,CA-ACCORD-198289,ACCORD,,61.0,YR,,F,Y,,,20200901.0,,HP,CA,CA,2020,Q3,Adult
182168621,18216862,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200825.0,20200901,20200901,EXP,000912710,CA-ACCORD-198289,ACCORD,,61.0,YR,,F,Y,,,20200901.0,,HP,CA,CA,2020,Q3,Adult
182168621,18216862,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,,20200825.0,20200901,20200901,EXP,000912710,CA-ACCORD-198289,ACCORD,,61.0,YR,,F,Y,,,20200901.0,,HP,CA,CA,2020,Q3,Adult
182168621,18216862,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200825.0,20200901,20200901,EXP,000912710,CA-ACCORD-198289,ACCORD,,61.0,YR,,F,Y,,,20200901.0,,HP,CA,CA,2020,Q3,Adult
182173451,18217345,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200624.0,,20200831,20200831,DIR,,,FDA-CTU,,55.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Adult
182180161,18218016,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q3,Abdominal pain,,2020,Q3,1,I,20200401.0,,20200901,20200901,DIR,,,FDA-CTU,,31.0,YR,,M,N,91.0,KG,20200819.0,N,PH,US,US,2020,Q3,Young Adult
182180161,18218016,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q3,Chest pain,,2020,Q3,1,I,20200401.0,,20200901,20200901,DIR,,,FDA-CTU,,31.0,YR,,M,N,91.0,KG,20200819.0,N,PH,US,US,2020,Q3,Young Adult
182182201,18218220,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Dysuria,,2020,Q3,1,I,20200529.0,,20200831,20200831,DIR,,,FDA-CTU,,74.0,YR,,F,N,96.62,KG,20200718.0,N,PH,US,US,2020,Q3,Elderly
182182201,18218220,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,12.5,MG,,QD,2020,Q3,Vulvovaginal candidiasis,,2020,Q3,1,I,20200529.0,,20200831,20200831,DIR,,,FDA-CTU,,74.0,YR,,F,N,96.62,KG,20200718.0,N,PH,US,US,2020,Q3,Elderly
182183231,18218323,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,12.5,MG,,,2020,Q3,Penile pain,,2020,Q3,1,I,20200407.0,,20200831,20200831,DIR,,,FDA-CTU,,66.0,YR,,M,N,117.03,KG,20200626.0,N,PH,US,US,2020,Q3,Elderly
182183231,18218323,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,12.5,MG,,,2020,Q3,Urinary incontinence,,2020,Q3,1,I,20200407.0,,20200831,20200831,DIR,,,FDA-CTU,,66.0,YR,,M,N,117.03,KG,20200626.0,N,PH,US,US,2020,Q3,Elderly
182183231,18218323,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,12.5,MG,,,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20200407.0,,20200831,20200831,DIR,,,FDA-CTU,,66.0,YR,,M,N,117.03,KG,20200626.0,N,PH,US,US,2020,Q3,Elderly
182184111,18218411,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,12.5,MG,TABLET,,2020,Q3,Rash,,2020,Q3,1,I,20200529.0,,20200831,20200831,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200626.0,N,PH,US,US,2020,Q3,Adult
182185531,18218553,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,,,,,12.5,MG,,,2020,Q3,Genital infection fungal,,2020,Q3,1,I,20200607.0,,20200831,20200831,DIR,,,FDA-CTU,,66.0,YR,,M,N,93.0,KG,20200610.0,N,,US,US,2020,Q3,Elderly
182185531,18218553,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,,,,,12.5,MG,,,2020,Q3,Rash,,2020,Q3,1,I,20200607.0,,20200831,20200831,DIR,,,FDA-CTU,,66.0,YR,,M,N,93.0,KG,20200610.0,N,,US,US,2020,Q3,Elderly
182222181,18222218,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,1,I,20200608.0,,20200902,20200902,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182222741,18222274,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20200601.0,,20200902,20200902,DIR,,,FDA-CTU,,82.0,YR,,M,N,114.0,KG,20200819.0,N,PH,US,US,2020,Q3,Elderly
182224921,18222492,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200902.0,,20200902,20200902,DIR,,,FDA-CTU,,57.0,YR,,F,N,74.84,KG,20200902.0,N,MD,US,US,2020,Q3,Adult
182226261,18222626,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Migraine,,2020,Q3,1,I,20200622.0,,20200902,20200902,DIR,,,FDA-CTU,,49.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Adult
182226671,18222667,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Penile discomfort,,2020,Q3,1,I,20200615.0,,20200902,20200902,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182261531,18226153,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Penile discomfort,,2020,Q3,1,I,20200603.0,,20200902,20200902,DIR,,,FDA-CTU,,70.0,YR,,M,N,118.0,KG,20200819.0,N,PH,US,US,2020,Q3,Elderly
182261531,18226153,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Phimosis,,2020,Q3,1,I,20200603.0,,20200902,20200902,DIR,,,FDA-CTU,,70.0,YR,,M,N,118.0,KG,20200819.0,N,PH,US,US,2020,Q3,Elderly
182262001,18226200,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,N,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200616.0,,20200902,20200902,DIR,,,FDA-CTU,,66.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182262071,18226207,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,D,,,,12.5,MG,,,2020,Q3,Pollakiuria,,2020,Q3,1,I,20200603.0,,20200902,20200902,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182262421,18226242,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,N,,,,12.5,MG,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200618.0,,20200902,20200902,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182262421,18226242,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,Y,N,,,,12.5,MG,,,2020,Q3,Renal impairment,,2020,Q3,1,I,20200618.0,,20200902,20200902,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182264981,18226498,4,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,U,,,204629.0,10.0,MG,,QD,2020,Q3,Fournier's gangrene,,2020,Q3,1,I,,20200901.0,20200903,20200903,EXP,GB-MHRA-EYC 00227546,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-044831",BOEHRINGER INGELHEIM,,45.0,YR,A,M,Y,117.0,KG,20200820.0,,MD,GB,GB,2020,Q3,Adult
182324831,18232483,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,25.0,MG,,,2020,Q3,Nausea,,2020,Q3,1,I,20200623.0,,20200904,20200904,DIR,,,FDA-CTU,,65.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182324831,18232483,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,25.0,MG,,,2020,Q3,Vomiting,,2020,Q3,1,I,20200623.0,,20200904,20200904,DIR,,,FDA-CTU,,65.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182324831,18232483,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,20200623.0,,20200904,20200904,DIR,,,FDA-CTU,,65.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182324831,18232483,2,SS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,20200623.0,,20200904,20200904,DIR,,,FDA-CTU,,65.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182325571,18232557,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20200614.0,,20200904,20200904,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182325851,18232585,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Blood creatine increased,,2020,Q3,1,I,20200624.0,,20200904,20200904,DIR,,,FDA-CTU,,70.0,YR,,M,N,172.0,KG,20200819.0,N,PH,US,US,2020,Q3,Elderly
182325851,18232585,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Blood urea increased,,2020,Q3,1,I,20200624.0,,20200904,20200904,DIR,,,FDA-CTU,,70.0,YR,,M,N,172.0,KG,20200819.0,N,PH,US,US,2020,Q3,Elderly
182325851,18232585,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Renal impairment,,2020,Q3,1,I,20200624.0,,20200904,20200904,DIR,,,FDA-CTU,,70.0,YR,,M,N,172.0,KG,20200819.0,N,PH,US,US,2020,Q3,Elderly
182325901,18232590,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q3,Dizziness,,2020,Q3,1,I,20200630.0,,20200904,20200904,DIR,,,FDA-CTU,,50.0,YR,,M,N,99.0,KG,20200819.0,N,PH,US,US,2020,Q3,Adult
182325901,18232590,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q3,Dry mouth,,2020,Q3,1,I,20200630.0,,20200904,20200904,DIR,,,FDA-CTU,,50.0,YR,,M,N,99.0,KG,20200819.0,N,PH,US,US,2020,Q3,Adult
182325901,18232590,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q3,Pollakiuria,,2020,Q3,1,I,20200630.0,,20200904,20200904,DIR,,,FDA-CTU,,50.0,YR,,M,N,99.0,KG,20200819.0,N,PH,US,US,2020,Q3,Adult
182333472,18233347,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Malaise,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Product dose omission issue,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182499231,18249923,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,,QD,2020,Q3,Transient ischaemic attack,,2020,Q3,1,I,202004.0,20200508.0,20200909,20200909,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0314,BIODELIVERY SCIENCES INTERNATIONAL,,68.0,YR,E,F,Y,95.79,KG,20200909.0,,CN,US,US,2020,Q3,Elderly
182595661,18259566,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U,,,204629.0,25.0,MG,,QD,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,20200818.0,20200902.0,20200912,20200912,EXP,GB-MHRA-EYC 00228006,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-045089",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,100.0,KG,20200827.0,,HP,GB,GB,2020,Q3,Adult
182613011,18261301,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Diabetic foot,,2020,Q3,1,I,,20200902.0,20200914,20200914,EXP,,AE-ELI_LILLY_AND_COMPANY-AE202009002164,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20200914.0,,MD,AE,AE,2020,Q3,Adult
182613011,18261301,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200902.0,20200914,20200914,EXP,,AE-ELI_LILLY_AND_COMPANY-AE202009002164,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20200914.0,,MD,AE,AE,2020,Q3,Adult
182722351,18272235,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q3,Liver injury,,2020,Q3,1,I,,20200804.0,20200916,20200916,EXP,,AU-MYLANLABS-2020M1079044,MYLAN,ARMSTRONG G. EMPAGLIFLOZIN?MEDIATED LITHIUM EXCRETIONA CASE STUDY AND CLINICAL APPLICATIONS. AMERICAN JOURNAL OF CASE REPORTS. 2020?21,29.0,YR,,M,Y,,,20200916.0,,HP,AU,AU,2020,Q3,Young Adult
182739181,18273918,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,,20200902.0,20200916,20200916,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK049534,GLENMARK,"STEINMETZ?WOOD S, GILBERT M, MENSON K.. A CASE OF DIABETIC KETOACIDOSIS IN A PATIENT ON AN SGLT2 INHIBITOR AND A KETOGENIC DIET: A CRITICAL TRIO NOT TO BE MISSED.. CASE REPORTS IN ENDOCRINOLOGY.. 2020?2",47.0,YR,,M,Y,,,20200916.0,,HP,US,US,2020,Q3,Adult
182755491,18275549,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Blood pressure increased,,2020,Q3,1,I,2019.0,20200610.0,20200916,20200916,EXP,,CO-JNJFOC-20200618283,JOHNSON AND JOHNSON,,78.0,YR,E,F,Y,72.0,KG,20200916.0,,HP,CO,CO,2020,Q3,Elderly
182755491,18275549,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Chest pain,,2020,Q3,1,I,2019.0,20200610.0,20200916,20200916,EXP,,CO-JNJFOC-20200618283,JOHNSON AND JOHNSON,,78.0,YR,E,F,Y,72.0,KG,20200916.0,,HP,CO,CO,2020,Q3,Elderly
182755491,18275549,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Pain in extremity,,2020,Q3,1,I,2019.0,20200610.0,20200916,20200916,EXP,,CO-JNJFOC-20200618283,JOHNSON AND JOHNSON,,78.0,YR,E,F,Y,72.0,KG,20200916.0,,HP,CO,CO,2020,Q3,Elderly
182755491,18275549,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,2019.0,20200610.0,20200916,20200916,EXP,,CO-JNJFOC-20200618283,JOHNSON AND JOHNSON,,78.0,YR,E,F,Y,72.0,KG,20200916.0,,HP,CO,CO,2020,Q3,Elderly
182755491,18275549,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Productive cough,,2020,Q3,1,I,2019.0,20200610.0,20200916,20200916,EXP,,CO-JNJFOC-20200618283,JOHNSON AND JOHNSON,,78.0,YR,E,F,Y,72.0,KG,20200916.0,,HP,CO,CO,2020,Q3,Elderly
182755491,18275549,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Rheumatoid arthritis,,2020,Q3,1,I,2019.0,20200610.0,20200916,20200916,EXP,,CO-JNJFOC-20200618283,JOHNSON AND JOHNSON,,78.0,YR,E,F,Y,72.0,KG,20200916.0,,HP,CO,CO,2020,Q3,Elderly
182755491,18275549,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,1,I,2019.0,20200610.0,20200916,20200916,EXP,,CO-JNJFOC-20200618283,JOHNSON AND JOHNSON,,78.0,YR,E,F,Y,72.0,KG,20200916.0,,HP,CO,CO,2020,Q3,Elderly
182784551,18278455,4,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200522.0,20200917,20200917,PER,,JP-LUPIN PHARMACEUTICALS INC.-2020-02460,LUPIN,"MIYAUCHI T. VALPROATE INTOXICATION IN A PATIENT WITH BIPOLAR I DISORDER DUE TO SGLT2 INHIBITOR?INDUCED WEIGHT REDUCTION. DARU, JOURNAL OF PHARMACEUTICAL SCIENCES. 2020?28(1):419?421",67.0,YR,,M,Y,,,20200917.0,,HP,JP,JP,2020,Q3,Elderly
182784551,18278455,4,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2020,Q3,Overdose,,2020,Q3,1,I,,20200522.0,20200917,20200917,PER,,JP-LUPIN PHARMACEUTICALS INC.-2020-02460,LUPIN,"MIYAUCHI T. VALPROATE INTOXICATION IN A PATIENT WITH BIPOLAR I DISORDER DUE TO SGLT2 INHIBITOR?INDUCED WEIGHT REDUCTION. DARU, JOURNAL OF PHARMACEUTICAL SCIENCES. 2020?28(1):419?421",67.0,YR,,M,Y,,,20200917.0,,HP,JP,JP,2020,Q3,Elderly
182784551,18278455,4,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2020,Q3,Toxicity to various agents,,2020,Q3,1,I,,20200522.0,20200917,20200917,PER,,JP-LUPIN PHARMACEUTICALS INC.-2020-02460,LUPIN,"MIYAUCHI T. VALPROATE INTOXICATION IN A PATIENT WITH BIPOLAR I DISORDER DUE TO SGLT2 INHIBITOR?INDUCED WEIGHT REDUCTION. DARU, JOURNAL OF PHARMACEUTICAL SCIENCES. 2020?28(1):419?421",67.0,YR,,M,Y,,,20200917.0,,HP,JP,JP,2020,Q3,Elderly
182784551,18278455,4,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2020,Q3,Tremor,,2020,Q3,1,I,,20200522.0,20200917,20200917,PER,,JP-LUPIN PHARMACEUTICALS INC.-2020-02460,LUPIN,"MIYAUCHI T. VALPROATE INTOXICATION IN A PATIENT WITH BIPOLAR I DISORDER DUE TO SGLT2 INHIBITOR?INDUCED WEIGHT REDUCTION. DARU, JOURNAL OF PHARMACEUTICAL SCIENCES. 2020?28(1):419?421",67.0,YR,,M,Y,,,20200917.0,,HP,JP,JP,2020,Q3,Elderly
182784551,18278455,4,I,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200522.0,20200917,20200917,PER,,JP-LUPIN PHARMACEUTICALS INC.-2020-02460,LUPIN,"MIYAUCHI T. VALPROATE INTOXICATION IN A PATIENT WITH BIPOLAR I DISORDER DUE TO SGLT2 INHIBITOR?INDUCED WEIGHT REDUCTION. DARU, JOURNAL OF PHARMACEUTICAL SCIENCES. 2020?28(1):419?421",67.0,YR,,M,Y,,,20200917.0,,HP,JP,JP,2020,Q3,Elderly
182814571,18281457,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,20200914.0,,20200917,20200917,DIR,,,FDA-CTU,,41.0,YR,,F,N,101.9,KG,20200917.0,N,MD,US,US,2020,Q3,Adult
182842911,18284291,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Chills,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,CA-ASTRAZENECA-2020SF17007,ASTRAZENECA,,66.0,YR,,M,Y,,,20200918.0,,HP,CA,CA,2020,Q3,Elderly
182842911,18284291,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,CA-ASTRAZENECA-2020SF17007,ASTRAZENECA,,66.0,YR,,M,Y,,,20200918.0,,HP,CA,CA,2020,Q3,Elderly
182842911,18284291,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,CA-ASTRAZENECA-2020SF17007,ASTRAZENECA,,66.0,YR,,M,Y,,,20200918.0,,HP,CA,CA,2020,Q3,Elderly
182882311,18288231,11,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Renal failure,,2020,Q3,1,I,20200904.0,20200912.0,20200921,20200921,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-048159",BOEHRINGER INGELHEIM,,84.0,YR,E,F,Y,63.0,KG,20200921.0,,MD,BR,BR,2020,Q3,Elderly
182932731,18293273,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM (25 MG, 1?0?0?0, TABLETS)",,,,,,,,25.0,MG,TABLET,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200915.0,20200922,20200922,EXP,,DE-AUROBINDO-AUR-APL-2020-048565,AUROBINDO,,60.0,YR,,M,Y,97.0,KG,20200922.0,,PH,DE,DE,2020,Q3,Adult
182932731,18293273,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM (25 MG, 1?0?0?0, TABLETS)",,,,,,,,25.0,MG,TABLET,,2020,Q3,Cough,,2020,Q3,1,I,,20200915.0,20200922,20200922,EXP,,DE-AUROBINDO-AUR-APL-2020-048565,AUROBINDO,,60.0,YR,,M,Y,97.0,KG,20200922.0,,PH,DE,DE,2020,Q3,Adult
182932731,18293273,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM (25 MG, 1?0?0?0, TABLETS)",,,,,,,,25.0,MG,TABLET,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200915.0,20200922,20200922,EXP,,DE-AUROBINDO-AUR-APL-2020-048565,AUROBINDO,,60.0,YR,,M,Y,97.0,KG,20200922.0,,PH,DE,DE,2020,Q3,Adult
183003391,18300339,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,TABLET,,,Y,U, 030465,,204629.0,10.0,MG,,QD,2020,Q3,Eye swelling,,2020,Q3,1,I,20200816.0,20200914.0,20200923,20200923,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-048229",BOEHRINGER INGELHEIM,,50.0,YR,A,M,Y,72.0,KG,20200923.0,,CN,US,US,2020,Q3,Adult
183003391,18300339,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,TABLET,,,Y,U, 030465,,204629.0,10.0,MG,,QD,2020,Q3,Polyuria,,2020,Q3,1,I,20200816.0,20200914.0,20200923,20200923,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-048229",BOEHRINGER INGELHEIM,,50.0,YR,A,M,Y,72.0,KG,20200923.0,,CN,US,US,2020,Q3,Adult
183005091,18300509,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q3,Angioedema,,2020,Q3,1,I,20200803.0,,20200923,20200923,DIR,,,FDA-CTU,,60.0,YR,,F,N,78.0,KG,20200914.0,N,PH,US,US,2020,Q3,Adult
183005091,18300509,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q3,Dysuria,,2020,Q3,1,I,20200803.0,,20200923,20200923,DIR,,,FDA-CTU,,60.0,YR,,F,N,78.0,KG,20200914.0,N,PH,US,US,2020,Q3,Adult
183005391,18300539,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N,,,,12.5,MG,,QD,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200727.0,,20200923,20200923,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20200917.0,N,PH,US,US,2020,Q3,Adult
183005391,18300539,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N,,,,12.5,MG,,QD,2020,Q3,Chills,,2020,Q3,1,I,20200727.0,,20200923,20200923,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20200917.0,N,PH,US,US,2020,Q3,Adult
183005391,18300539,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N,,,,12.5,MG,,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,20200727.0,,20200923,20200923,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20200917.0,N,PH,US,US,2020,Q3,Adult
183005391,18300539,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,N,,,,12.5,MG,,QD,2020,Q3,Weight decreased,,2020,Q3,1,I,20200727.0,,20200923,20200923,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20200917.0,N,PH,US,US,2020,Q3,Adult
183006881,18300688,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,OTHER,,,Y,D,,,,12.5,MG,,QD,2020,Q3,Genital infection fungal,,2020,Q3,1,I,20200917.0,,20200923,20200923,DIR,,,FDA-CTU,,74.0,YR,,M,N,198.0,KG,20200922.0,N,PH,US,US,2020,Q3,Elderly
183020031,18302003,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,TABLET,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200918.0,20200923,20200923,EXP,,DE-EMD SERONO-E2B_90080378,EMD SERONO INC,,60.0,YR,A,M,Y,97.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Adult
183020031,18302003,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,TABLET,QD,2020,Q3,Cough,,2020,Q3,1,I,,20200918.0,20200923,20200923,EXP,,DE-EMD SERONO-E2B_90080378,EMD SERONO INC,,60.0,YR,A,M,Y,97.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Adult
183020031,18302003,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,25.0,MG,TABLET,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200918.0,20200923,20200923,EXP,,DE-EMD SERONO-E2B_90080378,EMD SERONO INC,,60.0,YR,A,M,Y,97.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Adult
183048181,18304818,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,125 MG AM PO,,,D,D,,,,12.5,MG,,,2020,Q3,Rash,,2020,Q3,1,I,20200801.0,,20200923,20200923,DIR,,,FDA-CTU,,71.0,YR,,M,N,122.0,KG,20200901.0,N,PH,US,US,2020,Q3,Elderly
183053701,18305370,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,N,D,,,,12.5,MG,,,2020,Q3,Genital rash,,2020,Q3,1,I,20200505.0,,20200923,20200923,DIR,,,FDA-CTU,,64.0,YR,,M,N,97.0,KG,20200821.0,N,PH,US,US,2020,Q3,Adult
183057941,18305794,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,20200915.0,,20200923,20200923,DIR,,,FDA-CTU,,59.0,YR,,F,N,70.0,KG,20200923.0,N,PH,US,US,2020,Q3,Adult
183057941,18305794,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q3,Nausea,,2020,Q3,1,I,20200915.0,,20200923,20200923,DIR,,,FDA-CTU,,59.0,YR,,F,N,70.0,KG,20200923.0,N,PH,US,US,2020,Q3,Adult
183057941,18305794,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q3,Vomiting,,2020,Q3,1,I,20200915.0,,20200923,20200923,DIR,,,FDA-CTU,,59.0,YR,,F,N,70.0,KG,20200923.0,N,PH,US,US,2020,Q3,Adult
183065061,18306506,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,, 962417,20221031,,12.5,MG,,QD,2020,Q3,Hypotension,,2020,Q3,1,I,20200820.0,,20200923,20200923,DIR,,,FDA-CTU,,59.0,YR,,M,N,151.05,KG,20200904.0,N,PH,US,US,2020,Q3,Adult
183065061,18306506,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,, 962417,20221031,,12.5,MG,,QD,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20200820.0,,20200923,20200923,DIR,,,FDA-CTU,,59.0,YR,,M,N,151.05,KG,20200904.0,N,PH,US,US,2020,Q3,Adult
183065191,18306519,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,D,, C16081,20230228,,12.5,MG,TABLET,QD,2020,Q3,Amputation,,2020,Q3,1,I,20200828.0,,20200923,20200923,DIR,,,FDA-CTU,,55.0,YR,,M,N,90.72,KG,20200904.0,N,PH,US,US,2020,Q3,Adult
183067871,18306787,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD  (1?0?0?0)",,,U,,,,,25.0,MG,TABLET,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200917.0,20200924,20200924,EXP,,NVSC2020DE254574,NOVARTIS,,60.0,YR,,M,Y,97.0,KG,20200924.0,,HP,DE,DE,2020,Q3,Adult
183067871,18306787,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD  (1?0?0?0)",,,U,,,,,25.0,MG,TABLET,QD,2020,Q3,Cough,,2020,Q3,1,I,,20200917.0,20200924,20200924,EXP,,NVSC2020DE254574,NOVARTIS,,60.0,YR,,M,Y,97.0,KG,20200924.0,,HP,DE,DE,2020,Q3,Adult
183067871,18306787,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD  (1?0?0?0)",,,U,,,,,25.0,MG,TABLET,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200917.0,20200924,20200924,EXP,,NVSC2020DE254574,NOVARTIS,,60.0,YR,,M,Y,97.0,KG,20200924.0,,HP,DE,DE,2020,Q3,Adult
183080901,18308090,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, 1?0?0?0, TABLET",,,,,,,,25.0,MG,TABLET,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200917.0,20200924,20200924,EXP,DE-ADRED-05421-01,DE-BAUSCH-BL-2020-027072,BAUSCH AND LOMB,,60.0,YR,,M,Y,97.0,KG,20200924.0,,PH,DE,DE,2020,Q3,Adult
183080901,18308090,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, 1?0?0?0, TABLET",,,,,,,,25.0,MG,TABLET,QD,2020,Q3,Cough,,2020,Q3,1,I,,20200917.0,20200924,20200924,EXP,DE-ADRED-05421-01,DE-BAUSCH-BL-2020-027072,BAUSCH AND LOMB,,60.0,YR,,M,Y,97.0,KG,20200924.0,,PH,DE,DE,2020,Q3,Adult
183080901,18308090,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, 1?0?0?0, TABLET",,,,,,,,25.0,MG,TABLET,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200917.0,20200924,20200924,EXP,DE-ADRED-05421-01,DE-BAUSCH-BL-2020-027072,BAUSCH AND LOMB,,60.0,YR,,M,Y,97.0,KG,20200924.0,,PH,DE,DE,2020,Q3,Adult
183108061,18310806,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U,,,204629.0,,,FILM-COATED TABLET,,2020,Q3,Emphysema,,2020,Q3,1,I,20200420.0,20200827.0,20200925,20200925,PER,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-045153",BOEHRINGER INGELHEIM,,68.0,YR,E,,Y,,,20200925.0,,MD,CN,CN,2020,Q3,Elderly
183117901,18311790,1,PS,EMPAGLIFLOZIN/ METFORMIN (EMPAGLIFLOZIN 12.5MG/ METFORMIN 1000MG 24HR,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,D,D,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,20200713.0,,20200924,20200924,DIR,,,FDA-CTU,,55.0,YR,,M,N,,,20200811.0,N,PH,US,US,2020,Q3,Adult
183117901,18311790,1,PS,EMPAGLIFLOZIN/ METFORMIN (EMPAGLIFLOZIN 12.5MG/ METFORMIN 1000MG 24HR,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,D,D,,,,,,,,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,20200713.0,,20200924,20200924,DIR,,,FDA-CTU,,55.0,YR,,M,N,,,20200811.0,N,PH,US,US,2020,Q3,Adult
183118971,18311897,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,LINAGLIPTIN,,,,,,,,,,UNSPECIFIED,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,LINAGLIPTIN,,,,,,,,,,UNSPECIFIED,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,LINAGLIPTIN,,,,,,,,,,UNSPECIFIED,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,LINAGLIPTIN,,,,,,,,,,UNSPECIFIED,,2020,Q3,Malaise,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,LINAGLIPTIN,,,,,,,,,,UNSPECIFIED,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,LINAGLIPTIN,,,,,,,,,,UNSPECIFIED,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183138431,18313843,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG QD,,,U,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200922.0,20200925,20200925,EXP,,DE-ANIPHARMA-2020-DE-000215,ANI,,60.0,YR,,M,Y,97.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Adult
183138431,18313843,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG QD,,,U,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200922.0,20200925,20200925,EXP,,DE-ANIPHARMA-2020-DE-000215,ANI,,60.0,YR,,M,Y,97.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Adult
183138431,18313843,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,25 MG QD,,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200922.0,20200925,20200925,EXP,,DE-ANIPHARMA-2020-DE-000215,ANI,,60.0,YR,,M,Y,97.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Adult
183145981,18314598,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q3,Product use in unapproved indication,,2020,Q3,1,I,20191008.0,20191011.0,20200926,20200926,PER,,US-ALVOGEN-2020-ALVOGEN-113354,ALVOGEN,,68.0,YR,,M,Y,,,20200926.0,,MD,US,US,2020,Q3,Elderly
183145981,18314598,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q3,Rash,,2020,Q3,1,I,20191008.0,20191011.0,20200926,20200926,PER,,US-ALVOGEN-2020-ALVOGEN-113354,ALVOGEN,,68.0,YR,,M,Y,,,20200926.0,,MD,US,US,2020,Q3,Elderly
183278161,18327816,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",3670.0,MG,U,U,,,,10.0,MG,,QD,2020,Q3,Hyperhidrosis,,2020,Q3,1,I,20200821.0,20200923.0,20200930,20200930,EXP,,IT-AUROBINDO-AUR-APL-2020-049812,AUROBINDO,,70.0,YR,,M,Y,,,20200930.0,,MD,IT,IT,2020,Q3,Elderly
183278161,18327816,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",3670.0,MG,U,U,,,,10.0,MG,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200821.0,20200923.0,20200930,20200930,EXP,,IT-AUROBINDO-AUR-APL-2020-049812,AUROBINDO,,70.0,YR,,M,Y,,,20200930.0,,MD,IT,IT,2020,Q3,Elderly
183278161,18327816,2,SS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",3670.0,MG,U,U,,,,10.0,MG,,QD,2020,Q3,Sopor,,2020,Q3,1,I,20200821.0,20200923.0,20200930,20200930,EXP,,IT-AUROBINDO-AUR-APL-2020-049812,AUROBINDO,,70.0,YR,,M,Y,,,20200930.0,,MD,IT,IT,2020,Q3,Elderly
183302181,18330218,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD",3670.0,MG,U,U,,,,10.0,MG,,QD,2020,Q3,Hyperhidrosis,,2020,Q3,1,I,20200821.0,20200925.0,20200930,20200930,EXP,IT-MINISAL02-635292,NVSC2020IT263125,NOVARTIS,,70.0,YR,,M,Y,,,20200930.0,,HP,IT,IT,2020,Q3,Elderly
183302181,18330218,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD",3670.0,MG,U,U,,,,10.0,MG,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200821.0,20200925.0,20200930,20200930,EXP,IT-MINISAL02-635292,NVSC2020IT263125,NOVARTIS,,70.0,YR,,M,Y,,,20200930.0,,HP,IT,IT,2020,Q3,Elderly
183302181,18330218,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD",3670.0,MG,U,U,,,,10.0,MG,,QD,2020,Q3,Sopor,,2020,Q3,1,I,20200821.0,20200925.0,20200930,20200930,EXP,IT-MINISAL02-635292,NVSC2020IT263125,NOVARTIS,,70.0,YR,,M,Y,,,20200930.0,,HP,IT,IT,2020,Q3,Elderly
183390481,18339048,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,OTHER FREQUENCY:AM;?,,,Y,D,,,,25.0,MG,,,2020,Q3,Acquired phimosis,,2020,Q3,1,I,20200901.0,,20200930,20200930,DIR,,,FDA-CTU,,75.0,YR,,M,N,86.0,KG,20200923.0,N,PH,US,US,2020,Q3,Elderly
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Abdominal pain upper,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Blood pressure systolic increased,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Blood prolactin abnormal,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Brain neoplasm,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Diabetes mellitus,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Fatigue,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Food allergy,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Heart rate decreased,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Hormone level abnormal,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Injection site pain,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Memory impairment,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Nausea,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Needle issue,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
911685110,9116851,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 OT,,,U,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,10,F,201302.0,20200820.0,20130225,20200828,EXP,,PHHY2013CA010870,NOVARTIS,,53.0,YR,,M,Y,,,20200828.0,,PH,CA,CA,2020,Q3,Adult
140476854,14047685,3,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204629.0,10.0,MG,TABLET,,2020,Q4,Urine ketone body present,,2020,Q4,4,F,20170214.0,20201102.0,20171005,20201110,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-005642",BOEHRINGER INGELHEIM,,35.0,YR,A,F,Y,90.5,KG,20201110.0,,MD,JP,JP,2020,Q4,Adult
140476854,14047685,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204629.0,10.0,MG,TABLET,QD,2020,Q4,Urine ketone body present,,2020,Q4,4,F,20170214.0,20201102.0,20171005,20201110,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-005642",BOEHRINGER INGELHEIM,,35.0,YR,A,F,Y,90.5,KG,20201110.0,,MD,JP,JP,2020,Q4,Adult
150667694,15066769,4,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,10.0,MG,TABLET,QD,2020,Q4,Loss of consciousness,,2020,Q4,4,F,20180228.0,20201112.0,20180626,20201119,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-003161",BOEHRINGER INGELHEIM,,63.0,YR,A,M,Y,94.2,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1524040411,15240404,14,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,10.0,MG,,,2020,Q4,Hypotension,,2020,Q4,11,F,20180723.0,20201020.0,20180804,20201028,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-038855",BOEHRINGER INGELHEIM,,88.0,YR,E,,Y,73.0,KG,20201028.0,,MD,CA,CA,2020,Q4,Elderly
155722448,15572244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNK",,,D,,,,,10.0,MG,,,2020,Q4,Acute myocardial infarction,,2020,Q4,8,F,200508.0,20201012.0,20181031,20201016,EXP,,SK-MYLANLABS-2018M1081194,MYLAN,POLKO J.. GLYCEMIA COMPENSATION IN A PATIENT WITH TYPE 2. DIABETES MELLITUS AND CARDIAL PRIMORBIDITY. INTERNA MEDICINA. 2018;52:10-11,66.0,YR,,M,Y,,,20201016.0,,MD,SK,SK,2020,Q4,Elderly
155722448,15572244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNK",,,D,,,,,10.0,MG,,,2020,Q4,Diabetes mellitus,,2020,Q4,8,F,200508.0,20201012.0,20181031,20201016,EXP,,SK-MYLANLABS-2018M1081194,MYLAN,POLKO J.. GLYCEMIA COMPENSATION IN A PATIENT WITH TYPE 2. DIABETES MELLITUS AND CARDIAL PRIMORBIDITY. INTERNA MEDICINA. 2018;52:10-11,66.0,YR,,M,Y,,,20201016.0,,MD,SK,SK,2020,Q4,Elderly
155722448,15572244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNK",,,D,,,,,10.0,MG,,,2020,Q4,Drug ineffective,,2020,Q4,8,F,200508.0,20201012.0,20181031,20201016,EXP,,SK-MYLANLABS-2018M1081194,MYLAN,POLKO J.. GLYCEMIA COMPENSATION IN A PATIENT WITH TYPE 2. DIABETES MELLITUS AND CARDIAL PRIMORBIDITY. INTERNA MEDICINA. 2018;52:10-11,66.0,YR,,M,Y,,,20201016.0,,MD,SK,SK,2020,Q4,Elderly
155722448,15572244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNK",,,D,,,,,10.0,MG,,,2020,Q4,Glycosylated haemoglobin decreased,,2020,Q4,8,F,200508.0,20201012.0,20181031,20201016,EXP,,SK-MYLANLABS-2018M1081194,MYLAN,POLKO J.. GLYCEMIA COMPENSATION IN A PATIENT WITH TYPE 2. DIABETES MELLITUS AND CARDIAL PRIMORBIDITY. INTERNA MEDICINA. 2018;52:10-11,66.0,YR,,M,Y,,,20201016.0,,MD,SK,SK,2020,Q4,Elderly
155722448,15572244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNK",,,D,,,,,10.0,MG,,,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,8,F,200508.0,20201012.0,20181031,20201016,EXP,,SK-MYLANLABS-2018M1081194,MYLAN,POLKO J.. GLYCEMIA COMPENSATION IN A PATIENT WITH TYPE 2. DIABETES MELLITUS AND CARDIAL PRIMORBIDITY. INTERNA MEDICINA. 2018;52:10-11,66.0,YR,,M,Y,,,20201016.0,,MD,SK,SK,2020,Q4,Elderly
155722448,15572244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNK",,,D,,,,,10.0,MG,,,2020,Q4,Hyperlipidaemia,,2020,Q4,8,F,200508.0,20201012.0,20181031,20201016,EXP,,SK-MYLANLABS-2018M1081194,MYLAN,POLKO J.. GLYCEMIA COMPENSATION IN A PATIENT WITH TYPE 2. DIABETES MELLITUS AND CARDIAL PRIMORBIDITY. INTERNA MEDICINA. 2018;52:10-11,66.0,YR,,M,Y,,,20201016.0,,MD,SK,SK,2020,Q4,Elderly
155722448,15572244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNK",,,D,,,,,10.0,MG,,,2020,Q4,Hypertension,,2020,Q4,8,F,200508.0,20201012.0,20181031,20201016,EXP,,SK-MYLANLABS-2018M1081194,MYLAN,POLKO J.. GLYCEMIA COMPENSATION IN A PATIENT WITH TYPE 2. DIABETES MELLITUS AND CARDIAL PRIMORBIDITY. INTERNA MEDICINA. 2018;52:10-11,66.0,YR,,M,Y,,,20201016.0,,MD,SK,SK,2020,Q4,Elderly
155722448,15572244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNK",,,D,,,,,10.0,MG,,,2020,Q4,Myocardial infarction,,2020,Q4,8,F,200508.0,20201012.0,20181031,20201016,EXP,,SK-MYLANLABS-2018M1081194,MYLAN,POLKO J.. GLYCEMIA COMPENSATION IN A PATIENT WITH TYPE 2. DIABETES MELLITUS AND CARDIAL PRIMORBIDITY. INTERNA MEDICINA. 2018;52:10-11,66.0,YR,,M,Y,,,20201016.0,,MD,SK,SK,2020,Q4,Elderly
155722448,15572244,26,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, UNK",,,D,,,,,10.0,MG,,,2020,Q4,Weight increased,,2020,Q4,8,F,200508.0,20201012.0,20181031,20201016,EXP,,SK-MYLANLABS-2018M1081194,MYLAN,POLKO J.. GLYCEMIA COMPENSATION IN A PATIENT WITH TYPE 2. DIABETES MELLITUS AND CARDIAL PRIMORBIDITY. INTERNA MEDICINA. 2018;52:10-11,66.0,YR,,M,Y,,,20201016.0,,MD,SK,SK,2020,Q4,Elderly
156034204,15603420,4,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, ASKED BUT UNKNOWN,,204629.0,10.0,MG,TABLET,QD,2020,Q4,Cerebral infarction,,2020,Q4,4,F,20180110.0,20201112.0,20181109,20201119,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-004378",BOEHRINGER INGELHEIM,,43.0,YR,A,M,Y,120.1,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
156034204,15603420,4,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, ASKED BUT UNKNOWN,,204629.0,10.0,MG,TABLET,QD,2020,Q4,Infarction,,2020,Q4,4,F,20180110.0,20201112.0,20181109,20201119,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-NB-004378",BOEHRINGER INGELHEIM,,43.0,YR,A,M,Y,120.1,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
156614454,15661445,43,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,4,F,2018.0,20201118.0,20181127,20201126,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20201126.0,,CN,US,US,2020,Q4,Adult
156614454,15661445,43,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Anhedonia,,2020,Q4,4,F,2018.0,20201118.0,20181127,20201126,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20201126.0,,CN,US,US,2020,Q4,Adult
156614454,15661445,43,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Anxiety,,2020,Q4,4,F,2018.0,20201118.0,20181127,20201126,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20201126.0,,CN,US,US,2020,Q4,Adult
156614454,15661445,43,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Bone density decreased,,2020,Q4,4,F,2018.0,20201118.0,20181127,20201126,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20201126.0,,CN,US,US,2020,Q4,Adult
156614454,15661445,43,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Economic problem,,2020,Q4,4,F,2018.0,20201118.0,20181127,20201126,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20201126.0,,CN,US,US,2020,Q4,Adult
156614454,15661445,43,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Emotional distress,,2020,Q4,4,F,2018.0,20201118.0,20181127,20201126,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20201126.0,,CN,US,US,2020,Q4,Adult
156614454,15661445,43,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Pain,,2020,Q4,4,F,2018.0,20201118.0,20181127,20201126,EXP,,US-GILEAD-2018-0376064,GILEAD,,38.0,YR,A,M,Y,,,20201126.0,,CN,US,US,2020,Q4,Adult
157777055,15777705,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Abdominal mass,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Back pain,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Fall,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Metastases to spine,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Nail discolouration,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Needle issue,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Sinusitis,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Vertigo,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Vitamin D decreased,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,,,,,,25.0,MG,,,2020,Q4,Abdominal mass,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,,,,,,25.0,MG,,,2020,Q4,Back pain,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,,,,,,25.0,MG,,,2020,Q4,Fall,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,,,,,,25.0,MG,,,2020,Q4,Metastases to spine,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,,,,,,25.0,MG,,,2020,Q4,Nail discolouration,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,,,,,,25.0,MG,,,2020,Q4,Needle issue,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,,,,,,25.0,MG,,,2020,Q4,Sinusitis,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,,,,,,25.0,MG,,,2020,Q4,Vertigo,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
157777055,15777705,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,,,,,,25.0,MG,,,2020,Q4,Vitamin D decreased,,2020,Q4,5,F,,20200929.0,20181231,20201007,EXP,,PHHY2018GB197608,NOVARTIS,,59.0,YR,,M,Y,,,20201007.0,,CN,COUNTRY NOT SPECIFIED,GB,2020,Q4,Adult
1671002810,16710028,8,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,TABLETS,,2020,Q4,Intestinal haemorrhage,,2020,Q4,10,F,20190805.0,20201209.0,20190816,20201211,EXP,,JP-CELGENEUS-JPN-20190804062,CELGENE,,76.0,YR,,M,Y,64.4,KG,20201211.0,,MD,JP,JP,2020,Q4,Elderly
1684464113,16844641,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,TABLETS,,2020,Q4,Diarrhoea,,2020,Q4,13,F,20190912.0,20201106.0,20190924,20201112,PER,,DE-EISAI MEDICAL RESEARCH-EC-2019-062532,EISAI,,63.0,YR,A,F,Y,84.5,KG,20201112.0,,MD,DE,DE,2020,Q4,Adult
1684464113,16844641,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,TABLETS,,2020,Q4,Hypertension,,2020,Q4,13,F,20190912.0,20201106.0,20190924,20201112,PER,,DE-EISAI MEDICAL RESEARCH-EC-2019-062532,EISAI,,63.0,YR,A,F,Y,84.5,KG,20201112.0,,MD,DE,DE,2020,Q4,Adult
1687739312,16877393,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q4,Ascites,,2020,Q4,12,F,20190301.0,20201216.0,20191002,20201222,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-104458",BOEHRINGER INGELHEIM,,77.0,YR,E,M,Y,62.4,KG,20201221.0,,MD,AR,AR,2020,Q4,Elderly
1687739312,16877393,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q4,Jaundice,,2020,Q4,12,F,20190301.0,20201216.0,20191002,20201222,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-104458",BOEHRINGER INGELHEIM,,77.0,YR,E,M,Y,62.4,KG,20201221.0,,MD,AR,AR,2020,Q4,Elderly
1687739312,16877393,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q4,Liver disorder,,2020,Q4,12,F,20190301.0,20201216.0,20191002,20201222,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-104458",BOEHRINGER INGELHEIM,,77.0,YR,E,M,Y,62.4,KG,20201221.0,,MD,AR,AR,2020,Q4,Elderly
169630015,16963001,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, EVERY 1 DAY",,,U,,,,,10.0,MG,,,2020,Q4,Chronic kidney disease,,2020,Q4,5,F,20181222.0,20201023.0,20191025,20201026,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-101486,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,50.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
169630015,16963001,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, EVERY 1 DAY",,,U,,,,,10.0,MG,,,2020,Q4,Metabolic acidosis,,2020,Q4,5,F,20181222.0,20201023.0,20191025,20201026,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-101486,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,50.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
169630015,16963001,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, EVERY 1 DAY",,,U,,,,,10.0,MG,,,2020,Q4,Sepsis,,2020,Q4,5,F,20181222.0,20201023.0,20191025,20201026,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-101486,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,50.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
170195615,17019561,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q4,Blood creatinine increased,,2020,Q4,5,F,20191102.0,20201012.0,20191112,20201016,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-112197",BOEHRINGER INGELHEIM,,15.0,YR,T,F,Y,96.0,KG,20201016.0,,MD,US,US,2020,Q4,Youth
170195615,17019561,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q4,Colitis,,2020,Q4,5,F,20191102.0,20201012.0,20191112,20201016,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-112197",BOEHRINGER INGELHEIM,,15.0,YR,T,F,Y,96.0,KG,20201016.0,,MD,US,US,2020,Q4,Youth
170195615,17019561,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,10.0,MG,FILM-COATED TABLET,,2020,Q4,Tubulointerstitial nephritis,,2020,Q4,5,F,20191102.0,20201012.0,20191112,20201016,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-112197",BOEHRINGER INGELHEIM,,15.0,YR,T,F,Y,96.0,KG,20201016.0,,MD,US,US,2020,Q4,Youth
170617302,17061730,1,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,,, UNKNOWN,,,25.0,MG,,QD,2020,Q4,Sudden death,,2020,Q4,2,F,20191105.0,20191108.0,20191121,20201020,EXP,,GB-NOVOPROD-695921,NOVO NORDISK,,73.0,YR,,M,Y,107.6,KG,20201020.0,,MD,GB,GB,2020,Q4,Elderly
1718146310,17181463,8,C,Empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Hepatic encephalopathy,,2020,Q4,10,F,20191205.0,20201022.0,20191219,20201028,EXP,,CH-EXELIXIS-XL18419026014,EXELIXIS,,61.0,YR,,M,Y,92.5,KG,20201028.0,,MD,CH,CH,2020,Q4,Adult
1718146310,17181463,8,C,Empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Visceral venous thrombosis,,2020,Q4,10,F,20191205.0,20201022.0,20191219,20201028,EXP,,CH-EXELIXIS-XL18419026014,EXELIXIS,,61.0,YR,,M,Y,92.5,KG,20201028.0,,MD,CH,CH,2020,Q4,Adult
172079212,17207921,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Fournier's gangrene,,2020,Q4,2,F,20150919.0,20201026.0,20191227,20201103,EXP,,US-ASTRAZENECA-2019SF85158,ASTRAZENECA,,18114.0,DY,,M,Y,102.1,KG,20201103.0,,,US,US,2020,Q4,Elderly
172079212,17207921,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Scrotal abscess,,2020,Q4,2,F,20150919.0,20201026.0,20191227,20201103,EXP,,US-ASTRAZENECA-2019SF85158,ASTRAZENECA,,18114.0,DY,,M,Y,102.1,KG,20201103.0,,,US,US,2020,Q4,Elderly
1741474710,17414747,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Anaemia,,2020,Q4,10,F,20200127.0,20201119.0,20200213,20201120,EXP,,MX-CELGENEUS-MEX-20200202416,CELGENE,,68.0,YR,,M,Y,,,20201120.0,,HP,MX,MX,2020,Q4,Elderly
1741474710,17414747,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Pneumonia,,2020,Q4,10,F,20200127.0,20201119.0,20200213,20201120,EXP,,MX-CELGENEUS-MEX-20200202416,CELGENE,,68.0,YR,,M,Y,,,20201120.0,,HP,MX,MX,2020,Q4,Elderly
175116283,17511628,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,,QD,2020,Q4,Diabetic ketoacidosis,,2020,Q4,3,F,20200820.0,20201013.0,20200307,20201015,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-013243",BOEHRINGER INGELHEIM,,23.0,YR,A,M,Y,100.0,KG,20201015.0,,MD,DE,DE,2020,Q4,Youth
175116283,17511628,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,25.0,MG,,QD,2020,Q4,Ketoacidosis,,2020,Q4,3,F,20200820.0,20201013.0,20200307,20201015,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-013243",BOEHRINGER INGELHEIM,,23.0,YR,A,M,Y,100.0,KG,20201015.0,,MD,DE,DE,2020,Q4,Youth
175393062,17539306,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Breast cancer,,2020,Q4,2,F,,20200925.0,20200313,20201005,EXP,,CO-EMD SERONO-9151652,EMD SERONO INC,,67.0,YR,E,F,Y,81.0,KG,20201005.0,,CN,CO,CO,2020,Q4,Elderly
175393062,17539306,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Procedural pain,,2020,Q4,2,F,,20200925.0,20200313,20201005,EXP,,CO-EMD SERONO-9151652,EMD SERONO INC,,67.0,YR,E,F,Y,81.0,KG,20201005.0,,CN,CO,CO,2020,Q4,Elderly
177256657,17725665,12,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Cardiac failure,,2020,Q4,7,F,202002.0,20201127.0,20200429,20201130,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-021407",BOEHRINGER INGELHEIM,,39.0,YR,A,M,Y,127.5,KG,20201130.0,,MD,BR,BR,2020,Q4,Adult
177256657,17725665,12,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Renal failure,,2020,Q4,7,F,202002.0,20201127.0,20200429,20201130,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-021407",BOEHRINGER INGELHEIM,,39.0,YR,A,M,Y,127.5,KG,20201130.0,,MD,BR,BR,2020,Q4,Adult
177524062,17752406,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,TABLET,QD,2020,Q4,Hyperglycaemia,,2020,Q4,2,F,202002.0,20201029.0,20200506,20201103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-035657,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,95.1,KG,20201103.0,,HP,US,US,2020,Q4,Adult
177524062,17752406,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, QD",,,Y,,,,,25.0,MG,TABLET,QD,2020,Q4,Immune-mediated enterocolitis,,2020,Q4,2,F,202002.0,20201029.0,20200506,20201103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-035657,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,95.1,KG,20201103.0,,HP,US,US,2020,Q4,Adult
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Aortic valve sclerosis,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Aortic valve stenosis,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Arteriosclerosis coronary artery,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Chronic obstructive pulmonary disease,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Infection,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Lipase increased,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Mitral valve incompetence,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Pulmonary hypertension,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
178773076,17877307,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Tricuspid valve incompetence,,2020,Q4,6,F,20200303.0,20201201.0,20200609,20201203,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-021514,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20201203.0,,HP,DE,DE,2020,Q4,Elderly
179120936,17912093,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, BID",,,,,,,,25.0,MG,,BID,2020,Q4,Haematuria,,2020,Q4,6,F,20200601.0,20201124.0,20200618,20201130,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-047354,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,115.0,KG,20201130.0,,MD,SK,SK,2020,Q4,Elderly
179120936,17912093,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, BID",,,,,,,,25.0,MG,,BID,2020,Q4,Renal impairment,,2020,Q4,6,F,20200601.0,20201124.0,20200618,20201130,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-047354,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,115.0,KG,20201130.0,,MD,SK,SK,2020,Q4,Elderly
179120936,17912093,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, BID",,,,,,,,25.0,MG,,BID,2020,Q4,Urinary retention,,2020,Q4,6,F,20200601.0,20201124.0,20200618,20201130,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-047354,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,115.0,KG,20201130.0,,MD,SK,SK,2020,Q4,Elderly
180109199,18010919,8,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Chronic kidney disease,,2020,Q4,9,F,20200604.0,20201209.0,20200710,20201211,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-030331",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,82.6,KG,20201211.0,,MD,CO,CO,2020,Q4,Elderly
180109199,18010919,8,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Urinary tract infection,,2020,Q4,9,F,20200604.0,20201209.0,20200710,20201211,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-030331",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,82.6,KG,20201211.0,,MD,CO,CO,2020,Q4,Elderly
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Candida infection,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Candida sepsis,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Coagulation test abnormal,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Coagulopathy,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Emphysematous pyelonephritis,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Oliguria,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Perinephric abscess,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Product use in unapproved indication,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Pyelonephritis fungal,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Systemic candida,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Therapy non-responder,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Urinary tract candidiasis,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Urinary tract infection,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Urinary tract infection enterococcal,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180590727,18059072,7,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q4,Vesicoureteric reflux,,2020,Q4,7,F,,20201105.0,20200723,20201106,EXP,,NVSC2020ES206671,NOVARTIS,,56.0,YR,,F,Y,,,20201106.0,,HP,ES,ES,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Breast cancer metastatic,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Hyperglycaemic hyperosmolar nonketotic syndrome,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Malaise,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Malignant neoplasm progression,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Nausea,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Off label use,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Product use in unapproved indication,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180618454,18061845,5,SS,EMPAGLIFLOZIN W/METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,Y,U,,,,,,,,2020,Q4,Therapy partial responder,,2020,Q4,4,F,20150604.0,20201102.0,20200723,20201105,EXP,,IE-MYLANLABS-2020M1065694,MYLAN,,64.0,YR,,F,Y,70.0,KG,20201105.0,,MD,IE,IE,2020,Q4,Adult
180899874,18089987,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Weight increased,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180929885,18092988,9,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Septic shock,,2020,Q4,5,F,20200720.0,20201209.0,20200730,20201210,EXP,,"KR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037161",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,61.6,KG,20201210.0,,MD,KR,KR,2020,Q4,Elderly
180929885,18092988,9,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Urinary tract infection,,2020,Q4,5,F,20200720.0,20201209.0,20200730,20201210,EXP,,"KR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037161",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,61.6,KG,20201210.0,,MD,KR,KR,2020,Q4,Elderly
181081738,18108173,20,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG DAILY,,,Y,U, UNKNOWN,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q4,Acute kidney injury,,2020,Q4,8,F,20200309.0,20201201.0,20200803,20201203,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015702",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,88.2,KG,20201203.0,,MD,BR,BR,2020,Q4,Elderly
181081738,18108173,20,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG DAILY,,,Y,U, UNKNOWN,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q4,COVID-19,,2020,Q4,8,F,20200309.0,20201201.0,20200803,20201203,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015702",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,88.2,KG,20201203.0,,MD,BR,BR,2020,Q4,Elderly
181081738,18108173,20,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG DAILY,,,Y,U, UNKNOWN,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q4,Cardiac failure,,2020,Q4,8,F,20200309.0,20201201.0,20200803,20201203,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015702",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,88.2,KG,20201203.0,,MD,BR,BR,2020,Q4,Elderly
181081738,18108173,20,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG DAILY,,,Y,U, UNKNOWN,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q4,Hyperkalaemia,,2020,Q4,8,F,20200309.0,20201201.0,20200803,20201203,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015702",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,88.2,KG,20201203.0,,MD,BR,BR,2020,Q4,Elderly
181081738,18108173,20,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG DAILY,,,Y,U, UNKNOWN,,204629.0,10.0,MG,FILM-COATED TABLET,QD,2020,Q4,Metabolic acidosis,,2020,Q4,8,F,20200309.0,20201201.0,20200803,20201203,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015702",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,88.2,KG,20201203.0,,MD,BR,BR,2020,Q4,Elderly
181091112,18109111,9,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U,,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Vasculitis,,2020,Q4,2,F,20200709.0,20201103.0,20200804,20201105,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-038620",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20201105.0,,MD,DE,DE,2020,Q4,Elderly
181436193,18143619,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2020,Q4,Monoparesis,,2020,Q4,3,F,20200805.0,20201203.0,20200813,20201208,EXP,,DE-ROCHE-2655728,ROCHE,,72.0,YR,,F,Y,63.0,KG,20201208.0,,MD,DE,DE,2020,Q4,Elderly
181462223,18146222,28,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,28,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,28,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,28,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,28,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,28,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181926212,18192621,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20180307.0,20200930.0,20200825,20201009,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-067946,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,81.63,KG,20201009.0,,HP,US,US,2020,Q4,Elderly
181926212,18192621,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Invasive ductal breast carcinoma,,2020,Q4,2,F,20180307.0,20200930.0,20200825,20201009,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-067946,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,81.63,KG,20201009.0,,HP,US,US,2020,Q4,Elderly
182421463,18242146,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q4,Cushing's syndrome,,2020,Q4,3,F,20191220.0,20201222.0,20200908,20201228,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202008012218,ELI LILLY AND CO,"KOJIMA Y, ET AL..A CASE OF CUSHING^S SYNDROME SUSPECTED OF CONTRIBUTION OF DULAGLUTIDE.THE JAPAN DIABETES SOCIOETY, HOKKAIDO BRANCH 2020;:.",75.0,YR,,M,Y,62.0,KG,20201228.0,,MD,JP,JP,2020,Q4,Elderly
182421463,18242146,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2020,Q4,Oesophageal candidiasis,,2020,Q4,3,F,20191220.0,20201222.0,20200908,20201228,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202008012218,ELI LILLY AND CO,"KOJIMA Y, ET AL..A CASE OF CUSHING^S SYNDROME SUSPECTED OF CONTRIBUTION OF DULAGLUTIDE.THE JAPAN DIABETES SOCIOETY, HOKKAIDO BRANCH 2020;:.",75.0,YR,,M,Y,62.0,KG,20201228.0,,MD,JP,JP,2020,Q4,Elderly
182854356,18285435,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Pathogen resistance,,2020,Q4,6,F,20200906.0,20201205.0,20200918,20201211,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-047126",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,121.6,KG,20201211.0,,MD,US,US,2020,Q4,Adult
182858075,18285807,4,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,70963.0,,,FILM-COATED TABLET,,2020,Q4,Cardiac ventricular thrombosis,,2020,Q4,5,F,20200827.0,20201106.0,20200918,20201109,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-045151",BOEHRINGER INGELHEIM,,52.0,YR,A,M,Y,82.0,KG,20201109.0,,MD,JP,JP,2020,Q4,Adult
182858075,18285807,4,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,70963.0,,,FILM-COATED TABLET,,2020,Q4,Coronary artery stenosis,,2020,Q4,5,F,20200827.0,20201106.0,20200918,20201109,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-045151",BOEHRINGER INGELHEIM,,52.0,YR,A,M,Y,82.0,KG,20201109.0,,MD,JP,JP,2020,Q4,Adult
182858075,18285807,4,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,70963.0,,,FILM-COATED TABLET,,2020,Q4,Ventricular tachycardia,,2020,Q4,5,F,20200827.0,20201106.0,20200918,20201109,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-045151",BOEHRINGER INGELHEIM,,52.0,YR,A,M,Y,82.0,KG,20201109.0,,MD,JP,JP,2020,Q4,Adult
182882312,18288231,11,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Renal failure,,2020,Q4,2,F,20200904.0,20200926.0,20200921,20201125,EXP,,"BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-048159",BOEHRINGER INGELHEIM,,84.0,YR,E,F,Y,63.0,KG,20201125.0,,MD,BR,BR,2020,Q4,Elderly
182894742,18289474,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"12.5 MILLIGRAM, BID",,,D,, UNKNOWN,,,12.5,MG,,BID,2020,Q4,Diabetic ketoacidosis,,2020,Q4,2,F,201610.0,20200922.0,20200921,20201005,EXP,,MX-LUPIN PHARMACEUTICALS INC.-2020-06007,LUPIN,,42.0,YR,,F,Y,,,20201005.0,,HP,MX,MX,2020,Q4,Adult
182894742,18289474,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"12.5 MILLIGRAM, BID",,,D,, UNKNOWN,,,12.5,MG,,BID,2020,Q4,Leukocytosis,,2020,Q4,2,F,201610.0,20200922.0,20200921,20201005,EXP,,MX-LUPIN PHARMACEUTICALS INC.-2020-06007,LUPIN,,42.0,YR,,F,Y,,,20201005.0,,HP,MX,MX,2020,Q4,Adult
182894742,18289474,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"12.5 MILLIGRAM, BID",,,D,, UNKNOWN,,,12.5,MG,,BID,2020,Q4,Neurological decompensation,,2020,Q4,2,F,201610.0,20200922.0,20200921,20201005,EXP,,MX-LUPIN PHARMACEUTICALS INC.-2020-06007,LUPIN,,42.0,YR,,F,Y,,,20201005.0,,HP,MX,MX,2020,Q4,Adult
182894742,18289474,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"12.5 MILLIGRAM, BID",,,D,, UNKNOWN,,,12.5,MG,,BID,2020,Q4,Systemic inflammatory response syndrome,,2020,Q4,2,F,201610.0,20200922.0,20200921,20201005,EXP,,MX-LUPIN PHARMACEUTICALS INC.-2020-06007,LUPIN,,42.0,YR,,F,Y,,,20201005.0,,HP,MX,MX,2020,Q4,Adult
182894742,18289474,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"12.5 MILLIGRAM, BID",,,D,, UNKNOWN,,,12.5,MG,,BID,2020,Q4,Weight decreased,,2020,Q4,2,F,201610.0,20200922.0,20200921,20201005,EXP,,MX-LUPIN PHARMACEUTICALS INC.-2020-06007,LUPIN,,42.0,YR,,F,Y,,,20201005.0,,HP,MX,MX,2020,Q4,Adult
183113562,18311356,24,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK (DAILY DOSE),,,,,,,,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,2,F,200508.0,20201008.0,20200925,20201014,EXP,SK-SAKK-2018SA150955AA,SK-STRIDES ARCOLAB LIMITED-2019SP008025,STRIDES,,66.0,YR,,M,Y,,,20201014.0,,CN,SK,SK,2020,Q4,Elderly
183113562,18311356,24,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK (DAILY DOSE),,,,,,,,,,,,2020,Q4,Diabetes mellitus,,2020,Q4,2,F,200508.0,20201008.0,20200925,20201014,EXP,SK-SAKK-2018SA150955AA,SK-STRIDES ARCOLAB LIMITED-2019SP008025,STRIDES,,66.0,YR,,M,Y,,,20201014.0,,CN,SK,SK,2020,Q4,Elderly
183113562,18311356,24,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK (DAILY DOSE),,,,,,,,,,,,2020,Q4,Glycosylated haemoglobin decreased,,2020,Q4,2,F,200508.0,20201008.0,20200925,20201014,EXP,SK-SAKK-2018SA150955AA,SK-STRIDES ARCOLAB LIMITED-2019SP008025,STRIDES,,66.0,YR,,M,Y,,,20201014.0,,CN,SK,SK,2020,Q4,Elderly
183113562,18311356,24,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK (DAILY DOSE),,,,,,,,,,,,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,2,F,200508.0,20201008.0,20200925,20201014,EXP,SK-SAKK-2018SA150955AA,SK-STRIDES ARCOLAB LIMITED-2019SP008025,STRIDES,,66.0,YR,,M,Y,,,20201014.0,,CN,SK,SK,2020,Q4,Elderly
183113562,18311356,24,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK (DAILY DOSE),,,,,,,,,,,,2020,Q4,Hyperlipidaemia,,2020,Q4,2,F,200508.0,20201008.0,20200925,20201014,EXP,SK-SAKK-2018SA150955AA,SK-STRIDES ARCOLAB LIMITED-2019SP008025,STRIDES,,66.0,YR,,M,Y,,,20201014.0,,CN,SK,SK,2020,Q4,Elderly
183113562,18311356,24,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK (DAILY DOSE),,,,,,,,,,,,2020,Q4,Hypertension,,2020,Q4,2,F,200508.0,20201008.0,20200925,20201014,EXP,SK-SAKK-2018SA150955AA,SK-STRIDES ARCOLAB LIMITED-2019SP008025,STRIDES,,66.0,YR,,M,Y,,,20201014.0,,CN,SK,SK,2020,Q4,Elderly
183113562,18311356,24,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK (DAILY DOSE),,,,,,,,,,,,2020,Q4,Myocardial infarction,,2020,Q4,2,F,200508.0,20201008.0,20200925,20201014,EXP,SK-SAKK-2018SA150955AA,SK-STRIDES ARCOLAB LIMITED-2019SP008025,STRIDES,,66.0,YR,,M,Y,,,20201014.0,,CN,SK,SK,2020,Q4,Elderly
183113562,18311356,24,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK (DAILY DOSE),,,,,,,,,,,,2020,Q4,Weight increased,,2020,Q4,2,F,200508.0,20201008.0,20200925,20201014,EXP,SK-SAKK-2018SA150955AA,SK-STRIDES ARCOLAB LIMITED-2019SP008025,STRIDES,,66.0,YR,,M,Y,,,20201014.0,,CN,SK,SK,2020,Q4,Elderly
183142892,18314289,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,2,F,20200918.0,20201030.0,20200925,20201103,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-049669",BOEHRINGER INGELHEIM,,65.0,YR,E,M,Y,108.0,KG,20201103.0,,MD,PL,PL,2020,Q4,Elderly
183142892,18314289,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Ischaemic stroke,,2020,Q4,2,F,20200918.0,20201030.0,20200925,20201103,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-049669",BOEHRINGER INGELHEIM,,65.0,YR,E,M,Y,108.0,KG,20201103.0,,MD,PL,PL,2020,Q4,Elderly
183385321,18338532,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,OTHER FREQUENCY:AM;?,,,Y,D,,,,12.5,MG,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200702.0,,20201001,20201001,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200919.0,N,PH,US,US,2020,Q4,Elderly
183385321,18338532,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,OTHER FREQUENCY:AM;?,,,Y,D,,,,12.5,MG,,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20200702.0,,20201001,20201001,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20200919.0,N,PH,US,US,2020,Q4,Elderly
183391781,18339178,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, 1-0-0-0, TABLETTEN",,,,,,,,25.0,MG,TABLET,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,DE-MYLANLABS-2020M1082873,MYLAN,,60.0,YR,,M,Y,97.0,KG,20201002.0,,PH,DE,DE,2020,Q4,Adult
183391781,18339178,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, 1-0-0-0, TABLETTEN",,,,,,,,25.0,MG,TABLET,QD,2020,Q4,Cough,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,DE-MYLANLABS-2020M1082873,MYLAN,,60.0,YR,,M,Y,97.0,KG,20201002.0,,PH,DE,DE,2020,Q4,Adult
183391781,18339178,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, 1-0-0-0, TABLETTEN",,,,,,,,25.0,MG,TABLET,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,DE-MYLANLABS-2020M1082873,MYLAN,,60.0,YR,,M,Y,97.0,KG,20201002.0,,PH,DE,DE,2020,Q4,Adult
183411951,18341195,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY; 1-0-0-0,,,,, UNKNOWN,,,25.0,MG,TABLET,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20200924.0,20201003,20201003,EXP,,DE-TEVA-2020-DE-1833791,TEVA,,60.0,YR,A,M,Y,97.0,KG,20201003.0,,PH,DE,DE,2020,Q4,Adult
183411951,18341195,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY; 1-0-0-0,,,,, UNKNOWN,,,25.0,MG,TABLET,QD,2020,Q4,Cough,,2020,Q4,1,I,,20200924.0,20201003,20201003,EXP,,DE-TEVA-2020-DE-1833791,TEVA,,60.0,YR,A,M,Y,97.0,KG,20201003.0,,PH,DE,DE,2020,Q4,Adult
183411951,18341195,4,C,empagliflozin,EMPAGLIFLOZIN,1,Oral,25 MILLIGRAM DAILY; 1-0-0-0,,,,, UNKNOWN,,,25.0,MG,TABLET,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200924.0,20201003,20201003,EXP,,DE-TEVA-2020-DE-1833791,TEVA,,60.0,YR,A,M,Y,97.0,KG,20201003.0,,PH,DE,DE,2020,Q4,Adult
183425911,18342591,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,N,D,,,,,,,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20200715.0,,20201001,20201001,DIR,,,FDA-CTU,,74.0,YR,,M,N,,,20200919.0,N,PH,US,US,2020,Q4,Elderly
183428521,18342852,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2020,Q4,Pollakiuria,,2020,Q4,1,I,20200701.0,,20201001,20201001,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20200919.0,N,PH,US,US,2020,Q4,Elderly
183456081,18345608,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Malaise,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Product dose omission issue,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,10,C,EMPAGLIFLOZIN/LINAGLIPTIN,EMPAGLIFLOZIN\LINAGLIPTIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183504753,18350475,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,,,2020,Q4,Sudden death,,2020,Q4,3,F,,20201030.0,20201006,20201104,EXP,,ES-JNJFOC-20200954227,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,,,20201104.0,,CN,ES,ES,2020,Q4,Adult
183511212,18351121,8,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,3670.0,MG,U,U, UNKNOWN,,204629.0,10.0,MG,,QD,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,20200821.0,20201125.0,20201006,20201202,EXP,IT-MINISAL02-635292,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-050805",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,0.0,KG,20201202.0,,,COUNTRY NOT SPECIFIED,IT,2020,Q4,Elderly
183511212,18351121,8,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,3670.0,MG,U,U, UNKNOWN,,204629.0,10.0,MG,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,20200821.0,20201125.0,20201006,20201202,EXP,IT-MINISAL02-635292,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-050805",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,0.0,KG,20201202.0,,,COUNTRY NOT SPECIFIED,IT,2020,Q4,Elderly
183511212,18351121,8,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,3670.0,MG,U,U, UNKNOWN,,204629.0,10.0,MG,,QD,2020,Q4,Sopor,,2020,Q4,2,F,20200821.0,20201125.0,20201006,20201202,EXP,IT-MINISAL02-635292,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-050805",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,0.0,KG,20201202.0,,,COUNTRY NOT SPECIFIED,IT,2020,Q4,Elderly
183539061,18353906,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,Y,U,,,204629.0,,,TABLETS,,2020,Q4,Feeling jittery,,2020,Q4,1,I,202009.0,20201005.0,20201007,20201007,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-053033",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20201007.0,,CN,US,US,2020,Q4,Elderly
183539061,18353906,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,Y,U,,,204629.0,,,TABLETS,,2020,Q4,Fungal infection,,2020,Q4,1,I,202009.0,20201005.0,20201007,20201007,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-053033",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20201007.0,,CN,US,US,2020,Q4,Elderly
183539061,18353906,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,Y,U,,,204629.0,,,TABLETS,,2020,Q4,Urinary tract infection,,2020,Q4,1,I,202009.0,20201005.0,20201007,20201007,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-053033",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,,,20201007.0,,CN,US,US,2020,Q4,Elderly
183544341,18354434,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q4,Cellulitis,,2020,Q4,1,I,20200630.0,,20201006,20201006,DIR,,,FDA-CTU,,55.0,YR,,M,N,119.29,KG,20200916.0,N,PH,US,US,2020,Q4,Adult
183544341,18354434,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,12.5,MG,,QD,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,20200630.0,,20201006,20201006,DIR,,,FDA-CTU,,55.0,YR,,M,N,119.29,KG,20200916.0,N,PH,US,US,2020,Q4,Adult
183608401,18360840,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10MG PO QAM,,,U,N,,,,,,,,2020,Q4,C-reactive protein increased,,2020,Q4,1,I,20200417.0,20200420.0,20201008,20201008,EXP,,CA-HLS-202000397,HLS THERAPEUTICS,,60.0,YR,A,F,Y,82.0,KG,20201008.0,,MD,CA,CA,2020,Q4,Adult
183608401,18360840,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10MG PO QAM,,,U,N,,,,,,,,2020,Q4,Lethargy,,2020,Q4,1,I,20200417.0,20200420.0,20201008,20201008,EXP,,CA-HLS-202000397,HLS THERAPEUTICS,,60.0,YR,A,F,Y,82.0,KG,20201008.0,,MD,CA,CA,2020,Q4,Adult
183608401,18360840,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10MG PO QAM,,,U,N,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,1,I,20200417.0,20200420.0,20201008,20201008,EXP,,CA-HLS-202000397,HLS THERAPEUTICS,,60.0,YR,A,F,Y,82.0,KG,20201008.0,,MD,CA,CA,2020,Q4,Adult
183608401,18360840,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10MG PO QAM,,,U,N,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200417.0,20200420.0,20201008,20201008,EXP,,CA-HLS-202000397,HLS THERAPEUTICS,,60.0,YR,A,F,Y,82.0,KG,20201008.0,,MD,CA,CA,2020,Q4,Adult
183608401,18360840,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10MG PO QAM,,,U,N,,,,,,,,2020,Q4,Tremor,,2020,Q4,1,I,20200417.0,20200420.0,20201008,20201008,EXP,,CA-HLS-202000397,HLS THERAPEUTICS,,60.0,YR,A,F,Y,82.0,KG,20201008.0,,MD,CA,CA,2020,Q4,Adult
183614853,18361485,16,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Dementia,,2020,Q4,3,F,20200708.0,20201125.0,20201008,20201202,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-034633",BOEHRINGER INGELHEIM,,83.0,YR,E,F,Y,63.3,KG,20201202.0,,MD,JP,JP,2020,Q4,Elderly
183614853,18361485,17,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Dementia,,2020,Q4,3,F,20200708.0,20201125.0,20201008,20201202,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-034633",BOEHRINGER INGELHEIM,,83.0,YR,E,F,Y,63.3,KG,20201202.0,,MD,JP,JP,2020,Q4,Elderly
183656171,18365617,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2020,Q4,Acetonaemia,,2020,Q4,1,I,,20200928.0,20201009,20201009,EXP,,PT-EMD SERONO-9190165,EMD SERONO INC,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING - MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020 SEP;535-536.",54.0,YR,A,M,Y,,,20201009.0,,MD,PT,PT,2020,Q4,Adult
183656171,18365617,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2020,Q4,Acidosis,,2020,Q4,1,I,,20200928.0,20201009,20201009,EXP,,PT-EMD SERONO-9190165,EMD SERONO INC,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING - MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020 SEP;535-536.",54.0,YR,A,M,Y,,,20201009.0,,MD,PT,PT,2020,Q4,Adult
183656171,18365617,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20200928.0,20201009,20201009,EXP,,PT-EMD SERONO-9190165,EMD SERONO INC,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING - MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020 SEP;535-536.",54.0,YR,A,M,Y,,,20201009.0,,MD,PT,PT,2020,Q4,Adult
183656171,18365617,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20200928.0,20201009,20201009,EXP,,PT-EMD SERONO-9190165,EMD SERONO INC,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING - MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020 SEP;535-536.",54.0,YR,A,M,Y,,,20201009.0,,MD,PT,PT,2020,Q4,Adult
183656171,18365617,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20200928.0,20201009,20201009,EXP,,PT-EMD SERONO-9190165,EMD SERONO INC,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING - MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020 SEP;535-536.",54.0,YR,A,M,Y,,,20201009.0,,MD,PT,PT,2020,Q4,Adult
183656171,18365617,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,1,I,,20200928.0,20201009,20201009,EXP,,PT-EMD SERONO-9190165,EMD SERONO INC,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING - MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020 SEP;535-536.",54.0,YR,A,M,Y,,,20201009.0,,MD,PT,PT,2020,Q4,Adult
183656171,18365617,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20200928.0,20201009,20201009,EXP,,PT-EMD SERONO-9190165,EMD SERONO INC,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING - MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020 SEP;535-536.",54.0,YR,A,M,Y,,,20201009.0,,MD,PT,PT,2020,Q4,Adult
183688331,18368833,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Weight increased,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183706871,18370687,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",3670.0,MG,U,U,,,,10.0,MG,,QD,2020,Q4,Hyperhidrosis,,2020,Q4,1,I,20200821.0,20201005.0,20201012,20201012,EXP,IT-MINISAL02-635292,IT-MYLANLABS-2020M1085190,MYLAN,,70.0,YR,,M,Y,,,20201012.0,,MD,IT,IT,2020,Q4,Elderly
183706871,18370687,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",3670.0,MG,U,U,,,,10.0,MG,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,20200821.0,20201005.0,20201012,20201012,EXP,IT-MINISAL02-635292,IT-MYLANLABS-2020M1085190,MYLAN,,70.0,YR,,M,Y,,,20201012.0,,MD,IT,IT,2020,Q4,Elderly
183706871,18370687,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",3670.0,MG,U,U,,,,10.0,MG,,QD,2020,Q4,Sopor,,2020,Q4,1,I,20200821.0,20201005.0,20201012,20201012,EXP,IT-MINISAL02-635292,IT-MYLANLABS-2020M1085190,MYLAN,,70.0,YR,,M,Y,,,20201012.0,,MD,IT,IT,2020,Q4,Elderly
183720101,18372010,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10MG,3670.0,MG,U,, UNKNOWN,,,10.0,MG,,,2020,Q4,Hyperhidrosis,,2020,Q4,1,I,20200821.0,20201004.0,20201012,20201012,EXP,IT-MINISAL02-635292,IT-TEVA-2020-IT-1836896,TEVA,,70.0,YR,E,M,Y,,,20201012.0,,MD,IT,IT,2020,Q4,Elderly
183720101,18372010,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10MG,3670.0,MG,U,, UNKNOWN,,,10.0,MG,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,20200821.0,20201004.0,20201012,20201012,EXP,IT-MINISAL02-635292,IT-TEVA-2020-IT-1836896,TEVA,,70.0,YR,E,M,Y,,,20201012.0,,MD,IT,IT,2020,Q4,Elderly
183720101,18372010,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10MG,3670.0,MG,U,, UNKNOWN,,,10.0,MG,,,2020,Q4,Sopor,,2020,Q4,1,I,20200821.0,20201004.0,20201012,20201012,EXP,IT-MINISAL02-635292,IT-TEVA-2020-IT-1836896,TEVA,,70.0,YR,E,M,Y,,,20201012.0,,MD,IT,IT,2020,Q4,Elderly
183828221,18382822,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"UNK, UNKNOWN",,,,,,,,,,FILM-COATED TABLET,,2020,Q4,Blood albumin increased,,2020,Q4,1,I,20180907.0,20201005.0,20201014,20201014,EXP,,NVSC2020US271978,NOVARTIS,,64.0,YR,,M,Y,94.0,KG,20201014.0,,CN,US,US,2020,Q4,Adult
183828221,18382822,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"UNK, UNKNOWN",,,,,,,,,,FILM-COATED TABLET,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20180907.0,20201005.0,20201014,20201014,EXP,,NVSC2020US271978,NOVARTIS,,64.0,YR,,M,Y,94.0,KG,20201014.0,,CN,US,US,2020,Q4,Adult
183828221,18382822,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"UNK, UNKNOWN",,,,,,,,,,FILM-COATED TABLET,,2020,Q4,Renal impairment,,2020,Q4,1,I,20180907.0,20201005.0,20201014,20201014,EXP,,NVSC2020US271978,NOVARTIS,,64.0,YR,,M,Y,94.0,KG,20201014.0,,CN,US,US,2020,Q4,Adult
183828221,18382822,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"UNK, UNKNOWN",,,,,,,,,,FILM-COATED TABLET,,2020,Q4,Blood albumin increased,,2020,Q4,1,I,20180907.0,20201005.0,20201014,20201014,EXP,,NVSC2020US271978,NOVARTIS,,64.0,YR,,M,Y,94.0,KG,20201014.0,,CN,US,US,2020,Q4,Adult
183828221,18382822,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"UNK, UNKNOWN",,,,,,,,,,FILM-COATED TABLET,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20180907.0,20201005.0,20201014,20201014,EXP,,NVSC2020US271978,NOVARTIS,,64.0,YR,,M,Y,94.0,KG,20201014.0,,CN,US,US,2020,Q4,Adult
183828221,18382822,3,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"UNK, UNKNOWN",,,,,,,,,,FILM-COATED TABLET,,2020,Q4,Renal impairment,,2020,Q4,1,I,20180907.0,20201005.0,20201014,20201014,EXP,,NVSC2020US271978,NOVARTIS,,64.0,YR,,M,Y,94.0,KG,20201014.0,,CN,US,US,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Acetonaemia,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Acidosis,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Acute kidney injury,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Altered state of consciousness,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Hyperlactacidaemia,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Lactic acidosis,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Metabolic acidosis,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Acetonaemia,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Altered state of consciousness,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Hyperlactacidaemia,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183846675,18384667,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,5,F,,20201026.0,20201015,20201027,EXP,,NVSC2020PT275038,NOVARTIS,"SOFIA C, SUSANA E, INES S, FRANCISCO R, DIANA C, DIOGO C. METFORMIN POISONING-MULTIFACTORIAL METABOLIC ACIDOSIS. BOOK OF ABSTRACTS OF THE CONGRESS OF INTERNAL MEDICINE. 2020;535-6",54.0,YR,,M,Y,,,20201027.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Acetonaemia,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Acidosis,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Acute kidney injury,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Altered state of consciousness,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Hyperlactacidaemia,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Lactic acidosis,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Metabolic acidosis,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183853594,18385359,3,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"25 MILLIGRAM, ONCE A DAY",,,U,,,,,25.0,MG,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,4,F,,20201019.0,20201014,20201031,EXP,,PT-AUROBINDO-AUR-APL-2020-051831,AUROBINDO,,54.0,YR,,M,Y,,,20201031.0,,HP,PT,PT,2020,Q4,Adult
183885672,18388567,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,2,F,,20201015.0,20201015,20201026,EXP,,PT-BAUSCH-BL-2020-029541,BAUSCH AND LOMB,"CALACA S, ESCARIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D. INTOXICACAO POR METFORMINA - ACIDOSE METABOLICA MULTIFACTORIAL. REVISTA DA SOCIEDADE PORTUGUSA DE MEDICINA INTERNA. 2020 SEP;535.",54.0,YR,,M,Y,,,20201026.0,,HP,PT,PT,2020,Q4,Adult
183885672,18388567,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,2,F,,20201015.0,20201015,20201026,EXP,,PT-BAUSCH-BL-2020-029541,BAUSCH AND LOMB,"CALACA S, ESCARIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D. INTOXICACAO POR METFORMINA - ACIDOSE METABOLICA MULTIFACTORIAL. REVISTA DA SOCIEDADE PORTUGUSA DE MEDICINA INTERNA. 2020 SEP;535.",54.0,YR,,M,Y,,,20201026.0,,HP,PT,PT,2020,Q4,Adult
184101851,18410185,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Cardiac failure congestive,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,CA-PFIZER INC-2020404706,PFIZER,,86.0,YR,,F,Y,75.0,KG,20201021.0,,HP,CA,CA,2020,Q4,Elderly
184101851,18410185,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,CA-PFIZER INC-2020404706,PFIZER,,86.0,YR,,F,Y,75.0,KG,20201021.0,,HP,CA,CA,2020,Q4,Elderly
184101851,18410185,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,CA-PFIZER INC-2020404706,PFIZER,,86.0,YR,,F,Y,75.0,KG,20201021.0,,HP,CA,CA,2020,Q4,Elderly
184146131,18414613,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q4,Dizziness,,2020,Q4,1,I,20200804.0,,20201022,20201022,DIR,,,FDA-CTU,,59.0,YR,,F,N,,,20201018.0,N,PH,US,US,2020,Q4,Adult
184146131,18414613,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q4,Rash,,2020,Q4,1,I,20200804.0,,20201022,20201022,DIR,,,FDA-CTU,,59.0,YR,,F,N,,,20201018.0,N,PH,US,US,2020,Q4,Adult
184148131,18414813,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q4,Pollakiuria,,2020,Q4,1,I,20200825.0,,20201022,20201022,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Adult
184151841,18415184,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,20200916.0,,20201022,20201022,DIR,,,FDA-CTU,,63.0,YR,,M,N,79.0,KG,20201016.0,N,PH,US,US,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Acetonaemia,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Acute kidney injury,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Altered state of consciousness,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Diarrhoea,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Hyperlactacidaemia,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Lactic acidosis,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Metabolic acidosis,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"25 MG, QD",,,,,,,,25.0,MG,,QD,2020,Q4,Vomiting,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Acetonaemia,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Acute kidney injury,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Altered state of consciousness,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Diarrhoea,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Hyperlactacidaemia,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Lactic acidosis,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Metabolic acidosis,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184155423,18415542,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Vomiting,,2020,Q4,3,F,,20201102.0,20201022,20201106,EXP,,PT-MYLANLABS-2020M1089059,MYLAN,"CALA?A S, ESC?RIA S, SANTOS I, REBOCHO F, COUTINHO D, CANUDO D.. PE-362 METFORMIN POISONING -MULTIFACTORIAL METABOLIC ACIDOSIS. 535-536",54.0,YR,,M,Y,,,20201106.0,,MD,PT,PT,2020,Q4,Adult
184188063,18418806,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, DAILY",6010.0,MG,,,,,,10.0,MG,,QD,2020,Q4,Hypoglycaemic encephalopathy,,2020,Q4,3,F,20200512.0,20201119.0,20201023,20201201,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010005391,ELI LILLY AND CO,AZUMA. K ET AL..A CASE OF HYPOGLYCEMIC ENCEPHALOPATHY WHICH SUSPECTED OVERDOSE OF PREVIOUSLY USED INSULIN SELF-INJECTION.THE 94TH CHUBU BRANCH MEETING OF JAPAN DIABETES MELLITUS SOCIETY 2020;:77.,57.0,YR,,F,Y,,,20201201.0,,MD,JP,JP,2020,Q4,Adult
184188063,18418806,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, DAILY",6010.0,MG,,,,,,10.0,MG,,QD,2020,Q4,Wrong drug,,2020,Q4,3,F,20200512.0,20201119.0,20201023,20201201,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010005391,ELI LILLY AND CO,AZUMA. K ET AL..A CASE OF HYPOGLYCEMIC ENCEPHALOPATHY WHICH SUSPECTED OVERDOSE OF PREVIOUSLY USED INSULIN SELF-INJECTION.THE 94TH CHUBU BRANCH MEETING OF JAPAN DIABETES MELLITUS SOCIETY 2020;:77.,57.0,YR,,F,Y,,,20201201.0,,MD,JP,JP,2020,Q4,Adult
184190661,18419066,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q4,Pruritus genital,,2020,Q4,1,I,20200721.0,,20201023,20201023,DIR,,,FDA-CTU,,57.0,YR,,M,N,102.06,KG,20200929.0,N,PH,US,US,2020,Q4,Adult
184190661,18419066,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q4,Rash,,2020,Q4,1,I,20200721.0,,20201023,20201023,DIR,,,FDA-CTU,,57.0,YR,,M,N,102.06,KG,20200929.0,N,PH,US,US,2020,Q4,Adult
184190661,18419066,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,12.5,MG,,QD,2020,Q4,Urticaria,,2020,Q4,1,I,20200721.0,,20201023,20201023,DIR,,,FDA-CTU,,57.0,YR,,M,N,102.06,KG,20200929.0,N,PH,US,US,2020,Q4,Adult
184256941,18425694,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2020,Q4,Asthenia,,2020,Q4,1,I,20201022.0,,20201025,20201025,DIR,,,FDA-CTU,,55.0,YR,,F,N,90.4,KG,20201025.0,N,PH,US,US,2020,Q4,Adult
184256941,18425694,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,20201022.0,,20201025,20201025,DIR,,,FDA-CTU,,55.0,YR,,F,N,90.4,KG,20201025.0,N,PH,US,US,2020,Q4,Adult
184256941,18425694,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2020,Q4,Fatigue,,2020,Q4,1,I,20201022.0,,20201025,20201025,DIR,,,FDA-CTU,,55.0,YR,,F,N,90.4,KG,20201025.0,N,PH,US,US,2020,Q4,Adult
184256941,18425694,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2020,Q4,Malaise,,2020,Q4,1,I,20201022.0,,20201025,20201025,DIR,,,FDA-CTU,,55.0,YR,,F,N,90.4,KG,20201025.0,N,PH,US,US,2020,Q4,Adult
184256941,18425694,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2020,Q4,Nausea,,2020,Q4,1,I,20201022.0,,20201025,20201025,DIR,,,FDA-CTU,,55.0,YR,,F,N,90.4,KG,20201025.0,N,PH,US,US,2020,Q4,Adult
184256941,18425694,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2020,Q4,Pain,,2020,Q4,1,I,20201022.0,,20201025,20201025,DIR,,,FDA-CTU,,55.0,YR,,F,N,90.4,KG,20201025.0,N,PH,US,US,2020,Q4,Adult
184256941,18425694,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2020,Q4,Syncope,,2020,Q4,1,I,20201022.0,,20201025,20201025,DIR,,,FDA-CTU,,55.0,YR,,F,N,90.4,KG,20201025.0,N,PH,US,US,2020,Q4,Adult
184256941,18425694,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2020,Q4,Vomiting,,2020,Q4,1,I,20201022.0,,20201025,20201025,DIR,,,FDA-CTU,,55.0,YR,,F,N,90.4,KG,20201025.0,N,PH,US,US,2020,Q4,Adult
184387751,18438775,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q4,Acute coronary syndrome,,2020,Q4,1,I,,20201023.0,20201028,20201028,EXP,,DE-ASTRAZENECA-2020SF40449,ASTRAZENECA,,69.0,YR,,F,Y,,,20201028.0,,,DE,DE,2020,Q4,Elderly
184387751,18438775,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,,20201023.0,20201028,20201028,EXP,,DE-ASTRAZENECA-2020SF40449,ASTRAZENECA,,69.0,YR,,F,Y,,,20201028.0,,,DE,DE,2020,Q4,Elderly
184387751,18438775,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20201023.0,20201028,20201028,EXP,,DE-ASTRAZENECA-2020SF40449,ASTRAZENECA,,69.0,YR,,F,Y,,,20201028.0,,,DE,DE,2020,Q4,Elderly
184387751,18438775,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q4,Blood pressure increased,,2020,Q4,1,I,,20201023.0,20201028,20201028,EXP,,DE-ASTRAZENECA-2020SF40449,ASTRAZENECA,,69.0,YR,,F,Y,,,20201028.0,,,DE,DE,2020,Q4,Elderly
184387751,18438775,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q4,Chest pain,,2020,Q4,1,I,,20201023.0,20201028,20201028,EXP,,DE-ASTRAZENECA-2020SF40449,ASTRAZENECA,,69.0,YR,,F,Y,,,20201028.0,,,DE,DE,2020,Q4,Elderly
184387751,18438775,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q4,Dyspnoea exertional,,2020,Q4,1,I,,20201023.0,20201028,20201028,EXP,,DE-ASTRAZENECA-2020SF40449,ASTRAZENECA,,69.0,YR,,F,Y,,,20201028.0,,,DE,DE,2020,Q4,Elderly
184387751,18438775,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q4,Glucose tolerance impaired,,2020,Q4,1,I,,20201023.0,20201028,20201028,EXP,,DE-ASTRAZENECA-2020SF40449,ASTRAZENECA,,69.0,YR,,F,Y,,,20201028.0,,,DE,DE,2020,Q4,Elderly
184387751,18438775,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2020,Q4,Low density lipoprotein increased,,2020,Q4,1,I,,20201023.0,20201028,20201028,EXP,,DE-ASTRAZENECA-2020SF40449,ASTRAZENECA,,69.0,YR,,F,Y,,,20201028.0,,,DE,DE,2020,Q4,Elderly
184391296,18439129,28,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,6,F,20201018.0,20201211.0,20201028,20201215,EXP,,US-GILEAD-2020-0501671,GILEAD,,77.0,YR,E,F,Y,59.41,KG,20201215.0,,HP,US,US,2020,Q4,Elderly
184461071,18446107,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG DAILY,,,,,,,,,,,,2020,Q4,Acute coronary syndrome,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,DE-ANIPHARMA-2020-DE-000251,ANI,,69.0,YR,,F,Y,,,20201030.0,,MD,DE,DE,2020,Q4,Elderly
184461071,18446107,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG DAILY,,,,,,,,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,DE-ANIPHARMA-2020-DE-000251,ANI,,69.0,YR,,F,Y,,,20201030.0,,MD,DE,DE,2020,Q4,Elderly
184461071,18446107,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG DAILY,,,,,,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,DE-ANIPHARMA-2020-DE-000251,ANI,,69.0,YR,,F,Y,,,20201030.0,,MD,DE,DE,2020,Q4,Elderly
184461071,18446107,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG DAILY,,,,,,,,,,,,2020,Q4,Blood pressure increased,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,DE-ANIPHARMA-2020-DE-000251,ANI,,69.0,YR,,F,Y,,,20201030.0,,MD,DE,DE,2020,Q4,Elderly
184461071,18446107,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG DAILY,,,,,,,,,,,,2020,Q4,Chest pain,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,DE-ANIPHARMA-2020-DE-000251,ANI,,69.0,YR,,F,Y,,,20201030.0,,MD,DE,DE,2020,Q4,Elderly
184461071,18446107,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG DAILY,,,,,,,,,,,,2020,Q4,Dyspnoea exertional,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,DE-ANIPHARMA-2020-DE-000251,ANI,,69.0,YR,,F,Y,,,20201030.0,,MD,DE,DE,2020,Q4,Elderly
184461071,18446107,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG DAILY,,,,,,,,,,,,2020,Q4,Glucose tolerance impaired,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,DE-ANIPHARMA-2020-DE-000251,ANI,,69.0,YR,,F,Y,,,20201030.0,,MD,DE,DE,2020,Q4,Elderly
184461071,18446107,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG DAILY,,,,,,,,,,,,2020,Q4,Low density lipoprotein increased,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,DE-ANIPHARMA-2020-DE-000251,ANI,,69.0,YR,,F,Y,,,20201030.0,,MD,DE,DE,2020,Q4,Elderly
184464711,18446471,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Subcutaneous,"25 MG, QD",,,,,,,,25.0,MG,INJECTION,QD,2020,Q4,Cholelithiasis,,2020,Q4,1,I,20200912.0,20201020.0,20201030,20201030,EXP,,AU-INTERCEPT-CT2020002138,INTERCEPT PHARMACEUTICALS,,67.0,YR,,M,Y,93.0,KG,20201030.0,,MD,AU,AU,2020,Q4,Elderly
184519041,18451904,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Alpha hydroxybutyrate dehydrogenase increased,,2020,Q4,1,I,20201030.0,,20201030,20201030,DIR,,,FDA-CTU,,45.0,YR,,F,N,,,20201030.0,N,PH,AL,AL,2020,Q4,Adult
184519041,18451904,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Anion gap abnormal,,2020,Q4,1,I,20201030.0,,20201030,20201030,DIR,,,FDA-CTU,,45.0,YR,,F,N,,,20201030.0,N,PH,AL,AL,2020,Q4,Adult
184519041,18451904,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,20201030.0,,20201030,20201030,DIR,,,FDA-CTU,,45.0,YR,,F,N,,,20201030.0,N,PH,AL,AL,2020,Q4,Adult
184531541,18453154,8,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Arthralgia,,2020,Q4,1,I,20200921.0,,20201102,20201102,DIR,,,FDA-CTU,,79.0,YR,,M,N,85.0,KG,20201102.0,N,PH,US,US,2020,Q4,Elderly
184531541,18453154,8,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Erythema,,2020,Q4,1,I,20200921.0,,20201102,20201102,DIR,,,FDA-CTU,,79.0,YR,,M,N,85.0,KG,20201102.0,N,PH,US,US,2020,Q4,Elderly
184531541,18453154,8,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Muscle rupture,,2020,Q4,1,I,20200921.0,,20201102,20201102,DIR,,,FDA-CTU,,79.0,YR,,M,N,85.0,KG,20201102.0,N,PH,US,US,2020,Q4,Elderly
184531541,18453154,8,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Tendonitis,,2020,Q4,1,I,20200921.0,,20201102,20201102,DIR,,,FDA-CTU,,79.0,YR,,M,N,85.0,KG,20201102.0,N,PH,US,US,2020,Q4,Elderly
184582162,18458216,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,TABLET,QD,2020,Q4,Atrioventricular block first degree,,2020,Q4,2,F,,20201022.0,20201103,20201105,EXP,,NVSC2020RS288210,NOVARTIS,,71.0,YR,,M,Y,,,20201105.0,,MD,RS,RS,2020,Q4,Elderly
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Candida infection,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Candida sepsis,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Coagulation test abnormal,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Coagulopathy,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Emphysematous pyelonephritis,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Oliguria,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Perinephric abscess,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Pyelonephritis fungal,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Systemic candida,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Urinary tract infection enterococcal,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184614681,18461468,4,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2020,Q4,Vesicoureteric reflux,,2020,Q4,1,I,,20201030.0,20201104,20201104,EXP,ES-EMA-DD-20201029-PAWAR_P-112841,ES-ACCORD-207265,ACCORD,,56.0,YR,A,F,Y,,,20201104.0,,HP,ES,ES,2020,Q4,Adult
184616131,18461613,22,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 12.5/1000 MG,,,,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184616131,18461613,22,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 12.5/1000 MG,,,,,,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184616131,18461613,22,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 12.5/1000 MG,,,,,,,,,,,,2020,Q4,Cardioversion,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184616131,18461613,22,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 12.5/1000 MG,,,,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184616131,18461613,22,C,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,2 X 12.5/1000 MG,,,,,,,,,,,,2020,Q4,Weight decreased,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184670381,18467038,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q4,Dehydration,,2020,Q4,1,I,20200801.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20200831.0,N,PH,US,US,2020,Q4,Elderly
184670381,18467038,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q4,Dizziness,,2020,Q4,1,I,20200801.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20200831.0,N,PH,US,US,2020,Q4,Elderly
184670381,18467038,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q4,Loss of consciousness,,2020,Q4,1,I,20200801.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20200831.0,N,PH,US,US,2020,Q4,Elderly
184670381,18467038,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2020,Q4,Urinary tract infection,,2020,Q4,1,I,20200801.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20200831.0,N,PH,US,US,2020,Q4,Elderly
184671341,18467134,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20200520.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,261.0,KG,20200626.0,N,PH,US,US,2020,Q4,Adult
184671341,18467134,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Blood urea increased,,2020,Q4,1,I,20200520.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,261.0,KG,20200626.0,N,PH,US,US,2020,Q4,Adult
184671341,18467134,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Hypovolaemia,,2020,Q4,1,I,20200520.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,261.0,KG,20200626.0,N,PH,US,US,2020,Q4,Adult
184671341,18467134,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Syncope,,2020,Q4,1,I,20200520.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,261.0,KG,20200626.0,N,PH,US,US,2020,Q4,Adult
184676781,18467678,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,25.0,MG,,QD,2020,Q4,Anal abscess,,2020,Q4,1,I,20200916.0,,20201104,20201104,DIR,,,FDA-CTU,,52.0,YR,,M,N,141.0,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184676781,18467678,1,PS,EMPAGLIFLOZIN (EMPAGLIFOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,?          OTHER FREQUENCY:AM;?,,,,,,,,25.0,MG,,QD,2020,Q4,Skin exfoliation,,2020,Q4,1,I,20200916.0,,20201104,20201104,DIR,,,FDA-CTU,,52.0,YR,,M,N,141.0,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184679991,18467999,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200826.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Elderly
184679991,18467999,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20200826.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Elderly
184679991,18467999,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Blood urea increased,,2020,Q4,1,I,20200826.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Elderly
184679991,18467999,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,20200826.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Elderly
184693322,18469332,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,,,FILM-COATED TABLET,,2020,Q4,Acute hepatic failure,,2020,Q4,2,F,20201014.0,20201110.0,20201105,20201118,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-059574",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,55.0,KG,20201118.0,,MD,DE,DE,2020,Q4,Elderly
184693322,18469332,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,,,FILM-COATED TABLET,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20201014.0,20201110.0,20201105,20201118,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-059574",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,55.0,KG,20201118.0,,MD,DE,DE,2020,Q4,Elderly
184693322,18469332,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,N,,,,,,,FILM-COATED TABLET,,2020,Q4,Acute myocardial infarction,,2020,Q4,2,F,20201014.0,20201110.0,20201105,20201118,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-059574",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,55.0,KG,20201118.0,,MD,DE,DE,2020,Q4,Elderly
184722331,18472233,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETS",,,,,,,,,,TABLET,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201031.0,20201106,20201106,EXP,DE-BFARM-20011875,DE-ACCORD-207482,ACCORD,,68.0,YR,E,M,Y,99.0,KG,20201106.0,,PH,DE,DE,2020,Q4,Elderly
184722331,18472233,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETS",,,,,,,,,,TABLET,,2020,Q4,Cough,,2020,Q4,1,I,,20201031.0,20201106,20201106,EXP,DE-BFARM-20011875,DE-ACCORD-207482,ACCORD,,68.0,YR,E,M,Y,99.0,KG,20201106.0,,PH,DE,DE,2020,Q4,Elderly
184722331,18472233,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETS",,,,,,,,,,TABLET,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201031.0,20201106,20201106,EXP,DE-BFARM-20011875,DE-ACCORD-207482,ACCORD,,68.0,YR,E,M,Y,99.0,KG,20201106.0,,PH,DE,DE,2020,Q4,Elderly
184741101,18474110,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,20201101.0,,20201106,20201106,DIR,,,FDA-CTU,,54.0,YR,,M,N,97.6,KG,20201106.0,Y,,US,US,2020,Q4,Adult
184741101,18474110,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q4,Hypertensive urgency,,2020,Q4,1,I,20201101.0,,20201106,20201106,DIR,,,FDA-CTU,,54.0,YR,,M,N,97.6,KG,20201106.0,Y,,US,US,2020,Q4,Adult
184741101,18474110,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q4,Pancreatitis acute,,2020,Q4,1,I,20201101.0,,20201106,20201106,DIR,,,FDA-CTU,,54.0,YR,,M,N,97.6,KG,20201106.0,Y,,US,US,2020,Q4,Adult
184810952,18481095,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Retinal haemorrhage,,2020,Q4,2,F,,20201028.0,20201109,20201119,EXP,,US-BAYER-2020-240281,BAYER,KATARIA CHANPREET OD. PLUGGED: HOLLENHORST PLAQUES MIMICKING GLAUCOMA. 2020 ANNUAL MEETING OF THE AMERICAN ACADEMY OF OPTOMETRY. 2020;XX:ABSTR 096 R2020105,68.0,YR,E,M,Y,,,20201119.0,,HP,US,US,2020,Q4,Elderly
184821751,18482175,10,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2020,Q4,Cataract,,2020,Q4,1,I,20201019.0,20201104.0,20201110,20201110,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,60.0,YR,,F,Y,,,20201109.0,,MD,JP,JP,2020,Q4,Adult
184922111,18492211,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY 1-0-0-0",,,,,,,,10.0,MG,TABLET,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201109.0,20201111,20201111,EXP,DE-ADRED-05681-01,DE-PFIZER INC-2020442910,PFIZER,,68.0,YR,,M,Y,99.0,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184922111,18492211,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY 1-0-0-0",,,,,,,,10.0,MG,TABLET,QD,2020,Q4,Cough,,2020,Q4,1,I,,20201109.0,20201111,20201111,EXP,DE-ADRED-05681-01,DE-PFIZER INC-2020442910,PFIZER,,68.0,YR,,M,Y,99.0,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184922111,18492211,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY 1-0-0-0",,,,,,,,10.0,MG,TABLET,QD,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201109.0,20201111,20201111,EXP,DE-ADRED-05681-01,DE-PFIZER INC-2020442910,PFIZER,,68.0,YR,,M,Y,99.0,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Arthralgia,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Back pain,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Bacterial test positive,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Balanoposthitis,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Blood glucose abnormal,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Diabetes mellitus,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Dizziness,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Dysuria,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Emotional distress,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Erectile dysfunction,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Fall,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Fatigue,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Flank pain,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Gastrointestinal disorder,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Glycosylated haemoglobin abnormal,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Groin pain,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Haematoma,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Headache,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Herpes zoster,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Hypoaesthesia,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Incontinence,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Leukocyturia,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Loss of libido,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Malaise,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Nausea,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Osteoarthritis,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Pain in extremity,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Peripheral coldness,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Phimosis,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Plantar fasciitis,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Pollakiuria,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Pruritus,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Quality of life decreased,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Renal cyst,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Restlessness,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Sacroiliac joint dysfunction,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Stress urinary incontinence,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Urinary tract infection bacterial,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184922263,18492226,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Urine flow decreased,,2020,Q4,3,F,20140414.0,20201207.0,20201111,20201218,EXP,,NVSC2020DE140272,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
184952481,18495248,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM (1-0-0-0, TABLETTEN)",,,,,,,,10.0,MG,TABLET,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055970,AUROBINDO,,68.0,YR,,M,Y,99.0,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184952481,18495248,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM (1-0-0-0, TABLETTEN)",,,,,,,,10.0,MG,TABLET,,2020,Q4,Cough,,2020,Q4,1,I,,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055970,AUROBINDO,,68.0,YR,,M,Y,99.0,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184952481,18495248,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM (1-0-0-0, TABLETTEN)",,,,,,,,10.0,MG,TABLET,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055970,AUROBINDO,,68.0,YR,,M,Y,99.0,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184955251,18495525,1,PS,"EMPAGLIFLOZIN, JARDIANCE 25MG",EMPAGLIFLOZIN,1,Oral,?          QUANTITY:90 TABLET(S);?,,,Y,D, NA,20210825.0,999999.0,,,,,2020,Q4,Groin pain,,2020,Q4,1,I,20201023.0,,20201112,20201112,DIR,,,FDA-CTU,,48.0,YR,,M,N,101.25,KG,20201112.0,N,CN,US,US,2020,Q4,Adult
184955251,18495525,1,PS,"EMPAGLIFLOZIN, JARDIANCE 25MG",EMPAGLIFLOZIN,1,Oral,?          QUANTITY:90 TABLET(S);?,,,Y,D, NA,20210825.0,999999.0,,,,,2020,Q4,Pain of skin,,2020,Q4,1,I,20201023.0,,20201112,20201112,DIR,,,FDA-CTU,,48.0,YR,,M,N,101.25,KG,20201112.0,N,CN,US,US,2020,Q4,Adult
184955251,18495525,1,PS,"EMPAGLIFLOZIN, JARDIANCE 25MG",EMPAGLIFLOZIN,1,Oral,?          QUANTITY:90 TABLET(S);?,,,Y,D, NA,20210825.0,999999.0,,,,,2020,Q4,Pruritus,,2020,Q4,1,I,20201023.0,,20201112,20201112,DIR,,,FDA-CTU,,48.0,YR,,M,N,101.25,KG,20201112.0,N,CN,US,US,2020,Q4,Adult
184955251,18495525,1,PS,"EMPAGLIFLOZIN, JARDIANCE 25MG",EMPAGLIFLOZIN,1,Oral,?          QUANTITY:90 TABLET(S);?,,,Y,D, NA,20210825.0,999999.0,,,,,2020,Q4,Skin irritation,,2020,Q4,1,I,20201023.0,,20201112,20201112,DIR,,,FDA-CTU,,48.0,YR,,M,N,101.25,KG,20201112.0,N,CN,US,US,2020,Q4,Adult
185002711,18500271,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLET",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201104.0,20201113,20201113,PER,,DE-DRREDDYS-GER/GER/20/0128803,DR REDDYS,,68.0,YR,E,M,Y,99.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185002711,18500271,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLET",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q4,Cough,,2020,Q4,1,I,,20201104.0,20201113,20201113,PER,,DE-DRREDDYS-GER/GER/20/0128803,DR REDDYS,,68.0,YR,E,M,Y,99.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185002711,18500271,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLET",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201104.0,20201113,20201113,PER,,DE-DRREDDYS-GER/GER/20/0128803,DR REDDYS,,68.0,YR,E,M,Y,99.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185003641,18500364,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD (1-0-0-0)",,,U,, UNK,,,10.0,MG,TABLET,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298565,NOVARTIS,,68.0,YR,,M,Y,99.0,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185003641,18500364,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD (1-0-0-0)",,,U,, UNK,,,10.0,MG,TABLET,QD,2020,Q4,Cough,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298565,NOVARTIS,,68.0,YR,,M,Y,99.0,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185003641,18500364,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,"10 MG, QD (1-0-0-0)",,,U,, UNK,,,10.0,MG,TABLET,QD,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298565,NOVARTIS,,68.0,YR,,M,Y,99.0,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185016751,18501675,6,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Pemphigoid,,2020,Q4,1,I,,20201101.0,20201113,20201113,EXP,,TH-ACCORD-208086,ACCORD,"THEWJITCHAROEN Y, WANOTHAYAROJ E, THAMMAWIWAT C, PORRAMATIKUL S, VORAYINGYONG C, NAKASATIEN S ET AL. CLINICAL FEATURES AND OUTCOMES OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR-ASSOCIATED BULLOUS PEMPHIGOID (DPP4I-ASSOCIATED BP) IN THAI PATIENTS. CASE REP ENDOCRINOL. 2020 OCT 10;2020:8832643.",74.0,YR,,M,Y,,,20201113.0,,HP,TH,TH,2020,Q4,Elderly
185074611,18507461,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2020,Q4,Balanoposthitis,,2020,Q4,1,I,20201022.0,,20201116,20201116,DIR,,,FDA-CTU,,46.0,YR,,M,N,,,20201116.0,N,PH,US,US,2020,Q4,Adult
185099801,18509980,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM DAILY;  1-0-0-0,",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848290,TEVA,,68.0,YR,E,M,Y,99.0,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185099801,18509980,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM DAILY;  1-0-0-0,",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q4,Cough,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848290,TEVA,,68.0,YR,E,M,Y,99.0,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185099801,18509980,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MILLIGRAM DAILY;  1-0-0-0,",,,,, UNKNOWN,,,10.0,MG,TABLET,QD,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848290,TEVA,,68.0,YR,E,M,Y,99.0,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185100641,18510064,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN ()",,,U,,,,,,,TABLET,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201103.0,20201117,20201117,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267739,RANBAXY,,68.0,YR,,M,Y,99.0,KG,20201117.0,,HP,NL,DE,2020,Q4,Elderly
185100641,18510064,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN ()",,,U,,,,,,,TABLET,,2020,Q4,Cough,,2020,Q4,1,I,,20201103.0,20201117,20201117,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267739,RANBAXY,,68.0,YR,,M,Y,99.0,KG,20201117.0,,HP,NL,DE,2020,Q4,Elderly
185100641,18510064,5,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN ()",,,U,,,,,,,TABLET,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201103.0,20201117,20201117,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267739,RANBAXY,,68.0,YR,,M,Y,99.0,KG,20201117.0,,HP,NL,DE,2020,Q4,Elderly
185102971,18510297,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20201115.0,,20201116,20201116,DIR,,,FDA-CTU,,54.0,YR,,F,N,75.0,KG,20201116.0,N,PH,US,US,2020,Q4,Adult
185102971,18510297,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q4,Blood potassium decreased,,2020,Q4,1,I,20201115.0,,20201116,20201116,DIR,,,FDA-CTU,,54.0,YR,,F,N,75.0,KG,20201116.0,N,PH,US,US,2020,Q4,Adult
185102971,18510297,1,PS,empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,20201115.0,,20201116,20201116,DIR,,,FDA-CTU,,54.0,YR,,F,N,75.0,KG,20201116.0,N,PH,US,US,2020,Q4,Adult
185164461,18516446,1,PS,Empagliflozin,EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,,QD,2020,Q4,Fournier's gangrene,,2020,Q4,1,I,20201101.0,,20201118,20201118,DIR,,,FDA-CTU,,61.0,YR,,F,N,86.2,KG,20201118.0,N,PH,US,US,2020,Q4,Adult
185196902,18519690,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG,,,,,,,,10.0,MG,ORAL DRUG UNSPECIFIED FORM,,2020,Q4,Pyelonephritis,,2020,Q4,2,F,,20201112.0,20201118,20201119,EXP,,JP-009507513-2011JPN010413,MERCK,,56.0,YR,,F,Y,,,20201119.0,,MD,JP,JP,2020,Q4,Adult
185196902,18519690,3,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,10 MG,,,,,,,,10.0,MG,ORAL DRUG UNSPECIFIED FORM,,2020,Q4,Weight increased,,2020,Q4,2,F,,20201112.0,20201118,20201119,EXP,,JP-009507513-2011JPN010413,MERCK,,56.0,YR,,F,Y,,,20201119.0,,MD,JP,JP,2020,Q4,Adult
185207762,18520776,2,SS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,2,F,,20201109.0,20201119,20201208,EXP,,JP-009507513-2011JPN001247J,MERCK,"WATANABE K, MAKITA A, NAKAMURA R, HAYAKAWA N, MIYASHITA K, OKAZAKI M.. 7-03 A CASE OF TYPE 2 DIABETES MELLITUS WITH EUGLYCAEMIC KETOSIS DUE TO SGLT2 INHIBITOR AND CARBOHYDRATE RESTRICTION.. THE 58TH ANNUAL MEETING OF THE CHUGOKU/SHIKOKU DIVISION OF THE JAPAN DIABETES. 46",54.0,YR,,M,Y,,,20201208.0,,MD,JP,JP,2020,Q4,Adult
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Arrhythmia,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Arthralgia,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Back pain,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Bacterial test positive,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Balanoposthitis,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Blood glucose abnormal,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Diabetes mellitus,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Dizziness,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Dysuria,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Emotional distress,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Erectile dysfunction,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Fall,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Fatigue,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Flank pain,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Gastrointestinal disorder,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Glycosylated haemoglobin abnormal,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Groin pain,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Haematoma,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Headache,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Herpes zoster,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Hypoaesthesia,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Incontinence,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Leukocyturia,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Loss of libido,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Malaise,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Nausea,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Osteoarthritis,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Pain in extremity,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Peripheral coldness,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Phimosis,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Plantar fasciitis,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Pollakiuria,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Pruritus,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Quality of life decreased,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Renal cyst,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Restlessness,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Sacroiliac joint dysfunction,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Stress urinary incontinence,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Urinary tract infection bacterial,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185387164,18538716,20,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"UNK, ONCE A DAY (1-0-0-0), IN MORNING )",,,U,,,,,,,TABLET,QD,2020,Q4,Urine flow decreased,,2020,Q4,4,F,20140414.0,20201224.0,20201124,20201231,EXP,,DE-AUROBINDO-AUR-APL-2020-026873,AUROBINDO,,65.0,YR,,M,Y,134.0,KG,20201231.0,,CN,DE,DE,2020,Q4,Elderly
185440831,18544083,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Chills,,2020,Q4,1,I,,20190622.0,20201125,20201125,EXP,,CA-APOTEX-2019AP017387,APOTEX,,66.0,YR,,M,Y,,,20201125.0,,CN,CA,CA,2020,Q4,Elderly
185440831,18544083,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,1,I,,20190622.0,20201125,20201125,EXP,,CA-APOTEX-2019AP017387,APOTEX,,66.0,YR,,M,Y,,,20201125.0,,CN,CA,CA,2020,Q4,Elderly
185440831,18544083,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20190622.0,20201125,20201125,EXP,,CA-APOTEX-2019AP017387,APOTEX,,66.0,YR,,M,Y,,,20201125.0,,CN,CA,CA,2020,Q4,Elderly
185456521,18545652,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Acute coronary syndrome,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096335,MYLAN,,69.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185456521,18545652,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096335,MYLAN,,69.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185456521,18545652,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096335,MYLAN,,69.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185456521,18545652,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Blood pressure increased,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096335,MYLAN,,69.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185456521,18545652,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Chest pain,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096335,MYLAN,,69.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185456521,18545652,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Dyspnoea exertional,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096335,MYLAN,,69.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185456521,18545652,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Glucose tolerance impaired,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096335,MYLAN,,69.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185456521,18545652,15,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Low density lipoprotein increased,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096335,MYLAN,,69.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185459531,18545953,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q4,Ageusia,,2020,Q4,1,I,2020.0,20201123.0,20201125,20201125,EXP,,AU-KOWA-20US003868,KOWA PHARM,TIMOTHY M.E. DAVIS. FENOFIBRATE AND IMPAIRED TASTE PERCEPTION IN TYPE 2 DIABETES. AMERICAN JOURNAL OF CASE REPORTS. 2020;21:E927647 (1-4),65.0,YR,,F,Y,80.0,KG,20201125.0,,HP,AU,US,2020,Q4,Elderly
185459531,18545953,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2020,Q4,Taste disorder,,2020,Q4,1,I,2020.0,20201123.0,20201125,20201125,EXP,,AU-KOWA-20US003868,KOWA PHARM,TIMOTHY M.E. DAVIS. FENOFIBRATE AND IMPAIRED TASTE PERCEPTION IN TYPE 2 DIABETES. AMERICAN JOURNAL OF CASE REPORTS. 2020;21:E927647 (1-4),65.0,YR,,F,Y,80.0,KG,20201125.0,,HP,AU,US,2020,Q4,Elderly
185490521,18549052,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Application site haematoma,,2020,Q4,1,I,20200921.0,20201120.0,20201126,20201126,EXP,GB-MHRA-EYC 00232893,GB-STRIDES ARCOLAB LIMITED-2020SP014576,STRIDES,,69.0,YR,,M,Y,122.0,KG,20201126.0,,,NL,GB,2020,Q4,Elderly
185543851,18554385,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Application site haematoma,,2020,Q4,1,I,20200921.0,20201123.0,20201127,20201127,EXP,GB-MHRA-EYC 00232893,NVSC2020GB314190,NOVARTIS,,69.0,YR,,M,Y,122.0,KG,20201127.0,,HP,GB,GB,2020,Q4,Elderly
185579411,18557941,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Application site haematoma,,2020,Q4,1,I,20200921.0,20201120.0,20201130,20201130,EXP,,GB-AUROBINDO-AUR-APL-2020-058501,AUROBINDO,,69.0,YR,,M,Y,122.0,KG,20201130.0,,PH,GB,GB,2020,Q4,Elderly
185613121,18561312,9,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Acquired phimosis,,2020,Q4,1,I,20180823.0,20181218.0,20201130,20201130,EXP,,"CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-061001",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,120.0,KG,20201130.0,,MD,CZ,CZ,2020,Q4,Elderly
185613121,18561312,9,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Prostate cancer,,2020,Q4,1,I,20180823.0,20181218.0,20201130,20201130,EXP,,"CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-061001",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,120.0,KG,20201130.0,,MD,CZ,CZ,2020,Q4,Elderly
185626111,18562611,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hyperpyrexia,,2020,Q4,1,I,,20201117.0,20201130,20201130,EXP,,US-HQ SPECIALTY-US-2020INT000144,HQ SPECIALTY,"CZEPIEL K, LUCAS A. DEXMEDETOMIDINE-ASSOCIATED HYPERPYREXIA IN THREE CRITICALLY ILL PATIENTS WITH CORONAVIRUS DISEASE 2019.. CRIT CARE EXPLOR. 2020;2(9):E0213",46.0,YR,,M,Y,,,20201130.0,,HP,US,US,2020,Q4,Adult
185626111,18562611,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Intensive care unit acquired weakness,,2020,Q4,1,I,,20201117.0,20201130,20201130,EXP,,US-HQ SPECIALTY-US-2020INT000144,HQ SPECIALTY,"CZEPIEL K, LUCAS A. DEXMEDETOMIDINE-ASSOCIATED HYPERPYREXIA IN THREE CRITICALLY ILL PATIENTS WITH CORONAVIRUS DISEASE 2019.. CRIT CARE EXPLOR. 2020;2(9):E0213",46.0,YR,,M,Y,,,20201130.0,,HP,US,US,2020,Q4,Adult
185626111,18562611,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Overdose,,2020,Q4,1,I,,20201117.0,20201130,20201130,EXP,,US-HQ SPECIALTY-US-2020INT000144,HQ SPECIALTY,"CZEPIEL K, LUCAS A. DEXMEDETOMIDINE-ASSOCIATED HYPERPYREXIA IN THREE CRITICALLY ILL PATIENTS WITH CORONAVIRUS DISEASE 2019.. CRIT CARE EXPLOR. 2020;2(9):E0213",46.0,YR,,M,Y,,,20201130.0,,HP,US,US,2020,Q4,Adult
185665561,18566556,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Application site haematoma,,2020,Q4,1,I,20200921.0,20201120.0,20201201,20201201,EXP,,"GB-CANTON LABORATORIES, LLC-2096507",CANTON LABORATORIES,,69.0,YR,,M,Y,,,20201201.0,,HP,GB,GB,2020,Q4,Elderly
185741931,18574193,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q4,Dysuria,,2020,Q4,1,I,20200630.0,,20201202,20201202,DIR,,,FDA-CTU,,68.0,YR,,M,N,122.47,KG,20200819.0,N,PH,US,US,2020,Q4,Elderly
185741931,18574193,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,,,,,25.0,MG,,QD,2020,Q4,Pyelonephritis,,2020,Q4,1,I,20200630.0,,20201202,20201202,DIR,,,FDA-CTU,,68.0,YR,,M,N,122.47,KG,20200819.0,N,PH,US,US,2020,Q4,Elderly
185750271,18575027,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Haematoma,,2020,Q4,1,I,20200921.0,20201127.0,20201203,20201203,EXP,GB-MHRA-EYC 00232893,GB-PFIZER INC-2020470281,PFIZER,,69.0,YR,,M,Y,122.0,KG,20201203.0,,PH,GB,GB,2020,Q4,Elderly
185750271,18575027,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,1,I,20200921.0,20201127.0,20201203,20201203,EXP,GB-MHRA-EYC 00232893,GB-PFIZER INC-2020470281,PFIZER,,69.0,YR,,M,Y,122.0,KG,20201203.0,,PH,GB,GB,2020,Q4,Elderly
185750911,18575091,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,TABLET,QD,2020,Q4,Fournier's gangrene,,2020,Q4,1,I,20200910.0,,20201202,20201202,DIR,,,FDA-CTU,,60.0,YR,,M,N,107.05,KG,20201113.0,N,PH,US,US,2020,Q4,Adult
185750911,18575091,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,TABLET,QD,2020,Q4,Necrotising fasciitis,,2020,Q4,1,I,20200910.0,,20201202,20201202,DIR,,,FDA-CTU,,60.0,YR,,M,N,107.05,KG,20201113.0,N,PH,US,US,2020,Q4,Adult
185750911,18575091,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,25.0,MG,TABLET,QD,2020,Q4,Septic shock,,2020,Q4,1,I,20200910.0,,20201202,20201202,DIR,,,FDA-CTU,,60.0,YR,,M,N,107.05,KG,20201113.0,N,PH,US,US,2020,Q4,Adult
185755601,18575560,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Abdominal distension,,2020,Q4,1,I,20200729.0,,20201202,20201202,DIR,,,FDA-CTU,,47.0,YR,,M,N,104.0,KG,20201018.0,N,PH,US,US,2020,Q4,Adult
185755601,18575560,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Malaise,,2020,Q4,1,I,20200729.0,,20201202,20201202,DIR,,,FDA-CTU,,47.0,YR,,M,N,104.0,KG,20201018.0,N,PH,US,US,2020,Q4,Adult
185755601,18575560,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,20200729.0,,20201202,20201202,DIR,,,FDA-CTU,,47.0,YR,,M,N,104.0,KG,20201018.0,N,PH,US,US,2020,Q4,Adult
185755601,18575560,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,20200729.0,,20201202,20201202,DIR,,,FDA-CTU,,47.0,YR,,M,N,104.0,KG,20201018.0,N,PH,US,US,2020,Q4,Adult
185782251,18578225,11,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,SARS-CoV-2 test positive,,2020,Q4,1,I,20200503.0,20201127.0,20201204,20201204,PER,,GB-AMGEN-GBRSP2020194253,AMGEN,,50.0,YR,A,F,Y,113.0,KG,20201204.0,,HP,GB,GB,2020,Q4,Adult
185783591,18578359,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200918.0,,20201202,20201202,DIR,,,FDA-CTU,,74.0,YR,,M,N,,,20201119.0,N,PH,US,US,2020,Q4,Elderly
185783591,18578359,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,,,,,,12.5,MG,,QD,2020,Q4,Renal impairment,,2020,Q4,1,I,20200918.0,,20201202,20201202,DIR,,,FDA-CTU,,74.0,YR,,M,N,,,20201119.0,N,PH,US,US,2020,Q4,Elderly
185786171,18578617,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Application site haematoma,,2020,Q4,1,I,20200921.0,20201126.0,20201204,20201204,EXP,GB-MHRA-EYC 00232893,GB-TEVA-2020-GB-1854595,TEVA,,69.0,YR,E,M,Y,122.0,KG,20201204.0,,PH,GB,GB,2020,Q4,Elderly
185800831,18580083,1,PS,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204629.0,,,FILM-COATED TABLET,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,20200916.0,20201129.0,20201204,20201204,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-065004",BOEHRINGER INGELHEIM,,76.0,YR,E,F,Y,,,20201204.0,,MD,CN,CN,2020,Q4,Elderly
185817421,18581742,3,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,20200219.0,,20201203,20201203,DIR,,,FDA-CTU,,55.0,YR,,F,N,105.0,KG,20201203.0,N,PH,US,US,2020,Q4,Adult
185817421,18581742,3,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200219.0,,20201203,20201203,DIR,,,FDA-CTU,,55.0,YR,,F,N,105.0,KG,20201203.0,N,PH,US,US,2020,Q4,Adult
185817421,18581742,3,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Paraesthesia oral,,2020,Q4,1,I,20200219.0,,20201203,20201203,DIR,,,FDA-CTU,,55.0,YR,,F,N,105.0,KG,20201203.0,N,PH,US,US,2020,Q4,Adult
185817421,18581742,3,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Pharyngeal swelling,,2020,Q4,1,I,20200219.0,,20201203,20201203,DIR,,,FDA-CTU,,55.0,YR,,F,N,105.0,KG,20201203.0,N,PH,US,US,2020,Q4,Adult
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Atelectasis,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Chills,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Haemoptysis,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Headache,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Pain,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Pulmonary fibrosis,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Pulmonary oedema,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,7,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185943111,18594311,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (1X1 TABLET IN THE MORNING)",,,U,,,,,10.0,MG,,QD,2020,Q4,Malaise,,2020,Q4,1,I,,20201124.0,20201209,20201209,EXP,,NVSC2020PL318392,NOVARTIS,,58.0,YR,,M,Y,,,20201209.0,,MD,PL,PL,2020,Q4,Adult
185943111,18594311,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (1X1 TABLET IN THE MORNING)",,,U,,,,,10.0,MG,,QD,2020,Q4,Ventricular tachycardia,,2020,Q4,1,I,,20201124.0,20201209,20201209,EXP,,NVSC2020PL318392,NOVARTIS,,58.0,YR,,M,Y,,,20201209.0,,MD,PL,PL,2020,Q4,Adult
185988111,18598811,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,1 DOSAGE FORMS,240.0,DF,,, UNKNOWN,,,1.0,DF,,,2020,Q4,Rash macular,,2020,Q4,1,I,20201112.0,20201202.0,20201210,20201210,EXP,GB-MHRA-TPP48564040C955956YC1605205324699,GB-TEVA-2020-GB-1855863,TEVA,,70.0,YR,E,M,Y,72.0,KG,20201210.0,,MD,GB,GB,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Gastrointestinal inflammation,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Inflammatory marker increased,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Intestinal polyp,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Iron deficiency anaemia,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Rectal haemorrhage,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186064962,18606496,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Somnolence,,2020,Q4,2,F,20200719.0,20201227.0,20201211,20201231,EXP,,IL-TAKEDA-2020TUS032395,TAKEDA,,71.0,YR,,M,Y,78.0,KG,20201231.0,,CN,IL,IL,2020,Q4,Elderly
186124161,18612416,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2020,Q4,Application site haematoma,,2020,Q4,1,I,20200921.0,20201204.0,20201214,20201214,EXP,GB-MHRA-EYC 00232893,GB-MYLANLABS-2020M1101157,MYLAN,,69.0,YR,,M,Y,122.0,KG,20201214.0,,PH,GB,GB,2020,Q4,Elderly
186150861,18615086,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q4,Myalgia,,2020,Q4,1,I,,20201205.0,20201215,20201215,EXP,,GB-AUROBINDO-AUR-APL-2020-060708,AUROBINDO,,51.0,YR,,M,Y,101.6,KG,20201215.0,,CN,GB,GB,2020,Q4,Adult
186150861,18615086,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,,20201205.0,20201215,20201215,EXP,,GB-AUROBINDO-AUR-APL-2020-060708,AUROBINDO,,51.0,YR,,M,Y,101.6,KG,20201215.0,,CN,GB,GB,2020,Q4,Adult
186150861,18615086,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM,,,U,,,,,25.0,MG,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201205.0,20201215,20201215,EXP,,GB-AUROBINDO-AUR-APL-2020-060708,AUROBINDO,,51.0,YR,,M,Y,101.6,KG,20201215.0,,CN,GB,GB,2020,Q4,Adult
186169181,18616918,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,25.0,MG,,,2020,Q4,Myalgia,,2020,Q4,1,I,,20201207.0,20201215,20201215,EXP,GB-MHRA-EYC 00233766,GB-BIOCON-BCN-2020-001479,BIOCON,,51.0,YR,A,M,Y,101.6,KG,20201215.0,,CN,GB,GB,2020,Q4,Adult
186169181,18616918,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,25.0,MG,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,,20201207.0,20201215,20201215,EXP,GB-MHRA-EYC 00233766,GB-BIOCON-BCN-2020-001479,BIOCON,,51.0,YR,A,M,Y,101.6,KG,20201215.0,,CN,GB,GB,2020,Q4,Adult
186169181,18616918,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,25.0,MG,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201207.0,20201215,20201215,EXP,GB-MHRA-EYC 00233766,GB-BIOCON-BCN-2020-001479,BIOCON,,51.0,YR,A,M,Y,101.6,KG,20201215.0,,CN,GB,GB,2020,Q4,Adult
186171001,18617100,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,1,I,,20200721.0,20201215,20201215,PER,,PL-LUPIN PHARMACEUTICALS INC.-2020-04039,LUPIN,,42.0,YR,,M,Y,,,20201215.0,,HP,PL,PL,2020,Q4,Adult
186171001,18617100,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Myopathy,,2020,Q4,1,I,,20200721.0,20201215,20201215,PER,,PL-LUPIN PHARMACEUTICALS INC.-2020-04039,LUPIN,,42.0,YR,,M,Y,,,20201215.0,,HP,PL,PL,2020,Q4,Adult
186174421,18617442,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,U,,,,,25.0,MG,,,2020,Q4,Myalgia,,2020,Q4,1,I,,20201207.0,20201215,20201215,EXP,GB-MHRA-EYC 00233766,NVSC2020GB326077,NOVARTIS,,51.0,YR,,M,Y,101.6,KG,20201215.0,,HP,GB,GB,2020,Q4,Adult
186174421,18617442,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,U,,,,,25.0,MG,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,,20201207.0,20201215,20201215,EXP,GB-MHRA-EYC 00233766,NVSC2020GB326077,NOVARTIS,,51.0,YR,,M,Y,101.6,KG,20201215.0,,HP,GB,GB,2020,Q4,Adult
186174421,18617442,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,25 MG,,,U,,,,,25.0,MG,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201207.0,20201215,20201215,EXP,GB-MHRA-EYC 00233766,NVSC2020GB326077,NOVARTIS,,51.0,YR,,M,Y,101.6,KG,20201215.0,,HP,GB,GB,2020,Q4,Adult
186222711,18622271,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2020,Q4,Blood pressure systolic increased,,2020,Q4,1,I,,20201202.0,20201216,20201216,EXP,,NVSJ2020JP013608,NOVARTIS,,83.0,YR,,M,Y,,,20201216.0,,MD,JP,JP,2020,Q4,Elderly
186222711,18622271,17,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2020,Q4,Product use in unapproved indication,,2020,Q4,1,I,,20201202.0,20201216,20201216,EXP,,NVSJ2020JP013608,NOVARTIS,,83.0,YR,,M,Y,,,20201216.0,,MD,JP,JP,2020,Q4,Elderly
186226941,18622694,5,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"5 MG, BID",,,,, UNKNOWN,,,5.0,MG,,BID,2020,Q4,Pancreatic neuroendocrine tumour,,2020,Q4,1,I,20190705.0,20201207.0,20201216,20201216,EXP,ES-AEMPS-702575,ES-NOVOPROD-772574,NOVO NORDISK,,51.0,YR,,F,Y,80.0,KG,20201216.0,,PH,ES,ES,2020,Q4,Adult
186246102,18624610,7,SS,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,U,,,,,,,,2020,Q4,Aggression,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,7,SS,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,U,,,,,,,,2020,Q4,Agitation,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,7,SS,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,U,,,,,,,,2020,Q4,Communication disorder,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,7,SS,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,U,,,,,,,,2020,Q4,Confusional state,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,7,SS,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,U,,,,,,,,2020,Q4,Disorientation,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,7,SS,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,U,,,,,,,,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,7,SS,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,U,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,7,SS,EMPAGLIFLOZIN;METFORMIN,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,U,,,,,,,,2020,Q4,Mental disorder,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Akinesia,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Cardiac failure,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Decreased appetite,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Ejection fraction decreased,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Hepatic steatosis,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Iron deficiency anaemia,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Mitral valve incompetence,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Oedema peripheral,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Peripheral swelling,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Polyarthritis,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Ventricular hypokinesia,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Weight decreased,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186248051,18624805,12,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, BID",,,Y,,,,,10.0,MG,,BID,2020,Q4,Weight increased,,2020,Q4,1,I,2016.0,20201208.0,20201216,20201216,EXP,,NVSC2020PL329963,NOVARTIS,,55.0,YR,,M,Y,,,20201216.0,,MD,PL,PL,2020,Q4,Adult
186250701,18625070,6,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,5 MG EVERY 12 HOURS,,,,U,,,,5.0,MG,,Q12H,2020,Q4,Pancreatic neuroendocrine tumour,,2020,Q4,1,I,20190705.0,20201210.0,20201217,20201217,EXP,ES-AEMPS-702575,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-068050",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,80.0,KG,20201217.0,,PH,ES,ES,2020,Q4,Adult
186261171,18626117,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,Anaemia,,2020,Q4,1,I,,20201211.0,20201217,20201217,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-106092,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Elderly
186261171,18626117,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201211.0,20201217,20201217,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-106092,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Elderly
186261171,18626117,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201211.0,20201217,20201217,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-106092,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Elderly
186261171,18626117,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201211.0,20201217,20201217,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-106092,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Elderly
186261171,18626117,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,Pallor,,2020,Q4,1,I,,20201211.0,20201217,20201217,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-106092,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Elderly
186284211,18628421,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,,QD,2020,Q4,Fournier's gangrene,,2020,Q4,1,I,20201208.0,,20201216,20201216,DIR,,,FDA-CTU,,62.0,YR,,M,N,118.0,KG,20201214.0,N,PH,US,US,2020,Q4,Adult
186297521,18629752,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, EACH MORNING",,,U,,,,,25.0,MG,,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186297521,18629752,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, EACH MORNING",,,U,,,,,25.0,MG,,QD,2020,Q4,Dizziness,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186297521,18629752,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, EACH MORNING",,,U,,,,,25.0,MG,,QD,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186297521,18629752,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"25 MG, EACH MORNING",,,U,,,,,25.0,MG,,QD,2020,Q4,Fall,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186314041,18631404,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,25.0,MG,,,2020,Q4,Myalgia,,2020,Q4,1,I,,20201207.0,20201218,20201218,EXP,GB-MHRA-ADR 24537587,GB-ACCORD-211163,ACCORD,,51.0,YR,,M,Y,101.6,KG,20201218.0,,CN,GB,GB,2020,Q4,Adult
186314041,18631404,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,25.0,MG,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,,20201207.0,20201218,20201218,EXP,GB-MHRA-ADR 24537587,GB-ACCORD-211163,ACCORD,,51.0,YR,,M,Y,101.6,KG,20201218.0,,CN,GB,GB,2020,Q4,Adult
186314041,18631404,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,25.0,MG,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201207.0,20201218,20201218,EXP,GB-MHRA-ADR 24537587,GB-ACCORD-211163,ACCORD,,51.0,YR,,M,Y,101.6,KG,20201218.0,,CN,GB,GB,2020,Q4,Adult
186315991,18631599,14,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM (1-0-0-0),,,,,,,,25.0,MG,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186315991,18631599,14,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM (1-0-0-0),,,,,,,,25.0,MG,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186315991,18631599,14,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM (1-0-0-0),,,,,,,,25.0,MG,,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186315991,18631599,14,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,25 MILLIGRAM (1-0-0-0),,,,,,,,25.0,MG,,,2020,Q4,Fall,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186316061,18631606,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061411,AUROBINDO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186316061,18631606,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061411,AUROBINDO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186316061,18631606,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061411,AUROBINDO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186316061,18631606,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061411,AUROBINDO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186316061,18631606,13,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,10 MILLIGRAM (1-0-0-0),,,,,,,,10.0,MG,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061411,AUROBINDO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186337611,18633761,5,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Dermatitis exfoliative generalised,,2020,Q4,1,I,20201201.0,,20201218,20201218,DIR,,,FDA-CTU,,82.0,YR,,F,N,61.5,KG,20201218.0,N,PH,US,US,2020,Q4,Elderly
186337611,18633761,5,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Drug reaction with eosinophilia and systemic symptoms,,2020,Q4,1,I,20201201.0,,20201218,20201218,DIR,,,FDA-CTU,,82.0,YR,,F,N,61.5,KG,20201218.0,N,PH,US,US,2020,Q4,Elderly
186337611,18633761,5,C,empagliflozin,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Sensitive skin,,2020,Q4,1,I,20201201.0,,20201218,20201218,DIR,,,FDA-CTU,,82.0,YR,,F,N,61.5,KG,20201218.0,N,PH,US,US,2020,Q4,Elderly
186359881,18635988,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005972,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186359881,18635988,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005972,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186359881,18635988,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005972,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186359881,18635988,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005972,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186359881,18635988,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005972,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186371991,18637199,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK (ABGESETZT),,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186371991,18637199,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK (ABGESETZT),,,,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186371991,18637199,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK (ABGESETZT),,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186371991,18637199,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK (ABGESETZT),,,,,,,,,,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186371991,18637199,6,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNK (ABGESETZT),,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186391891,18639189,5,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,,,,,,,,,2020,Q4,Aggression,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,5,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,,,,,,,,,2020,Q4,Agitation,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,5,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,,,,,,,,,2020,Q4,Communication disorder,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,5,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,5,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,,,,,,,,,2020,Q4,Disorientation,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,5,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,,,,,,,,,2020,Q4,Hyperhidrosis,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,5,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,5,SS,empagliflozin (+) metformin hydrochloride,EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,U,,,,,,,,,2020,Q4,Mental disorder,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186411471,18641147,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,25 MG,,,,, UNKNOWN,,,25.0,MG,,,2020,Q4,Myalgia,,2020,Q4,1,I,,20201213.0,20201221,20201221,EXP,GB-MHRA-EYC 00233766,GB-TEVA-2020-GB-1859340,TEVA,,51.0,YR,A,M,Y,101.6,KG,20201221.0,,CN,GB,GB,2020,Q4,Adult
186411471,18641147,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,25 MG,,,,, UNKNOWN,,,25.0,MG,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,,20201213.0,20201221,20201221,EXP,GB-MHRA-EYC 00233766,GB-TEVA-2020-GB-1859340,TEVA,,51.0,YR,A,M,Y,101.6,KG,20201221.0,,CN,GB,GB,2020,Q4,Adult
186411471,18641147,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,25 MG,,,,, UNKNOWN,,,25.0,MG,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201213.0,20201221,20201221,EXP,GB-MHRA-EYC 00233766,GB-TEVA-2020-GB-1859340,TEVA,,51.0,YR,A,M,Y,101.6,KG,20201221.0,,CN,GB,GB,2020,Q4,Adult
186421151,18642115,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013227,DE-ACCORD-211584,ACCORD,,80.0,YR,E,F,Y,,,20201221.0,,MD,DE,DE,2020,Q4,Elderly
186421151,18642115,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013227,DE-ACCORD-211584,ACCORD,,80.0,YR,E,F,Y,,,20201221.0,,MD,DE,DE,2020,Q4,Elderly
186421151,18642115,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013227,DE-ACCORD-211584,ACCORD,,80.0,YR,E,F,Y,,,20201221.0,,MD,DE,DE,2020,Q4,Elderly
186421151,18642115,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013227,DE-ACCORD-211584,ACCORD,,80.0,YR,E,F,Y,,,20201221.0,,MD,DE,DE,2020,Q4,Elderly
186421151,18642115,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013227,DE-ACCORD-211584,ACCORD,,80.0,YR,E,F,Y,,,20201221.0,,MD,DE,DE,2020,Q4,Elderly
186423131,18642313,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186423131,18642313,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186423131,18642313,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186423131,18642313,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186423131,18642313,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186439551,18643955,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Diabetes mellitus,,2020,Q4,1,I,,20201215.0,20201221,20201221,EXP,,AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-107878,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,60.0,KG,20201221.0,,PH,AU,AU,2020,Q4,Elderly
186458671,18645867,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q4,Asthenia,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-107347,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186458671,18645867,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q4,Circulatory collapse,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-107347,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186458671,18645867,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-107347,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186458671,18645867,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-107347,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186458671,18645867,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q4,Headache,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-107347,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186458671,18645867,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2020,Q4,Hypotension,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-107347,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186462901,18646290,1,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,1.0,DF,,QD,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,GB-MHRA-TPP33309356C5995550YC1606487432798,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-068825",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,71.0,KG,20201222.0,,HP,GB,GB,2020,Q4,Adult
186462901,18646290,1,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,1.0,DF,,QD,2020,Q4,Lethargy,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,GB-MHRA-TPP33309356C5995550YC1606487432798,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-068825",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,71.0,KG,20201222.0,,HP,GB,GB,2020,Q4,Adult
186468331,18646833,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MILLIGRAM, UNK",,,U,,,,,25.0,MG,,,2020,Q4,Myalgia,,2020,Q4,1,I,,20201208.0,20201222,20201222,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-272352,RANBAXY,,51.0,YR,,M,Y,101.6,KG,20201222.0,,HP,NL,GB,2020,Q4,Adult
186468331,18646833,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MILLIGRAM, UNK",,,U,,,,,25.0,MG,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,,20201208.0,20201222,20201222,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-272352,RANBAXY,,51.0,YR,,M,Y,101.6,KG,20201222.0,,HP,NL,GB,2020,Q4,Adult
186468331,18646833,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MILLIGRAM, UNK",,,U,,,,,25.0,MG,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201208.0,20201222,20201222,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-272352,RANBAXY,,51.0,YR,,M,Y,101.6,KG,20201222.0,,HP,NL,GB,2020,Q4,Adult
186468541,18646854,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MILLIGRAM, QD (1-0-0-0)",,,,,,,,25.0,MG,,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186468541,18646854,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MILLIGRAM, QD (1-0-0-0)",,,,,,,,25.0,MG,,QD,2020,Q4,Dizziness,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186468541,18646854,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MILLIGRAM, QD (1-0-0-0)",,,,,,,,25.0,MG,,QD,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186468541,18646854,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MILLIGRAM, QD (1-0-0-0)",,,,,,,,25.0,MG,,QD,2020,Q4,Fall,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186490401,18649040,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 10MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Fournier's gangrene,,2020,Q4,1,I,20201006.0,,20201221,20201221,DIR,,,FDA-CTU,,57.0,YR,,M,N,,,20201113.0,N,PH,US,US,2020,Q4,Adult
186492631,18649263,1,PS,EMPAGLIFLOZIN (EMPAGLIFLOZIN 25MG TAB),EMPAGLIFLOZIN,1,,,,,,,,,,,,TABLET,,2020,Q4,Pollakiuria,,2020,Q4,1,I,20200623.0,,20201221,20201221,DIR,,,FDA-CTU,,62.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q4,Adult
186499021,18649902,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,,DE-ASTRAZENECA-2020SF67472,ASTRAZENECA,,64.0,YR,,F,Y,88.0,KG,20201222.0,,,US,DE,2020,Q4,Adult
186499021,18649902,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,,DE-ASTRAZENECA-2020SF67472,ASTRAZENECA,,64.0,YR,,F,Y,88.0,KG,20201222.0,,,US,DE,2020,Q4,Adult
186499021,18649902,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,,DE-ASTRAZENECA-2020SF67472,ASTRAZENECA,,64.0,YR,,F,Y,88.0,KG,20201222.0,,,US,DE,2020,Q4,Adult
186499021,18649902,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,,DE-ASTRAZENECA-2020SF67472,ASTRAZENECA,,64.0,YR,,F,Y,88.0,KG,20201222.0,,,US,DE,2020,Q4,Adult
186499021,18649902,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,DISCONTINUED,,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,,DE-ASTRAZENECA-2020SF67472,ASTRAZENECA,,64.0,YR,,F,Y,88.0,KG,20201222.0,,,US,DE,2020,Q4,Adult
186499821,18649982,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,Anaemia,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,DE-ADRED-06119-01,NVSC2020DE332297,NOVARTIS,,80.0,YR,,F,Y,,,20201222.0,,HP,DE,DE,2020,Q4,Elderly
186499821,18649982,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,DE-ADRED-06119-01,NVSC2020DE332297,NOVARTIS,,80.0,YR,,F,Y,,,20201222.0,,HP,DE,DE,2020,Q4,Elderly
186499821,18649982,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,DE-ADRED-06119-01,NVSC2020DE332297,NOVARTIS,,80.0,YR,,F,Y,,,20201222.0,,HP,DE,DE,2020,Q4,Elderly
186499821,18649982,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,DE-ADRED-06119-01,NVSC2020DE332297,NOVARTIS,,80.0,YR,,F,Y,,,20201222.0,,HP,DE,DE,2020,Q4,Elderly
186499821,18649982,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MG, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2020,Q4,Pallor,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,DE-ADRED-06119-01,NVSC2020DE332297,NOVARTIS,,80.0,YR,,F,Y,,,20201222.0,,HP,DE,DE,2020,Q4,Elderly
186503391,18650339,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",179.042,DF,U,,,,,1.0,DF,,QD,2020,Q4,Dysphagia,,2020,Q4,1,I,20201122.0,20201214.0,20201222,20201222,EXP,GB-MHRA-TPP334501C5826079YC1606392125711,NVSC2020GB332162,NOVARTIS,,53.0,YR,,F,Y,95.0,KG,20201222.0,,HP,GB,GB,2020,Q4,Adult
186503391,18650339,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",179.042,DF,U,,,,,1.0,DF,,QD,2020,Q4,Oropharyngeal pain,,2020,Q4,1,I,20201122.0,20201214.0,20201222,20201222,EXP,GB-MHRA-TPP334501C5826079YC1606392125711,NVSC2020GB332162,NOVARTIS,,53.0,YR,,F,Y,95.0,KG,20201222.0,,HP,GB,GB,2020,Q4,Adult
186503391,18650339,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",179.042,DF,U,,,,,1.0,DF,,QD,2020,Q4,Swelling,,2020,Q4,1,I,20201122.0,20201214.0,20201222,20201222,EXP,GB-MHRA-TPP334501C5826079YC1606392125711,NVSC2020GB332162,NOVARTIS,,53.0,YR,,F,Y,95.0,KG,20201222.0,,HP,GB,GB,2020,Q4,Adult
186503391,18650339,8,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"1 DF, QD",179.042,DF,U,,,,,1.0,DF,,QD,2020,Q4,Tachycardia,,2020,Q4,1,I,20201122.0,20201214.0,20201222,20201222,EXP,GB-MHRA-TPP334501C5826079YC1606392125711,NVSC2020GB332162,NOVARTIS,,53.0,YR,,F,Y,95.0,KG,20201222.0,,HP,GB,GB,2020,Q4,Adult
186521351,18652135,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Anaemia,,2020,Q4,1,I,,20201210.0,20201223,20201223,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10470,LUPIN,,80.0,YR,,F,Y,,,20201223.0,,CN,NL,DE,2020,Q4,Elderly
186521351,18652135,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201210.0,20201223,20201223,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10470,LUPIN,,80.0,YR,,F,Y,,,20201223.0,,CN,NL,DE,2020,Q4,Elderly
186521351,18652135,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201210.0,20201223,20201223,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10470,LUPIN,,80.0,YR,,F,Y,,,20201223.0,,CN,NL,DE,2020,Q4,Elderly
186521351,18652135,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201210.0,20201223,20201223,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10470,LUPIN,,80.0,YR,,F,Y,,,20201223.0,,CN,NL,DE,2020,Q4,Elderly
186521351,18652135,14,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2020,Q4,Pallor,,2020,Q4,1,I,,20201210.0,20201223,20201223,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10470,LUPIN,,80.0,YR,,F,Y,,,20201223.0,,CN,NL,DE,2020,Q4,Elderly
186524991,18652499,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,WITHDRAWN,,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186524991,18652499,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,WITHDRAWN,,,,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186524991,18652499,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,WITHDRAWN,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186524991,18652499,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,WITHDRAWN,,,,,,,,,,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186524991,18652499,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Oral,WITHDRAWN,,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Arthralgia,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Back pain,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Balanoposthitis,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Blood glucose abnormal,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Diabetes mellitus,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Dizziness,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Dysuria,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Emotional distress,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Erectile dysfunction,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Fall,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Fatigue,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Flank pain,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Gastrointestinal disorder,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Groin pain,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Haematoma,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Headache,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Herpes zoster,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Hypoaesthesia,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Incontinence,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Leukocyturia,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Loss of libido,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Malaise,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Nausea,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Osteoarthritis,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Pain in extremity,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Peripheral coldness,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Phimosis,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Plantar fasciitis,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Pollakiuria,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Pruritus,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Quality of life decreased,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Renal cyst,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Restlessness,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Sacroiliac joint dysfunction,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Stress urinary incontinence,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Urinary tract infection bacterial,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186551341,18655134,20,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, QD (1-0-0-0), IN MORNING",,,U,,,,,,,TABLET,QD,2020,Q4,Urine flow decreased,,2020,Q4,1,I,20140414.0,20200515.0,20201223,20201223,EXP,,NVSC2020DE337118,NOVARTIS,,65.0,YR,,M,Y,134.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186565831,18656583,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Aggression,,2020,Q4,1,I,20200710.0,20201216.0,20201224,20201224,EXP,,GB-AUROBINDO-AUR-APL-2020-062380,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20201224.0,,CN,GB,GB,2020,Q4,Elderly
186565831,18656583,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Anger,,2020,Q4,1,I,20200710.0,20201216.0,20201224,20201224,EXP,,GB-AUROBINDO-AUR-APL-2020-062380,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20201224.0,,CN,GB,GB,2020,Q4,Elderly
186565831,18656583,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,20200710.0,20201216.0,20201224,20201224,EXP,,GB-AUROBINDO-AUR-APL-2020-062380,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20201224.0,,CN,GB,GB,2020,Q4,Elderly
186565831,18656583,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Mood altered,,2020,Q4,1,I,20200710.0,20201216.0,20201224,20201224,EXP,,GB-AUROBINDO-AUR-APL-2020-062380,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20201224.0,,CN,GB,GB,2020,Q4,Elderly
186565831,18656583,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Personality change,,2020,Q4,1,I,20200710.0,20201216.0,20201224,20201224,EXP,,GB-AUROBINDO-AUR-APL-2020-062380,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20201224.0,,CN,GB,GB,2020,Q4,Elderly
186565831,18656583,4,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Tachyphrenia,,2020,Q4,1,I,20200710.0,20201216.0,20201224,20201224,EXP,,GB-AUROBINDO-AUR-APL-2020-062380,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20201224.0,,CN,GB,GB,2020,Q4,Elderly
186566641,18656664,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"5 MG, EVERY 12 HOURS",,,,,,,,5.0,MG,,Q12H,2020,Q4,Pancreatic neuroendocrine tumour,,2020,Q4,1,I,20190705.0,20201218.0,20201223,20201223,EXP,ES-AEMPS-702575,ES-009507513-2012ESP009276,MERCK,,51.0,YR,,F,Y,80.0,KG,20201223.0,,PH,ES,ES,2020,Q4,Adult
186598631,18659863,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0, TABLETS",,,,,,,,,,TABLET,,2020,Q4,Asthenia,,2020,Q4,1,I,,20201215.0,20201224,20201224,EXP,DE-BFARM-20013493,DE-ACCORD-212137,ACCORD,,63.0,YR,A,M,Y,,,20201224.0,,MD,DE,DE,2020,Q4,Adult
186598631,18659863,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0, TABLETS",,,,,,,,,,TABLET,,2020,Q4,Circulatory collapse,,2020,Q4,1,I,,20201215.0,20201224,20201224,EXP,DE-BFARM-20013493,DE-ACCORD-212137,ACCORD,,63.0,YR,A,M,Y,,,20201224.0,,MD,DE,DE,2020,Q4,Adult
186598631,18659863,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0, TABLETS",,,,,,,,,,TABLET,,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201215.0,20201224,20201224,EXP,DE-BFARM-20013493,DE-ACCORD-212137,ACCORD,,63.0,YR,A,M,Y,,,20201224.0,,MD,DE,DE,2020,Q4,Adult
186598631,18659863,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0, TABLETS",,,,,,,,,,TABLET,,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201215.0,20201224,20201224,EXP,DE-BFARM-20013493,DE-ACCORD-212137,ACCORD,,63.0,YR,A,M,Y,,,20201224.0,,MD,DE,DE,2020,Q4,Adult
186598631,18659863,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0, TABLETS",,,,,,,,,,TABLET,,2020,Q4,Headache,,2020,Q4,1,I,,20201215.0,20201224,20201224,EXP,DE-BFARM-20013493,DE-ACCORD-212137,ACCORD,,63.0,YR,A,M,Y,,,20201224.0,,MD,DE,DE,2020,Q4,Adult
186598631,18659863,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0, TABLETS",,,,,,,,,,TABLET,,2020,Q4,Hypotension,,2020,Q4,1,I,,20201215.0,20201224,20201224,EXP,DE-BFARM-20013493,DE-ACCORD-212137,ACCORD,,63.0,YR,A,M,Y,,,20201224.0,,MD,DE,DE,2020,Q4,Adult
186643111,18664311,13,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q4,Anaemia,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860873,TEVA,,80.0,YR,E,F,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Elderly
186643111,18664311,13,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860873,TEVA,,80.0,YR,E,F,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Elderly
186643111,18664311,13,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860873,TEVA,,80.0,YR,E,F,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Elderly
186643111,18664311,13,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860873,TEVA,,80.0,YR,E,F,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Elderly
186643111,18664311,13,C,Empagliflozin,EMPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,,QD,2020,Q4,Pallor,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860873,TEVA,,80.0,YR,E,F,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Elderly
186643651,18664365,14,C,empagliflozin,EMPAGLIFLOZIN,1,,25 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,25.0,MG,,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643651,18664365,14,C,empagliflozin,EMPAGLIFLOZIN,1,,25 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,25.0,MG,,QD,2020,Q4,Dizziness,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643651,18664365,14,C,empagliflozin,EMPAGLIFLOZIN,1,,25 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,25.0,MG,,QD,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643651,18664365,14,C,empagliflozin,EMPAGLIFLOZIN,1,,25 MILLIGRAM DAILY;  1-0-0-0,,,,,,,,25.0,MG,,QD,2020,Q4,Fall,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186650251,18665025,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,,2020,Q4,Myalgia,,2020,Q4,1,I,,20201215.0,20201225,20201225,EXP,GB-MHRA-EYC 00233766,GB-TORRENT-00024594,TORRENT,,51.0,YR,A,M,Y,101.0,KG,20201225.0,,CN,GB,GB,2020,Q4,Adult
186650251,18665025,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,,20201215.0,20201225,20201225,EXP,GB-MHRA-EYC 00233766,GB-TORRENT-00024594,TORRENT,,51.0,YR,A,M,Y,101.0,KG,20201225.0,,CN,GB,GB,2020,Q4,Adult
186650251,18665025,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,U,,,,,25.0,MG,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201215.0,20201225,20201225,EXP,GB-MHRA-EYC 00233766,GB-TORRENT-00024594,TORRENT,,51.0,YR,A,M,Y,101.0,KG,20201225.0,,CN,GB,GB,2020,Q4,Adult
186662631,18666263,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Aggression,,2020,Q4,1,I,20200710.0,20201218.0,20201226,20201226,EXP,GB-MHRA-EYC 00234802,NVSC2020GB339327,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20201226.0,,HP,GB,GB,2020,Q4,Elderly
186662631,18666263,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Anger,,2020,Q4,1,I,20200710.0,20201218.0,20201226,20201226,EXP,GB-MHRA-EYC 00234802,NVSC2020GB339327,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20201226.0,,HP,GB,GB,2020,Q4,Elderly
186662631,18666263,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,20200710.0,20201218.0,20201226,20201226,EXP,GB-MHRA-EYC 00234802,NVSC2020GB339327,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20201226.0,,HP,GB,GB,2020,Q4,Elderly
186662631,18666263,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Mood altered,,2020,Q4,1,I,20200710.0,20201218.0,20201226,20201226,EXP,GB-MHRA-EYC 00234802,NVSC2020GB339327,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20201226.0,,HP,GB,GB,2020,Q4,Elderly
186662631,18666263,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Personality change,,2020,Q4,1,I,20200710.0,20201218.0,20201226,20201226,EXP,GB-MHRA-EYC 00234802,NVSC2020GB339327,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20201226.0,,HP,GB,GB,2020,Q4,Elderly
186662631,18666263,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Tachyphrenia,,2020,Q4,1,I,20200710.0,20201218.0,20201226,20201226,EXP,GB-MHRA-EYC 00234802,NVSC2020GB339327,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20201226.0,,HP,GB,GB,2020,Q4,Elderly
186667341,18666734,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Aggression,,2020,Q4,1,I,20200710.0,20201218.0,20201227,20201227,EXP,GB-MHRA-EYC 00234802,GB-BAUSCH-BL-2020-038292,BAUSCH AND LOMB,,65.0,YR,,M,Y,90.0,KG,20201228.0,,CN,GB,GB,2020,Q4,Elderly
186667341,18666734,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Anger,,2020,Q4,1,I,20200710.0,20201218.0,20201227,20201227,EXP,GB-MHRA-EYC 00234802,GB-BAUSCH-BL-2020-038292,BAUSCH AND LOMB,,65.0,YR,,M,Y,90.0,KG,20201228.0,,CN,GB,GB,2020,Q4,Elderly
186667341,18666734,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,20200710.0,20201218.0,20201227,20201227,EXP,GB-MHRA-EYC 00234802,GB-BAUSCH-BL-2020-038292,BAUSCH AND LOMB,,65.0,YR,,M,Y,90.0,KG,20201228.0,,CN,GB,GB,2020,Q4,Elderly
186667341,18666734,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Mood altered,,2020,Q4,1,I,20200710.0,20201218.0,20201227,20201227,EXP,GB-MHRA-EYC 00234802,GB-BAUSCH-BL-2020-038292,BAUSCH AND LOMB,,65.0,YR,,M,Y,90.0,KG,20201228.0,,CN,GB,GB,2020,Q4,Elderly
186667341,18666734,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Personality change,,2020,Q4,1,I,20200710.0,20201218.0,20201227,20201227,EXP,GB-MHRA-EYC 00234802,GB-BAUSCH-BL-2020-038292,BAUSCH AND LOMB,,65.0,YR,,M,Y,90.0,KG,20201228.0,,CN,GB,GB,2020,Q4,Elderly
186667341,18666734,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Tachyphrenia,,2020,Q4,1,I,20200710.0,20201218.0,20201227,20201227,EXP,GB-MHRA-EYC 00234802,GB-BAUSCH-BL-2020-038292,BAUSCH AND LOMB,,65.0,YR,,M,Y,90.0,KG,20201228.0,,CN,GB,GB,2020,Q4,Elderly
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Akinesia,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Decreased appetite,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Ejection fraction decreased,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Hepatic steatosis,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Iron deficiency anaemia,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Mitral valve incompetence,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Oedema peripheral,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Peripheral swelling,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Polyarthritis,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Ventricular hypokinesia,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Weight decreased,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186668831,18666883,7,C,Empagliflozin,EMPAGLIFLOZIN,1,Unknown,"20 MILLIGRAM, DAILY (10 MG, BID)",,,Y,,,,,20.0,MG,,,2020,Q4,Weight increased,,2020,Q4,1,I,2016.0,20201218.0,20201228,20201228,EXP,,PL-AUROBINDO-AUR-APL-2020-062744,AUROBINDO,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186711521,18671152,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-04739-08,DE-TORRENT-00019251,TORRENT,,64.0,YR,A,F,Y,88.0,KG,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711521,18671152,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-04739-08,DE-TORRENT-00019251,TORRENT,,64.0,YR,A,F,Y,88.0,KG,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711521,18671152,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-04739-08,DE-TORRENT-00019251,TORRENT,,64.0,YR,A,F,Y,88.0,KG,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711521,18671152,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,,,,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-04739-08,DE-TORRENT-00019251,TORRENT,,64.0,YR,A,F,Y,88.0,KG,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711521,18671152,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-04739-08,DE-TORRENT-00019251,TORRENT,,64.0,YR,A,F,Y,88.0,KG,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,13,C,empagliflozin,EMPAGLIFLOZIN,1,,"25 MG, 1-0-0-0",,,U,,,,,25.0,MG,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,13,C,empagliflozin,EMPAGLIFLOZIN,1,,"25 MG, 1-0-0-0",,,U,,,,,25.0,MG,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,13,C,empagliflozin,EMPAGLIFLOZIN,1,,"25 MG, 1-0-0-0",,,U,,,,,25.0,MG,,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,13,C,empagliflozin,EMPAGLIFLOZIN,1,,"25 MG, 1-0-0-0",,,U,,,,,25.0,MG,,,2020,Q4,Fall,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711631,18671163,12,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06119-01,DE-TORRENT-00019242,TORRENT,,80.0,YR,E,F,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Elderly
186711631,18671163,12,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06119-01,DE-TORRENT-00019242,TORRENT,,80.0,YR,E,F,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Elderly
186711631,18671163,12,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06119-01,DE-TORRENT-00019242,TORRENT,,80.0,YR,E,F,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Elderly
186711631,18671163,12,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06119-01,DE-TORRENT-00019242,TORRENT,,80.0,YR,E,F,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Elderly
186711631,18671163,12,C,Empagliflozin,EMPAGLIFLOZIN,1,,"10 MG, 1-0-0-0",,,U,,,,,10.0,MG,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06119-01,DE-TORRENT-00019242,TORRENT,,80.0,YR,E,F,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Elderly
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Akinesia,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Cardiac failure,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Decreased appetite,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Ejection fraction decreased,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Hepatic steatosis,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Iron deficiency anaemia,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Mitral valve incompetence,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Oedema peripheral,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Peripheral swelling,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Polyarthritis,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Ventricular hypokinesia,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Weight decreased,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186712111,18671211,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"20 MG, 1X/DAY",,,,, UNKNOWN,,,20.0,MG,,QD,2020,Q4,Weight increased,,2020,Q4,1,I,2016.0,20201222.0,20201228,20201228,EXP,,PL-PFIZER INC-2020507098,PFIZER,,55.0,YR,,M,Y,,,20201228.0,,MD,PL,PL,2020,Q4,Adult
186720341,18672034,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Gastroenteritis,,2020,Q4,1,I,20201209.0,20201221.0,20201228,20201228,EXP,GB-MHRA-EYC 00234979,GB-ELI_LILLY_AND_COMPANY-GB202012011044,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20201228.0,,HP,GB,GB,2020,Q4,Adult
186720341,18672034,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,20201209.0,20201221.0,20201228,20201228,EXP,GB-MHRA-EYC 00234979,GB-ELI_LILLY_AND_COMPANY-GB202012011044,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20201228.0,,HP,GB,GB,2020,Q4,Adult
186736491,18673649,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNK,,,,,,,2020,Q4,Aggression,,2020,Q4,1,I,20200710.0,20201222.0,20201229,20201229,EXP,GB-MHRA-ADR 24541237,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-002319,EMCURE,,65.0,YR,,M,Y,90.0,KG,20201229.0,,CN,GB,GB,2020,Q4,Elderly
186736491,18673649,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNK,,,,,,,2020,Q4,Anger,,2020,Q4,1,I,20200710.0,20201222.0,20201229,20201229,EXP,GB-MHRA-ADR 24541237,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-002319,EMCURE,,65.0,YR,,M,Y,90.0,KG,20201229.0,,CN,GB,GB,2020,Q4,Elderly
186736491,18673649,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNK,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,20200710.0,20201222.0,20201229,20201229,EXP,GB-MHRA-ADR 24541237,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-002319,EMCURE,,65.0,YR,,M,Y,90.0,KG,20201229.0,,CN,GB,GB,2020,Q4,Elderly
186736491,18673649,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNK,,,,,,,2020,Q4,Mood altered,,2020,Q4,1,I,20200710.0,20201222.0,20201229,20201229,EXP,GB-MHRA-ADR 24541237,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-002319,EMCURE,,65.0,YR,,M,Y,90.0,KG,20201229.0,,CN,GB,GB,2020,Q4,Elderly
186736491,18673649,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNK,,,,,,,2020,Q4,Personality change,,2020,Q4,1,I,20200710.0,20201222.0,20201229,20201229,EXP,GB-MHRA-ADR 24541237,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-002319,EMCURE,,65.0,YR,,M,Y,90.0,KG,20201229.0,,CN,GB,GB,2020,Q4,Elderly
186736491,18673649,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNK,,,,,,,2020,Q4,Tachyphrenia,,2020,Q4,1,I,20200710.0,20201222.0,20201229,20201229,EXP,GB-MHRA-ADR 24541237,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-002319,EMCURE,,65.0,YR,,M,Y,90.0,KG,20201229.0,,CN,GB,GB,2020,Q4,Elderly
186763781,18676378,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,ABGESETZT (),,,U,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-273148,RANBAXY,,64.0,YR,,F,Y,88.0,KG,20201229.0,,HP,NL,DE,2020,Q4,Adult
186763781,18676378,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,ABGESETZT (),,,U,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-273148,RANBAXY,,64.0,YR,,F,Y,88.0,KG,20201229.0,,HP,NL,DE,2020,Q4,Adult
186763781,18676378,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,ABGESETZT (),,,U,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-273148,RANBAXY,,64.0,YR,,F,Y,88.0,KG,20201229.0,,HP,NL,DE,2020,Q4,Adult
186763781,18676378,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,ABGESETZT (),,,U,,,,,,,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-273148,RANBAXY,,64.0,YR,,F,Y,88.0,KG,20201229.0,,HP,NL,DE,2020,Q4,Adult
186763781,18676378,9,C,Empagliflozin,EMPAGLIFLOZIN,1,Oral,ABGESETZT (),,,U,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-273148,RANBAXY,,64.0,YR,,F,Y,88.0,KG,20201229.0,,HP,NL,DE,2020,Q4,Adult
186771371,18677137,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,25 MILLIGRAM,,,,,,,,25.0,MG,,,2020,Q4,Myalgia,,2020,Q4,1,I,,20201214.0,20201229,20201229,EXP,GB-MHRA-EYC 00233766,GB-MYLANLABS-2020M1104251,MYLAN,,51.0,YR,,M,Y,101.6,KG,20201229.0,,CN,GB,GB,2020,Q4,Adult
186771371,18677137,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,25 MILLIGRAM,,,,,,,,25.0,MG,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,,20201214.0,20201229,20201229,EXP,GB-MHRA-EYC 00233766,GB-MYLANLABS-2020M1104251,MYLAN,,51.0,YR,,M,Y,101.6,KG,20201229.0,,CN,GB,GB,2020,Q4,Adult
186771371,18677137,4,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,25 MILLIGRAM,,,,,,,,25.0,MG,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201214.0,20201229,20201229,EXP,GB-MHRA-EYC 00233766,GB-MYLANLABS-2020M1104251,MYLAN,,51.0,YR,,M,Y,101.6,KG,20201229.0,,CN,GB,GB,2020,Q4,Adult
186774841,18677484,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,DE-ADRED-06119-01,DE-VALIDUS PHARMACEUTICALS LLC-DE-2020VAL001079,VALIDUS,,80.0,YR,,F,Y,,,20201229.0,,MD,DE,DE,2020,Q4,Elderly
186774841,18677484,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,DE-ADRED-06119-01,DE-VALIDUS PHARMACEUTICALS LLC-DE-2020VAL001079,VALIDUS,,80.0,YR,,F,Y,,,20201229.0,,MD,DE,DE,2020,Q4,Elderly
186774841,18677484,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,DE-ADRED-06119-01,DE-VALIDUS PHARMACEUTICALS LLC-DE-2020VAL001079,VALIDUS,,80.0,YR,,F,Y,,,20201229.0,,MD,DE,DE,2020,Q4,Elderly
186774841,18677484,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q4,Haematochezia,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,DE-ADRED-06119-01,DE-VALIDUS PHARMACEUTICALS LLC-DE-2020VAL001079,VALIDUS,,80.0,YR,,F,Y,,,20201229.0,,MD,DE,DE,2020,Q4,Elderly
186774841,18677484,13,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201215.0,20201229,20201229,EXP,DE-ADRED-06119-01,DE-VALIDUS PHARMACEUTICALS LLC-DE-2020VAL001079,VALIDUS,,80.0,YR,,F,Y,,,20201229.0,,MD,DE,DE,2020,Q4,Elderly
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Akinesia,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Cardiac failure,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Decreased appetite,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Ejection fraction decreased,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Hepatic steatosis,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Iron deficiency anaemia,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Mitral valve incompetence,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Oedema peripheral,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Peripheral swelling,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Polyarthritis,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Ventricular hypokinesia,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Weight decreased,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186834111,18683411,7,C,Empagliflozin,EMPAGLIFLOZIN,1,,20 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,BID,2020,Q4,Weight increased,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-TEVA-2020-PL-1864597,TEVA,,55.0,YR,A,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Akinesia,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Cardiac failure,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Decreased appetite,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Ejection fraction decreased,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Hepatic steatosis,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Iron deficiency anaemia,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Mitral valve incompetence,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Oedema peripheral,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Peripheral swelling,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Polyarthritis,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Ventricular hypokinesia,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Weight decreased,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186838021,18683802,7,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,BID,2020,Q4,Weight increased,,2020,Q4,1,I,2016.0,20201222.0,20201230,20201230,EXP,,PL-ASTRAZENECA-2020SF72053,ASTRAZENECA,,55.0,YR,,M,Y,,,20201230.0,,MD,PL,PL,2020,Q4,Adult
186842081,18684208,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Aggression,,2020,Q4,1,I,20200710.0,20201222.0,20201230,20201230,EXP,GB-MHRA-EYC 00234802,GB-TEVA-2020-GB-1862918,TEVA,,65.0,YR,E,M,Y,90.0,KG,20201230.0,,CN,GB,GB,2020,Q4,Elderly
186842081,18684208,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Anger,,2020,Q4,1,I,20200710.0,20201222.0,20201230,20201230,EXP,GB-MHRA-EYC 00234802,GB-TEVA-2020-GB-1862918,TEVA,,65.0,YR,E,M,Y,90.0,KG,20201230.0,,CN,GB,GB,2020,Q4,Elderly
186842081,18684208,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,20200710.0,20201222.0,20201230,20201230,EXP,GB-MHRA-EYC 00234802,GB-TEVA-2020-GB-1862918,TEVA,,65.0,YR,E,M,Y,90.0,KG,20201230.0,,CN,GB,GB,2020,Q4,Elderly
186842081,18684208,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Mood altered,,2020,Q4,1,I,20200710.0,20201222.0,20201230,20201230,EXP,GB-MHRA-EYC 00234802,GB-TEVA-2020-GB-1862918,TEVA,,65.0,YR,E,M,Y,90.0,KG,20201230.0,,CN,GB,GB,2020,Q4,Elderly
186842081,18684208,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Personality change,,2020,Q4,1,I,20200710.0,20201222.0,20201230,20201230,EXP,GB-MHRA-EYC 00234802,GB-TEVA-2020-GB-1862918,TEVA,,65.0,YR,E,M,Y,90.0,KG,20201230.0,,CN,GB,GB,2020,Q4,Elderly
186842081,18684208,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Tachyphrenia,,2020,Q4,1,I,20200710.0,20201222.0,20201230,20201230,EXP,GB-MHRA-EYC 00234802,GB-TEVA-2020-GB-1862918,TEVA,,65.0,YR,E,M,Y,90.0,KG,20201230.0,,CN,GB,GB,2020,Q4,Elderly
186868181,18686818,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Aggression,,2020,Q4,1,I,20200710.0,20201221.0,20201231,20201231,EXP,GB-MHRA-EYC 00234802,GB-EMD SERONO-E2B_90081802,EMD SERONO INC,,65.0,YR,E,M,Y,90.0,KG,20201231.0,,CN,GB,GB,2020,Q4,Elderly
186868181,18686818,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Anger,,2020,Q4,1,I,20200710.0,20201221.0,20201231,20201231,EXP,GB-MHRA-EYC 00234802,GB-EMD SERONO-E2B_90081802,EMD SERONO INC,,65.0,YR,E,M,Y,90.0,KG,20201231.0,,CN,GB,GB,2020,Q4,Elderly
186868181,18686818,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,20200710.0,20201221.0,20201231,20201231,EXP,GB-MHRA-EYC 00234802,GB-EMD SERONO-E2B_90081802,EMD SERONO INC,,65.0,YR,E,M,Y,90.0,KG,20201231.0,,CN,GB,GB,2020,Q4,Elderly
186868181,18686818,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Mood altered,,2020,Q4,1,I,20200710.0,20201221.0,20201231,20201231,EXP,GB-MHRA-EYC 00234802,GB-EMD SERONO-E2B_90081802,EMD SERONO INC,,65.0,YR,E,M,Y,90.0,KG,20201231.0,,CN,GB,GB,2020,Q4,Elderly
186868181,18686818,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Personality change,,2020,Q4,1,I,20200710.0,20201221.0,20201231,20201231,EXP,GB-MHRA-EYC 00234802,GB-EMD SERONO-E2B_90081802,EMD SERONO INC,,65.0,YR,E,M,Y,90.0,KG,20201231.0,,CN,GB,GB,2020,Q4,Elderly
186868181,18686818,2,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,,,,,,,,,,,,,,2020,Q4,Tachyphrenia,,2020,Q4,1,I,20200710.0,20201221.0,20201231,20201231,EXP,GB-MHRA-EYC 00234802,GB-EMD SERONO-E2B_90081802,EMD SERONO INC,,65.0,YR,E,M,Y,90.0,KG,20201231.0,,CN,GB,GB,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Anxiety,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Arthralgia,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Basal cell carcinoma,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Blood pressure diastolic decreased,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Blood pressure increased,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Cataract,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Cough,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Dyspepsia,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Gastrooesophageal reflux disease,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Malaise,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Nasal congestion,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Nasopharyngitis,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Pancreatic carcinoma,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Pyrexia,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Second primary malignancy,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
946404947,9464049,9,C,EMPAGLIFLOZIN,EMPAGLIFLOZIN,1,Unknown,"25 MG, QD",,,U,,,,,25.0,MG,,QD,2020,Q4,Skin mass,,2020,Q4,47,F,20141127.0,20201217.0,20130819,20201229,EXP,,PHHY2013CA085730,NOVARTIS,,67.0,YR,,M,Y,,,20201229.0,,MD,CA,CA,2020,Q4,Elderly
